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Abstract 
Telomeres are present at the ends of most eukaryotic chromosomes and are bound by 
specialized telomere ‘capping’ proteins, preventing them from initiating a DNA 
Damage Response and cell cycle arrest analogous to that triggered by DNA Double 
Strand Breaks (DSBs). Resection of ‘uncapped’ telomeres and DSBs to generate 
extensive single-stranded DNA (ssDNA) is one of the most upstream events in this 
DDR, but while the nuclease activities that resect DSBs are well-defined, only a single 
nuclease, Exo1, is known to function at uncapped telomeres. 
This work establishes that the helicase Pif1, is required for a nuclease activity that 
resects uncapped telomeres in a parallel pathway to one defined by Exo1, Rad27 (Flap 
Endonuclease 1) and Rad24 (the 9-1-1 clamp loader). Following inactivation of the 
essential telomere capping protein Cdc13, Pif1 is shown to resect telomeres 
independently of Exo1 close to the chromosome end, but to play a less-crucial role in 
extensive resection. Furthermore, elimination of both Pif1 and Exo1 prevents the 
accumulation of ssDNA, thus eliminating the DDR at uncapped telomeres. Although 
Pif1 has no role in the resection of DSBs and has primarily been studied as a negative 
regulator of telomerase, it is shown to contribute to the DDR at uncapped telomeres in 
cells lacking telomerase and also to be crucial for telomere maintenance in telomerase-
deficient cells. 
Cdc13 inhibits the DDR at uncapped telomeres and is believed to be required for 
telomerase recruitment. Astonishingly, elimination of Pif1 and Exo1 permits the 
viability of cells lacking Cdc13 and cdc13∆ exo1∆ pif1∆ mutants maintain and 
lengthen their telomeres over time, in a manner dependent on Ku, Rad52 and 
telomerase. Thus, Cdc13 is not a requirement for telomerase recruitment and 
elimination of the nuclease activities that function at uncapped telomeres can by pass 
the requirement for otherwise-essential telomere capping proteins. 
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Budding yeast genetic nomenclature 
CDC13 is a gene, encoding the protein Cdc13 (or Cdc13p). cdc13-1 is a mutant allele 
of CDC13 encoding the mutant protein Cdc13-1 (Garvik et al., 1995). It is possible to 
delete CDC13 from the yeast genome, resulting in the null mutation cdc13∆ and 
preventing Cdc13 being produced (Larrivee and Wellinger, 2006, Petreaca et al., 2006, 
Zubko and Lydall, 2006).  
TLC1 encodes the RNA subunit of telomerase TLC1, which is not transcribed to 
produce a protein (Singer and Gottschling, 1994). 
The protein Pif1 exists as mitochondrial and nuclear isoforms produced by 
transcription of the gene PIF1 from beginning at either the first methionine (m1) or 
second methionine (m2), respectively (Schulz and Zakian, 1994). pif1-m2 is mutated at 
the second methionine in the PIF1 open reading frame and produces only the 
mitochondrial form of Pif1, while pif1-m1 is mutated at the first methionine in the PIF1 
open reading frame and produces only nuclear Pif1. pif1-m1 encodes the protein Pif1-
m1 (the nuclear form) while pif1-m2 encodes the protein Pif1-m2 (the mitochondrial 
form) (Boule et al., 2005). 
1 
3’ G-strand replication by lagging strand machinery
!"
#"$
%
%
5’ C-strand replication by leading strand machinery
!"
#"$
!"
!"
#"
#"
S. cerevisiae
H. sapiens
ssDNAdsDNA
TRF1TRF2 POT1
Telomerase
DDR
Ageing
Cancer
!"
#"
#"
!"
Rap1 Cdc13-Stn1-Ten1 (CST)
&
'
RAP1
TIN2 TPP1
Rif2Rif1
KU
yKu
2 
 
Figure 1: Telomeres permit maintenance of terminal chromosomal sequences 
A. The DNA at chromosome ends is replicated unidirectionally and the lagging strand is 
not able to replicate all the way to the chromosome end, resulting in sequence loss 
following each mitosis. Illustrated are the replication products (blue arrows) of a single 
leading and lagging strand telomere, of a single chromosome from a single cell. 
B. Telomeres are nucleoprotein caps present at the ends of most eukaryotic 
chromosomes, consisting of dsDNA with a ssDNA overhang, bound by dsDNA- and 
ssDNA-binding proteins. Collectively, the telomere binding proteins ‘cap’ the telomere 
and serve to regulate telomerase activity and inhibit the DDR, posing a barrier to cancer 
and cellular ageing, respectively. In budding yeast the telomeric dsDNA is bound by 
Rap1, which recruits the accessory factors Rif1 and Rif2. In humans the telomeric 
dsDNA is bound by TRF1 and TRF2 (held together by TIN2) and TRF2 recruits RAP1 
to telomeres. In budding yeast, Cdc13 binds the telomeric ssDNA and recruits Stn1 and 
Ten1 to form the CST complex, while in humans the telomeric ssDNA is bound by 
POT1. In human beings, POT1 and TRF1-TRF2-TIN2 are linked together by TPP1, 
which may permit the adoption of higher-order structures. In both budding yeast and 
humans, the Ku complex, a DDR component that binds to both telomeres and DSBs, 
also binds and plays a protective role. Model based on data discussed in Section 1.3. 
 
3 
1 Introduction 
“Humans are a good model organism for studying yeast” 
- Steve Elledge 
1.1 The end replication problem 
Eukaryotes possess linear chromosomes and replicate their DNA bidirectionally, from 
internal origins. Thus, synthesis from the terminal origin of replication to the end of the 
chromosome will result in unreplicated DNA at the end of the lagging strand as the 
replication machinery will, at the very least, be unable to replicate the region of the 
template strand occupied by the terminal Okazaki fragment primer (approximately 8-12 
bases) (Waga and Stillman, 1998). This is termed ‘the end replication problem’ and has 
the consequence that ends of chromosomes will lose terminal sequences with each cell 
division, ultimately guaranteeing that loss of viability will occur when the sequence loss 
reaches an essential gene (Olovnikov, 1971, Watson, 1972). Thus, a special mechanism 
of DNA replication is required at the chromosomal terminus in order for chromosomes 
to be maintained (Figure 1A). 
The shortening caused by the end replication problem is likely to be much greater than 
the theoretical minimum for two reasons. First, on the lagging strand, approximately 30 
bases of RNA-DNA synthesized by Polymerase α are actually required to prime 
Okazaki fragment synthesis, and loss of even this theoretical minimum will only occur 
if the terminal Okazaki fragment can be primed from the very end of the chromosome 
(Waga and Stillman, 1998). If the distance between the sub-terminal Okazaki fragment 
and the chromosome end is too great to facilitate priming at very end of the 
chromosome, then the terminal Okazaki fragment will need to be primed away from the 
chromosome end, in principle leading to sequence loss of up to one Okazaki fragment in 
size (up to approximately 200 bases) (Waga and Stillman, 1998). Second, although 
leading strand replication is usually assumed to proceed to the very end of the 
chromosome, the replication machinery is unlikely to be able to replicate the region of 
the template strand occupied by the replisome itself (approximately 20-40 bases in 
metazoans) (Raschle et al., 2008). Furthermore, both these considerations also fail to 
take into account the nucleolytic processing that might be required of the chromosome 
ends (Dionne and Wellinger, 1996). Thus, a specialized mechanism for the replication 
of chromosome ends is of paramount importance. 
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1.1.1 Telomeres and Telomerase 
Telomeres are specialized nucleoprotein structures that exist at the ends of most 
eukaryotic chromosomes, usually consisting of double-stranded DNA (dsDNA) with a 
3’ single-stranded DNA overhang (ssDNA) (Figure 1A-B) (Blackburn et al., 2006, de 
Lange, 2009, Lydall, 2009). Telomeres contain specific, simple GC-rich repeat 
sequences that are G rich on the 3’ strand (the TG strand) and C-rich on the 5’ strand 
(the AC strand) (Figure 1B). Telomeric repeat sequences function to recruit specialized 
proteins to the telomere that mediate its function and telomeric repeat sequences can 
also be added de novo to the chromosome end by the enzyme telomerase in order to 
counteract telomere shortening caused by the end replication problem. Both the general 
structure and function of telomere structure are conserved, from human beings down to 
the budding yeast Saccharomyces cerevisiae and thus model organisms has been highly 
informative in the study of telomere biology (Figure 1B) (Blackburn et al., 2006).  
Telomerase is a specialized reverse transcriptase, consisting of a catalytic core of a 
RNA template (TERC in mammals, TLC1 in budding yeast) and a catalytic subunit 
(TERT in mammals, Est2 in budding yeast), which is sufficient for telomerase activity 
in vitro (Bianchi and Shore, 2008, Blackburn et al., 2006, de Lange, 2009). In vivo in 
budding yeast, the accessory factors Est1 and Est3 are also required for telomerase 
recruitment to the telomeres (Lendvay et al., 1996, Lingner et al., 1997). 
In budding yeast, it appears that two pathways recruit telomerase to the telomeres. In 
G1, the Ku complex (a DDR component that binds to both telomeres and DSBs) 
recruits the Est2-TLC1 catalytic core to the telomeres in a pathway that promotes 
telomerase activity at telomeres and supports telomere maintenance but is insufficient 
for telomere maintenance (Fisher et al., 2004, Lendvay et al., 1996, Peterson et al., 
2001, Porter et al., 1996). In G2, Cdc13 (a specialized telomere-binding protein that 
binds to telomeric ssDNA) interacts with Est1 to recruit the Est2-TLC1 catalytic core in 
a second pathway that is both necessary and sufficient for telomere maintenance by 
telomerase (Chan et al., 2008, Nugent et al., 1996). The role of Est3 in telomerase 
recruitment is poorly defined, although it likely plays a role in the G2 pathway of 
telomerase recruitment (given that it is required for telomere maintenance) and this may 
occur through interactions with Est1 or Est2 (Friedman et al., 2003, Hughes et al., 2000, 
Lendvay et al., 1996, Osterhage et al., 2006). Though the regulation of telomerase in 
5 
mammalian cells is much less well understood, the telomere-binding protein POT1 may 
have similar roles to Cdc13 in regulating telomerase (Churikov and Price, 2008). 
1.2 The ‘end protection problem’ 
The ends of linear chromosomes resemble one half of a DNA Double Strand Break 
(DSB) and have the potential to be recognized and processed as a DSB (Sandell and 
Zakian, 1993). DSBs initiate a robust cell cycle arrest and are either processed by 
nucleases for repair by homologous recombination (HR) or repaired by Non-
Homologous End Joining (NHEJ) (Harrison and Haber, 2006). Therefore, chromosome 
ends are at risk of preventing cell cycle progression, being degraded or undergoing 
chromosome-chromosome fusion events. This has been termed ‘the end protection 
problem’ in analogy to the ‘end replication problem’ (de Lange, 2009).  
1.2.1 The cellular response to DSBs 
In budding yeast, following the induction of a DSB, DNA ends are either rapidly 
directed towards HR or, where HR is impaired or cannot function, repaired by NHEJ 
(Usui et al., 2001). The initial step in this process is resection to generate ssDNA, the 
presence of which can be considered the stimulus for HR and the absence of which 
(impaired resection) can be considered the stimulus for NHEJ (Usui et al., 2001). The 
presence or absence of an ssDNA intermediate leads to the recruitment of sensor 
kinases (Mec1, Tel1) to the DSB, and the activation of kinase cascades, ultimately 
leading to checkpoint activation, cell cycle arrest and repair of the damage (Usui et al., 
2001, Zou and Elledge, 2003). 
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Figure 2: The DDR at DSBs and uncapped telomeres  
A. At DSBs, resection of blunt ends is initiated by the MRX complex (Mre11-Rad50-
Xrs2) in combination with the nuclease Sae2 to generate the initial overhang and 
extensive resection is carried out by Exo1. A nuclease activity dependent upon the 
helicase Sgs1 and the nuclease Dna2 has partially-overlapping function with both 
MRX/Sae2 and Exo1 and has roles in both generation of the initial overhang and in 
extensive resection. The 9-1-1 complex contributes to resection and is presumed to 
tether either Sgs1/Dna2 or Exo1 or both to the DNA but could possibly promote 
resection by an unidentified nuclease. 3’ ssDNA exposed by resection then stimulates 
checkpoint activation and metaphase arrest dependent upon both the 9-1-1 complex and 
Mec1-Ddc2. (See Section 1.2.2 for detailed discussion). 
B. At telomeres, inactivation of the ssDNA-binding protein Cdc13 leads to resection by 
at least three distinct nuclease activities. Exo1 carries out extensive resection >30kb 
from the chromosome end. ExoX is a hypothetical 9-1-1-dependent nuclease activity 
involved in resection >15kb from the chromosome end and which is inhibited by Rad9 
and causes extensive (>30kb) resection of uncapped telomeres when Rad9 is eliminated. 
ExoY is a hypothetical nuclease believed to function independently of Exo1 and ExoX 
>5kb from the chromosome end. Exposed telomeric ssDNA then stimulates checkpoint 
activation and metaphase arrest dependent upon both the 9-1-1 complex and Mec1-
Ddc2. (See Section 1.3.1 for detailed discussion).  
C. At telomeres, inactivation of the Ku complex leads to resection >0.6kb from the 
chromosome end by Exo1. Elimination of Rad9 causes resection >8.5kb from the 
chromosome end and thus Rad9 is believed to inhibit Exo1. Exposed telomeric ssDNA 
triggers checkpoint activation and metaphase arrest dependent upon Mec1-Ddc2 but not 
the 9-1-1 complex. Thicker arrows represent pathways more important for arrest. 
Checkpoint activation is primarily dependent upon Chk1, though the kinases Rad53 and 
Mad2 also function. (See Section 1.3.2 for detailed discussion). 
D. At telomeres, inactivation of Rap1 leads to resection primarily by Exo1. In the 
absence of Exo1, resection is carried out by another nuclease that appears to be 
inhibited by Exo1 and is likely to be dependent upon MRX. Cells accumulate in G1 
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following inactivation of Rap1 but the stimulus and transduction pathway behind this 
cell cycle defect are unknown. (See Section 1.3.3 for detailed discussion). 
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1.2.2 Resection 
The initial nuclease activity that functions at DSBs is dependent upon the MRX 
complex (Mre11-Xrs2-Rad50) and the nuclease Sae2 (Ivanov et al., 1994, Lee et al., 
1998b, Mimitou and Symington, 2008). Sae2 appears to create small, step-wise cuts on 
the 5’ strand to generate 50-100 nucleotide overhangs of 3’ ssDNA (Mimitou and 
Symington, 2008). Short ssDNA overhangs generated by Sae2/MRX appear to be 
processed by a second nuclease activity dependent upon Exo1 to generate many 
kilobases of 3’ ssDNA (Tsubouchi and Ogawa, 2000). A third nuclease activity 
dependent upon the helicase Sgs1 and the multifunctional helicase-nuclease Dna2 also 
appears to be involved in both the generation of the initial overhang and extensive 
resection (Bonetti et al., 2009, Gravel et al., 2008, Mimitou and Symington, 2008, Zhu 
et al., 2008). The cooperation between these three nuclease activities has been 
exquisitely demonstrated by showing that elimination of Sae2, Sgs1 and Exo1 
completely eliminates the formation of detectable ssDNA following the induction of a 
DSB (Mimitou and Symington, 2008). The best explanation for these data is that 
MRX/Sae2 cooperates with Sgs1/Dna2 in the initial overhang generation and then 
Sgs1/Dna2 cooperates with Exo1 in extensive resection (Figure 2A). Such a model 
explains how elimination of Sgs1 and Exo1 or Sae2 and Sgs1 essentially eliminates 
resection, while elimination of Sae2 and Exo1 does not (Bonetti et al., 2009, Mimitou 
and Symington, 2008, Zhu et al., 2008). Consistent with this model, end resection can 
be reconstituted in vitro either by the combined activities of MRX (but not Sae2) and 
Sgs1-Dna2 (Cejka et al., 2010, Niu et al., 2010) or by the combined activity of 
MRX/Sae2 and Exo1 (Nicolette et al., 2010). However, this model does not explain 
how elimination of Mre11 and Exo1 or Sgs1 essentially eliminates repair (Gravel et al., 
2008), though there are conflicting reports about this (Tsubouchi and Ogawa, 2000).  
The 9-1-1 complex is named after the mammalian orthologues Rad9-Hus1-Rad1 and is 
composed of the yeast proteins Rad17-Mec3-Ddc1 (Ellison and Stillman, 2003, Majka 
and Burgers, 2003). This specialized PCNA analogue has dual roles contributions to 
resection and checkpoint activation and is referred to as the ‘checkpoint clamp’ due to 
its homology to the ‘DNA clamp’ PCNA (Venclovas and Thelen, 2000). Just as PCNA 
is loaded onto DNA by the ‘clamp loader’ RFC (Rfc1-6), the 9-1-1 complex is loaded 
onto DNA by the ‘checkpoint clamp loader’, an alternate RFC in which Rfc1 is replaced 
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by Rad24 (Venclovas and Thelen, 2000). Likewise, just as PCNA tethers Polymerase δ 
to DNA, the 9-1-1 complex is presumed to tether a nuclease to the DNA (Lydall and 
Weinert, 1995, Zubko et al., 2004). The 9-1-1 complex probably functions downstream 
of MRX/Sae2, as it requires ssDNA to be loaded, but does not seem to be affected by 
the level of extensive ssDNA (Figure 2A) (Lisby et al., 2004, Nakada et al., 2004). If 
the 50-100 nucleotide overhangs generated by MRX/Sae2 (following elimination of 
Exo1 and Sgs1/Dna2) are sufficient for the 9-1-1 complex to be loaded, this would 
suggest that the 9-1-1 complex tethers either Exo1 or Sgs1/Dna2 or both (Figure 2A) 
(Mimitou and Symington, 2008). It is most likely that the 9-1-1 complex contributes to 
the tethering of both Exo1 and Sgs1/Dna2 at DSBs, as elimination of Rad24 confers a 
severe defect in resection, while elimination of either Exo1 or Sgs1/Dna2 confers only a 
minimal resection defect (Mimitou and Symington, 2008, Aylon and Kupiec, 2003). 
However, this remains to be tested and it is possible that the 9-1-1 complex is 
responsible for loading an unknown nuclease (ExoX) whose role at DSBs has not yet 
been elucidated (Figure 2A) (Zubko et al., 2004). 
Following resection, the 3’ ssDNA that is generated becomes coated in RPA and serves 
as the stimulus for checkpoint activation by the sensor kinase Mec1 in cooperation with 
the 9-1-1 complex (Lisby et al., 2004, Zou et al., 2003) (Figure 2A). Resection by Sae2 
appears to stimulate Mre11 nuclease activity, which is believed to cleave the DSB and 
liberate the MRX complex (Lisby et al., 2004). In the absence of resection, MRX 
remains stably associated with the break and serves as the stimulus for checkpoint 
activation by the kinase Tel1, via its Xrs2 subunit (Nakada et al., 2003, Usui et al., 
2001). 
1.2.3 Checkpoint activation 
RPA-coated ssDNA is recognized and bound by a heterodimer of Mec1 and Ddc2 and 
this is absolutely required for checkpoint activation (Lisby et al., 2004, Sanchez et al., 
1999). In parallel, the 9-1-1 complex is loaded onto RPA-coated ssDNA and plays a 
critical role in checkpoint activation, but is not required for it (Lisby et al., 2004). 
Initiation of signaling by Mec1-Ddc2 and the 9-1-1 complex appears to require 
extensive (>100 nucleotides) ssDNA, as elimination of Sgs1 and Exo1 prevents 
activation of the downstream checkpoint kinase cascade (Gravel et al., 2008). 
Subsequently Mec1-phosphorylated histone H2A and methylated histone H3 
accumulate at the site of DNA damage, to which Rad9 binds (Hammet et al., 2007, 
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Wysocki et al., 2005, Downs et al., 2004). Rad9 then functions as an adaptor to permit 
Mec1 to activate the effecter kinases Rad53 and Chk1, thus activating the checkpoint 
(Sanchez et al., 1999, Sun et al., 1998). Strikingly, the recruitment of Rad9 appears to 
negatively regulate resection by the 9-1-1 complex (Lazzaro et al., 2008, Lydall and 
Weinert, 1995). 
Mec1 phosphorylates a series of conserved Serine/Threonine motifs in Rad9 which 
promote oligomerization of Rad9 (Usui et al., 2009). Rad53 is then recruited and also 
oligomerizes by binding to the phosphorylated Serine/Threonine motifs on Rad9, via its 
FHA domains (Schwartz et al., 2002). Rad53 then stimulates its own 
autophosphorylation, leading to the production of hyperphosphorylated, active Rad53 
(Sweeney et al., 2005). Chk1 appears to bind to the N-terminus of Rad9, stimulating its 
phosphorylation and activation (Blankley and Lydall, 2004).  Activated Chk1 and 
Rad53 function in parallel to prevent sister chromatid separation, thus inhibiting 
anaphase and sustaining cell cycle arrest at metaphase (Sanchez et al., 1999). To do this, 
Chk1 hyperphosphorylates Pds1 (‘Securin’, which functions to maintain sister 
chromatid cohesion), preventing its ubiquitinylation and degradation by the Anaphase 
Promoting Complex (APC), while Rad53 inhibits Cdc20, which is required for the APC 
to recognize Pds1 (Agarwal et al., 2003, Ciosk et al., 1998, Sanchez et al., 1999). 
Activated Rad53 also inhibits mitotic exit by phosphorylating and activating the 
downstream checkpoint kinase Dun1 (Chen et al., 2007, Hu et al., 2001, Lee et al., 
2003, Sanchez et al., 1999). In addition to inhibition of mitotic exit, Dun1 also has other 
roles, such as regulating ribonucleotide biosynthesis (Zhao and Rothstein, 2002). 
Although ssDNA is an important DDR stimulus for activation of this Mec1-dependent 
kinase cascade and thus is required for repair of damage, ssDNA is generated by the 
resection of the 5’ strand to generate 3’ ssDNA (Figure 2) and does itself constitute 
damage. Thus, it is unsurprising that negative feedback loops exist to limit the extent of 
the damage incurred. Indeed, Rad53 phosphorylates Exo1 following initiation of the 
DDR to limit resection (Jia et al., 2004, Morin et al., 2008, Segurado and Diffley, 
2008). Furthermore, even without activation of Rad53, the binding of Rad9 to 
chromatin appears to inhibit resection (Lazzaro et al., 2008, Lydall and Weinert, 1995, 
Jia et al., 2004). Thus, negative feedback exists by multiple molecular mechanisms to 
prevent inappropriately high levels of ssDNA being generated at the site of damage. 
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In the absence of ssDNA generation, it appears that MRX remains stably associated 
with the break site and is able to recruit the sensor kinase Tel1 (Lisby et al., 2004). Tel1 
then functions analogously to Mec1 to recruit the adaptor Rad9 and initiate the 
downstream checkpoint kinase cascade, activating the checkpoint (Usui et al., 2001). 
However, it should be noted that the full role of Tel1 is likely far more complex than 
this simple model, as Tel1 appears to have a second role in promoting resection at DSBs 
which cannot currently be well-explained (Mantiero et al., 2007). 
 
 
 
1.2.4 Differences in metazoan and yeast responses to DSBs 
In metazoans, the Mre11-Rad50-Nbs1 (MRN) complex and the nuclease CtIP initiate 
DSB processing in an analogous manner to the function of MRX and Sae2 (Sartori et 
al., 2007). Overhangs generated by MRN/CtIP are then processed further two nuclease 
activities dependent upon the helicase BLM and the metazoan EXO1, analogously to 
the nuclease activities dependent on Sgs1/Dna2 and Exo1 in budding yeast, to generate 
RPA-coated ssDNA that can by recognized by sensor kinases (Gravel et al., 2008). 
Additionally, the 9-1-1 complex also operates to generate ssDNA in mammalian cells, 
composed of its namesakes Rad9, Hus1 and Rad1 (Ellison and Stillman, 2003). 
Metazoan cells possess a similar checkpoint machinery to yeast. The sensor kinase ATR 
binds to its interacting partner ATRIP to form an ATR-ATRIP complex that recognizes 
RPA-coated ssDNA in a manner analogous to Mec1-Ddc2 (Zou and Elledge, 2003). 
The sensor kinase ATM also functions similarly to Tel1 (Falck et al., 2005). However, 
metazoans also possess a third kinase, DNA-PK, which specifically regulates NHEJ at 
DSBs but does not appear to activate downstream effector kinases (Ciccia and Elledge, 
2010). Additionally, ATM appears to cooperate to promote ATR activation at DSBs, in 
contrast to the situation in yeast where Tel1 does not contribute to Mec1 activation 
(Jazayeri et al., 2006). Still, these sensor kinases function via the mediators 53BP1, 
MDC1 and BRCA1 (all similar to Rad9) to activate the downstream effector kinases 
CHK1 (Chk1) and CHK2 (Rad53), so the general scheme is conserved (Harrison and 
Haber, 2006). Roles for the mediators in restraining nuclease activities are also 
conserved, as it appears that 53BP1 also inhibits resection, just like Rad9 (Bunting et 
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al., 2010, Lazzaro et al., 2008). Interestingly, metazoans primarily rely upon NHEJ for 
the repair of DSBs, which may account for some of the differences in checkpoint 
signaling, including utilization of an additional kinase (DNA-PK) specifically to 
regulate NHEJ (Lansdorp, 2009). 
1.2.5 Telomeres confer ‘end protection’ 
The processes described above ensure that a rapid DNA damage response is mounted 
against a DSB, leading to checkpoint activation and ultimately activating processes 
involved in repair of the damage. However, in budding yeast, 64 telomeres exist 
following the completion of S phase, each resembling a DSB and yet, under conditions 
of homeostasis, the cell cycle progresses relatively unhindered (Lydall, 2009). Thus, 
telomeres function as specialized structures to render DNA ends inert from DNA 
damage responses such as NHEJ (which would lead to chromosome-chromosome 
fusions) and HR (which would lead to resection and generation of ssDNA) (Figure 1B). 
1.3 Telomeres are nucleoprotein caps 
Telomeres do not initiate a DDR or activate the checkpoint and thus are said to ‘cap’ 
chromosome ends. This requires the tethering of telomere-specific ‘capping’ proteins to 
the chromosome ends by their recognition of the telomeric DNA sequence (Figure 1B). 
Paradoxically, though the DDR is attenuated at telomeres it appears that DDR 
components are present at telomeres but instead of promoting the DDR are co-opted to 
inhibit activation of downstream DDR components and this scheme occurs at both yeast 
and mammalian telomeres (de Lange, 2009, Lydall, 2009). 
1.3.1 Cdc13 and the CST complex 
The telomeric ssDNA-binding protein Cdc13 has essential roles at the telomeres of 
budding yeast in both chromosome end protection and in telomerase regulation, which 
can be eliminated by the cdc13-1 and cdc13-2 alleles, respectively (Garvik et al., 1995, 
Nugent et al., 1996). These separate roles appear to be due to the ability of Cdc13 to 
nucleate the formation of either the protective CST complex (with Stn1 and Ten1) or a 
telomerase-binding complex (Gao et al., 2007, Li et al., 2009). 
The Cdc13-Stn1-Ten1 (CST) complex is an evolutionarily conserved RPA-like 
complex, that binds to the ssDNA overhang at the telomeres of budding yeast and 
prevents telomeres being recognized as DSBs, presumably at least in part by out-
competing RPA for binding to the telomeric ssDNA (Figure 1B) (Gao et al., 2007, 
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Garvik et al., 1995, Miyake et al., 2009, Surovtseva et al., 2009). Using the temperature-
sensitive allele cdc13-1, telomere end protection by the CST complex can be eliminated 
and telomeres become ‘uncapped’ (Garvik et al., 1995). Inactivation of Cdc13 leads to 
resection of the telomeric DNA by nucleases to generate extensive (>30 kilobase) tracts 
of ssDNA, causing loss of viability and stimulating Mec1-dependent checkpoint, which 
culminates in a robust cell cycle arrest, as occurs in response to DSBs (Figure 2B) (Jia 
et al., 2004, Lydall and Weinert, 1995). However, the nuclease activities that function at 
‘uncapped’ telomeres and DSBs are different, despite the similar schemes of ssDNA 
generation and Mec1-dependent checkpoint activation. 
At DSBs, resection is initiated by MRX/Sae2 and extensive resection occurs due to the 
activity of Exo1 and Dna2/Sgs1-dependent nucleases. However, at uncapped telomeres 
in cdc13-1 mutants, MRX plays an important role in inhibiting resection and 
inactivation of MRX causes increased levels of ssDNA (Foster et al., 2006). MRX binds 
specifically to leading strand telomeres and is required for the binding of Cdc13 to 
leading strand telomeres so MRX could generate overhangs for Cdc13 or other 
protective telomeric proteins to bind to, potentially inhibiting resection (Faure et al., 
2010). One candidate for this is telomerase itself, which appears to inhibit the resection 
of uncapped telomeres (Vega et al., 2007). Alternatively, as suggested, the nuclease 
activity of MRX may somehow be rendered inert at the telomere and MRX might 
inhibit resection by physically occluding other nucleases (Foster et al., 2006). 
Exo1 is involved in the resection of DSBs but elimination of Exo1 alone has relatively 
little effect on the efficiency and extent of resection (Mimitou and Symington, 2009, 
Tsubouchi and Ogawa, 2000). In contrast, Exo1 appears to be the major nuclease that 
functions at uncapped telomeres in cdc13-1 mutants, as the extent of ssDNA is reduced 
from >30 kilobases from the chromosome end to <5 kilobases, and the quantity of 
ssDNA generated <5 kilobases of the chromosome end is severely diminished (Figure 
2B) (Maringele and Lydall, 2002, Zubko et al., 2004). One possible explanation for this 
difference that 3’ ssDNA overhangs occur natively at telomeres, while at DSBs 
processing by MRX/Sae2 is required to generate them. Indeed, in vitro MRX/Sae2 
appears to promote Exo1 activity by generating overhangs for Exo1 (Nicolette et al., 
2010). Thus, the function of Exo1 at uncapped telomeres in cdc13-1 mutants might be 
equivalent to the combined activity of Exo1 and MRX/Sae2 at DSBs (Mimitou and 
Symington, 2008). Indeed, elimination of Exo1 and MRX/Sae2 appears to severely 
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diminish resection at a DSB (Tsubouchi and Ogawa, 2000). However, if Exo1 plays a 
more prominent role in resection at telomeres due to its ability to process the native 
telomeric overhangs, it would probably only be involved in resection of the lagging 
strand because, as mentioned above, MRX appears to be required for overhang 
generation at leading strand telomeres (Faure et al., 2010). This is certainly feasible, as 
significantly less than 50% of telomeric loci in cells with uncapped telomeres are 
single-stranded (Zubko et al., 2004). 
Sgs1/Dna2 are also involved in the resection of DSBs (Mimitou and Symington, 2008, 
Zhu et al., 2008). Sgs1 also plays an important role in the resection of uncapped 
telomeres in cdc13-1 mutants, though the role of Dna2 has not yet been examined (Ngo 
and Lydall, 2010). At DSBs, elimination of Sgs1 and Exo1 appears to cause a 
synergistic decrease in ssDNA at DSBs, limiting ssDNA generation to <100 bases 
(Mimitou and Symington, 2008). However, at uncapped telomeres, elimination of Sgs1 
and Exo1 appears to have no more effect than elimination of Exo1 alone and > 5,000 
bases of ssDNA are still generated (Figure 2B) (Ngo and Lydall, 2010). Thus, in 
contrast to the situation at DSBs, Sgs1 appears to support Exo1 in resection at uncapped 
telomeres and an Exo1- and Sgs1-independent nuclease termed ‘ExoY’ appears to play 
a significant role in residual resection at uncapped telomeres (Mimitou and Symington, 
2008, Ngo and Lydall, 2010).  
Perhaps the greatest similarity between the resection at DSBs and uncapped telomeres is 
the critical requirement for the 9-1-1 complex. At DSBs, elimination of Rad24 and thus 
loading of the 9-1-1 complex imparts a severe resection defect and appears to prevent 
the formation of ssDNA approximately >1,000 bases from the break site (Aylon and 
Kupiec, 2003). Similarly at uncapped telomeres in cdc13-1 mutants, it appears that 
loading of the 9-1-1 complex by Rad24 contributes to resection >15,000 bases from the 
chromosome end (Figure 2B) (Zubko et al., 2004). Even more striking is that at both 
DSBs and uncapped telomeres, Rad9 appears to specifically inhibit nuclease activity 
that is dependent on the 9-1-1 complex (Lazzaro et al., 2008, Lydall and Weinert, 
1995). It appears this is due to the ability of Rad9 to bind to chromatin following a DDR 
(Lazzaro et al., 2008). Additionally, Sgs1 appears to be required for the Rad9-inhibited 
resection that occurs at uncapped telomeres and high levels of Dna2 disrupt telomeric 
chromatin structure, suggesting that a Sgs1/Dna2-dependent nuclease activity at 
uncapped telomeres might be opposed by Rad9 and chromatin (Figure 2B) (Ngo and 
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Lydall, 2010, Singer et al., 1998). Thus, it has been suggested that Sgs1 is a component 
of ‘ExoX’, which is a hypothetical Rad24-dependent nuclease activity that generates 
high levels of extensive (>30,000 bases) ssDNA in the absence of Rad9 (Ngo and 
Lydall, 2010, Zubko et al., 2004). 
The ‘end protection’ function of Cdc13 is essential and elimination of Cdc13 causes 
robust arrest within a cell cycle, while elimination of the telomerase-recruitment 
function of Cdc13 does not immediately cause loss of viability (Lydall and Weinert, 
1995, Nugent et al., 1996). At low rates, cells can be generated that are viable in the 
absence of Cdc13, either by elimination of checkpoint components and nucleases (rate 
of approximately 4-6x10-5) or selective overexpression of Stn1 and Ten 1 (rate of 
approximately 1.6x10-1) (Petreaca et al., 2006, Zubko et al., 2004). Fusion of the DNA-
binding domain of Cdc13 to Stn1 also eliminates the lethality associated with loss of 
Cdc13 (Pennock et al., 2001). Collectively, these observations indicate that the essential 
role of Cdc13 is to recruit Stn1 and Ten1 to telomeres to prevent inappropriate 
activation of the DNA damage response. Thus, it would appear that Cdc13 functions as 
a platform for end protection by Stn1 and Ten1. Indeed, specific inactivation of Ten1 
also causes telomere uncapping and induces resection, despite Cdc13 remaining 
associated with the telomeres (Xu et al., 2009). 
Though nonessential for viability, the role of Cdc13 in telomerase regulation is very 
important. Inactivation of this function in cdc13-2 mutants leads to continued telomere 
shortening with passage and loss of proliferative capacity (i.e. senescence, as seen in 
cells lacking telomerase) (Nugent et al., 1996). To recruit telomerase to telomeres, 
Cdc13 binds to Est1, which in turns binds to the TLC1 subunit of the catalytic core of 
telomerase (Chan et al., 2008, Nugent et al., 1996). This recruitment appears to be 
stimulated by phosphorylation of Cdc13 by the cyclin-dependent kinase Cdk1, causing 
Cdc13 to exchange Stn1-Ten1 for Est1-telomerase (Li et al., 2009). As the CST 
complex forms an RPA-like structure, it is tempting to speculate that Cdc13-Est1-
telomerase also forms an alternative RPA-like structure (Gao et al., 2007). In addition to 
being required for the recruitment of telomerase, Cdc13 also functions as a negative 
regulator of telomerase and inhibits extension of the telomeres by telomerase (Chandra 
et al., 2001). Interestingly the negative regulation of telomerase by Cdc13 appears 
dependent upon Stn1, suggesting that following binding of Est1-telomerase to Cdc13, 
Stn1-Ten compete for binding to Cdc13 with Est1-telomerase, ultimately causing the 
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dissociation of telomerase and reforming the CST complex (Chandra et al., 2001).  
However, it is also possible that Cdc13 regulates telomerase by some other mechanism, 
which is more sensitive to Cdc13 levels than the CST complex formation, as the net 
effect of decreased cellular Cdc13 levels is increased telomere length (Ungar et al., 
2009). 
1.3.2 The Ku Complex 
Similarly to how MRX plays a role in mounting the DDR at DSBs, but plays a role in 
inhibiting the DDR at uncapped telomeres, so does the Ku complex function to ‘cap’ 
telomeres. The Ku complex in yeast is a heterodimer of Yku70-Yku80 that binds to all 
DNA ends, including telomeres and DSBs. At DSBs, the Ku complex cooperates with 
DNA Ligase IV (Dnl4) to coordinate non-homologous end joining (Wilson et al., 1997). 
Additionally, the Ku complex is required for the recruitment of telomerase to telomeres 
in G1 by binding specifically to a 48 nucleotide stem-loop on TLC1 to recruit the 
catalytic core of telomerase (Chan et al., 2008, Peterson et al., 2001). The telomerase 
recruitment role of the Ku complex is critcally important, as cells lacking Ku have short 
telomeres (Porter et al., 1996). 
The Ku complex also has a role in end protection, partially distinct from its role in 
telomerase recruitment. Elimination of Ku increases the length of the telomeric ssDNA 
overhangs and causes them to persist throughout the cell cycle (Gravel et al., 1998, 
Polotnianka et al., 1998). Yeast cells lacking Ku also display a temperature-sensitive 
growth defect, which can be partially suppressed by overexpression of telomerase 
subunits, suggesting that at high temperatures a telomere-specific defect occurs 
(Feldmann and Winnacker, 1993, Teo and Jackson, 2001). Accordingly, at high 
temperatures cells, telomeres in cells lacking Ku become ‘uncapped’ and undergo 
resection specifically at the telomeres, resulting in ssDNA accumulation, cell cycle 
arrest and loss of viability (Maringele and Lydall, 2002). Checkpoint activation at 
telomeres lacking Ku occurs similarly to at DSBs, in that both Rad53 and Chk1 
activation occur (Figure 2A,C). However in contrast to DSBs, Chk1 is primarily 
responsible for arrest at uncapped telomeres lacking Ku, Rad53 is only weakly activated 
and Dun1 has no role in arrest (Maringele and Lydall, 2002, Teo and Jackson, 2001). 
Additionally it appears that the spindle checkpoint kinase Mad2, which also inhibits the 
APC, contributes to checkpoint activation at uncapped telomeres lacking Ku (Maringele 
and Lydall, 2002). It is unclear how Mad2 is activated in response to uncapped 
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telomeres lacking Ku, but likely that it occurs through Mec1 and (presumably) Rad9 
(Kim and Burke, 2008). 
Resection at uncapped telomeres in yku70∆ mutants occurs less rapidly than in cdc13-1 
mutants, and multiple cell cycles in the presence of uncapped telomeres are required for 
ssDNA to accumulate (Figure 2C) (Lydall and Weinert, 1995, Maringele and Lydall, 
2002). Indeed, yku70∆ mutants accumulate less ssDNA than cdc13-1 mutants and the 
extent of resection is reduced from >30,000 bases in cdc13-1 mutants compared to 
<8,500 bases in yku70∆ mutants (Maringele and Lydall, 2002, Zubko et al., 2004). 
Furthermore, although both yku70∆ mutants and cdc13-1 mutants undergo a Mec1-
dependent checkpoint activation following telomere uncapping, the 9-1-1 complex 
appears to play no role in checkpoint activation following telomere uncapping in 
yku70∆ mutants (Maringele and Lydall, 2002). Thus, the inability of the 9-1-1 complex 
to support checkpoint activation at uncapped telomeres in yku70∆ mutants may account 
for the relatively weak arrest and Rad53 activation compared to that seen at DSBs and 
following telomere uncapping in cdc13-1 mutants. Given these collective observations, 
it is unsurprising that the regulation of nuclease activities at uncapped telomeres in 
cdc13-1 mutants and yku70∆ mutants is quite different.  
At uncapped telomeres in yku70∆ mutants, resection is essentially entirely dependent 
upon Exo1 (Figure 2C) (Maringele and Lydall, 2002). In fact, elimination of Exo1 
prevents accumulation of detectable ssDNA at the telomeres of yku70∆ mutants and 
permits the growth of yku70∆ mutants at high temperature (Maringele and Lydall, 
2002). Perhaps most strikingly, the 9-1-1 complex appears to have no role in the 
resection of uncapped telomeres in yku70∆ mutants, in contrast to its prominent role in 
cdc13-1 mutants (Lydall and Weinert, 1995, Maringele and Lydall, 2002). This is 
consistent with the inability of the 9-1-1 complex to contribute to checkpoint activation 
at uncapped telomeres in yku70∆ mutants. 
However, two salient similarities do exist between the resection of uncapped telomeres 
in yku70∆ and cdc13-1 mutants. The MRX complex inhibits resection at uncapped 
telomeres of both cdc13-1 and yku70∆ mutants, and elevated levels of ssDNA 
accumulate in the absence of MRX (Foster et al., 2006, Maringele and Lydall, 2002). 
This increased ssDNA generated in yku70∆ mre11∆ mutants is dependent on Exo1, 
suggesting that the same may be true for uncapped telomeres in cdc13-1 mutants. 
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Second, Rad9 also inhibits resection at uncapped telomeres of yku70∆ mutants 
(Maringele and Lydall, 2002). The nuclease that Rad9 inhibits at uncapped telomeres in 
yku70∆ mutants has not formally been identified, but is likely to be Exo1, which 
appears to be the only nuclease activity that functions at uncapped telomeres of yku70∆ 
mutants. However, in principle ExoX could be required for the Rad9-inhibited nuclease 
at uncapped telomeres in yku70∆ mutants (Lydall and Weinert, 1995). This could only 
be the case if ExoX was able to recognize uncapped telomeres independently of the 9-1-
1 complex at uncapped telomeres in yku70∆ mutants as the 9-1-1 complex appears to 
have no effect in yku70∆ rad9∆ mutants with uncapped telomeres (Maringele and 
Lydall, 2002). 
1.3.3 Rap1-Rif1-Rif2 
Rap1 binds to telomeric dsDNA and other sites within the budding yeast genome and 
also provides a platform for the binding of Rif1 and Rif2 via its C-terminus (Shore and 
Nasmyth, 1987, Wotton and Shore, 1997). Like the CST and Ku complexes, the Rap1-
Rif1-Rif2 complex appears to have roles in both telomerase regulation and end 
protection, but these are much less well defined. Rif1 and Rif2 appear to function in a 
generalized manner by inhibiting the binding of Tel1 at both telomeres and DSBs, 
presumably with the telomeric consequence of inhibiting the phosphorylation of Cdc13 
by Tel1 that is required for telomerase recruitment to the telomere (Hirano et al., 2009, 
Mishra and Shore, 1999). Rif1 and Rif2 appear to display a high level of redundancy 
because elimination of either causes modest telomere lengthening, while elimination of 
both or of the C-terminus of Rap1 leads to massive telomere lengthening (Wotton and 
Shore, 1997). 
Inactivation of Rap1 leads to telomere ‘uncapping’ and resection that is primarily 
dependent upon Exo1, but – surprisingly – without the consequence of Mec1-dependent 
checkpoint activation, and instead leading to accumulation of cells in G1 (Figure 2D) 
(Vodenicharov et al., 2010). Intriguingly, low levels of Exo1-independent resection 
occur following inactivation of Rap1 and this Exo1-independent resection persists, and 
may even be inhibited by Exo1, in stationary phase cells (Vodenicharov et al., 2010). 
RAP1 is an essential gene, but cells are viable with a C-terminal deletion, which leads to 
telomere lengthening due to the inability to recruit Rif1-Rif2 (Wotton and Shore, 1997). 
Interestingly, elimination of the C-terminal domain leads to accumulation of MRX-
dependent telomeric ssDNA (Bonetti et al., 2010). Thus it appears that the essential 
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function of Rap1 is to cap telomeres and inhibit Exo1, but it also has non-essential roles 
to inhbit resection by MRX and regulation telomere length via Rif1-Rif2 (Figure 2D). 
Paradoxically, the central domain of Rap1 has also been shown to inhibit NHEJ at 
telomeres, independently of Rif1-Rif2 (Marcand et al., 2008, Pardo and Marcand, 
2005). This is surprising because ssDNA should inhibit NHEJ, yet elimination of Rap1 
renders telomeres vulnerable to both NHEJ and resection (Vodenicharov et al., 2010). 
Clearly further work is required to elicidate the complex role of Rap1 at telomeres. 
1.3.4 Mammalian and Fission Yeast telomeres 
In broad terms, the telomeres of mammalian and fission yeast cells are similar to those 
of budding yeast in that they contain specialized dsDNA- and ssDNA-binding proteins 
(Figure 1B) (de Lange, 2005, Lydall, 2009). However, the specific complexes involved 
are different, perhaps as a reflection of the slightly different threats posed by the DDRs 
of mammalian and fission yeast cells. 
In mammalian cells, the telomeric dsDNA is bound by TRF1 and TRF2, while the 
ssDNA overhang is bound by POT1 (Figure 1B) (Baumann and Cech, 2001, Bilaud et 
al., 1997, Broccoli et al., 1997, Zhong et al., 1992). Humans possess a RAP1 orthologue 
which is recruited to telomeres by TRF2 (Figure 1B) (Li et al., 2000). In contrast to the 
situation in budding yeast, where separate complexes bind the telomeric ssDNA and the 
dsDNA, in mammalian cells POT1 and TRF1/TRF2/RAP1 are linked together by 
TIN2/TPP1 to form a single complex referred to as ‘shelterin’ (de Lange, 2005, 
Houghtaling et al., 2004, Kim et al., 1999, Liu et al., 2004, Ye et al., 2004). This 
linkage of the ssDNA- and dsDNA- binding components of shelterin has been proposed 
to function in promoting higher-order DNA structures at mammalian telomeres that 
might function to occlude telomerase and components of the DDR (de Lange, 2005, 
Griffith et al., 1999, Stansel et al., 2001). 
In the fission yeast Schizosaccharomyces pombe, a partially-analagous partially-
orthologous shelterin-like complex exists. In S. pombe, the telomeric dsDNA is bound 
by Taz1 (like TRF1-TRF2), while the ssDNA overhang is bound by Pot1 (Baumann and 
Cech, 2001, Cooper et al., 1997, Cooper et al., 1998). Fission yeast Rap1 is recruited to 
telomeres by its interaction with Taz1, analogously to the recruitment of Rap1 to 
mammalian telomeres by Trf2 (Chikashige and Hiraoka, 2001, Kanoh and Ishikawa, 
2001). Pot1 and Taz1 are linked together by Tpz1, analogously to the linkage between 
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POT1 and TRF1-TRF2 by TIN2/TPP1 (Miyoshi et al., 2008). Of all the components of 
the fission yeast shelterin-like complex, Pot1 has the greatest level of conservation with 
the mammalian shelterin complex and has been highly informative as to POT1 function 
in mammalian cells (Baumann and Cech, 2001). 
Broadly speaking, POT1 appears to fulfill similar roles to the Cdc13 in budding yeast. 
Inactivation of Pot1 in either fission yeast or POT1 in mammalian cells leads to rapid 
loss of telomeric DNA, involving resection of telomeres (presumably by nucleases, 
though none have yet been identified) and checkpoint activation (Baumann and Cech, 
2001, Palm et al., 2009, Pitt and Cooper, 2010, Wu et al., 2006). Much like Cdc13 
requires Stn1/Ten1 to protect telomeres from the DDR, POT1 does not appear to 
function in isolation, as Tpz1/TPP1 is required for protection of the telomeric DNA by 
Pot1/POT1 (Hockemeyer et al., 2007, Miyoshi et al., 2008). Furthermore just as Cdc13 
negatively regulates telomerase, POT1 also appear to, though unlike Cdc13, no roles in 
telomerase recruitment have yet been identified for POT1 (Churikov and Price, 2008, 
Kelleher et al., 2005). 
Recently, orthologues of the CST complex were discovered in both mammalian and 
plant cells, making the comparison of Cdc13 to POT1 somewhat contentious (Miyake et 
al., 2009, Surovtseva et al., 2009). Just as inactivation of the budding yeast CST 
complex leads to rapid degradation of telomeric DNA and ssDNA generation, so does 
inactivation of the mammalian and plant CST complexes (Miyake et al., 2009, 
Surovtseva et al., 2009). However, mammalian CST does not have specific affinity for 
telomeric repeats and localizes both telomeric and non-telomeric chromosomal regions, 
leading to the suggestion that the CST complex is involved in DNA replication in a 
manner that is frequently required by the telomeres, but also by other loci (Miyake et 
al., 2009). More work is clearly required to understand the role of the CST complex in 
higher organisms, and how this more generalized complex in mammalian cells can 
fulfill such a specialized telomeric role in budding yeast.  
RAP1 appears to inhibit NHEJ at human telomeres, similarly to the ability of Rap1 to 
inhibit NHEJ in budding yeast (Bae and Baumann, 2007, Bombarde et al., 2010). 
Strikingly, inactivation of RAP1 can also lead to HR occurring between mammalian 
telomeres, without activation of ATR checkpoint kinase (Sfeir et al., 2010). This is 
potentially similar to the resection that occurs following inactivation of Rap1 at budding 
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yeast telomeres, which does not lead to activation of the Mec1 checkpoint kinase 
(Vodenicharov et al., 2010). 
Though the binding of TRF1 and TRF2 to mammalian telomeric dsDNA is comparable 
to the binding of Rap1 to yeast telomeric dsDNA, the similarities between mammalian 
RAP1 and yeast Rap1 leave TRF1/TRF2 without yeast analogues. It appears that TRF2 
functions primarily to repress NHEJ and prevent activation of the ATM checkpoint 
kinase but also has roles in ensuring proper telomere replication (Bombarde et al., 2010, 
Celli and de Lange, 2005, Karlseder et al., 1999, Ye et al., 2010). TRF1 on the other 
hand appears to regulate telomere length via POT1 in addition to having roles in 
ensuring proper telomere replication (Loayza and De Lange, 2003, Ohki and Ishikawa, 
2004, Sfeir et al., 2009, van Steensel and de Lange, 1997). It has been speculated that 
the increased time spent at G1/interphase in mammalian cells might necessitate more 
stringent mechanisms of repressing NHEJ/ATM than budding yeast might require for 
the repression of NHEJ/Tel1, which would explain the lack of a TRF2 analogue in 
budding yeast (de Lange, 2009). Likewise, as human telomeres are much longer 
(approximately 15,000 bases) than those of budding yeast (approximately 350 bases), it 
is interesting to speculate that replication of much longer tract of telomeric repeats 
requires a special aid to replication in human cells, explaining the lack of TRF1/TRF2 
analogues in yeast (Allshire et al., 1989, de Lange et al., 1990, Shampay and Blackburn, 
1988). 
In budding yeast, the Ku complex is present at the telomeres and has dual roles in 
telomerase recruitment and end protection (Maringele and Lydall, 2002, Peterson et al., 
2001). Similarly, mammalian Ku is also present at the telomeres and may be able to 
recruit telomerase (Ting et al., 2005). Interestingly, although Ku is able to bind 
telomeric DNA with high affinity in vitro it appears to be localized to telomeres 
indirectly, via an interaction with TRF1, in vivo (Bianchi and de Lange, 1999, Hsu et 
al., 1999, Hsu et al., 2000). Surprisingly, though elimination of Ku in yeast appears to 
cause resection of the telomeric DNA and ssDNA generation, elimination of Ku in 
mammalian cells leads to telomere fusions via NHEJ, suggesting that although Ku does 
inhibit a DDR at telomeres, it does not guard against resection (Samper et al., 2000). 
However, elimination of Ku at human telomeres also leads to telomeric deletions and 
formation of extrachromosomal circles of telomeric DNA, which is compatible with Ku 
inhibiting HR and thus resection (Wang et al., 2009). Inhibition of both NHEJ and, 
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potentially, HR at mammalian telomeres by Ku would be surprising as resection 
required for HR would be expected to inhibit NHEJ. Clearly it will be important to 
understand these potentially contradictory roles of Ku at mammalian telomeres. As 
discussed earlier (Section 1.3.3) Rap1 in budding yeast also has roles in both inhibition 
of resection and inhibition of NHEJ and thus might provide insight into these roles of 
Ku at mammalian telomeres. 
1.3.5 Drosophila and Caenorhabditis telomeres 
Though the telomeres of budding yeast and humans serve as valuable models for 
understanding telomere telomere biology, organisms with different telomere structures 
do exist. Drosophila are a striking example as they lack TG-rich repeat sequences or 
any telomere-specific repeat at all (George et al., 2006). Instead, Drosophila telomeres 
are maintained by transposable elements and chromosome ends are protected from the 
DDR by maintaining high levels of heterochromatinisation (Rong, 2008). This 
mechanism of telomere maintenance may be less atypical than it appears, as there is 
conjecture that in fission yeast elimination of telomerase can in rare cases lead to the 
generation of rare mutants that use heterochromatin to cap their telomeres (Jain et al., 
2010). 
Though telomeres are usually composed of telomeric dsDNA with a 3’ ssDNA 
overhang, Caenorhabditis telomeres are maintained by telomerase yet possess persistent 
3’ and 5’ overhangs (Raices et al., 2008). 5’ overhangs have been reported in 
mammalian cells, but it is thought these are transient intermediates stemming from 
impaired leading strand regulation (Cimino-Reale et al., 2003). Remarkably, 
Caenorhabditis utilize telomerase for telomere maintenance, so although complexes 
such as the CST complex function in budding yeast to maintain 3’ overhangs as a 
substrate for telomerase, other organisms are remarkably flexible in the DNA structure 
at the ends of chromosomes (Raices et al., 2008). 
1.3.6 Shortened telomeres 
Shortened telomeres are presumed to be ‘uncapped’ if there is insufficient telomeric 
DNA for capping proteins to bind and short telomeres are preferentially recognized by 
telomerase for elongation (Bianchi and Shore, 2007). Consistent with this, induction of 
a short telomere leads to recruitment of DDR components such as RPA, in addition to 
recruitment of Cdc13 and telomerase (Bianchi et al., 2004, Khadaroo et al., 2009). 
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However, this response is clearly distinct from that caused specifically by elimination or 
inactivation of telomere cap components, as resection at DSB-induced short telomeres 
is dependent upon Sae2/MRX, Sgs1/Dna2 and Exo1 in essentially the exact same 
manner that DSBs are resected and this resection readily leads to elongation by 
telomerase (Bonetti et al., 2009). 
The most popular tool for inducing a shortened telomere is an inducible DSB with an 
adjacent tract of telomeric TG repeats (Bianchi et al., 2004, Bonetti et al., 2009). Thus, 
one interpretation of this data (particularly that the coordination of nucleases at 
shortened telomeres is identical to that at DSBs) is that these so-called ‘shortened 
telomeres’ are more reflective of DSBs. However, modulation of the nuclease activities 
that function to generate overhangs at inducible shortened telomeres can have a 
significant effect on telomere length homeostasis – for example, elimination of Sgs1 
and Sae2 eliminates overhang generation at DSB-induced short telomeres and causes 
drastic telomere shortening (Bonetti et al., 2009). This suggests the lessons learned from 
DSB-induced short telomeres are generally applicable to telomere biology.  
Interestingly, it appears that Cdc13 potently inhibits ssDNA generation at DSB-induced 
short telomeres, but has essentially no effect at control telomeres ‘induced’ to wild type 
length (Negrini et al., 2007). Furthermore, DSB-induced short telomeres have been used 
to further dissect the roles of the Ku complex and Rap1-Rif1-Rif2 in resection – while 
both complexes inhibit resection, Ku appears to primarily inhibit the initiation of 
resection at the end of the telomere, while Rap1-Rif1-Rif2 appear to primarily limit the 
extent of any resection that does occur (Bonetti et al., 2010).  When considering the 
differential regulation of nucleases at DSB-induced short telomeres compared to 
uncapped telomeres, it is important to recognize that DSB-induced short telomeres do 
not constitute telomere dysfunction, as they are readily elongated by telomerase and 
restored to homeostasis (Bianchi et al., 2004, Bonetti et al., 2009). This is in stark 
contrast to the sustained degradation and checkpoint activation that occurs following 
inactivation of specific telomere capping components (Maringele and Lydall, 2002, 
Vodenicharov et al., 2010, Zubko et al., 2004). Thus, uncapped telomeres are 
considered to be dysfunctional while shortened telomeres are not, and there is 
differential coordination of nuclease activities at uncapped compared to shortened 
telomeres. The key question remaining is whether nuclease activities at uncapped 
telomeres cause telomere dysfunction or whether the differential coordination of 
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nuclease activities is a consequence of some upstream molecular even that marks a 
telomere as dysfunctional or not. 
1.3.7 Telomerase-deficient telomeres 
Inactivation of telomerase in cultures of budding yeast prevents cells from solving the 
end replication problem (Cohn and Blackburn, 1995, Singer and Gottschling, 1994). 
Consequentially, telomeres shorten following each S phase and the growth of the 
culture becomes limited by telomere length, causing a loss in proliferative capacity 
termed ‘senescence’ (Lundblad and Blackburn, 1993). Usually within the senescent 
culture, rare clones arise that utilize telomerase-independent, HR-dependent 
(specifically BIR-dependent) mechanisms of telomere maintenance to maintain and 
lengthen their telomeres, though telomerase-and-recombination-independent 
mechanisms can also occur (Lydeard et al., 2007, Maringele and Lydall, 2004b, Teng 
and Zakian, 1999). As these ‘survivors’ overtake the culture, it regains its proliferative 
capacity. 
When telomerase-deficient telomeres become critically short, there is an increase in 
recruitment of HR proteins in addition to Cdc13 and Tel1, presumably in a failed 
attempt to elongate telomeres by telomerase (Khadaroo et al., 2009). Additionally, 
critically-short telomeres become coated in RPA and recognized by Mec1, triggering a 
DDR similar to that at DSBs and preventing further growth (Abdallah et al., 2009). It 
has been speculated that exposed ssDNA from non-telomeric sequences is ultimately 
what activates the senescence-inducing DDR and consistent with this, elimination of 
Exo1 or Tel1 (which both contribute to resection at DSBs) inhibits the rate of 
senescence and telomere shortening that occur following senescence (Abdallah et al., 
2009, Maringele and Lydall, 2004a, Ritchie et al., 1999). However, the response to 
telomerase-deficient shortened telomeres is clearly more complex as the helicase Sgs1 
contributes to resection at DSBs but inhibits entry into senescence in telomerase 
deficient cells (Cohen and Sinclair, 2001). 
1.4 Telomeres and disease states 
The study of telomere biology began in the 1980’s using basic model organisms to ask 
fundamental questions about how cells maintain chromosome ends. By the 1990’s the 
number of papers published that dealt with telomere biology was increasing 
exponentially, primarily due to the profound implications that the field has for human 
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health (Blackburn et al., 2006). This was further acknowledged when the Nobel Prize 
for Physiology or Medicine 2009 was awarded to Elizabeth Blackburn, Carol Greider 
and Jack Szostack for “the discovery of how chromosomes are protected by telomeres 
and the enzyme telomerase” (Blackburn et al., 2009). 
1.4.1 Senescence 
The growth of cells in culture is limited by a phenomenon known as ‘replicative 
senescence’ (Blasco, 2007, Hayflick, 1965). At the whole organism level, ‘senescence’ 
is defined as the irreversible loss of proliferative capacity and leads to ageing and 
ultimately mortality. As telomeres shorten with each cell division and are of paramount 
importance for cell survival, telomere shortening is a prime candidate for a causal agent 
in mammalian ageing. 
Telomerase activity is not detectable in most human somatic (differentiated) tissues, 
thus a progressive loss of telomere length is inevitable (Kim et al., 1994). Accordingly, 
just as telomerase-deficient budding yeast undergo telomere shortening and an eventual 
loss of proliferative capacity over passage, so do human fibroblasts in culture (Harley et 
al., 1990). A causal role for telomere shortening in cellular ageing was established by 
the demonstration that re-introduction of telomerase into human cells increased 
telomere length and life span (Bodnar et al., 1998). At the whole organism level it has 
been shown that late-generation telomerase knock-out mice display premature ageing 
phenotypes (Blasco et al., 1997, Lee et al., 1998a). Crucially, the demonstration that 
late, rather than early generation telomerase knock-out mice show premature ageing 
phenotypes provides a robust demonstration that the premature ageing seen is a 
consequence of short, dysfunctional telomeres rather than some toxic effect caused by 
lack of telomerase. Finally, and most astonishingly, reactivation of telomerase in late 
generation telomerase knock-out mice prevents further telomere shortening and 
alleviates the progression of premature ageing phenotypes (Jaskelioff et al., 2010). This 
result stops short of reversing telomere dysfunction-driven senescence, but does indicate 
that restoring telomere homeostasis at any stage of telomere dysfunction is likely to 
inhibit the progression of further pathologies.  
Though ethical and technical considerations limit the strong establishment of such a 
strong causal effect in human beings, it has been shown that replicatively senescent 
human cells (i.e. aged, non-dividing) are kept locked in senescent by a persistent DDR, 
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to which shortened telomeres contribute (d'Adda di Fagagna et al., 2003). Furthermore, 
inactivation of components of the telomere cap in human cells can mimick such a DDR 
and trigger senescence (Takai et al., 2003). Collectively, these data argue that at both 
the cellular and whole organism level in humans and mice, telomere shortening 
increases with age, until telomeres become so short that telomeres become ‘uncapped’ 
and a DDR is initiated, triggering senescence. 
1.4.2 Cancer 
Cancer usually stems from uncontrolled proliferation of an organism’s own cells 
(though transmissible cancer has been reported between canines) (Murgia et al., 2006). 
As telomeres shorten with each division and telomere shortening ultimately results in 
senescence, they provide a potent barrier to cancer. In fact, telomere shortening can be 
viewed as a double-edged sword; on the one hand it contributes to the mortality of the 
organism by promoting senescence; on the other hand promotes the vitality of the 
organism by limiting the number of divisions any given cell can go through and thus 
preventing the continued proliferation required for oncogenesis (Blasco, 2007). 
Therefore, a necessary step in the establishment of any immortal cancer is the 
establishment of a mechanism of indefinite telomere maintenance (Cesare and Reddel, 
2010). In the majority (approximately 85%) of cancers this occurs simply through up-
regulation of telomerase components while in a minority this occurs without telomerase 
up-regulation through ‘ALT’ mechanisms (Bryan et al., 1997, Kim et al., 1994). ALT 
mechanisms are believed to be similar to the recombination-based mechanisms used by 
budding yeast for the generation of telomerase-independent ‘survivors’ and indeed, 
recombination within the telomeric DNA has been shown to be prevalent in human 
ALT cells but not wild type cells (Dunham et al., 2000). Furthermore, progression of 
cancers appears to be associated with increased chromosome fusion events and telomere 
dysfunction, likely indicating that telomere dysfunction drives genomic instability and 
thus promotes the accumulation mutations that facilitate cancer (Lin et al., 2010). 
1.4.3 Dyskeratosis congenita 
Dyskeratosis congenita (DC) is a rare, inherited syndrome in humans leading to bone 
marrow failure and cancer predisposition (Bessler et al., 2010). DC can be caused by 
mutations in genes encoding either the catalytic core components of telomerase (TERT 
or TERC) or DKT1, which was discovered due to its causal role in some forms of 
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Dyskeratosis congenita and encodes Dyskeratin, a protein important for stabilizing 
TERC RNA  (Heiss et al., 1998, Mitchell et al., 1999, Vulliamy et al., 2001, Yamaguchi 
et al., 2005). 
DC patients have short telomeres, which effect the two major pathologies of DC 
(Bessler et al., 2010). First, shorter telomeres reduce the number of divisions a cell can 
go through, so in DC patients the somatic tissues need to be more frequently 
replenished by hematopoietic stem cells, leading to their depletion. Second, short 
telomeres are believed to readily become dysfunctional, inducing genome instability 
and predisposing patients to cancer. Thus, defective telomerase does not directly cause 
DC, but instead DC is caused by the telomere dysfunction, which is a consequence of 
defective telomerase in DC patients. This is highlighted by ‘anticipation’ seen in DC 
patients – as telomere length decreases in later generations of families affected by DC, 
the onset of disease occurs more severely and at an earlier age (Vulliamy et al., 2004). 
This is similar to disease states that are specifically seen in late generation telomerase 
knock-out mice, which occur due to telomere shortening rather than the absence of 
telomerase per se, highlighting how informative model organisms can be in 
understanding human diseases (Blasco et al., 1997, Lee et al., 1998a). 
1.4.4 Diabetes 
Telomere dysfunction has been linked to both diabetes and obesity (Fuster and Andres, 
2006). Insulin resistance is a hallmark of obesity and recently it has been exquisitely 
shown that late-generation telomerase knock-out mice are more prone to developing 
insulin-resistance in the liver (Minamino et al., 2009). Remarkably, it has been shown 
that transplanting dysfunctional adipose tissue from late generation telomerase knock-
out mice into wild type mice led to the induction of insulin resistance and this appeared 
to be dependent upon a DDR occurring in the adipose tissue (Minamino et al., 2009). 
Though it is premature to try and generalize based on a single study, it will be 
interesting to know whether there is a specific link between diabetes and telomere 
dysfunction, or whether this is a sign that telomere homeostasis is necessary to 
safeguard against a wide range of diseases that can be induced by tissue dysfunction.  
1.4.5 Uncapped telomeres in budding yeast as a model for senescence 
As discussed above, studies in budding yeast over the last two decades have been 
informative into the nature of DNA damage responses and particularly how telomere 
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dysfunction can initiate a DDR. Additionally, understanding the regulation of 
telomerase at telomeres may provide valuable insight into how to combat cancer, given 
that the majority of cancers depend upon telomerase for survival. Perhaps the most 
clinically-relevant information provided thus far by the study of telomere biology, has 
been that working knowledge of how ALT cancers maintain their telomeres has been 
primarily derived from studies of the rare events that lead to recombination-dependent 
telomerase-independent telomere maintenance in budding yeast (Cesare and Reddel, 
2010). 
Work originating in budding yeast demonstrated that the exonuclease Exo1 had a 
particularly pivotal role in the initiation of the DDR at uncapped telomeres (Maringele 
and Lydall, 2002, Zubko et al., 2004). It was subsequently shown that elimination of 
murine EXO1 extended the life span of telomerase knock-out mice by alleviating the 
DDR at dysfunctional telomeres (Schaetzlein et al., 2007). Remarkably, the lifespan 
extension obtained in telomerase knock-out mice occurred without the consequence of 
increased cancer susceptibility, demonstrating that a genuine lifespan extension had 
occurred (Schaetzlein et al., 2007). Interestingly, EXO1-knock out mice do show 
premature mortality compared to Wild Type mice due to cancer susceptibility, 
indicating that simply eliminating EXO1 is unlikely to extend lifespan except in 
organisms where telomeres are highly dysfunctional (Wei et al., 2003). However, these 
data suggest the possibility that careful modulation of EXO1 activity in whole 
organisms may be sufficient to extend the lifespan of a wild type organism, or combat 
the pathologies seen in diseases of telomere dysfunction, such as Dyskeratosis 
congenita. Considering this, determining the identity of other nuclease activities that 
function to resect uncapped telomeres in budding yeast (ExoX and ExoY) may have 
profound implications for human health (Zubko et al., 2004). 
Finally, EXO1 appears to degrade both telomerase-deficient and ‘uncapped’ telomeres, 
both of which are able to initiate a DDR (Garvik et al., 1995, Khadaroo et al., 2009, 
Maringele and Lydall, 2002, Maringele and Lydall, 2004a). It will be important to 
understand which of these two sets of dysfunctional telomeres more closely resembles 
the situation seen in senescent mammalian and human cells and this will be facilitated 
by the identification of nuclease activities involved in the resection of either telomerase-
deficient or uncapped telomeres but not both.  
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1.5 Aims and Objectives 
Telomere dysfunction plays a causal role in ageing and can play causal roles in diseases 
such as cancer and DC (Bessler et al., 2010, Lin et al., 2010, Blasco et al., 1997, Lee et 
al., 1998a). The exonuclease Exo1 has been shown to play a pivotal role in driving 
telomere dysfunction at both ‘uncapped’ telomeres in budding yeast and at 
dysfunctional telomeres in telomerase knock-out mice (Maringele and Lydall, 2002, 
Schaetzlein et al., 2007). Thus, Exo1 is likely to be a determinant of cellular ageing and 
may promote disease states such as cancer and DC. At uncapped telomeres in budding 
yeast, additional nucleases that function independently of Exo1 (such as ExoX and 
ExoY) are known to exist but have not yet been identified (Zubko et al., 2004). These 
unidentified nucleases, like Exo1, might also play critical roles at dysfunctional 
telomeres in higher organisms. Thus, the purpose of this work was; to identify novel 
determinants of Exo1-independent nuclease activities that function at uncapped 
telomeres in budding yeast; to assess the contribution of Exo1-independent nuclease 
activities to resection of uncapped telomeres in cdc13-1 mutants and subsequent 
checkpoint activation; to gain mechanistic insight into the roles of Exo1-independent 
nuclease activities at uncapped telomeres. 
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2 Methods 
2.1 Yeast Strains and Growth 
2.1.1 Yeast Strains 
All strains used in this study were in the W303 background and were ade2-1 trp1-1 
can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5+. Gene deletions were 
all constructed using PCR-based cassettes and confirmed by PCR to check the presence 
of the TEF promoter (Goldstein and McCusker, 1999, Longtine et al., 1998). 
Point mutations were confirmed by restriction digest of PCR products to confirm the 
presence of an RFLP carried by the mutant allele. M1877 and M1878 were used to 
amplify a 500bp fragment of Pif1 that contained an ApaI site in pif1-m1 strains or a 
XhoI site in pif1-m2 strains (Schulz and Zakian, 1994). M1879 and M1880 were used to 
amplify a 350bp fragment of Pif1 that contained a MboI site in pif1-hd mutants 
(Ribeyre et al., 2009). 
For all cdc13∆ mutants and cdc13-1 mutants able to grow at 36°C, the presence of a 
null mutation in CDC13 was confirmed by mating to a cdc13-1 mutant of the opposite 
mating type to confirm that the diploid was thermosensitive at 36°C.  
BAR1+/bar1∆ mutants were typed by PCR with either primers M1114 and M1156 to 
amplify a fragment of BAR1 or M1157 and M1158 to amplify the hisG sequence, which 
replaced BAR1+.  
Presence of the cdc15-2 mutation was confirmed by mating to a cdc15-2 mutant of the 
opposite mating type (DLY349/DLY350) to see whether the diploid was 
thermosensitive at 36°C (homozygous for cdc15-2).  
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Strain 
Number 
Genotype Source 
DLY349 MATa cdc15-2 Kim Nasmyth Lab. 
DLY350 MATα cdc15-2 Kim Nasmyth Lab. 
DLY640 MATa Rodney Rothstein 
DLY657 MATa rad9∆::HIS3 (Zubko et al., 2004) 
DLY658 MATα rad9∆::HIS3 (Zubko et al., 2004) 
DLY1108 MATa cdc13-1 (Zubko et al., 2004) 
DLY1195 MATα cdc13-1 (Zubko et al., 2004) 
DLY1255 MATa cdc13-1 rad9∆::HIS3 (Zubko et al., 2004) 
DLY1256 MATα cdc13-1 rad9∆::HIS3 (Zubko et al., 2004) 
DLY1256 MATα cdc13-1 rad9∆::HIS3 (Zubko et al., 2004) 
DLY1257 MATa cdc13-1 rad24∆::TRP1 (Zubko et al., 2004) 
DLY1258 MATα cdc13-1 rad24∆::TRP1 (Zubko et al., 2004) 
DLY1259 MATa cdc13-1 rad24∆::TRP1 rad9∆::HIS3 (Zubko et al., 2004) 
DLY1272 MATα exo1∆::LEU2 (Zubko et al., 2004) 
DLY1273 MATα exo1∆::LEU2 (Zubko et al., 2004) 
DLY1296 MATa cdc13-1 exo1Δ::LEU2 (Zubko et al., 2004) 
DLY1297 MATα cdc13-1 exo1Δ::LEU2 (Zubko et al., 2004) 
DLY1358 MATα cdc13-1 rad24∆::TRP1 rad9∆::HIS3 (Zubko et al., 2004) 
DLY1377 MATa rad27∆::TRP1  LSY702 2A. Generous gift 
from Alain Nicolas. 
DLY1408 MATa exo1∆::LEU2 yku70::HIS3 (Maringele and Lydall, 
2002) 
DLY1412 MATa yku70∆::HIS3 (Maringele and Lydall, 
2002) 
DLY1434 MATa bar1Δ::hisG cdc15-2 cdc13-1 exo1Δ::LEU2 
rad24Δ::TRP1 
(Zubko et al., 2004) 
DLY1470 MATa bar1Δ::hisG cdc15-2 cdc13-1 rad9Δ::HIS3 (Zubko et al., 2004) 
DLY1569 MATα rad52∆::TRP1 (Maringele and Lydall, 
2004a) 
DLY1628 MATα tlc1∆::HIS3 yCP::TLC1::URA3 (Maringele and Lydall, 
2004a) 
DLY1692 MATa cdc13-1 rad9∆::HIS3 exo1∆::LEU2 (Zubko et al., 2004) 
DLY1693 MATα cdc13-1 rad9∆::HIS3 exo1∆::LEU2 (Zubko et al., 2004) 
DLY1694 MATα cdc13-1 rad24∆::TRP1 rad9∆::HIS3 exo1∆::LEU2 (Zubko et al., 2004) 
DLY1695 MATa cdc13-1 rad24∆::TRP1 rad9∆::HIS3 exo1∆::LEU2 (Zubko et al., 2004) 
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DLY1696 MATα cdc13-1 exo1Δ::LEU2 rad24Δ::TRP1 (Zubko et al., 2004) 
DLY1696 MATα cdc13-1 rad24∆::TRP1 exo1∆::LEU2 (Zubko et al., 2004) 
DLY1697 MATα cdc13-1 rad24∆::TRP1 exo1∆::LEU2 (Zubko et al., 2004) 
DLY1701 MATα exo1Δ::LEU2 rad24Δ::TRP1 (Zubko et al., 2004) 
DLY2384 MATa cdc13-1 pif1∆::KANMX (Downey et al., 2006) 
DLY3001 MATα Rodney Rothstein 
DLY3799 MATα can1∆ ::STE2pr-Sp_his5 lyp1∆::STE3pr-LEU2 his3∆1 
leu2∆0 ura3∆0 
Y8205 
DLY4681 MATa cdc13-1 pif1∆::KANMX ogg1∆::NATMX 2384 transformed with 
ogg1∆::NATMX 
DLY4718 MATα cdc13-1 sgs1∆::KANMX (Ngo and Lydall, 2010) 
DLY4719 MATa cdc13-1 sgs1∆::KANMX (Ngo and Lydall, 2010) 
DLY4721 MATa sgs1∆::KANMX (Ngo and Lydall, 2010) 
DLY4722 MATa sgs1∆::KANMX (Ngo and Lydall, 2010) 
DLY4863 MATa pif1-m1 DLY640 transformed with 
pDL1213 and popped-out 
DLY4866 MATa pif1-m2 DLY640 transformed with 
pDL1215 and popped-out 
DLY4872 MATa cdc13-1 pif1∆::NATMX DDY244 
DLY4872 MATa pif1∆::NATMX DDY244 
DLY4872 MATa pif1∆::NATMX DDY244 
DLY4873 MATα cdc13-1 pif1Δ::NATMX DDY244 
DLY4873 MATα pif1∆::NATMX DDY244 
DLY4873 MATα pif1∆::NATMX DDY244 
DLY4874 MATa cdc13-1 pif1∆::NATMX DDY244 
DLY4875 MATα cdc13-1 pif1Δ::NATMX DDY244 
DLY4876 MATa pif1∆::NATMX rad9∆::HIS3 DDY244 
DLY4877 MATα pif1∆::NATMX rad9∆::HIS3 DDY244 
DLY4878 MATa cdc13-1 rad9∆::HIS3 pif1∆::NATMX DDY244 
DLY4879 MATα cdc13-1 rad9∆::HIS3 pif1∆::NATMX DDY244 
DLY4880 MATa ogg1∆::NATMX DDY241 
DLY4881 MATα ogg1∆::NATMX DDY241 
DLY4882 MATa cdc13-1 ogg1∆::NATMX  DDY241 
DLY4883 MATα cdc13-1 ogg1∆::NATMX DDY241 
DLY4884 MATa ogg1∆::NATMX rad9∆::HIS3 DDY241 
DLY4885 MATα ogg1∆::NATMX rad9∆::HIS3 DDY241 
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DLY4886 MATa cdc13-1 ogg1∆::NATMX DDY241 
DLY4887 MATα cdc13-1 ogg1∆::NATMX DDY241 
DLY4940 MATα ogg1∆::NATMX pif1∆::KANMX 4681 x 658 
DLY4941 MATα ogg1∆::NATMX pif1∆::KANMX 4681 x 658 
DLY4942 MATα cdc13-1 pif1∆::KANMX ogg1∆::NATMX 4861 x 658 
DLY4943 MATα cdc13-1 pif1∆::KANMX ogg1∆::NATMX 4861 x 658 
DLY4944 MATa pif1∆::KANMX ogg1∆::NATMX rad9∆::HIS3 4681 x 658 
DLY4945 MATα pif1∆::KANMX ogg1∆::NATMX rad9∆::HIS3 4681 x 658 
DLY4946 MATa cdc13-1 ogg1∆::NATMX pif1∆::KANMX rad9∆::HIS3 4861 x 658 
DLY4947 MATα cdc13-1 ogg1∆::NATMX pif1∆::KANMX rad9∆::HIS3 4861 x 658 
DLY5110 MATα can1∆::STE2pr-Sp_his5 lyp1∆::STE3pr-LEU2 his3∆1 
leu2∆0 ura3∆0 pif1∆::NATMX 
Marker Swap of DLY5318 
with pDL1155 
DLY5205 MATα bar1Δ::hisG cdc15-2 cdc13-1 pif1Δ::NATMX 1470 x 4873 
DLY5318 MATα pif1∆::KANMX pif1∆ from Lydall Lab 
deletion library v1. 
DLY5323 MATa cdc13-1 exo1Δ::LEU2 pif1Δ::NATMX 4874 x 1696 
DLY5324 MATα cdc13-1 exo1Δ::LEU2 pif1Δ::NATMX 4874 x 1696 
DLY5325 MATa cdc13-1 rad24∆::TRP1 pif1∆::NATMX 4874 x 1696 
DLY5326 MATα cdc13-1 rad24∆::TRP1 pif1∆::NATMX 4874 x 1696 
DLY5327 MATa cdc13-1 rad24∆::TRP1 exo1∆::LEU2 pif1∆::NATMX 4874 x 1696 
DLY5328 MATα exo1∆::LEU2 rad24∆::TRP1 pif1∆::NATMX cdc13-1 4874 x 1696 
DLY5328 MATα cdc13-1 rad24∆::TRP1 exo1∆::LEU2 pif1∆::NATMX 4874 x 1696 
DLY5331 MATa cdc13-1 exo1∆::LEU2 rad9∆::HIS3 pif1∆::NATMX 4878 x 1694 
DLY5332 MATα cdc13-1 exo1∆::LEU2 rad9∆::HIS3 pif1∆::NATMX 4878 x 1694 
DLY5333 MAT cdc13-1 rad24∆::TRP1 rad9∆::HIS3 pif1∆::NATMX 4878 x 1694 
DLY5334 MAT cdc13-1 rad24∆::TRP1 rad9∆::HIS3 pif1∆::NATMX 4878 x 1694 
DLY5335 MATa cdc13-1 rad24∆::TRP1 rad9∆::HIS3 exo1∆::LEU2 
pif1∆::NATMX 
4878 x 1694 
DLY5336 MATα cdc13-1 rad24∆::TRP1 rad9∆::HIS3 exo1∆::LEU2 
pif1∆::NATMX 
4878 x 1694 
DLY5337 MATα rad27∆::TRP1 1377 x 4879 
DLY5338 MATa rad27∆::TRP1 pif1∆::NATMX 1377 x 4879 
DLY5339 MATα rad27∆::TRP1 pif1∆::NATMX 1377 x 4879 
DLY5340 MATa cdc13-1 rad27∆::TRP1  1377 x 4879 
DLY5341 MATα cdc13-1 rad27∆::TRP1 1377 x 4879 
DLY5342 MATa cdc13-1 rad27∆::TRP1 pif1∆::NATMX 1377 x 4879 
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DLY5343 MATα cdc13-1 rad27∆::TRP1 pif1∆::NATMX 1377 x 4879 
DLY5353 MATa cdc13-1 pif1-m2 4866 x 1256 
DLY5358 MATa bar1Δ::hisG cdc15-2 cdc13-1 1434 x 5205 
DLY5359 MATa bar1Δ::hisG cdc15-2 cdc13-1 pif1Δ::NATMX 1434 x 5205 
DLY5360 MATa bar1Δ::hisG cdc15-2 cdc13-1 exo1Δ::LEU2 1434 x 5205 
DLY5361 MATa bar1Δ::hisG cdc15-2 cdc13-1 exo1Δ::LEU2 
pif1Δ::NATMX  
1434 x 5205 
DLY5395 MATa exo1Δ::LEU2 pif1Δ::NATMX 4872 x 1701 
DLY5396 MATα exo1Δ::LEU2 pif1Δ::NATMX 4872 x 1701 
DLY5460 MATa cdc13-1 exo1Δ::LEU2 pif1-m2 5353 x 1696 
DLY5461 MATα cdc13-1 exo1Δ::LEU2 pif1-m2 5353 x 1696 
DLY5506 MATa yku70::HIS3 1408 x 4873 
DLY5507 MATα yku70∆::HIS3 1408 x 4872 
DLY5508 MATa yku70∆::HIS3 pif1∆::NATMX 1408 x 4872 
DLY5509 MATα yku70∆::HIS3 pif1∆::NATMX 1408 x 4872 
DLY5510 MATa yku70∆::HIS3 exo1∆::LEU2 1408 x 4872 
DLY5511 MATα yku70∆::HIS3 exo1∆::LEU2 1408 x 4872 
DLY5512 MATa yku70∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 1408 x 4872 
DLY5513 MATα yku70∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 1408 x 4872 
DLY5532 MATa cdc13-1 pif1-m1 4863 x 1256 
DLY5678 MATa pif1-hd DLY640 transformed with 
pDL1293 and popped-out 
DLY5682 MATa cdc13-1 exo1Δ::LEU2 pif1-m1 5532 x 1696 
DLY5683 MATα cdc13-1 exo1Δ::LEU2 pif1-m1 5532 x 1696 
DLY5702 MATα pol32∆::KANMX DDY335 
DLY5703 MATa pol32∆::KANMX DDY335 
DLY5704 MATα pol32∆::KANMX DDY335 
DLY5715 MATa cdc13-1 sgs1∆::KANMX pif1∆::NATMX 4719 x 5324 
DLY5716 MATα cdc13-1 sgs1∆::KANMX pif1∆::NATMX 4719 x 5324 
DLY5717 MATa cdc13-1 pol32∆::KANMX DDY335 
DLY5718 MATa cdc13-1 pol32∆::KANMX DDY335 
DLY5723 MATa cdc13-1 pif1-hd 5678 x 1256 
DLY5742 MATa pif1∆::NATMX dna2∆::HPHMX DDY352 
DLY5743 MATα pif1∆::NATMX dna2∆::HPHMX DDY352 
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DLY5744 MATa cdc13-1 pif1∆::NATMX dna2∆::HPHMX DDY352 
DLY5745 MATalpha cdc13-1 pif1∆::NATMX dna2∆::HPHMX DDY352 
DLY5771 MATa sgs1∆::KANMX pif1∆::NATMX 4721 x 5396 
DLY5772 MATα sgs1∆::KANMX pif1∆::NATMX 4721 x 5396 
DLY5781 MATa cdc13-1 exo1Δ::LEU2 pif1-hd 5723 x 1696 
DLY5782 MATα cdc13-1 exo1Δ::LEU2 pif1-hd 5723 x 1696 
DLY5860 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 1 (23°C) 
DLY5861 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 1 (23°C) 
DLY5862 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 1 (23°C) 
DLY5863 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 1 (23°C) 
DLY5864 MATa pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 1 (23°C) 
DLY5909 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 11 (23°C) 
DLY5910 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 11 (23°C) 
DLY5911 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 11 (23°C) 
DLY5912 MATα pif1∆::NATMX exo1∆::LEU2 cdc13∆::HPHMX DDY341, passage 11 (23°C) 
DLY5913 MATa tlc1∆::HIS3 5395 x 1628, passage 1 
(23°C) 
DLY5914 MATα tlc1∆::HIS3 5395 x 1628, passage 1 
(23°C) 
DLY5915 MATa exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(23°C) 
DLY5916 MATα exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(23°C) 
DLY5917 MATa tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(23°C) 
DLY5918 MATα tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(23°C) 
DLY5919 MATa tlc1∆::HIS3 5395 x 1628, passage 11 
(23°C) 
DLY5920 MATα tlc1∆::HIS3 5395 x 1628, passage 11 
(23°C) 
DLY5921 MATa exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 11 
(23°C) 
DLY5922 MATα exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 11 
(23°C) 
DLY5923 MATa tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 11 
(23°C) 
DLY5924 MATα tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 11 
(23°C) 
DLY5925 MATa 5395 x 1628, passage 1 
(30°C) 
DLY5926 MATa pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5927 MATa exo1∆::LEU2 5395 x 1628, passage 1 
(30°C) 
DLY5928 MATa exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5929 MATa tlc1∆::HIS3 5395 x 1628, passage 1 
(30°C) 
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DLY5930 MATα tlc1∆::HIS3 5395 x 1628, passage 1 
(30°C) 
DLY5931 MATa tlc1∆::HIS3 pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5932 MATα tlc1∆::HIS3 pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5933 MATa tlc1∆::HIS3 exo1∆::LEU2 5395 x 1628, passage 1 
(30°C) 
DLY5934 MATα tlc1∆::HIS3 exo1∆::LEU2 5395 x 1628, passage 1 
(30°C) 
DLY5935 MATa tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5936 MATα tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 1 
(30°C) 
DLY5937 MATa 5395 x 1628, passage 15 
(30°C) 
DLY5938 MATa pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5939 MATa exo1∆::LEU2 5395 x 1628, passage 15 
(30°C) 
DLY5940 MATa exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5941 MATa tlc1∆::HIS3 5395 x 1628, passage 15 
(30°C) 
DLY5942 MATα tlc1∆::HIS3 5395 x 1628, passage 15 
(30°C) 
DLY5943 MATa tlc1∆::HIS3 pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5944 MATα tlc1∆::HIS3 pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5945 MATa tlc1∆::HIS3 exo1∆::LEU2 5395 x 1628, passage 15 
(30°C) 
DLY5946 MATα tlc1∆::HIS3 exo1∆::LEU2 5395 x 1628, passage 15 
(30°C) 
DLY5947 MATa tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5948 MATα tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 5395 x 1628, passage 15 
(30°C) 
DLY5989 MATα pif1∆::NATMX exo1::LEU2 cdc13::HPHMX 
yEP::URA3::CDC13 
5860 transformed with 
pDL1012 
DLY5991 MATa pif1∆::NATMX exo1::LEU2 cdc13::HPHMX 
yEP::URA3::CDC13 
5864 transformed with  
pDL1012 
DLY6093 MATα yEP::URA3::CDC13 DDY419 (30°C) 
DLY6094 MATα tlc1∆::HIS3 yEP::URA3::CDC13 DDY419 (30°C) 
DLY6095 MATa exo1∆::LEU2 pif1∆::NATMX yEP::URA3::CDC13 DDY419 (30°C) 
DLY6096 MATα tlc1∆::HIS3 exo1∆::LEU2 pif1∆::NATMX 
yEP::URA3::CDC13 
DDY419 (30°C) 
DLY6097 MATa cdc13∆::HPHMX yEP::URA3::CDC13 DDY419 (30°C) 
DLY6098 MATα cdc13∆::HPHMX tlc1∆::HIS3 yEP::URA3::CDC13 DDY419 (30°C) 
DLY6099 MATα cdc13∆::HPHMX exo1∆::LEU2 pif1∆::NATMX 
yEP::URA3::CDC13 
DDY419 (30°C) 
DLY6100 MATα cdc13∆::HPHMX tlc1∆::HIS3 exo1∆::LEU2 
pif1∆::NATMX yEP::URA3::CDC13 
DDY419 (30°C) 
DLY6331 MATα ade2::NATMX  est2::KANMX yCP::URA3::EST2 YAB618. Generous Gift 
from Alessandro Bianchi. 
DLY6369 MATα est2::KANMX yCP::URA3::EST2 640 x 6331 
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DLY6440 MATα yEP::URA3::CDC13 5991 x 1628 
DLY6441 MATα yEP::URA3::CDC13 5991 x 1628 
DLY6442 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 1628 
DLY6443 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 1628 
DLY6444 MATa yEP::URA3::CDC13 tlc1∆::HIS3 5991 x 1628 
DLY6445 MATa yEP::URA3::CDC13 tlc1∆::HIS3 5991 x 1628 
DLY6446 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
tlc1∆::HIS3 
5991 x 1628 
DLY6447 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
tlc1∆::HIS3 
5991 x 1628 
DLY6448 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 1628 
DLY6449 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 1628 
DLY6450 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 1628 
DLY6451 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 1628 
DLY6452 MATα yEP::URA3::CDC13 tlc1∆::HIS3 cdc13∆::HPHMX 5991 x 1628 
DLY6453 MATα yEP::URA3::CDC13 tlc1∆::HIS3 cdc13∆::HPHMX 5991 x 1628 
DLY6454 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
tlc1∆::HIS3 cdc13∆::HPHMX 
5991 x 1628 
DLY6455 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
tlc1∆::HIS3 cdc13∆::HPHMX 
5991 x 1628 
DLY6456 MATa yEP::URA3::CDC13 5991 x 5702 
DLY6457 MATα yEP::URA3::CDC13 5991 x 5702 
DLY6458 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 5702 
DLY6459 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 5702 
DLY6460 MATa yEP::URA3::CDC13 pol32∆::KANMX 5991 x 5702 
DLY6461 MATα yEP::URA3::CDC13 pol32∆::KANMX 5991 x 5702 
DLY6462 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
pol32∆::KANMX 
5991 x 5702 
DLY6463 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
pol32∆::KANMX 
5991 x 5702 
DLY6464 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 5702 
DLY6465 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 5702 
DLY6466 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 5702 
DLY6467 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 5702 
DLY6468 MATα yEP::URA3::CDC13 pol32∆::KANMX 
cdc13∆::HPHMX 
5991 x 5702 
DLY6469 MATa yEP::URA3::CDC13 pol32∆::KANMX 
cdc13∆::HPHMX 
5991 x 5702 
DLY6470 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
pol32∆::KANMX cdc13∆::HPHMX 
5991 x 5702 
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DLY6471 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
pol32∆::KANMX cdc13∆::HPHMX 
5991 x 5702 
DLY6520 MATa yEP::URA3::CDC13 5506 x 5989 
DLY6521 MATα yEP::URA3::CDC13 5506 x 5989 
DLY6522 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5506 x 5989 
DLY6523 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5506 x 5989 
DLY6524 MATa yEP::URA3::CDC13 yku70∆::HIS3 5506 x 5989 
DLY6525 MATα yEP::URA3::CDC13 yku70∆::HIS3 5506 x 5989 
DLY6526 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
yku70∆::HIS3 
5506 x 5989 
DLY6527 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
yku70∆::HIS3 
5506 x 5989 
DLY6528 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5506 x 5989 
DLY6529 MATα yEP::URA3::CDC13 cdc13∆::HPHMX 5506 x 5989 
DLY6530 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5506 x 5989 
DLY6531 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5506 x 5989 
DLY6532 MATa yEP::URA3::CDC13 yku70∆::HIS3 cdc13∆::HPHMX 5506 x 5989 
DLY6533 MATa yEP::URA3::CDC13 yku70∆::HIS3 cdc13∆::HPHMX 5506 x 5989 
DLY6534 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
yku70∆::HIS3 cdc13∆::HPHMX 
5506 x 5989 
DLY6535 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
yku70∆::HIS3 cdc13∆::HPHMX 
5506 x 5989 
DLY6552 MATa yEP::URA3::CDC13 5991 x 1569 
DLY6553 MATα yEP::URA3::CDC13 5991 x 1569 
DLY6554 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 1569 
DLY6555 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 5991 x 1569 
DLY6556 MATa yEP::URA3::CDC13 rad52∆::TRP1 5991 x 1569 
DLY6557 MATα yEP::URA3::CDC13 rad52∆::TRP1 5991 x 1569 
DLY6558 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
rad52∆::TRP1 
5991 x 1569 
DLY6559 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
rad52∆::TRP1 
5991 x 1569 
DLY6560 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 1569 
DLY6561 MATa yEP::URA3::CDC13 cdc13∆::HPHMX 5991 x 1569 
DLY6562 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 1569 
DLY6563 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
cdc13∆::HPHMX 
5991 x 1569 
DLY6564 MATα yEP::URA3::CDC13 rad52∆::TRP1 cdc13∆::HPHMX 5991 x 1569 
DLY6565 MATα yEP::URA3::CDC13 rad52∆::TRP1 cdc13∆::HPHMX 5991 x 1569 
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DLY6566 MATa yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
rad52∆::TRP1 cdc13∆::HPHMX 
5991 x 1569 
DLY6567 MATα yEP::URA3::CDC13 pif1∆::NATMX exo1∆::LEU2 
rad52∆::TRP1 cdc13∆::HPHMX 
5991 x 1569 
DDY179 cdc13-1/CDC13+ rad9Δ::HIS3/RAD9+ DLY640 x DLY1256 
DDY241 cdc13-1/CDC13+ rad9Δ::HIS3/RAD9+ 
ogg1Δ::NATMX/OGG1+ 
Transformation of DDY179 
with ogg1∆::NATMX 
DDY244 cdc13-1/CDC13+ rad9Δ::HIS3/RAD9+ pif1Δ::NATMX/PIF1+ Transformation of DDY179 
with pif1Δ::NATMX 
DDY335 cdc13-1/CDC13+ rad9Δ::HIS3/RAD9+ 
pol32Δ::KANMX/POL32+ 
Transformation of DDY179 
with pol32Δ::KANMX 
DDY340 cdc13Δ::HPHMX/CDC13+ pif1Δ::NATMX/PIF1+ 
exo1Δ::LEU2/EXO1+ 
Transformation of 
DLY4872 x DLY1273 with 
cdc13Δ::HPHMX 
DDY341 cdc13Δ::HPHMX/CDC13+ pif1Δ::NATMX/PIF1+ 
exo1Δ::LEU2/EXO1+ 
Transformation of 
DLY4872 x DLY1273 with 
cdc13Δ::HPHMX 
DDY351 cdc13Δ::HPHMX/CDC13+ tlc1∆::HIS3/TLC1+ 
pif1Δ::NATMX/PIF1+ exo1Δ::LEU2/EXO1+ 
Transformation of 
DLY5395 x DLY1628 with 
cdc13∆::HPHMX 
DDY352 cdc13-1/CDC13+ rad9Δ::HIS3/RAD9+ pif1Δ::NATMX/PIF1+ 
dna2Δ::NATMX/DNA2+ 
Transformation of 
DLY1256 x DLY4872 with 
dna2∆::HPHMX 
DDY419 cdc13Δ::HPHMX/CDC13+ tlc1∆::HIS3/TLC1+ 
pif1Δ::NATMX/PIF1+ 
exo1Δ::LEU2/EXO1+yEP::URA3::CDC13 
Transformation of DDY351 
with pDL1012 
 
Table 1: yeast strains used in this study 
41 
 
2.1.2 Conditional mutants used in this study 
The cdc13-1 mutation in the essential gene CDC13 causes a temperature-sensitive 
capping defect, permitting growth at 23°C (permissive temperature), eliminating growth 
at 36°C (non-permissive) and inhibiting growth at 25°C-30°C (semi-permissive) 
(Garvik et al., 1995). 
The cdc15-2 mutation in the essential gene CDC15 causes a temperature-sensitive 
defect in mitotic exit. At the non-permissive temperature, mitotic exit is inhibited and 
cells remain arrested without loss of viability (Lydall and Weinert, 1995). 
The yku70∆ mutation eliminates the Yku70 subunit of the Ku complex and causes a 
temperature-sensitive telomere capping defect, with a permissive temperature of 30°C, a 
non-permissive temperature of 37.5°C and a semi-permissive temperature of 34°C-37°C 
(Feldmann and Winnacker, 1993, Teo and Jackson, 2001). 
The pif1∆ mutation eliminates the Pif1 helicase and causes a temperature-sensitive 
defect in mtDNA maintenance, with a permissive temperature on a non-fermentable 
carbon source (e.g. YEPG) of 23°C and a semi-permissive temperature range of 30°C-
36°C, while being permissive at all temperatures on a fermentable carbon source (Van 
Dyck et al., 1992). 
2.1.3 Strains with passage-dependent phenotypes 
Strains lacking telomerase components (TLC1, Est2) or Cdc13 displayed passage-
dependent phenotypes so, unless otherwise stated, all experimental strains and controls 
were germinated in parallel and (where possible) from the same diploid. 
2.1.4 Standard Growth Conditions 
Yeast strains were grown on agar plates by streaking for colonies and allowing growth 
to occur at 23°C for 3 days. To identify genetic markers, single colonies were patched 
onto YEPD plates and grown overnight, then replicated to selective plates and allowed 
to grow for 1-2 days. To make liquid cultures, 3-5 single colonies were pooled, and a 
small amount was innoculated into 2 ml YEPD and then grown at 23°C overnight (for 
overnight cultures) or for 2 days (for saturated cultures) in lidded glass tubes with 
aeration. Exponentially-dividing cultures were prepared by diluting a saturated culture 
1:500-1:1500 and allowing to grow for approximately 16 hours at 23°C with shaking at 
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180 RPM. Exponentially-dividing cultures were kept at 0.5-2.0x107 cells/ml with 
shaking at 180 RPM at the appropriate experimental temperature.  
2.1.5 Recipes for yeast media 
All reagents were from Sigma or Formedium, unless otherwise stated. 
Yeast Extract, Peptone, Dextrose (YEPD) 
1% yeast extract, 2% peptone, 2% dextrose, 75 mg/L adenine. 
For 1L of media: 10 g of yeast extract and 20 g peptone were made up to 935 ml with 
MQ water, shaken to mix, autoclaved then cooled to 60°C, before 50 ml of 40% (w/v) 
dextrose and 15 ml of 0.5% (w/v) adenine were added. 
For solid media, 20 g agar was added prior to autoclaving. 
YEPD + G418/ClonNAT/Hygromycin B 
Same as for YEPD except 1ml of 200 mg/ml G418, 1 ml 100 mg/ml ClonNAT or 1 ml 
300 mg/ml Hygromycin B was added following autoclaving. 
Camptothecin Media (CPT) 
Same as for YEPD except 10 mM Camptothecin in DMSO was added following 
autoclaving to a final concentration of 4-500 µM. 
Yeast extract, Peptone, Glycerol (YEPG) 
1% yeast extract, 2% peptone, 3% glycerol, 75 mg/L adenine. 
Same as for YEPD except 30 ml glycerol was added prior to autoclaving and dextrose 
was substituted with MQ water. 
Synthetic Media 
0.13% amino acids, 0.17% yeast nitrogen base, 0.5% ammonium sulphate 
For 1 L of media: 1.3 g of amino acid drop out powder (2.5 g adenine, 1.2 g argenine, 
6.0 g aspartic acid, 6.0 g glutamic acid, 1.2 g histidine, 3.6 g leucine, 1.8 g lysine, 1.2 g 
methionine, 3.0 g phenylalanine. 22.5 g serine, 12.0 g threonine, 2.4 g tryptophan, 1.8 g 
tyrosine, 9.0 g valine, 1.2 g uracil), 1.7 g of yeast nitrogen base and 5 g of ammonium 
sulphate were made up to 500 ml with MQ water, shaken to mix, autoclaved, mixed 
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with 500 ml of autoclaved MQ water (or 500 ml autoclaved MQ water containing 20 g 
agar, for solid media), then cooled to 60°C. 
-Histidine/-Uracil/-Leucine/-Tryptophan Media 
Same as synthetic media, except with exclusion of the appropriate amino acid(s) from 
the drop out powder. 
TMPyP4 Media (TMPyP4) 
Same as synthetic media, except TMPyP4 (50 mg/ml stock in water) was added to a 
final concentration of 100 µM following autoclaving. 
5-Fluoroorotic Acid Media (FOA) 
0.13% amino acids, 0.67% yeast nitrogen base, 0.005% uracil, 0.1% FOA 
For 1L of media: 1.3g of -Ura amino acid drop out powder (same as for synthetic 
media, but lacking uracil), 6.7g of yeast nitrogen base, 50mg Uracil and 1g of 5-
fluoroorotic acid were made up to 500ml with MQ water, shaken to mix, autoclaved, 
mixed with 500ml of autoclaved MQ water (or 500ml autoclaved MQ water containing 
20g agar, for solid media), then cooled to 60°C. 
2.2 Bacterial strains and growth 
2.2.1 Bacterial strains 
Bacteria used were all transformants of XL1-Blue competent Escherichia coli (recA1 
endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)]) 
from Stratagene. 
2.2.2 Standard growth conditions 
Bacteria were grown on agar plates by streaking for colonies and allowing to grow at 
36°C for 16 hours. To make overnight cultures, single colonies were innoculated into 
2ml LB and then grown at 36°C for 16 hours in a lidded glass tubes with aeration.  
2.2.3 Recipes for bacterial media 
Lysogeny Broth (LB) 
0.5% yeast extract, 1% peptone, 1% NaCL 
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For 1 L of media: 5 g of yeast extract, 10 g of peptone and 10 g of NaCl were made up 
to 1 L with MQ water, shaken to mix, autoclaved then cooled to 60°C. 
For solid media, 20 g agar was added prior to autoclaving 
LB + Ampicillin (LB + Amp) 
0.5% yeast extract, 1% peptone, 1% NaCL, 50µg/ml Ampicillin 
Same as LB but 1 ml of 50 mg/ml Ampicillin was added after cooling. 
Super Optimal broth with Catabolite repression (SOC) 
0.5% yeast extract, 2% tryptone, 9.7 mM NaCl, 2.2 mM KCl, 0.36% glucose, 10 mM 
MgCl2, 10 mM MgSO4 
For 1 L of media: 5 g of yeast extract, 20 g of tryptone, 0.585 g NaCL, 0.166 g KCl, 3.6 
g Glucose, 10 ml MgCl2 (1 M) and 10 ml MgSO4 (1 M) was made up to 1 L with MQ 
water, shaken to mix, autoclaved then cooled to 60°C. 
2.2.4 Bacterial transformation 
XL1-Blue cells (Stratagene) were transformed with 1 µL of plasmid DNA as per the 
manufacturer’s instructions, then plated onto LB + Amp and grown 16 hours at 36°C. 
2.2.5 Plasmid minipreps 
Overnight cultures in LB + Amp were spun in a bench-top centrifuge at 13,000 RPM to 
pellet cells, the supernatant was aspirated and then minipreps were performed using 
QIAprep Spin Miniprep Kits (Qiagen) using a microcentrifuge, as per the 
manufacturer’s instructions. 
2.2.6 Plasmids used in this study 
Plasmids used in this study are listed below and are stored at -20°C in 1X TE under 
standard conditions.
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Plasmid 
Number 
Details Source 
pDL698 Plasmid for amplification of hphMX4 gene deletion 
cassette by PCR. 
pAG32 (Goldstein and 
McCusker, 1999). Generous 
gift from Vincent Geli. 
pDL987 Carries a ~1000bp fragment of a yeast chromosomal end 
that contains 120-base pair telomere repeats and part of 
the Y’ repeat, which can be released by digestion with 
BamHI and XhoI. 
pHT128 (Tsubouchi and 
Ogawa, 2000). Generous gift 
of Hideo Tsubouchi. 
pDL1012 yEP::URA3::CDC13 yeast 2µ plasmid carrying CDC13 
on a 4.5kbp ApaI fragment, marked with URA3 
yep24::CDC13-1-4 (Garvik et 
al., 1995) 
pDL1042 Plasmid for amplification of kanMX6 gene deletion 
cassette by PCR 
pFA6a-kanMX6 (Longtine et 
al., 1998) 
pDL1155 Plasmid for switching deletion cassettes to NATMX. Cut 
with EcoRI and transform in to swap markers. 
pCRII-TOPO[TA::MX4-
natR] (Tong and Boone, 
2006) 
pDL1213 Plasmid for integrating pif1-m1 point mutation into the 
genome by pop-in-pop-out. Cut with HindIII to transform 
and pop-in.  
pVS30 (Schulz and Zakian, 
1994). Generous gift from 
Virginia Zakian. 
pDL1215 Plasmid for integrating pif1-m2 point mutation into the 
genome by pop-in-pop-out. Cut with HindIII to transform 
and pop-in. 
pVS31 (Schulz and Zakian, 
1994). Generous gift from 
Virginia Zakian. 
pDL1221 Plasmid for amplification of natMX4 gene deletion 
cassette by PCR. 
pAG25 (Goldstein and 
McCusker, 1999). Generous 
gift from Vincent Geli. 
pDL1223 Centromeric plasmid expressing both URA3 and the 
NATMX resistance cassette. 
pAG36 (Goldstein and 
McCusker, 1999). Generous 
gift from Vincent Geli. 
pDL1293 Plasmid for integrating pif1-hd (K264R) point mutation 
into the genome by pop-in-pop-out. Cut with Bsu36I to 
transform and pop-in. 
pJL71 (Ribeyre et al., 2009). 
Generous gift from Alain 
Nicolas. 
 
Table 2: plasmids used in this study 
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2.3 Yeast Genetics and Cell Biology 
2.3.1 Determination of mating type 
Patches of individual colonies were replicated onto lawns of MATa and MATα cells, 
grown overnight to permit mating and then replicated onto media that would only 
permit the growth of diploid cells. DLY26 (MATa) and DLY2440 (MATα) were HIS- 
LEU- URA- TRP- but would complement deficiencies in those biosynthetic pathways to 
form a HIS+ LEU+ URA+ TRP+ diploid when mated to a W303 strain and thus could 
conveniently be used to score mating type. 
2.3.2 Mating, sporulation and tetrad analysis 
Two parental strains of opposite mating type were picked up by toothpick, mixed on a 
YEPD plate and incubated overnight at 23°C to mate. Diploids were either struck onto 
selective plates (that selected for markers present in both parents) and allowed to form 
colonies or obtained by streaking for single colonies, patching onto YEPD plates and 
replica plating to identify non-mating strains.  
 
Individual diploid colonies were inoculated into 2ml YEPD and grown overnight with 
aeration. 0.5 ml of overnight culture was washed twice by spinning for 3 minutes at 
1,000 RPM and washing with with 4 ml sterile water. Diploid cells were re-suspended 
in 2 ml 1% KOAc and cultured for 2-3 days at 23°C with aeration. After 3 days 
sporulation, the culture was examined by phase contrast microscopy to check for the 
presence of spores. If spores were present, the culture was transferred to an eppendorf 
tube and the cells were pelleted by spinning at 13,000 RPM for 10 seconds. The cell 
pellet was washed twice in sterile water and re-suspended in a final volume of 1 ml 
sterile water then stored at 4°C. 40 µl of spores were transferred to a sterile eppendorf 
and mixed with 2.4 µl glusulase enzyme and incubated at 30°C for 10-13 min (usually 
12.5 min) until the sack around the tetrads was removed. The digested spores were then 
transferred to ice and 0.8 ml sterile water was added. 100 µl of digested spores were 
pipetted from the bottom of the tube and spread onto a YEPD plate along a marked line. 
Individual spores from <11 tetrads per plate were micromanipulated apart using a 
Microtec tetrad microscope then allowed to germinate and form colonies at 23°C for 3-
5 days or 30°C for 2-3 days. 
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Germinated spores were patched to another YEPD plate and grown overnight at 23°C. 
The YEPD plate was then replica plated onto appropriate selection plates for genotype 
identification.  
2.3.3 Gene deletion using antibiotic resistance constructs 
Gene deletion constructs were designed and amplified using plasmids constructs, as 
previously described (Goldstein and McCusker, 1999, Longtine et al., 1998) using PCR 
to amplify and tag antibiotic resistance cassettes with approximately 20 base pairs of 
sequence immediately flanking the relevant ORF. Constructs were designed to replace 
only the ORF and no flanking sequence, except when the flanking sequence contained 
repeat- or low GC-sequences that precluded primer design.  
Gene deletion constructs were amplified by PCR, run on an agarose, gel extracted and 
then transformed into diploid strains by high efficiency transformation of yeast (see 
Section 2.3.4).  
Presence of the deletion cassette was confirmed by PCR of yeast colonies, using 
inward-facing primers upstream and downstream of the ORF in combination with 
outward facing primers specific for the TEF promoter (m1942) and TEF terminator 
(m1941) which were present in the deletion cassettes.  
2.3.4 High efficiency transformation of yeast 
Exponentially-dividing cultures were allowed to reach 2x107 cells/ml. Cells were 
harvested at 3000 rpm for 3 min, the medium was poured off. Cells were washed once 
in 25 ml sterile water and then resuspended in 1 ml 0.1 M (1X) LiAc. Cells were 
transferred to an eppendorf tube and spun down at 13,000 RPM for 30 sec. LiAc was 
removed by aspiration. Cells were resuspended in a final volume of 0.5 ml by adding 
0.4 ml of 0.1M LiAc (2 x 109 cells/ml). Samples were vortexed and 50 µl of cell 
suspension was alliquoted out for each transformation. Cells were then kept on ice until 
ready for transformation. For each strain to be transformed, both positive and negative 
controls were carried out. Negative controls utilized water instead of transforming DNA 
was carried out to confirm selection for the transforming marker was successful. 
Positive controls utilized pDL1223 (a centromeric plasmid expressing both URA3 and 
NATMX) as transforming DNA and were selected for on -URA or ClonNAT plates, to 
confirm that the experiment supported successful transformation of auxotrophy or 
48 
antibiotic resistance markers (as appropriate). To transform, cell suspensions were 
pelleted at 13,000 rpm for 30 seconds, LiAc removed by aspiration and then the 
following reagents were then added in the following order: 
240 µl  PEG 4000 (50% w/v) 
36 µl  1M (10X) LiAc 
50 µl  Salmon Sperm DNA (10 mg/ml) 
50 µl  Transforming DNA in Water (0.1 – 10 µg) 
Samples were vortexed vigorously to ensure cell pellet was completely mixed, then 
incubated at 30°C for 30 min before being heat shocked at 42°C for 20 min. Cells were 
pelleted at 13 000 RPM for 30 sec and transformation mix removed by aspiration. Cells 
were resuspended in 200 µl sterile water then either plated onto selection plate to select 
for auxotrophy markers, or plated onto YEPD, incubated at 23°C overnight and then 
replica plated the next day onto plates containing antibiotics. Transformants were 
allowed to grow at 23°C for 4-5 days. Single colonies were then picked and struck out 
onto selective media to colony purify and prevent false positives. 
 
Salmon Sperm DNA (10 mg/ml) 
10 mg of DNA-sodium salt from Salmon testes (Sigma) per ml of water by was 
dissolved by sonicating for 10-20 second pulses. Prior to use, DNA was denatured by 
boiling for 5 minutes at 95°C and cooled rapidly on ice for 5 minutes.  
2.3.5 Quick transformation of yeast 
100 µl of stationary phase culture was spun down in a microcentrofuge for 1 minute at 
13,000 RPM then resuspended in 100 µl of one-step buffer, pipetting gently to mix. 
Transforming DNA (1 µl of plasmid miniprep, see Section 2.2.5, or 15 µl of high 
efficiency preparation of DNA, see Section 2.4.6) and 5.3 µl salmon sperm DNA (10 
mg/ml, see Section 2.3.4) were added then the transformation mix was vortexed and 
incubated at 45°C for 30 minutes. Transformation mix was then plated directly onto 
selective media and incubated at 23°C for 3-7 days. 
One-step buffer 
0.2 M LiAC, 40% PEG, 100 mM DTT. For 5 ml: 
 1 ml 2 M Lithium acetate 
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 4 ml 50% (V/V) PEG  
 75 mg DTT 
2.3.6 Introduction of point mutations into yeast strains 
URA3-marked integrating plasmids were cut by restriction digest using the appropriate 
restriction enzyme, purified by high efficiency preparation of DNA and then 
transformed into haploid yeast by high efficiency transformation. 
Single colonies from the transformation plates were restruck onto -URA plates to ensure 
purity. Single colonies were then restruck across half a YEPD plate, allowed to grow 
overnight, replica plated to FOA and allowed to grow overnight once more, then replica 
plated to FOA a final time and allowed to grow for 5-7 days so strains that had lost the 
insert could form colonies.  
Presence or absence of the point mutation was confirmed by colony PCR and restriction 
digest to test for the presence/absence of a restriction site introduced by the point 
mutation. 
2.3.7 Growth assays 
A 5-fold dilution series of stationary phase culture was prepared in a 96 well plate by 
adding 40 µl of the culture to 160 µl of fresh media then performing a serial dilution 
across the plate. 3-5 µl of each dilution was then spotted onto agar plates using a 
sterilized 48-prong replica plating device (Sigma). 
2.3.8 Passage experiments 
tlc1∆ strains and all controls were germinated for 3 days at 30°C, then restreaked for 
single colonies (passage 1 and onwards). cdc13∆ strains and all controls were 
germinated for 7 days at 23°C then patched onto a fresh YEPD plate (passage 1) before 
being restreaked for single colonies (passage 2 and onwards). For each passage, 
multiple single colonies were pooled and restreaked and each passage was stored at 4°C 
for the duration of the experiment. 
To generate stationary phase cultures for growth assays or DNA preps, plates 
corresponding to the appropriate strain and passage number were retrieved from 4°C 
and multiple single colonies were inoculated into 2 ml YEPD and grown to saturation 
for 2 days with aeration. To quantify growth at each passage, growth assays were 
performed on YEPD plates at 23°C for 4 days for cdc13∆ strains or 30°C for 3 days for 
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tlc1∆ strains, plates were photographed using a spImager (S&P Robotics) and the sum 
of the pixel intensity of the growth corresponding to each yeast strain was quantified 
using Colonyzer (Lawless et al., 2010).  
2.3.9 CDC13 Plasmid loss assay 
To test whether CDC13 was an essential gene, strains containing pURA3[CDC13] were 
generated by tetrad dissection, passaged on -URA plates for 3 days at 30°C to ensure 
retention of the plasmid, then multiple colonies were inoculated into YEPD, grown to 
stationary phase, and growth assays were performed on YEPD for 2 days, -URA for 3 
days and FOA for 5 days. For strains grown on FOA plates, either single colonies or the 
highest density spot were struck for single colonies onto YEPD, which were then 
patched and replica plated to determine genotype of any FOA-resistant colonies. 
2.3.10 Isolation of DNA from yeast (Yale DNA Preps) 
Yeast cells were grown to saturation in 2 ml YEPD. Cultures were transferred to an 
eppendorf tube and spun at 13,000 RPM (1 min) and the supernatant was removed by 
aspiration. Cells were resuspended in 250 µl 0.1M EDTA (pH 7.5), 1:1000 dilution β-
mercaptoethanol containing 2.5 mg/ml zymolase 20T. Cells were incubated at 37°C for 
approximately 1 hour until spheroplasted (monitored by microscopy), then shaken 
briefly after 15 minutes and vortexed at the end. 50 µl of miniprep mix (0.25 M EDTA 
pH 8.5, 0.5 M Tris base, 2.5% SDS) was then added to each of the tubes. Samples were 
mixed by inversion and incubated at 65°C for 30 min, mixing by inversion after 15 
minutes. Samples were vortexed before 68 µl of 5 M KAc was added, then vortexed 
again. Samples were then incubated on ice for 30 min until a viscous precipitate had 
formed, then spun at 13,000 RPM for 20 min before transferring supernatants to a new 
tube containing 720 µl of 100% ethanol. A visible DNA precipitate formed upon mixing 
by inversion. The samples were spun at 13,000 RPM for 10 min. 130 µl of TE 
containing 1 mg/ml RNAase A was added to the undried pellet and samples were 
resuspended by incubating at 37°C for 35 min with occasional vortexing. DNA was 
reprecipitated with 130 µl of isopropanol. Samples were mixed by inversion and spun 
for 20 minutes at 13,000 RPM. Tubes were then drained and 100 µl of 70% ethanol 
(vol/vol) was added to wash DNA and remove salts. Tubes were then spun again at 
13,000 RPM for 5 minutes before ethanol was aspirated. The pellets were then air dried 
for 30 minutes and resuspended in 40 µl TE with incubation at 37°C for 30 minutes, 
vortexing vigorously. Samples obtained contained approximately 10 µg of genomic 
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DNA and were stored at -20°C. 
2.3.11 Telomere uncapping in asynchronous cultures 
Asynchronously dividing (1x107 cells/ml) cdc13-1 mutants at 23°C were shifted to 
36°C. Every hour, cell density was counted by hemocytometry and, when necessary, 
diluted back down to 1x107 using media warmed to 36°C. 
2.3.12 Telomere uncapping and DSB induction in synchronous cultures 
Synchronous culture experiments were performed similarly to those described (Zubko 
et al., 2006). Exponentially-dividing bar1∆ cdc13-1 mutants, growing in culture flasks 
at 23°C were diluted down to 250 ml of 1.5x107 buds/ml (approximately 7.5x106 
cells/ml). α factor was added to 20nM (10 µl of 500 µM stock) and cells were grown 
for a further 2.5 hours at 23°C. Cells were counted again by hemocytometry and culture 
was removed from the highest density cultures so that each flask contained the same 
number of cells.  
Cultures were transferred to 250 ml tubes, 23°C YEPD was added up to 250 ml where 
necessary, then cells were spun down at 1,000 RPM for 4 minutes before discarding the 
supernatant. (This time point was noted as -40 minutes). The pellet was resuspended 
twice, each time resuspending in 50 ml YEPD and respinning in 50 ml Falcon tubes for 
3 min at 2,000 RPM. The final pellet was resuspended in 150ml of YEPD at 23°C in a 
500 ml flask and the culture was left at room temperature (23°C) until time 0. 
To induce telomere uncapping, 125 ml of YEPD at 51°C was added and then cultures 
were incubated at 36°C. To induce DSBs, 125 ml of YEPD at 23°C was added in 
addition to bleomycin to a final concentration of 50 µg/ml 
α factor (500 µM stock) 
0.842 mg dissolved per ml in water (25,000X for bar1∆ strains) 
2.3.13 Determination of cell number 
500 µl samples were taken from cultures and sonicated for 6 seconds at 5 microns 
(Sanyo Soniprep 150 sonicator) to separate clumps of cells. 10 µl of culture was then 
applied to a hemocytometer and >100 cells were counted to measure the number of cells 
in 100 nl, which was multiplied by 10,000 to obtained the number of cells per ml. 
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2.3.14 Determination of viability 
500 µl of culture was removed, vortexed thoroughly and 20 µl was removed and added 
to 980 µl of sterile water, before vortexting thoroughly to mix (1:50 dilution). 10 µl was 
then removed and added to 990 µl of sterile water (1:100 dilution) before vortexing to 
mix. 50 µl of the final 1:5,000 dilution was spread onto half an agar plate with a glass 
pipette, then another 50 µl spread onto the other half of the plate. Plates were incubated 
for 3 days at 23°C and viable cell number was determined as the mean number of 
colonies formed on each half of the plate. 
2.3.15 Scoring of cell cycle position 
2 ml of cell culture was fixed in Ethanol by spinning down at 13,000 rpm in a 
microcentrifuge for 10 seconds, aspirating the supernatant and then resuspending the 
pellet in 1 ml 70% Ethanol (V/V). Samples could then be stored at 4°C for up to a year. 
Ethanol was then washed out by spinning down again and resuspending in 500 µl sterile 
water, twice. Cells were then spun down once more, water aspirated and resuspended in 
200 µl – 500 µl of 0.2 µg/ml DAPI (4,6-diamidino-2-phenylindole). Samples were 
stored at 4°C in the dark. 
Samples were sonicated (Sanyo Soniprep 150 sonicator) for 1-10 seconds at 5 microns 
to separate clumps of cells, then 1-3 µl was applied to a cover slip and photographed 
under a fluorescence microscope (Nikon eclipse 50i) ensuring that the cells were not 
moving and to prevent preferential counting of larger cells. Photographs were then 
analyzed using the cell counter plugin for ImageJ (Abramoff et al., 2004), scoring cells 
as either G1 (no bud), S phase (single nucleus, bud less than or equal to half the 
diameter of the mother cell), metaphase (single nucleus, bud greater than half the 
diameter of the mother cell), anaphase (two nuclei) or other (none of the previous) as 
described (Zubko et al., 2006). 
2.3.16 Synthetic Genetic Array 
Synthetic genetic array was performed as described (Tong and Boone, 2006). The 
Lydall Lab deletion mutant library v2 was used as a deletion mutant array. The query 
strain for the pif1∆ SGA was pif1∆ MATα (DLY5110). To make DLY5110, MATa 
DLY5318 (pif1∆::KANMX  from Lydall Lab deletion mutant library v1) was mated to 
the MATα switcher strain (DLY3799), then the diploid transformed with cut pDL1155 
(pCRII-TOPO[TA::MX4-natR]) to swap pif1∆::KANMX to pif1∆::NATMX then which 
was then sporulated and tetrad dissected to produce DLY5110. 
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2.4 Molecular Biology 
2.4.1 Oligonucleotides 
Oligonucleotides listed below were stored at 20°C in 1X TE at 200 µM under standard 
conditions. The exception to this was CY5-labelled oligos, which were stored in Sigma 
H2O.
54 
 
Oligo 
Number 
Sequence Function 
M933 TGCAGGAATTTGGATCACACACTACAC Forward primer that binds upstream 
of TG repeats in pDL987. With 
m934 amplifies a ~180bp fragment 
which can be labeled to detect 
telomeric TG repeats on Southern 
Blots.  
M934 GCCGGGTAAGGAGTGACAGCG Reverse primer that binds 
downstream of TG repeats in 
pDL987. With m933 amplifies a 
~180bp fragment which can be 
labeled to detect telomeric TG 
repeats on Southern Blots.  
M935 AGCCCTACAACACTTCTACATAGCCCTAAA Forward primer that binds upstream 
of Y’ sequence in pDL987. With 
m936 amplifies a ~820bp fragment 
which can be labeled to detect Y’ 
sequences on Southern Blots.  
M936 TGTAATACGACTCACTATAGGGCGAATTGG Reverse primer that binds 
downstream of Y’ sequence in 
pDL987. With m935 amplifies a 
~820bp fragment which can be 
labeled to detect Y’ sequences on 
Southern Blots.  
M1012 AGCAAAGCAATAGTTCCCGTG Forward primer that binds within 
CDC13. With m1013 amplifies a 
~1500bp product which contains an 
EcoRI site in cdc13-1 
mutants.(Zubko and Lydall, 2006) 
M1013 TTGTGCGAGACGGATCGA Reverse primer that binds within 
CDC13. With m1011 amplifies a 
~1500bp product which contains an 
EcoRI site in cdc13-1 
mutants.(Zubko and Lydall, 2006) 
M1045 CTGCATTTGGCTCCATTTT Forward primer that binds within 
CDC15. With m1046 amplifies a 
~1800bp fragment which can be 
labeled to detect a single band from 
XhoI-digested DNA to serve as a 
loading control for telomere southern 
blots.(Foster et al., 2006) 
M1046 TGTTGTAATGGGGACGGAAA Reverse primer that binds within 
CDC15. With m1045 amplifies a 
~1800bp fragment which can be 
labeled to detect a single band from 
XhoI-digested DNA to serve as a 
loading control for telomere southern 
blots.(Foster et al., 2006) 
M1114 AGCGTCGACTATTGTGGGATA Reverse primer for amplifying 
BAR1. Binds within BAR1 and 
produces a 150bp product with 
M1156 in BAR1+ strains. 
M1156 AATAATCGATGTGGTCGCGTA Forward primer for amplifying 
BAR1. Binds within BAR1 and 
produces a 150bp product with 
M1114 in BAR1+ strains. 
M1157 CATATCCGCACCTCCTCAA Forward primer for amplifying hisG. 
Binds within hisG and produces a 
225bp product with M1158 in strains 
carrying a hisG locus. 
M1158 CTCTGTGCCATCTCACCGT Reverse primer for amplifying hisG. 
Binds within hisG and produces a 
225bp product with M1157 in strains 
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carrying a hisG locus. 
M1362 CGCACTTAACTTCGCATCTGGGC Reverse primer that recognizes the 
TEF terminator used in PCR based 
deletion modules. Used for 
confirming deletions.  
M1417 CGTGCGATACGTTTTTGAGT Forward primer which binds ~500bp 
upstream of OGG1. Used with 
m1362 to confirm gene deletion. 
M1475 TTGCTGGCCTATCTTCATTG Forward primer which binds ~500bp 
upstream of PIF1. Used with m1362 
to confirm gene deletion. 
M1579 tttgtgcaagcaaacactgacaattgaagagatcgtcagg 
CACATACGATTTAGGTGACAC 
Forward primer for gene deletion of 
DNA2 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1580 tagctttcctgttatggagaagctcttcttattccccctg 
AATACGACTCACTATAGGGAG 
Reverse primer for gene deletion of 
DNA2 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1581 agcgtcctgattcataattgcgattttatttatcaaccag 
CACATACGATTTAGGTGACAC 
Forward primer for gene deletion of 
OGG1 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1582 tcgcgtgcttttatcgtggtatttactatgactttttaag 
AATACGACTCACTATAGGGAG 
Reverse primer for gene deletion of 
OGG1 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1583 tccattgagcgattagcttacttgtatcaatcaattttac 
CACATACGATTTAGGTGACAC 
Forward primer for gene deletion of 
PIF1 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1584 gcagtttgtattctatataactatgtgtattaatatgtac 
AATACGACTCACTATAGGGAG 
Reverse primer for gene deletion of 
PIF1 using PCR based deletion 
modules (Goldstein and McCusker, 
1999) 
M1736 acaaccagaaataggctttagttaactcaatcggtaatta 
CGGATCCCCGGGTTAATTAA 
Forward primer for gene deletion of 
POL32 using PCR based deletion 
modules (Longtine et al., 1998) 
M1737 tttgtattatacattacatcacaattagtaatggaaagtg 
GAATTCGAGCTCGTTTAAAC 
Forward primer for gene deletion of 
POL32 using PCR based deletion 
modules (Longtine et al., 1998) 
M1743 CAGCTCAGTGTGCAAGTTGTT Forward primer which binds ~500bp 
upstream of POL32. Used with 
m1362 to confirm gene deletion 
M1828 ctctttggatacgaatgaccgtggaaactatcgcctaaaa 
CACATACGATTTAGGTGACAC 
Forward primer for gene deletion of 
CDC13 using PCR based deletion 
modules(Goldstein and McCusker, 
1999) 
M1829 gcaatttggcaccgccgcgttgggctgcgcggatcatgtc 
AATACGACTCACTATAGGGAG 
Reverse primer for gene deletion of 
CDC13 using PCR based deletion 
modules(Goldstein and McCusker, 
1999) 
M1877 GGCGCGTCTTAATTTTCTTC Forward primer which binds 
upstream of PIF1. With m1878 
amplifies a ~500bp product which 
contains an ApaI site in pif1-m1 
mutants, a XhoI site in pif1-m2 
mutants and neither site in PIF1+ 
strains.  
M1878 TCGTTCCAGGATAAAGGACTG Reverse primer that binds within 
PIF1. With m1877 amplifies a 
~500bp product which contains an 
ApaI site in pif1-m1 mutants, a XhoI 
site in pif1-m2 mutants and neither 
site in PIF1+ strains.  
M1897 TCTCCGCCATAGAATCATCA Forward primer which binds ~500bp 
upstream of CDC13. Used with 
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m1362 to confirm gene deletion. 
M1970 ATCGTTCGGACAGAAAATGG Forward primer which binds ~500bp 
upstream of DNA2. Used with 
m1362 to confirm gene deletion. 
M2188 [CY5] CCCACCACACACACCCACACCC Fluorescent oligo labeled with Cy5 
at the 5’ end for detection of 
telomeric ssDNA by in-gel assay 
M1879 CGCAAAGACCTAGCTTCACTG Forward primer which binds within 
PIF1. With m1880 amplifies a 
~350bp product which contains a 
MboI site in pif1-hd mutants. 
M1880 TTATCCGCATCACCTTTTCC Reverse primer which binds within 
PIF1. With m1879 amplifies a 
~350bp product which contains a 
MboI site in pif1-hd mutants. 
 
Table 3: Oligonucleotides used in this study 
57 
 
2.4.2 Restriction digests 
Restriction digests were performed using restriction enzymes, buffers (10X) and BSA 
(100X) from New England Biolabs (NEB). A master mix was prepared and added to 
DNA samples to give final reaction conditions of 4-10% enzyme, 1X NEB buffer and 
1X BSA. Buffers were used as per the manufacturer’s recommendation and where 
multiple buffers were suitable, NEB Buffer 4 was preferentially used. 
2.4.3 Primer Design 
Primers for PCR reactions were designed to be 18-24 bp in length with a GC content of 
approximately 50% and a Tm of 55-59°C. For genomic DNA primers, Primer3 
[http://fokker.wi.mit.edu/primer3/] (Rozen and Skaletsky, 2000) was used to pick the 
most appropriate primers for a target sequence and primers were searched against the 
yeast genome by BLASTN search to check they had <70% homology to any non-target 
sequence and hence ensure specificity. 
2.4.4 Polymerase Chain Reaction (PCR) 
Reactions were set up with to final concentration of 0.3 µM Forward primer, 0.3 µM 
Reverse primer, 0.24 mM dNTPs, 0.05 U/µl Ex Taq (TaKaRa Bio), 1X Ex Taq Buffer 
(TaKaRa Bio). 20 µl reactions were prepared: 
 1 µl  template DNA 
 0.2 µl  Forward primer (30 µM stock in TE) 
 0.2 µl  Reverse primer (30 µM stock in TE) 
 1.92µl  dNTP mix (2.5 mM each of dATP, dTTP, dGTP, dCTP) 
 0.2 µl  Ex Taq (5 U/µl stock) 
 2 µl  Ex Taq Buffer (10X) 
 14.48 µl Sigma water 
Reactions were prepared by making up a master mix to 1.1X the required volume (to 
account for pipetting errors) and aliquoting out 19 µl of master mix to each tube, before 
adding template. 
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Template was either a 1:100-1:1000 dilution of plasmid miniprep, 1 µl of 1:25 dilution 
of yeast genomic DNA prep or 1 µl of colony lysate for colony PCR (single colony 
picked into 20 µl of TE, vortexted and lysed at 95°C for 10 minutes prior to use as 
template).  
Standard reaction conditions were as follows: 
95°C X 5’   
94°C X 30s 
55°C X 30s 
72°C X 1’ 
} 35 Cycles 
4°C X ∞   
 
For most sequences an extension time of 1’/kb of product size was sufficient. However, 
for amplification of PCR-based deletion cassettes a 5’ extension time was always used. 
2 µl of PCR product was then run out on an agarose gel to visualize reaction products. 
 
2.4.5 Gel extraction of DNA 
Samples were run out on an agarose gel then gel extracted using QIAquick Gel 
Extraction Kit (Qiagen) according to the manufacturer’s conditions. 
2.4.6 High efficiency preparation of DNA for transformation 
15µl of plasmid miniprep was restriction digested with appropriate enzyme(s) in a 40 µl 
reaction. 0.8 µl 0.5 M EDTA, 4 µl NaAc pH 5.2 and 120 µl isopropanol were added 
then DNA was precipitated at -20°C for 10 minutes. DNA was pelleted by spinning in a 
microcentrifuge at 13,000 RPM for 5 minutes. DNA was washed by addition of 250 µl 
70% ethanol (V/V), re-spinning at 13,000 RPM for 5 minutes, aspirating the ethanol 
and allowing the pellet to air dry in a fume hood. Pellet was resuspended in 40 µl TE 
and 1 µl run out on an agarose gel to check recovery. 10 µl was used per transformation. 
2.4.7 Agarose gel electrophoresis 
1% agarose gels containing 1X SYBR Safe or 1 µg/ml EtBr were made up by adding 1 
g agarose to 100 ml buffer TBE (0.5X) or buffer TAE (1X) and dissolving in a 
microwave before cooling to 50°C and then adding 10 µl of SYBR SAFE (10,000X) or 
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10 µl EtBr (10 mg/ml). Molten agarose was poured into a casting tray, using combs 
with 3mm, wells to produce gels of the desired thickness and allowed to set. Samples 
were run until separated at <5 V/cm. All components were from the Mini-Sub Cell GT 
and Wide Mini-Sub Cell GT systems from Bio-Rad. 
 
Loading buffer (6X, blue or orange) was added to DNA samples to a final concentration 
of 1X prior to loading and DNA samples were run alongside 0.1 µg of 1KB DNA 
Ladder (Invitrogen) per mm of lane width. (E.g. 5 µl of 1 KB DNA Ladder at 0.1 µg/µl 
into lanes 5 mm wide). 
 
Blue Loading Buffer (6X) 
0.25% bromophenol blue, 0.25% xylene cyanol, 15% ficoll, 120 mM EDTA pH 8.0. 
For 50 ml: 
 0.125 g bromophenol blue 
 0.125 g xylene cyanol 
 7.5 g  Ficoll (Type 400, Pharmacia) 
 12 ml  0.5 M EDTA (pH 8.0) 
 to 50 ml Water 
 
Orange Loading Buffer (6X) 
0.25% Orange G, 15% ficoll, 120 mM EDTA pH 8.0. For 50 ml: 
 0.125 g Orange G 
 7.5 g  Ficoll (Type 400, Pharmacia) 
 12 ml  0.5 M EDTA (pH 8.0) 
 to 50 ml Water 
 
Note: in both loading buffers, 30% glycerol can be used as an alternative to 15% Ficoll 
by substitution of Ficoll for 15 ml glycerol. 
 
2.4.8 TCA Extraction of Proteins 
TCA extractions were performed as desrcribed (Foiani et al., 1994). 
108 cells in liquid culture were spun down (1,000 RPM, 3 minutes), resuspended in 10 
ml sterile ice-cold water then spun down again and the supernatent poured off. Cells 
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were resuspended in 1 ml TCA (20%), transferred to a 2 ml tube and pelleted at 13,000 
RPM for 1’ in a microcentrifuge. Supernatent was aspirated with a pipette and the pellet 
was resuspended in 100 µl of TCA (20%) and frozen at -20°C. 
Suspension was thawed at room temperature, an equal volume of glass beads (acid-
washed, 425 µm – 600 µm, Stratch) was added (using a 0.2 ml tube) and samples were 
vortexed for 4 minutes. 
Extract was transferred to a fresh tube, then beads were washed twice with 100 µl of 
TCA (5%), each time transferring the extract to the new tube, to give 300 µl of extract 
in 10% TCA. Proteins were pelleted by centrifugation at 3,000 RPM for 10 minutes in a 
microcentrifuge and supernatent was aspirated with a pipette. Sample was resuspended 
in 100 µl Laemmli loading buffer and neutralized by adding 50 µl of 2 M Tris. 
Sample was boiled for 3’ then centrifuged at 3,000 RPM for 10 minutes in a 
microcentrifuge and the pellet was discarded, to yield crude denatured protein extracts. 
Laemmli loading buffer 
50 µl of β-mercaptoethanol was added to 950 µl of Laemmli loading buffer (Bio-Rad). 
2.4.9 Western Blots 
5 µl of TCA protein extract was run on a 7.5% Tris-glycine gel (7.5% Ready gel, 15 
well, Bio-Rad) at 100 V alongside prestained protein markers (precision plus dual color 
standards, Bio-Rad) until the 50 kDa band was close to the bottom of the gel.  
Before the gel had finished running, a piece of nitrocellulose membrane (Hybond-ECL, 
GE Healthcare) and 2-4 sheets of Whatman paper (3MM, Scientific Laboratory 
Supplies) were cut slightly larger than the gel and soaked in transfer buffer. Fibre pads 
were also soaked in transfer buffer and an ice-pack containing frozen transfer buffer 
was inserted into the tank before the tank was filled with pre-cooled transfer buffer. 
When the gel had finished running, the wells were cut off and the remaining gel was 
placed in transfer buffer. While submerged in transfer buffer, the gel was then 
sandwiched against the membrane, with 1-2 pieces of Whatman paper either side, 
between two fibre pads. The fibre pads/whatman paper/membrane/gel composite was 
then inserted into the transfer cassette, air bubbles rolled out using a glass test tube, the 
cassette closed and inserted into the transfer tank, with the membrane between the gel 
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and the positive electrode. Transfer was performed for 2 hours at 100 V in a cold room 
(4-10°C). 
When the transfer was complete, the cassette was disassembled and the membrane 
removed from the Whatman paper and gel. (Note: if the gel stuck to the membrane, it 
was removed at this stage by gently stroking the membrane with a blank piece of 
membrane). The membrane was rinsed briefly in water, then stained for protein by 
incubating with 2-3 drops of Ponceau S on a rocker for 5 minutes, to confirm transfer. 
(Note: the Ponceau S stained any remaining pieces of gel stuck to the membrane, 
making it easy to identify and remove them by wiping with a blank piece of membrane 
soaked in Ponceau S). After confirming that the proteins had transferred, the membrane 
was rinsed with tap water to allow the salts in the water to destain it. 
The membrane was blocked in 5% milk for 1 hour, then incubated with 10 ml of 
primary antibody solution (1% milk containing primary antibody) overnight at 4°C. 
(Note: could be shortened to 2 hours at room temperature for convenience). The 
primary antibody was poured off (which could be saved at 4°C and re-used) and blot 
was rinsed briefly with sterile water. The membrane was washed with 80 ml of 5% milk 
for 1 hour. (Note: could be eliminated to save time). Milk was tipped off and the 
membrane was washed with 80 ml of PBST for 1 hour. (Note this could also be 
eliminated to save time). Membrane was washed 3 more times with 80 ml of PBST for 
10 minutes each wash. 
PBST was removed and the membrane was incubated with 10 ml of secondary antibody 
solution (1% milk containing secondary antibody). The secondary antibody was poured 
off (which could also be saved at 4°C and re-used) and the blot was rinsed briefly with 
sterile water. Membrane was washed 5 times with 80 ml of PBST for 10 minutes each 
wash. (Note: this could be shortened to 3 washes to save time). 
After the last wash, the membrane was incubated with a 1:1 ratio of peroxide and 
luminol solutions (SuperSignal West Pico Chemiluminescent substrate) for 5 minutes 
with rocking. Membrane was then placed face-up on a clear glass plate and covered 
with a piece of parafilm then immediately imaged with a chemiluminescent imager 
(Fuji LAS 4000) for 3 minutes at 15 second increments to detect bands. 
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Membrane was incubated with 10 ml stripping solution for 30 minutes at room 
temperature, then washed twice with 80ml PBST, for 15 minutes each. Membrane could 
then be blocked again and probed with a second set of antibodies. 
Running Buffer 
For 1 L: 
100 ml  10X tris/glycine/SDS buffer (Bio-Rad) 
 900 ml  MQ Water 
Transfer Buffer 
For 1 L: 
 100 ml  10X tris/glycine buffer (Bio-Rad) 
 200 ml  methanol 
 700 ml  MQ water 
Ponceau S 
For 500 ml: 
 2.5 g  Ponceau S 
 to 495 ml MQ Water 
 5 ml  acetic acid 
Filter before use. 
PBST 
For 1 L: 
 999 ml MQ Water 
 5 PBS Tablets (Sigma) 
 1 ml tween 20 
1%/5% milk 
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PBST containing 1%/5% (W/V) powdered milk (Marvel) 
Primary antibodies 
Goat polyclonal anti-Rad53   (Santa Cruz Biotech)  Dilute 1:1,000 
Mouse monoclonal anti-tubulin  (DLAb42)   Dilute 1:1,000 
Secondary antibodies 
Donkey polyclonal anti-goat-HRP (Santa Cruz Biotech)  Dilute 1:5,000 
Goat polyclonal anti-mouse-HRP (DLAb6)   Dilute 1:5,000 
Stripping Solution 
For 10.07 ml: 
 2ml 10% SDS 
 8ml PBST 
 70µl β-mercaptoethanol 
2.4.10 Normalization of DNA preps by densitometry 
20-fold dilutions of DNA preps were made (2 µl plus 38 µl of TE) along with a 4-fold 
dilution of a good quality DNA prep of Wild Type yeast (5 µl of DNA plus 16 µl TE). 6 
tubes of a 2-fold dilution series of the Wild-Type DNA was prepared (10 µl of the 4-
fold dilution plus 10 µl of TE). 6X loading buffer was added to each dilution and 2.4 µl 
was run on a thinly poured 1X TAE gel for 20-30 minutes at 70V. 
The gel was imaged and visualized in ImageJ. A rectangular selection was moved 
across the gel and the area measured to quantify the mean pixel intensity in each well 
and in blank wells. The mean pixel intensity of the blank wells was then subtracted 
from all other wells to measure signal. The signal intensity of the 2-fold dilution series 
was plotted against the dilution factor to determine the linear range of measurement and 
the points corresponding to this range had a trend line fit to them. The equation of the 
trend line was then used to calculate the relative quantities of each DNA prep. 
Sufficient 1X loading buffer was added to each diluted DNA prep to normalize them to 
the same concentration. 2.4 µl of each was diluted DNA prep was then re-run on a gel 
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alongside the 2-fold dilution series. (Note: if diluting the DNA preps was expected to 
bring the quantity of the preps outside of or towards the lower end of the linear range of 
the dilution series, the volume was increased).  All lanes were then re-quantified and the 
final measurement was multiplied by the total dilution to determine the relative quantity 
of each DNA prep. 
2.4.11 PCR synthesis of Digoxigenin-labelled probes 
To synthesize Digoxigenin-labelled probes, PCR was performed as described above, 
substituting 2.5 mM dNTPs for 2mM DIG-11-dUTP-containing dNTP mix (Roche 
Applied Science) to the same final concentration. Successful labelling of the PCR 
product with DIG-dUTP by decreased mobility on an agarose gel compared to an 
unlabelled control. 
TG probe was ~180 bp of TG repeats synthesized from pDL987 using oligos M933 and 
M934. Y’ probe was ~180 bp of Y’ sequence amplified from pDL987 using oligos 
M935 and M936. CDC15 probe was ~1.8 kb of CDC15 sequence amplified from yeast 
genomic DNA by oligos M1045 and M1046. 
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Figure 3: Transfer of DNA from an agarose gel to a membrane for a Southern Blot 
Diagram showing how to set up transfer apparatus for a Southern Blot. A support was 
assembled in a container of transfer buffer and a strip of Whatman paper laid across the 
support, making contact with the transfer buffer at each end. The agarose gel was placed 
face-down on the Whatman paper with a sheet of nylon membrane on top and two wet 
pieces of Whatman paper on top of that. Gel was surrounded with parafilm then a stack 
of paper towels were placed on top, along with a glass plate and a 400 g weight. 
As an alternative to the support and reservoir shown, a glass backing plate could be 
placed atop of a large plastic container as a support/reservoir and a long piece of 
whatman placed over the glass plate, dipping into the transfer buffer at each side. 
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2.4.12 Telomere Southern Blots 
Genomic DNA equivalent to 3 µl of a Wild Type prep from a 2ml stationary phase 
culture was cut with XhoI in a 25 µl digest (4% final concentration of enzyme) for 8 
hours at 37°C then chilled on ice, before adding 5 µl of loading buffer. 
A 120ml agarose gel in TBE was poured with 2 mm wide lanes and loaded with half of 
each digest (the remaining half was saved at -20°C in case the gel needed to be re-run) 
alongside 5 µl of DIG-labelled DNA ladder (DNA molecular weight marker III, DIG 
labeled, Roche Applied Science) and 2 µl of unlabelled DNA ladder (1 kb DNA ladder, 
invitrogen). Gel was run overnight at 1 - 1.5 V/cm. To detect strains that might have 
short telomeres or be undergoing senescence, gel was run until the 0.5 kb band was off 
the gel, while for all other situations the gel was run until the 1 kb band was off the gel. 
Gel was then trimmed with a scalpel to remove the wells and edges.  
Gel was soaked in 10 volumes of denaturation solution with gentle agitation for 45 
minutes. (Note: for this and subsequent wash steps the gel floated towards the surface, 
preventing thorough soaking. To keep the gel submerged, partially-filled 50 ml falcon 
tubes were added to the container). Denaturation solution was poured off and gel was 
washed in 10 volumes of neutralization solution for 30 minutes then washed with 
another 10 volumes of neutralization solution for 15 minutes. 
(Note: prior to denaturation, the gel could be soaked soaking in several volumes of 0.2N 
HCl is recommended until the bromophenol blue/xylene canol turned yellow, then 
washed in several volumes of water, to improve the transfer of >15kb fragments. 
However, no fragments of this size are detected when probing for telomere length). 
During the final wash step, positively charged nylon membrane (Roche Applied 
Science) and two sheets of Whatman paper (Scientific Laboratory Supplies) were cut to 
the same size as the gel. Membrane was soaked for 5 minutes in MQ water, then the 
membrane and Whatman sheets were soaked in transfer buffer for at least 5 minutes. 
While the Whatman and membrane soaked in transfer buffer, a support and reservoir 
were assembled as in Figure 3 with a piece of 3MM Whatman paper cut to the same 
width as the shortest dimension of the gel (length or width) and a length long enough 
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for both ends to be submerged in the reservoir. The Whatman paper was then wetted by 
pipetting transfer buffer along its length. 
When the final wash had finished, the gel was placed faced down on the support, on top 
of the Whatman paper (Figure 3) and air bubbles were forced out using gloved hands, 
before the gel was surrounded with parafilm. The wet membrane was placed carefully 
onto the gel, ensuring no air bubbles were trapped, then the two wet sheets of Whatman 
paper were placed on top (Figure 3) and air bubbles were rolled out using a 15 ml 
Falcon tube pre-wetted in transfer buffer. A 5-8 cm stack of paper towels was then 
placed on top, followed by a glass plate and a 400 g weight (Figure 3). Wet paper 
towels were removed after 1 hour and replaced with dry paper towels, then transfer was 
allowed to proceed for 12-72 hours. 
When the transfer was complete, the membrane and two sheets of Whatman were 
soaked in 6X SSC for 5 minutes. The membrane was then placed face-up on the wet 
Whatman paper and crosslinked in a UV Stratalinker 2400 (Stratagene) for 0.15 J/cm2 
at 254 nm. 
To hybridize, the membrane was first transferred to a glass hybrization tube and 
incubated with pre-warmed prehybridization solution (10 ml per 100 cm2 of membrane 
or a minimum of 20 ml) in a hybridization oven at the hybridization temperature 
(appropriate to the probe being used) with constant agitation, for at least 30 minutes. 
Hybridization temperature (Topt) was calculated as follows: 
Tm = 49.82 + 0.41 (% GC) - (600/l)  
%GC = GC Content of the sequence (%) 
l = length of the sequence in bases 
Topt = Tm – 20 to 25 °C 
For TG Probe a hybridization temperature of 44°C was used while for Y’ and CDC15 
probes a hybridization temperature of 42°C was used (see Section 2.4.11 for probe 
synthesis details). 
Hybridization solution was poured off and saved, then hybridization solution was added 
(3.5 ml per 100 cm2 of membrane or a minimum of 6 ml) and hybridization was 
allowed to proceed overnight with constant agitation. 
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The next morning, hybridization solution was poured off and saved. The membrane was 
washed twice at room temperature for 5 minutes with 25 ml of low stringency wash 
buffer while rocking, before being washed twice at 68°C (in the hybridization oven) 
with 25ml of high stringency wash buffer with constant agitation. 
All subsequent steps were performed with thorough rocking at room temperature and 
each time solutions were changed, the membrane was transferred to a fresh container 
that had been washed thoroughly and wiped down with 70% ethanol. Membrane was 
washed for 5 minutes with washing buffer (100 ml per 100 cm2 of membrane), blocked 
with blocking solution (100 ml per 100 cm2 of membrane) for 30 minutes, incubated 
with antibody solution for 30 minutes (20 ml per 100 cm2 of membrane), then washed 
twice for 15 minutes each with washing solution (100 ml per 100 cm2 of membrane). 
Finally, the membrane was incubated for 2-5 minutes in detection buffer (20 ml per 100 
cm2 of membrane). 
The membrane was placed face-up on a clean glass plate and CSPD, ready to use 
(Roche Applied Science) was applied along the length of the membrane, then spread 
evenly by applying a piece of parafilm over the membrane. The membrane was 
incubated for 5 minutes at room temperature, before using a PCR plate sealer (Applied 
Biosystems) to stroke the surface of the parafilm and squeeze out all bubbles and excess 
CSPD. The membrane was then imaged within 24 hours. 
The membrane was then detected in a chemiluminescent imager (Fuji LAS 4000) with 
an increment of 5-10 minutes, typically for less than an hour. When detecting telomeres, 
it was optimal to choose an exposure at which the Y’ bands were strong but did not 
merge. 
To strip the membrane, it was added to a container of 1 L of boiling 0.1% SDS 
(microwaved 15-20 minutes), which was then sealed and allowed to cool to room 
temperature with gentle agitation for several hours (or overnight). The membrane was 
then rinsed for 5 minutes at room temperature with 2X SSC and was then ready to be 
prehybridized again and hybridized with another probe. 
Denaturation solution 
1.5 M NaCl 0.5 M NaOH. For 1 L: 
 87.67 g NaCl 
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 20 g  NaOH 
 to 1 L  MQ Water 
Note: dissolving the NaCl first speeds up dissolving of the NaOH 
Neutralization solution 
1 M Tris (pH 7.5) 1.5M NaCl. For 1 L: 
 87.67g  NaCl 
 to 1 L  1M Tris (pH7.5) 
Transfer buffer 
10X SSC. For 1 L: 
 500 ml  20X SSC 
 500 ml  Water 
Prehybridization Solution 
DIG Easy Hyb was made up by adding 32 ml of water to DIG Easy Hyb granules 
(Roche Applied Science), stirring at 37°C for 5 minutes, then adding another 32 ml of 
water and stirring at 37°C until dissolved. DIG Easy Hyb was then preheated to the 
hybridization temperature. 
Following hybridization the prehybridization solution could be saved and used a further 
3-4 times. 
Hybridization solution 
DIG-labelled probe was denatured by heating at 95°C for 10’ in a PCR machine then 
rapidly cooling to 4°C. Denatured probe was then added to DIG easy hyb (preheated to 
the hybridization temperature) to a final concentration of 25 ng/ml. 
Low stringency wash buffer 
2X SSC 0.1% SDS. For 50 ml: 
 5 ml  SSC (20X) 
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 44.5 ml MQ Water 
 0.5 ml  SDS (10%) 
High stringency wash buffer 
0.5X SSC 0.1% SDS. For 50 ml: 
 1.25 ml SSC (20X) 
 48.25 ml MQ Water 
 0.5 ml  SDS (10%) 
Washing buffer 
0.1 M Maleic acid, 0.15 M NaCl; pH 7.5, 0.3% (v/v) Tween 20. For 100 ml: 
 10 ml  Washing Buffer (10X, Roche Applied Science) 
 90 ml  MQ Water 
Shake vigorously before use. 
Maleic Acid Buffer 
0.1 M Maleic acid, 0.15 M NaCl; pH 7.5. For 100 ml: 
 10 ml  Maleic Acid Buffer (10X, Roche Applied Science) 
 90 ml  MQ Water 
Blocking Buffer 
10X blocking buffer (Roche Applied Science) was diluted in maleic acid buffer to 1X 
final concentration. 
Antibody Solution 
Anti-Digoxigenin-AP conjugate (Roche Applied Science) was spun for 5 minutes at 
10,000 RPM in a microcentrifuge, then pipetted from the surface and diluted 1:10,000 
(75 U/ml) in blocking buffer. 
Detection Buffer 
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0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5. For 20 ml: 
 2 ml  Detection buffer (10X, Roche Applied Science) 
 18 ml  MQ Water 
2.4.13 Quantitative Amplification of ssDNA (QAOS) 
Quantitative Amplification of ssDNA was performed essentially as described (Zubko et 
al., 2006). The only exceptions being that all samples and PCR mixes were aliquotted 
out by manual pipetting (rather than using multichannel pipettes or repeating pipettes) 
to improve accuracy and prior to real time PCR, template DNA was aliquoted fresh 
from stocks thawed in Eppendorf tubes at 4°C (rather than template DNA being pre-
aliquotted into 96-well plates and stored at -20°C) to prevent loss of volume during 
freezing/thawing. 
2.4.14 In-gel assay 
50 ml of exponentially-dividing or G1-arrested cells, or 30 ml of G2/M arrested cells 
were chilled on ice water then spun down at 2,000 RPM for 5 minutes in a centrifuge 
chilled to 4°C and the supernatant was discarded. Pellets were resuspended in 1 ml ice 
cold sterile water, transferred to pre-chilled 1.5 ml Eppendorf tubes, pelleted at 13,000 
RPM for 5 minutes in a microcentrifuge chilled to 4°C. Supernatent was poured off, 
tubes were spun for a further 1 minute, then the remaining liquid was aspirated with a 
pipette before the pellets were frozen at -80°C. 
Cell pellets were thawed on ice, then resuspended in 200 µl lysis buffer by pipetting 
before transferring to a 2 ml screw cap tube with skirt (Sarstedt) containing 0.3 g of 
glass beads (acid-washed, 425µm-600µm, Stratch). 200 µl of 
phenol:chloroform:isoamyl alcohol (25:24:1, saturated with 10 mM Tris pH 8.0, 1 mM 
EDTA, Sigma) was added to each tube, lids were capped tightly and cells were lysed at 
5.5 power for 60 s using a Precellys 24 automated homogeniser. Tubes were spun for 
<5 seconds in a microcentrifuge to remove traces of phenol from the lids, then 200 µl of 
TE was added to each sample before vortexing briefly to mix. 
Tubes were spun at 13,000 RPM for 5 minutes in a microcentrifuge chilled to 4°C, 
ensuring that the tube label was positioned to one side (not the top or bottom) and 
would not obstruct view of the interface between the aqueous and organic phases. The 
aqueous phase was transferred to a fresh 1.5 ml tube by aspirating 175µl of aqueous 
73 
phase twice with a P200 pipette. (Note: to ensure a clean interface for each sample, it 
was best to remove 3-4 tubes from the microcentrifuge at once and keep the rest 
spinning so that tubes were not sat around for more than a couple of minutes before 
aspiration of the aqueous phase). Screw cap tubes were discarded. 
350 µl of chloroform:isoamyl alcohol (24:1, saturated with 10 mM Tris pH 8.0, 1 mM 
EDTA, Sigma) was added to each 1.5 ml tube and samples were mixed by inverting in a 
rack every 15 seconds for 2 minutes. The aqueous phase was aspirated incrementally 
with a P200 into a new tube, angling the tube slightly, pipetting from the side of the 
tube at which the aqueous phase was deepest and ceasing when the aqueous phase no 
longer occupied the entire diameter of the tube. Tubes containing the vitreous phase 
were discarded. 
1 ml of 100% ethanol was added to each aqueous phase, tubes were inverted gently and 
left to precipitate at room temperature for 5 minutes. Tubes were spun in a 
microcentrifuge at 13,000 RPM for 3 minutes, the supernatant was poured off, then 
tubes were re-spun for 1 minute and the remaining supernatant aspirated with a pipette. 
Tubes were dried in a fume hood for 5 minutes. 
400 µl TE and 3 µl RNase A (10 mg/ml, Sigma) was added to each tube. Tubes were 
incubated in a 37°C water bath for 30 minutes, vortexing thoroughly after 5, 15 and 30 
minutes. 13 µl of NaAc (3M, pH 5.2) and 1 ml of 100% ethanol were added to each 
tube. Tubes were inverted gently and left to precipitate at room temperature for 15 
minutes. 
Tubes were spun in a microcentrifuge for 3 minutes at 13,000 RPM. Supernatant was 
poured off, tubes were re-spun for 1 minute and the remaining supernatant aspirated 
with a pipette. Tubes were dried in the fume hood for 30 minutes. 
25 µl of TE was added to each DNA pellet and samples were resuspended by incubation 
in a 37°C water bath, vortexing thoroughly at 5, 15 and 30 minutes, then allowing to 
equilibrate on ice for 30 minutes. 
DNA samples were quantified by densitometry. DNA equivalent to 5-8 µl of the lowest-
yield DNA prep (equivalent to approximately 3-5 µl of a good quality DNA prep from a 
G1 arrested or asynchronously dividing culture) was cut in a 20 µl digest with XhoI 
(10% final concentration). Digests were heat-inactivated at 65°C for 20 minutes, then 1 
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µl of Cy5-labelled AC probe (oligo m2188, 500 nM in Sigma Water) was added to each 
tube. Tubes were mixed by flicking, spun down briefly, incubated at 37°C for 10 
minutes to anneal the probe then chilled on ice for 30 minutes.  
5 µl Orange G loading buffer (6X) was added to each tube. Tubes were mixed by 
flicking, then spun briefly and kept on ice. Blanks were prepared containing TE, NEB 
buffer, BSA, probe (but not enzyme) to the same final concentration. 
A 1% TBE agarose gel, 120 ml in volume, containing no EtBr or SYBR Safe was 
prepared. (Note: it was important that all measuring and casting apparatus were free of 
EtBr and SYBR Safe contamination, best accomplished by thorough cleaning prior to 
use and reserving a conical flask specifically for melting agarose for non-SYBR 
Safe/EtBr gels). Samples were loaded onto the gel, all lanes were blanked with an 
equivalent volume and DNA ladder was loaded into one of the edge wells using orange 
loading buffer. Gel was run at 5 V/cm for 90 minutes, then detected on a Typhoon Trio 
Imager (GE Healthcare) at maximum resolution and sensitivity, with the appropriate 
settings for detection of Cy5. 
Following detection for Cy5, gel was post-stained (1X SYBR Safe in a large enough 
volume of TBE to cover the gel) for 1 hour with constant agitation, then visualized to 
detect total DNA. To detect loading and confirm complete digestion, the gel was then 
used for a Southern Blot to detect CDC15. 
To quantify ssDNA the images corresponding to Cy5 and SYBR Safe detection were 
scaled to the same size using the background visibility of the gel. The DNA ladder on 
the SYBR Safe image was used to determine sizes on the Cy5 image. The mean pixel 
intensity of each lane between 0.8kb and 12kb was quantified in ImageJ by moving a 
rectangular selection across the gel and quantifying each lane. Background was 
quantified as the mean pixel intensity of the signal between the lanes within the 0.8kb 
and 12kb range. Signal-noise was determined as the pixel intensity of each lane, minus 
the mean pixel intensity of the background either side. Background was quantified in 
the same way for the CDC15 southern blot, and ssDNA signal was normalized for 
CDC15 signal. 
Lysis buffer 
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2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris (pH 8.0), 1 mM EDTA (pH 
8.0), 
For 5 ml: 
 100 µl  Triton X-100 
 500 µl  SDS (10%) 
 500 µl  NaCl (1M) 
 100 µl  Tris (0.5M, pH8.0) 
 10 µl  EDTA (0.5M, pH8.0) 
 3.79 ml MQ Water 
2.5 Bioinformatics 
Genetic interactions from Biogrid v2.0.53 (Stark et al., 2006) were parsed into 
Cytoscape (Cline et al., 2007) to create a genetic interaction network using ORF names 
as unique identifiers. Gene names were annotated using Saccharomyces Genome 
Database (Costanzo et al., 2009). Genes that affect telomere uncapping were annotated 
according to published work (Addinall et al., 2008, Downey et al., 2006, Foster et al., 
2006, Tsolou and Lydall, 2007, Zubko et al., 2004). Genes that increase or decrease 
telomere length were annotated if they appeared in any published high throughput 
screen for telomere length (Askree et al., 2004, Gatbonton et al., 2006, Ungar et al., 
2009). 
Genes that shared genetic interactions with EXO1 were identified based on how many 
of the first neighbors of EXO1 they had a genetic interaction with. This involved 
identifying the number of genetic interactions each first neighbor had with the other first 
neighbors and separately identifying how many of the first neighbors genes outside the 
first neighbors had a genetic interaction with. These two sets of genes were then merged 
and edges linking them to EXO1 were created, weighted by the number of shared 
genetic interactions. Genes connected by the top 10% most heavily weighted edges to 
EXO1 were isolated. 
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3 The search for the determinants of nuclease activities at uncapped 
telomeres 
“If you want to have good ideas you must have many ideas. Most of them will be 
wrong, and what you have to learn is which ones to throw away.” 
- Francis Crick 
3.1 Introduction 
3.1.1 Exo1 and other unknown nucleases resect uncapped telomeres 
Uncapped telomeres and DSBs both initiate a potent DDR, leading to resection by 
nucleases, which generate vast tracts of ssDNA to stimulate checkpoint activation 
(Lydall, 2009). At DSBs, this resection is dependent upon three nucleases activities 
dependent upon Exo1, Sgs1/Dna2 and Sae2/MRX (Gravel et al., 2008, Mimitou and 
Symington, 2008, Zhu et al., 2008). A most striking validation of this model is the 
demonstration that if Sae2 is conditionally inactivated in a cell lacking Exo1 and Sgs1, 
no detectable resection (<50bp) of a HO-induced DSB can be seen (Mimitou and 
Symington, 2008). In contrast, comparatively little is known about the resection of 
uncapped telomeres (Maringele and Lydall, 2002, Ngo and Lydall, 2010, Zubko et al., 
2004). 
At uncapped telomeres in cdc13-1 mutants nuclease activities dependent upon Exo1 or 
Rad24 (which loads the 9-1-1 complex) are active, but in cells lacking either Exo1 or 
Rad24, or both, >5,000bp of ssDNA is still generated following telomere uncapping in 
cdc13-1 mutants (Maringele and Lydall, 2002, Zubko et al., 2004). It is unlikely that a 
Sae2/MRX-dependent nuclease activity also resects uncapped telomeres because MRX 
plays a protective role in cells with uncapped telomeres and inactivation of Rad50 leads 
to increased ssDNA generation at uncapped telomeres (Foster et al., 2006). 
Additionally, although Sgs1 and Exo1 function in different pathways to carry out 
extensive resection at DSBs, Sgs1 appears to function in the same pathway as Exo1 at 
uncapped telomeres in cdc13-1 mutants (Ngo and Lydall, 2010). 
Exo1 inhibits the growth of cdc13-1 mutants with uncapped telomeres, due to its role in 
the resection of uncapped telomeres, which leads to loss of viability and stimulates 
checkpoint activation (Maringele and Lydall, 2002, Zubko et al., 2004) (Figure 2B). 
Genome-wide screens have been performed to identify genes that, like Exo1, inhibit the 
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growth of cdc13-1 mutants (Addinall et al., 2008, Downey et al., 2006). >200 genes 
have now been identified that inhibit the growth of cdc13-1 mutants but none of them 
are obvious candidates for nuclease activities (Addinall et al., 2008). Thus, the nuclease 
activities at uncapped telomeres are poorly defined and no striking candidates for 
residual nuclease activities exist. 
There are multiple reasons why a nuclease that functions at uncapped telomeres might 
not have been discovered by genetic screening for genes that inhibit the growth of 
cdc13-1 mutants. First, genes responsible for nuclease activities that function at 
uncapped telomeres may have been highlighted by genetic screening (Addinall et al., 
2008, Downey et al., 2006) but may encode a protein that is not an obvious nuclease. 
Secondly, genes encoding a nuclease activity may not have been tested or identified in 
the genetic screens carried out. 
The genetic screens performed by Addinall et al. and Downey et al. were based upon 
the SGA methodology (Tong and Boone, 2006) whereby a library of deletion mutants 
are each individually combined with a query mutation. There are many genes absent 
from the library due to poor growth or inviability of the null mutation (Addinall et al., 
2008). Thus, there are potential nuclease genes that have not been tested. Additionally, 
the screens performed by Addinall et al. and Downey et al. relied upon the temperature-
sensitive growth of cdc13-1 mutants to inactivate Cdc13. Thus, any candidate nuclease 
genes that also displayed temperature-sensitive growth may have been assayed but 
scored as false negative results, for technical reasons.  
To identify the determinants of nuclease activities apart from Exo1 that function at 
uncapped telomeres, this work focused on identifying and testing candidate genes by 
two different criteria. 1.) Bioinformatic analysis of candidate genes highlighted by 
Downey et al. and Addinall et al. to identify candidate nuclease genes that might not be 
obvious nucleases. 2.) Testing of genes required for known nuclease activities that were 
either essential for growth or conferred temperature-sensitive growth. 
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Figure 4: PIF1 shares genetic interactions with EXO1 
A. Genes that have a genetic interaction with EXO1 as obtained from BioGRID (Stark 
et al., 2006). B. A ranked list of genes that share a genetic interaction with EXO1 (i.e. 
have a genetic interaction with those genes shown in A.) 
Genes are colored according to their effect on cdc13-1 mutants with uncapped 
telomeres and circled according to their effect on telomere length (Addinall et al., 2008, 
Askree et al., 2004, Downey et al., 2006, Foster et al., 2006, Gatbonton et al., 2006, 
Shachar et al., 2008, Tsolou and Lydall, 2007, Ungar et al., 2009). 
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Figure 5: Pif1 and Exo1 inhibit growth of cdc13-1 and cdc13-1 rad9∆ mutants and 
function in parallel pathways 
A. and B. Saturated cultures of the indicated genotypes were serially diluted across agar 
plates and grown on YEPD plates either at the temperature indicated for 3 days or 
cycled from 23°C for 4 hours to 36°C for 4 hours for the number of times indicated then 
then allowed to form colonies on YEPD plates at 23°C for 3 days. For this figure and all 
onward, strain numbers (DLYs) are given as numbers adjacent to the strain in the 
figure. 
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3.2 Results 
3.2.1 PIF1 has similar genetic interactions to EXO1 
A bioinformatics-based search was applied to identify candidate genes for nuclease 
activities at uncapped telomeres amongst those that had already been identified by 
genetic screening (Addinall et al., 2008, Downey et al., 2006). It was hypothesized that 
any gene product responsible for a nuclease activity at uncapped telomeres would 
behave like Exo1 and thus its encoding gene would have similar genetic interactions to 
EXO1, in addition to inhibiting the growth of cdc13-1 mutants, like EXO1. 
To identify such genes, total genetic interactions from the BioGRID database were 
downloaded to permit the identification of all genes which had a genetic interaction 
with EXO1 (Figure 4A) (Stark et al., 2006). These 39 genes were also annotated using 
data from high throughput screens for genes that affect the growth of cdc13-1 mutants 
(Addinall et al., 2008, Downey et al., 2006) and for genes that affect telomere length 
(Askree et al., 2004, Gatbonton et al., 2006, Ungar et al., 2009). The BioGRID database 
was then used to identify genes that also interacted with any of the 39 genes that had a 
genetic interaction with EXO1 (and thus behaved like EXO1) and this list was ranked 
according to the number of genetic interactions they had with these 39 genes. The top 
10% of this list was then taken and displayed as a ranked graph (Figure 4B). The final 
ranked list of genes that had similar genetic interactions to EXO1 contained 19 ‘EXO1-
like’ genes. 
If there was validity to the bioinformatic search that had been applied, then the 19 most 
‘EXO1-like’ genes should include known nucleases, including those that cooperate with 
Exo1 in resection. To test this hypothesis, we examined the 19 most ‘EXO1-like’ genes 
to look for nuclease activities (Figure 4B). Components of 4 different nucleases that did 
not inhibit the growth of cdc13-1 mutants were identified; RAD27 (encoding Flap 
Endonuclease 1) (Reagan et al., 1995); SGS1 (encoding a component of the Sgs1/Dna2 
nuclease) (Gangloff et al., 1994); RAD1 (a ssDNA endonuclease involved in NER) 
(Tomkinson et al., 1993); MRE11 and RAD50 (encoding components of the MRX 
complex) (Ivanov et al., 1994). Rad27 cooperates with Exo1 during Okazaki fragment 
processing, while the Sgs1/Dna2 and MRX dependent nucleases play roles in DSBR 
along with Exo1 (Gravel et al., 2008, Mimitou and Symington, 2008, Stith et al., 2008, 
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Zhu et al., 2008). It was concluded that the bioinformatic search that had been applied 
was a valid method for identifying Exo1-like nuclease activities. 
Any EXO1-like nuclease with roles in the resection of uncapped telomeres might be 
expected to also resect telomeres under conditions of homeostasis. Though elimination 
of EXO1 itself does not affect telomere length (Tsubouchi and Ogawa, 2000), it was 
hypothesized that an EXO1-like nuclease could potentially be more potent and degrade 
telomeres transiently during each cell cycle, for example, following temporary 
displacement of telomere capping proteins due to DNA replication (Lydall, 2009). If 
this were the case, then a null mutation in the gene encoding such a nuclease activity 
might increase telomere length. 
To test this hypothesis, data from high throughput screens was used to examine the 
effect on telomere length of null mutations in the nuclease activities identified amongst 
the most ‘EXO1-like’ genes (Figure 4B). Null mutations in SGS1 and RAD1 did not 
affect telomere length or growth of cdc13-1 mutants; null mutations in RAD27 
increased telomere length but inhibited growth of cdc13-1 mutants; null mutations in 
MRE11 and RAD50 decreased telomere length and inhibited growth of cdc13-1 mutants 
(Figure 4B) (Addinall et al., 2008, Downey et al., 2006). It was concluded that there 
was no correlation between EXO1-like nucleases, their effect on the growth of cdc13-1 
mutants and their effect on telomere length that could be used to help identify unknown 
nuclease activities that function at telomeres. 
It was hypothesized that the most likely candidates for unidentified nuclease activities at 
uncapped telomeres would inhibit the growth of cdc13-1 mutants, like Exo1. To test 
this hypothesis, the 19 most ‘EXO1-like’ genes were examined for genes encoding 
products that inhibit the growth of cdc13-1 mutants (Figure 4B). It was found that 3 of 
the ‘EXO1-like’ genes encoded proteins that, like Exo1, inhibited the growth of cdc13-1 
mutants; RAD9 encodes a mediator protein, required for checkpoint activation in 
response to telomere uncapping and also plays a pivotal roles in inhibiting ssDNA 
generation at uncapped telomeres (Lydall and Weinert, 1995); RAD24 encodes a 
component of the clamp loader and is responsible for loading the 9-1-1 complex, which 
is required for checkpoint activation following telomere uncapping and is also required 
for a nuclease activity at uncapped telomeres (Zubko et al., 2004); PIF1 encodes a 
helicase that is believed to negatively regulate telomerase at telomeres, in addition to 
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having roles in unwinding G quadruplexes, disassembling stalled replication forks and 
generating ssDNA to be cleaved by nucleases during Okazaki fragment processing 
(Boule et al., 2005, Chang et al., 2009, Pike et al., 2009, Ribeyre et al., 2009, Rossi et 
al., 2008). Both Rad9 and Rad24 had well-characterized roles in the resection of 
uncapped telomeres, while Pif1 did not (Lydall and Weinert, 1995, Zubko et al., 2004). 
In conclusion, Pif1 is the most likely candidate for an unknown nuclease activity at 
uncapped telomeres. 
To test the hypothesis that Pif1 functions like Exo1 at uncapped telomeres, the effect of 
null mutations in PIF1 and EXO1 on the growth of cdc13-1 mutants was examined. At 
low temperatures, such as 23°C, Cdc13-1 is completely active and all cells containing 
the cdc13-1 allele are able to grow (Figure 5A) while at high temperatures, such as 
36°C, Cdc13-1 is completely inactive and no cells containing the cdc13-1 allele are able 
to grow (Figure 5A) (Maringele and Lydall, 2002). At intermediate temperatures, such 
as 27°C, low levels of Cdc13-1 activity persist and cdc13-1 mutants are unable to grow 
unless proteins that inhibit the growth of cdc13-1 mutants, such as Exo1, are eliminated 
(Zubko et al., 2004). Figure 5A shows that at 27°C, cdc13-1 mutants are unable to 
grow, while cdc13-1 pif1∆ and cdc13-1 exo1∆ mutants are. In conclusion, Pif1, like 
Exo1, inhibits the growth of cdc13-1 mutants at uncapped telomeres. 
At intermediate temperatures, such as 27°C, growth of cdc13-1 mutants is inhibited by 
checkpoint proteins (which cell cycle arrest) and by nuclease activities (which cause 
resection and loss of viability). It was hypothesized that Pif1 would function like Exo1 
at uncapped telomeres and inhibit the growth of cdc13-1 mutants independently of the 
checkpoint.  To test this hypothesis, the effect of Pif1 and Exo1 on the growth of cdc13-
1 mutants repeatedly cultured at 36°C was examined. Checkpoint-proficient cdc13-1 
mutants will undergo rapid cell cycle arrest at 36°C and undergo very little loss in 
viability for up to 4 hours, while checkpoint-defective cdc13-1 mutants, continue to 
divide at 36°C and rapidly lose viability (Zubko et al., 2004). Checkpoint-proficient 
cdc13-1 mutants do eventually lose viability after repeated rounds of growth at 36°C, 
unless nuclease activities that function at uncapped telomeres (such as Exo1) are 
eliminated (Zubko et al., 2004). Figure 5A shows that after 6 cycles of growth at 36°C 
for 4 hours, cdc13-1 mutants had almost completely lost viability while cdc13-1 pif1∆ 
and cdc13-1 exo1∆ mutants still grew well. In conclusion, Pif1, like Exo1, inhibits the 
viability of cdc13-1 mutants even when grown at 36°C. 
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Pif1, like Exo1, inhibits the growth of cdc13-1 mutants at 27°C and contributes to the 
loss of viability of cdc13-1 mutants at 36°C, suggesting that Pif1, like Exo1, is required 
for a nuclease activity at uncapped telomeres (Figure 4A). In cdc13-1 rad9∆ mutants, 
the absence of Rad9 prevents checkpoint activation and only the level of resection at 
uncapped telomeres limits growth. Thus, to test the hypothesis that Pif1 is required for a 
nuclease activity at uncapped telomeres, the effect of Pif1 and Exo1 on the growth of 
cdc13-1 rad9∆ mutants was examined. At 29°C, cdc13-1 rad9∆ pif1∆ and cdc13-1 
rad9∆ exo1∆ mutants are able to grow, while cdc13-1 rad9∆ mutants were not (Figure 
5A). After 3 cycles of growth at 36°C for 4 hours, cdc13-1 rad9∆ pif1∆ and cdc13-1 
rad9∆ exo1∆ mutants grew well, while cdc13-1 rad9∆ mutants had completely lost 
viability (Figure 5A). In conclusion, Pif1 is most likely required for a nuclease activity 
at uncapped telomeres, like Exo1. 
Pif1 appeared to be required for a nuclease activity at uncapped telomeres. To test 
whether Pif1 functioned in the same pathway as Exo1 or in a different pathway, the 
effect of Pif1 on the growth of cdc13-1 exo1∆ mutants was examined. At 27°C cdc13-1 
exo1∆ mutants grew well, but grew very poorly at 30°C and not at all at 36°C (Figure 
5B). However, cdc13-1 exo1∆ pif1∆ mutants grew well at 27°C and 30°C and even at 
36°C when cdc13-1 was completely inactivated (Figure 5B). In conclusion, Pif1 and 
Exo1 inhibit the growth of cdc13-1 mutants through different pathways and elimination 
of Pif1 and Exo1 might eliminate the requirement for Cdc13.  
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Figure 6: Pif1 inhibits the growth of cdc13-1 mutants in a parallel pathway to Exo1 
and Rad24 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown on YEPD plates either at the temperature indicated for 3 days or cycled from 
23°C for 4 hours to 36°C for 4 hours for the number of times indicated and then allowed 
to form colonies at 23°C for 2 days.  
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Figure 7: Growth of cdc13-1 exo1∆ pif1∆ and cdc13-1 exo1∆ rad24∆ mutants at 
36°C is not due to a second site suppressor 
cdc13-1 exo1∆ pif1∆ and cdc13-1 rad24∆ pif1∆ meiotic progeny from the crosses 
indicated in A. and B. were randomly selected and saturated cultures of the indicated 
genotypes were serially diluted across agar plates and grown at the temperature 
indicated for 3 days. 
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3.2.2 Pif1 inhibits the growth of cdc13-1 mutants in a parallel pathway to Exo1 and 
Rad24 
Pif1 inhibits the growth of cdc13-1 mutants most likely by controlling a nuclease 
activity that is independent of the nuclease Exo1 (Figure 5B). Rad24 loads the 9-1-1 
complex in response to DNA damage and has also been shown to control a nuclease 
activity at uncapped telomeres, so it was hypothesized that Rad24 might contribute to 
Pif1-dependent nuclease activity and thus inhibit the growth of cdc13-1 mutants in a 
Pif1-dependent manner. To test this hypothesis, the effect of Rad24 on the growth of 
cdc13-1 pif1∆ mutants was examined. As previously reported, cdc13-1 rad24∆ mutants 
were able to grow at 27°C while cdc13-1 mutants were not (Figure 6), thus Rad24 
inhibits the growth of cdc13-1 mutants (Figure 6). cdc13-1 pif1∆ mutants grew well at 
23°C-28°C, poorly from 29°C-30°C and not at all from 32°C-36°C while, surprisingly, 
cdc13-1 pif1∆ rad24∆ mutants grew well from 23°C-32°C and showed only a very 
slight growth defect at 36°C (Figure 6). In conclusion, Rad24 inhibits the growth of 
cdc13-1 mutants through a different pathway to Pif1 and cdc13-1 pif1∆ rad24∆ 
mutants, like cdc13-1 pif1∆ exo1∆ mutants, are able to grow at 36°C, even with cdc13-1 
completely inactivated. 
Elimination of Pif1 and Exo1 permitted growth of cdc13-1 (pif1∆ exo1∆) mutants at 
36°C without any noticeable loss in viability (Figure 5B) while elimination of Pif1 and 
Rad24 permitted growth of cdc13-1 (pif1∆ rad24∆) mutants at 36°C, but with a very 
slight loss in viability (Figure 6). It was hypothesized that the slight loss in viability 
seen in cdc13-1 pif1∆ rad24∆ mutants at 36°C might be due to Exo1. To test this 
hypothesis, the effect of Exo1 on the growth of cdc13-1 pif1∆ rad24∆ mutants was 
examined. At 36°C, cdc13-1 pif1∆ rad24∆ mutants displayed a very slight growth 
defect (compared to the viability of cdc13-1 pif1∆ rad24∆ mutants at 23°C) while 
cdc13-1 pif1∆ rad24∆ exo1∆ mutants did not (Figure 6). In conclusion, the slight loss in 
viability seen in cdc13-1 pif1∆ rad24∆ mutants at 36°C is dependent upon Exo1. 
A possible explanation for the ability of cdc13-1 pif1∆ exo1∆ and cdc13-1 pif1∆ 
rad24∆ mutants to grow at 36°C and for the Exo1-dependent decrease in viability of 
cdc13-1 pif1∆ rad24∆ mutants at 36°C was that Pif1 functioned to inhibit the growth of 
cdc13-1 mutants in a parallel pathway to Exo1 and Rad24, in which Rad24 was critical-
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but-not-essential-for Exo1 activity. To test this hypothesis, the effect of Rad24 on the 
growth of cdc13-1 exo1∆ mutants was examined. At 28°C, cdc13-1 exo1∆ rad24∆ 
mutants grew better than cdc13-1 exo1∆ mutants, indicating that Rad24 inhibited the 
growth of cdc13-1 mutants independently of Exo1 (Figure 6). However, Rad24 is 
required for checkpoint activation following telomere uncapping and thus could have 
been inhibiting the growth of cdc13-1 exo1∆ mutants by promoting checkpoint 
activation. To test this hypothesis, the effect of Rad24 on the growth of cdc13-1 rad9∆ 
exo1∆ mutants (in which checkpoint activation has been eliminated) was examined. At 
28°C-30°C no improvement in growth could be seen in cdc13-1 rad9∆ exo1∆ rad24∆ 
mutants compared to cdc13-1 rad9∆ exo1∆ mutants (Figure 6), as seen previously 
(Zubko et al., 2004). In conclusion, Rad24 inhibits the growth of cdc13-1 mutants in a 
manner dependent upon the checkpoint and Exo1. 
In addition to contributing to checkpoint activation, Rad9 also limits resection at 
uncapped telomeres and this Rad9-inhibited resection (ExoX activity) is dependent 
upon Rad24 (Lydall and Weinert, 1995). It was hypothesized that ExoX activity might 
function independently of Pif1 and Exo1 at uncapped telomeres. To test this hypothesis, 
it was examined whether there was a Rad24-dependent loss of viability in cdc13-1 
rad9∆ exo1∆ pif1∆ mutants. Surprisingly, cdc13-1 rad9∆ exo1∆ pif1∆ mutants showed 
no obvious loss in viability at 36°C compared to 23°C and this was the same for cdc13-
1 rad9∆ exo1∆ pif1∆ rad24∆ mutants (Figure 6). Furthermore, cdc13-1 rad9∆ rad24∆ 
pif1∆ mutants still showed only a very slight growth defect at 36°C, while cdc13-1 
rad9∆ rad24∆ pif1∆ exo1∆ mutants did not, demonstrating that the slight growth defect 
of cdc13-1 rad9∆ rad24∆ pif1∆ mutants at 36°C was due to Exo1 (Figure 6). In 
conclusion, it is likely that no ExoX activity occurs in cdc13-1 pif1∆ exo1∆ mutants and 
it is possible that all nuclease activities identified to date at uncapped telomeres are 
dependent upon Pif1 or Exo1, or both.  
Finally, the ability of cdc13-1 exo1∆ pif1∆ and cdc13-1 rad24∆ pif1∆ strains to grow at 
36°C (even with cdc13-1 completely inactive) was remarkable. However, it was 
possible that this could have been due to a second site suppressor arising in one of the 
parental strains used. To test this hypothesis, a cdc13-1 exo1∆ rad24∆ pif1∆ strain able 
to grow at 36°C was back-crossed to a cdc13-1 strain unable to grow at 36°C. Progeny 
from the cross were assayed for growth, and all cdc13-1 exo1∆ pif1∆ (Figure 7A) and 
cdc13-1 rad24∆ pif1∆ (Figure 7B) progeny were able to grow at 36°C. In conclusion, 
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the striking genetic interactions between PIF1 and EXO1/RAD24 in cdc13-1 mutants 
are legitimate and not a consequence of background mutations. 
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Figure 8: Sgs1 promotes the vitality of cdc13-1 mutants in a different pathway to 
Pif1 
A. and B. saturated cultures of the indicated genotypes were serially diluted across agar 
plates and grown at the temperatures indicated for 3 days. 
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Figure 9: Dna2 nuclease activity promotes the vitality of cdc13-1 pif1∆ mutants 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown at the temperatures indicated on either A. YEPD for 3 days or B. –URA for 4 
days. 
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3.2.3 Sgs1 and Dna2 have protective roles at uncapped telomeres 
Two distinct nuclease activities dependent upon Exo1 and Sgs1/Dna2 resect DNA 
double-strand breaks (Gravel et al., 2008, Mimitou and Symington, 2008, Zhu et al., 
2008). Despite this, Sgs1 and Dna2 were unlikely candidates for nuclease activities at 
uncapped telomeres because neither gene was highlighted by high throughput screening 
as inhibiting the growth of cdc13-1 mutants (Addinall et al., 2008, Downey et al., 
2006). However, Sgs1 has been identified as contributing to nuclease activity at 
uncapped telomeres (Ngo and Lydall, 2010) and Dna2 is an essential gene, so could not 
have been screened for (Budd et al., 2006). Thus, it was decided to test whether Sgs1 
and Dna2 might also function as nuclease activities at uncapped telomeres and whether 
they might do so in the same pathway as Pif1. 
To test whether Sgs1 might function as a nuclease activity at uncapped telomeres and 
whether it functioned in the same pathway or a different pathway to Pif1, the effect of 
Sgs1 on the growth of cdc13-1 and cdc13-1 pif1∆ mutants was examined. At 26°C, 
cdc13-1 mutants showed a slight growth defect, while cdc13-1 sgs1∆ mutants showed a 
more severe growth defect (Figure 8A), consistent with other work (Ngo and Lydall, 
2010).  At 27°C-28.5°C, cdc13-1 pif1∆ mutants grew well, while cdc13-1 pif1∆ sgs1∆ 
mutants showed a slight growth defect (Figure 8A). In conclusion, Sgs1 promotes 
growth of cdc13-1 mutants independently of Pif1. 
It was noted, cdc13-1 pif1∆ sgs1∆ mutants also grew poorly at 23°C, when cdc13-1 
should have been completely active. Thus, it was hypothesized that the growth defect in 
cdc13-1 pif1∆ sgs1∆ mutants at 27°C-28.5°C was due to the poor growth of pif1∆ 
sgs1∆ mutants and that Sgs1 might actually function in a Pif1-dependent manner. To 
test this hypothesis, the growth of CDC13+pif1∆ and cdc13-1 pif1∆ mutants was 
compared to the growth of CDC13+ pif1∆ sgs1∆ and cdc13-1 pif1∆ sgs1∆ mutants. At 
27°C-28.5°C there was no noticeable growth defect in cdc13-1 pif1∆ mutants compared 
to CDC13+ pif1∆ mutants (Figure 8B). At 23°C, cdc13-1 pif1∆ sgs1∆ mutants and 
CDC13+ pif1∆ sgs1∆ mutants grew equally and both grew worse than cdc13-1 pif1∆ 
mutants (Figure 8B). However, at 27°C-28.5°C, cdc13-1 pif1∆ sgs1∆ mutants grew 
worse than CDC13+ pif1∆ sgs1∆ mutants. In conclusion, pif1∆ sgs1∆ mutants grow 
poorly, but this does not account for the growth defect seen in cdc13-1 pif1∆ sgs1∆ 
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mutants at 27-28.5°C, and thus Sgs1 does indeed promote the growth of cdc13-1 
mutants independently of Pif1. 
Dna2 is an essential gene, but the lethality of a dna2∆ mutant can be suppressed in a 
pif1∆ background (Budd et al., 2006). To test whether Dna2 had any Pif1-independent 
functions at uncapped telomeres, the effect of Dna2 on the growth of cdc13-1 pif1∆ 
mutants was examined. At 27°C-28.5°C, cdc13-1 pif1∆ mutants grew well while cdc13-
1 pif1∆ dna2∆ mutants grew extremely poorly (Figure 9A). In conclusion, Dna2 
promotes the growth of cdc13-1 mutants independently of Pif1. Interestingly, cdc13-1 
pif1∆ dna2∆ mutants are unable to grow at 28.5°C (Figure 9A) while cdc13-1 pif1∆ 
sgs1∆ mutants are (Figure 8A), suggesting that Dna2 is more important than Sgs1 in 
protecting uncapped telomeres and, possibly, that Sgs1 and Dna2 have different roles at 
uncapped telomeres. 
Dna2 is both a helicase and a nuclease. Dna2 nuclease, but not helicase, activity is 
required for DSBR (Zhu et al., 2008). Dna2 helicase activity at telomeres is believed to 
be important to unwind G-quadruplex structures (Sfeir et al., 2009) and Dna2 has been 
shown to be important for processing of G-quadruplex structures during replication 
(Lopes et al., 2002). It was hypothesized that Dna2 nuclease activity might inhibit the 
growth of cdc13-1 mutants with uncapped telomeres by playing a role in resection, 
while Dna2 helicase activity might play a protective role by unwinding G-quadruplex 
structures. If the loss of protective helicase activity were more detrimental to the cell 
than the harmful nuclease activity, then deletion of DNA2 would cause a net decrease in 
growth and cdc13-1 pif1∆ dna2∆ mutants would be expected to grow worse than cdc13-
1 pif1∆ mutants, as observed (Figure 9A). 
To test whether the helicase and nuclease activities of Dna2 might have opposing roles 
at uncapped telomeres, cdc13-1 pif1∆ and cdc13-1 pif1∆ dna2∆ mutants were 
transformed with over-expression plasmids containing either no insert, wild type DNA2 
or helicase- or nuclease-defective DNA2 (Zhu et al., 2008). cdc13-1 pif1∆ dna2∆ 
mutants containing an empty over-expression plasmid grew much worse than cdc13-1 
pif1∆ mutants containing an empty over-expression plasmid at 28°C and 29°C (Figure 
9B), as expected (Figure 9A). At 28°C and 29°C cdc13-1 pif1∆ dna2∆ mutants over-
expressing wild type DNA2 or helicase-defective DNA2 (dna2-hd) grew as well as 
cdc13-1 pif1∆ mutants over-expressing wild type DNA2 or helicase-defective DNA2 
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(Figure 9B), demonstrating that over-expression of Dna2 nuclease activity could restore 
growth. At 28°C and 29°C cdc13-1 pif1∆ dna2∆ mutants over-expressing nuclease-
defective DNA2 (dna2-nd) grew worse than cdc13-1 pif1∆ mutants over-expressing 
nuclease-defective DNA2 (Figure 9B), demonstrating that over-expression of Dna2 
helicase activity could not restore growth. It was concluded that that, as expected, the 
helicase and nuclease activities of Dna2 had different roles at uncapped telomeres, but 
unexpectedly Dna2 nuclease activity appeared to have a protective role.  
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Figure 10: Pif1 and Ogg1 inhibit the growth of cdc13-1 mutants through different 
pathways 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown on YEPD plates either at the temperature indicated for 3 days or cycled from 
23°C for 4 hours to 36°C for 4 hours for the number of times indicated and then allowed 
to form colonies on YEPD plates at 23°C for 2 days. 
102 
 
3.2.4 Ogg1 and Pif1 function in different pathways at uncapped telomeres 
Ogg1 is a glycosylase/lyase responsible for recognizing and directing oxidized guanines 
to the BER and NER pathways. Ogg1 recognizes and excises oxidized guanines, before 
creating a single-strand break adjacent to the apurinic site, which is then a substrate for 
BER or NER (Boiteux and Guillet, 2004). Ogg1 was also identified as inhibiting the 
growth of cdc13-1 mutants (Addinall et al., 2008). As Ogg1 creates single-strand breaks 
at oxidized guanines and telomeres are guanine rich, it was possible that Ogg1 could be 
creating single-strand breaks that were then processed by other nuclease activities at 
uncapped telomeres. However, OGG1 is adjacent to and shares a promoter with PIF1, 
so it was possible that Ogg1 did not affect telomere uncapping directly and the ogg1∆ 
mutation interfered with PIF1 gene expression (Cherry et al., 1997).  
To test the hypothesis that Ogg1 inhibited the growth of cdc13-1 mutants independently 
of Pif1, the effect of Ogg1 on the growth of cdc13-1 and cdc13-1 pif1∆ mutants was 
examined. At 26.5°C, cdc13-1 ogg1∆ mutants grew well, while cdc13-1 mutants did not 
(Figure 10) and at 28.5°C, cdc13-1 pif1∆ ogg1∆ mutants grew well, while cdc13-1 
pif1∆ mutants did not (Figure 10). It was concluded that Ogg1 inhibits the growth of 
cdc13-1 mutants independently of Pif1. This suggests that deletion of OGG1 does not 
significantly decrease PIF1 function, consistent with other reports that ogg1∆ mutants 
do not display altered PIF1 expression compared to OGG1+ mutants (Lu and Liu, 
2009).  
Ogg1 appeared to have a Pif1-independent role following telomere uncapping. It was 
hypothesized that Ogg1 might create single-strand breaks to permit nucleases access to 
uncapped telomeres and thus that the role of Ogg1 would not be checkpoint-dependent. 
To test this hypothesis, the effect of Ogg1 on the growth of cdc13-1 rad9∆ and cdc13-1 
rad9∆ pif1∆ mutants was examined. At 28.5°C, cdc13-1 rad9∆ ogg1∆ mutants could 
grow poorly, while cdc13-1 rad9∆ mutants did not grow at all (Figure 10) and at 30°C, 
cdc13-1 rad9∆ pif1∆ ogg1∆ mutants grew better than cdc13-1 rad9∆ pif1∆ mutants. In 
conclusion, Ogg1 inhibits the growth of cdc13-1 mutants independently of the 
checkpoint and independently of Pif1. 
If Ogg1 did indeed contribute to nuclease activity at uncapped telomeres, then it was 
hypothesized that Ogg1 should inhibit the growth of cdc13-1 and cdc13-1 rad9∆ 
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mutants at 36°C, like Exo1 and Pif1 (Figure 5A). To test this hypothesis, the effect of 
Ogg1 on the growth of cdc13-1 and cdc13-1 rad9∆ mutants was examined. After 6 or 9 
cycles of growth at 36°C, cdc13-1 ogg1∆ mutants grew better than cdc13-1 mutants and 
cdc13-1 pif1∆ ogg1∆ mutants grew better than cdc13-1 pif1∆ mutants (Figure 10). 
However, after 6 or 9 cycles of growth at 36°C neither cdc13-1 rad9∆ nor cdc13-1 
rad9∆ ogg1∆ mutants were able to grow and cdc13-1 rad9∆ pif1∆ ogg1∆ mutants grew 
no better than cdc13-1 rad9∆ pif1∆ mutants (Figure 10). It was concluded that Ogg1 
probably does not contribute to a nuclease activity at uncapped telomeres, but does 
inhbit the growth of cdc13-1 mutants independently of the checkpoint and 
independently of Pif1. 
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Figure 11: Pol32 promotes the vitality of cdc13-1 mutants 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown on YEPD plates at the temperatures indicated for 4 days. 
106 
 
3.2.5 Pol32 plays a protective role at uncapped telomeres 
DNA Polymerase δ possesses intrinsic nuclease activity that can substitute during 
Okazaki fragment processing for other nucleases, such as Rad27 (Jin et al., 2001). Yeast 
POL32, encoding the Pol32 subunit of Polymerase δ genetically interacts with PIF1 and 
grows poorly at low temperatures (Budd et al., 2006). In previous screens for genes that 
inhibit the growth of cdc13-1 mutants, strains were constructed in a high throughput 
manner at 23°C (Addinall et al., 2008). Any pol32∆ strains constructed in this manner 
would have grown poorly and could have accumulated suppressor mutations, preventing 
a valid assessment of whether Pol32 promoted or inhibited the growth of cdc13-1 
mutants. Thus, Pol32 could inhibit the growth of cdc13-1 mutants but this may have 
been masked by the poor growth of pol32∆ mutants at 23°C. 
To test the hypothesis that Pol32 contributes to a nuclease activity at uncapped 
telomeres but this had not previously been detected due to the poor growth of pol32∆ 
mutants at 23°C, the effect of Pol32 on the growth of cdc13-1 mutants was examined by 
generating cdc13-1 pol32∆ and CDC13+ pol32∆ mutants with minimal passage at 23°C. 
In order to do this, CDC13+ pol32∆ mutants first were germinated from spores of a 
POL32+/pol32∆ CDC13+/cdc13-1 diploid (DDY335) and allowed to form colonies at 
30°C. CDC13+ pol32∆ colonies were then restreaked at 23°C and allowed to form 
single colonies while, simultaneously, cdc13-1 pol32∆ mutants were germinated from 
spores of the same POL32+/pol32∆ CDC13+/cdc13-1 diploid (DDY335) and allowed to 
form colonies at 23°C. Single colonies of CDC13+ pol32∆ and cdc13-1 pol32∆ mutants 
were then restreaked at 23°C, and then grown to stationary phase in YEPD at 23°C 
(along with CDC13+ POL32+ and cdc13-1 POL32+ strains), serially-diluted across agar 
plates and grown at a range of temperatures alongside CDC13+ POL32+ and cdc13-1 
POL32+ mutants (Figure 11). This allowed the growth of CDC13+ POL32+ and cdc13-1 
POL32+ mutants to be compared to the growth of cdc13-1 pol32∆ and CDC13+ pol32∆ 
that had undergone minimal passage at 23°C. 
Even at 23°C, cdc13-1 pol32∆ mutants were very sick and grew much worse than 
cdc13-1 POL32+ mutants (Figure 11). It was possible that the poor growth of cdc13-1 
pol32∆ mutants at 23°C was due to the cold sensitivity conferred by the pol32∆ 
mutation. To test this hypothesis, the growth of CDC13+ pol32∆ mutants was compared 
to that of CDC13+ POL32+ mutants. At 23°C, CDC13+ pol32∆ mutants grew only 
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slightly worse than CDC13+ POL32+ mutants (Figure 11) so the cold-sensitivity of 
pol32∆ mutants could only slightly account for the poor growth of cdc13-1 pol32∆ 
mutants at 23°C. In conclusion, Pol32 is unlikely to function as a nuclease that resects 
uncapped telomeres, but instead has an important protective role and strongly promotes 
the vitality of cdc13-1 mutants. 
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Figure 12: Rad27 inhibits the growth of cdc13-1 mutants in a parallel pathway to 
Pif1 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown on YEPD plates at the temperature indicated for 3 days. 
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3.2.6 Rad27 inhibits the growth of cdc13-1 mutants in a parallel pathway to Pif1 
Rad27 and Exo1 have homologous nuclease domains and have functional overlap 
during Okazaki Fragment processing (Tran et al., 2002). Thus, it was hypothesized that 
Rad27, like Exo1, might be involved in the resection of uncapped telomeres in parallel 
to Pif1. To test this hypothesis, the effect of Rad27 on the growth of cdc13-1 and cdc13-
1 pif1∆ mutants was examined. At 27°C cdc13-1 rad27∆ mutants displayed a very 
slight increase in growth compared to cdc13-1 mutants, while at 29°C-32°C, cdc13-1 
pif1∆ rad27∆ mutants grew much better than cdc13-1 pif1∆ mutants (Figure 12). It was 
concluded that Rad27 inhibits the growth of cdc13-1 mutants in a parallel pathway to 
Pif1.  
cdc13-1 pif1∆ rad27∆ mutants could not grow at 36°C. However, rad27∆ mutants are 
themselves temperature sensitive (Reagan et al., 1995) so it was possible that CDC13+ 
pif1∆ rad27∆ mutants might also be unable to grow at 36°C and thus that cdc13-1 pif1∆ 
rad27∆ mutants were not affected by inactivation of cdc13-1. To test this hypothesis, 
we compared the growth of CDC13+pif1∆ rad27∆ mutants to that of cdc13-1 pif1∆ 
rad27∆ mutants. At 30°C, CDC13+pif1∆ rad27∆ and cdc13-1 pif1∆ rad27∆ mutants 
were able to grow, however at 36°C neither cdc13-1 pif1∆ rad27∆ strain could grow, 
but only one CDC13+ pif1∆ rad27∆ strain could grow (Figure 12). Thus, it is possible 
that telomere uncapping causes no growth defect in cdc13-1 pif1∆ rad27∆ but without 
consistent CDC13+ pif1∆ rad27∆ strains to compare to, no definitive conclusions can 
be made. Furthermore, the striking differences in growth at 36°C of the two genetically-
identical CDC13+pif1∆ rad27∆ is perhaps an indicator that strains of this genotype are 
very sick and will be difficult to obtain reproducible results from. 
3.3 Discussion 
It has been shown here that Pif1, Exo1 and Rad24 strongly inhibit the growth of cdc13-
1 mutants and elimination of Pif1 and Exo1, or Pif1 and Rad24, but not Exo1 and 
Rad24, permits the growth of cdc13-1 mutants at 36°C (Figure 6). As cdc13-1 is 
believed to be completely inactive at 36°C, it suggests that the defect associated with 
inactivation of cdc13-1 is dependent upon the presence of Pif1 and either Rad24 or 
Exo1. This suggests the existence of two pathways that inhibit the growth of cdc13-1 
mutants, one dependent upon Pif1 and one dependent upon either Exo1 or Rad24. 
While Exo1 and Rad24 have previously been proposed to have different roles at 
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uncapped telomeres, this is based largely upon molecular observations occurring in 
cdc13-1 rad9∆ mutants at 36°C held within a single cell cycle at 36°C for several hours 
(Zubko et al., 2004). While such an experimental system is useful, it must be noted that 
cdc13-1 rad9∆ mutants generate elevated levels of extensive ssDNA and a budding 
yeast cell cycle takes less than two hours at 36°C (Lydall and Weinert, 1995). Thus, 
while inferring pathways from growth assays alone might seem speculative, the ability 
of cdc13-1 pif1∆ exo1∆ and cdc13-1 pif1∆ rad24∆ mutants to grow at 36°C provides a 
complementary approach by providing an opportunity to delineate the pathways that 
prevent growth of cdc13-1 mutants allowed to proliferate following telomere 
uncapping. 
If Rad24 and Exo1 function in the same pathway to inhibit the growth of cdc13-1 
mutants, this would suggest that the 9-1-1 complex (which Rad24 loads onto ssDNA) 
tethers Exo1 to the DNA. The suggestion that Exo1 and Rad24 function in the same 
pathway is bolstered by the observation that Rad24 does not inhibit the growth of 
cdc13-1 rad9∆ exo1∆ mutants (Figure 6). As Pif1, Exo1 and Rad24 inhibit the growth 
of checkpoint-defective cdc13-1 mutants (cdc13-1 rad9∆ mutants, Figure 6) it suggests 
these three proteins inhibit the growth of cdc13-1 mutants by resecting uncapped 
telomeres to generate ssDNA, which is the stimulus for checkpoint activation and the 
root cause of the loss of viability that occurs following telomere uncapping. Three 
nuclease activities have been proposed to function at uncapped telomeres in cdc13-1 
mutants (Zubko et al., 2004) – Exo1, ExoX (the Rad24-dependent nuclease tethered by 
the 9-1-1 complex) and ExoY (a Rad24- and Exo1-independent nuclease activity). 
Thus, it is proposed that Pif1 constitutes ExoY (Figure 2B).  
Previous work proposed that Exo1 and Rad24 control independently-functioning 
nucleases (Zubko et al., 2004) and a model in which Exo1 and Rad24 function in the 
same pathway to inhibit the growth of cdc13-1 mutants is in clear conflict with this. 
However, the evidence that Exo1 and Rad24 function in different pathways is primarily 
based on the observation that in cdc13-1 rad9∆ mutants (which accumulate ssDNA 
more rapidly and extensively than cdc13-1 mutants) Rad24 is required for extensive 
(>30kb) ssDNA generation while Exo1 is not (Zubko et al., 2004) and thus Rad24 has 
been interpreted to be more important than Exo1 for ssDNA generation in cdc13-1 
rad9∆ mutants. Additionally, Exo1 contributes to residual ssDNA generation in cdc13-1 
rad9∆ rad24∆ mutants (Zubko et al., 2004), so Exo1 and Rad24 have been interpreted 
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to act independently. However, Exo1 is required for extensive (>5kb) ssDNA 
generation in cdc13-1 RAD9+ mutants while Rad24 is not (Zubko et al., 2004) and 
Rad24 does not appear to contribute to ssDNA generation in cdc13-1 exo1∆ mutants 
(Zubko et al., 2004) so Rad24 could also be interpreted to be dependent upon Exo1 for 
ssDNA generation. Taken together, these observations indicate that Rad24 functions 
dependent upon Exo1 in cdc13-1 mutants but independently of Exo1 in cdc13-1 rad9∆ 
mutants. 
Two simple modifications to the existing model for nuclease regulation at uncapped 
telomeres (Zubko et al., 2004) can be proposed to reconcile these data. First, it is 
proposed that two pathways exist in cdc13-1 mutants – one dependent upon Pif1 (now 
termed the Pif1-dependent pathway) and one dependent upon Exo1 and ExoX (now 
termed the Exo1-dependent pathway). It is proposed that Rad24 promotes the activity of 
Exo1 and ExoX at uncapped telomeres by loading the 9-1-1 complex which then tethers 
Exo1 and ExoX to ssDNA at uncapped telomeres. Alternatively, it is possible that the 9-
1-1 complex functions to stabilize a DNA substrate that is recognized and degraded by 
Exo1-ExoX. Second, it is proposed that in cdc13-1 mutants, ExoX either has no effect 
on ssDNA generation or supports Exo1 activity, while in cdc13-1 rad9∆ mutants ExoX 
is able to generate ssDNA independently of Exo1. ExoX may have functions 
independent of Exo1 in cdc13-1 rad9∆ mutants because ExoX is either specifically 
inhibited by Rad9 or because extensive ssDNA generation (>30kb) occurs in cdc13-1 
rad9∆ mutants and ExoX is required for generation of long tracts of ssDNA. 
This model is useful for explaining multiple experimental observations related to 
telomere uncapping. According to this model, Pif1, Exo1 and Rad24 inhbit the growth 
of cdc13-1 mutants and cdc13-1 exo1∆ pif1∆ and cdc13-1 rad24∆ pif1∆ mutants are 
able to grow at 36°C (Figure 6) because both the Pif1-dependent and Exo1-dependent 
pathways have been essentially eliminated, while cdc13-1 exo1∆ rad24∆ mutants are 
unable to grow at 36°C (Figure 6) because only the Exo1-dependent pathway has been 
eliminated. This model also stipulates that cdc13-1 exo1∆ pif1∆ mutants are able to 
grow at 36°C because Pif1 and Exo1 are responsible for resection in cdc13-1 mutants 
and have been eliminated. cdc13-1 rad24∆ pif1∆ mutants show a slight growth defect at 
36°C because Rad24 promotes Exo1 activity but is not absolutely essential for it, so 
some residual Exo1 activity occurs (hence why cdc13-1 exo1∆ rad24∆ pif1∆ mutants 
show no growth defect at 36°C.) Finally, in cdc13-1 exo1∆ mutants, Rad24 does not 
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contribute to resection because ExoX is not involved in resection or requires Exo1 to 
function, while in cdc13-1 rad9∆ exo1∆ mutants Rad24 does contribute to resection 
because ExoX can function independently of Exo1 resection (Zubko et al., 2004). 
Finally, recent work indicates that Sgs1 contributes to a nuclease activity that functions 
in the same pathway as Exo1 to generate ssDNA in cdc13-1 mutants, but independently 
of Exo1 to generate extensive ssDNA in cdc13-1 rad9∆ mutants (Ngo and Lydall, 
2010). Interestingly, even in cdc13-1 rad9∆ mutants, Sgs1 appears to contribute to 
Exo1-dependent ssDNA generation at the very end of the chromosome (<5kb) but 
independently of Exo1 beyond this point, consistent with a model where Sgs1 is 
important for supporting Exo1 in extensive ssDNA generation (Ngo and Lydall, 2010). 
Thus, it is proposed that Sgs1 is ExoX. 
The flap endonuclease Rad27 appears to strongly inhibit the growth of cdc13-1 pif1∆ 
mutants and the improved growth in cdc13-1 pif1∆ rad27∆ mutants is quite remarkable 
(Figure 12), especially considering the temperature-sensitive nature of rad27∆ mutants. 
However, these data are difficult to interpret, due to the observed variability in growth 
of CDC13+ pif1∆ rad27∆ mutants (Figure 12). Still, it seems reasonable to assume that 
Rad27 plays an important role in the Exo1-dependent pathway at uncapped telomeres. 
Even taking into account the temperature-sensitivity of the rad27∆ mutation, Rad27 
appears to inhibit the growth of cdc13-1 pif1∆ mutants less than Exo1 or Rad24 (Figure 
6, Figure 12). This suggests that Rad27 either functions upstream of Exo1 to promote 
Exo1 activity at substrates which accumulate at uncapped telomeres or that Rad27 
functions downstream of Exo1 to process a sub-set of substrates generated by Exo1.  
Dna2 and Sgs1 are both involved in the resection of DSBs and shortened telomeres, and 
resection of uncapped telomeres is believed to be due to inappropriate activation of 
DSB-like DDRs (Lydall, 2009, Zhu et al., 2008, Mimitou and Symington, 2008). In this 
context, the protective roles of Dna2 and Sgs1, in a different pathway to Pif1, are 
surprising (Figures 8-9). However, even though Sgs1 promotes the vitality of cdc13-1 
mutants (Figure 8) it has been shown to be involved in Exo1-dependent ssDNA 
generation in cdc13-1 mutants (Ngo and Lydall, 2010). As Sgs1 and Dna2 are believed 
to function as a single nuclease activity in resection, it is likely that Sgs1 and Dna2 both 
contribute to Exo1-dependent ssDNA generation at uncapped telomeres and that their 
contribution to resection somehow plays a protective role. Consistent with this 
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hypothesis, Dna2 nuclease activity (required for the role of Dna2 in the resection of 
DSBs) was shown to play a protective role at uncapped telomeres (Figure 9B). 
If Sgs1/Dna2 do function in the same pathway as Exo1 at uncapped telomeres (Figures 
8-9) but function in parallel to Exo1 to cause extensive resection at DSBs then it 
suggests that in cdc13-1 mutants the Exo1-dependent pathway is DSB-like while the 
Pif1-dependent pathway is distinct. Consistent with this hypothesis, Pif1 plays no role 
in the resection of DSBs (Zhu et al., 2008) while the Pif1-dependent pathway at 
uncapped telomeres is likely to be involved in resection (Figure 6). Hence, it is unlikely 
that uncapped telomeres in cdc13-1 mutants are simply recognized as DSBs but instead 
are recognized and processed in a DSB-like pathway (Exo1-dependent) and a DSB-
distinct pathway (Pif1-dependent). 
Finally, the endonuclease Ogg1 (Figure 10) and the exonucleolytic Pol32 subunit of 
polymerase δ (Figure 11) have been assessed as potential nucleases functioning at 
uncapped telomeres. Though Ogg1 clearly inhibits the growth of cdc13-1 and cdc13-1 
rad9∆ mutants, the interaction was not striking enough to follow up (Figure 10). 
However, it has since been reported that oxidized guanines accumulate at the telomeres 
in ogg1∆ and inhibit the binding of Rap1 to telomeres (Lu and Liu, 2009). As Rap1-
binding inhibits resection of telomeres by Mre11 (which has a protective role at 
uncapped telomeres in cdc13-1 mutants), it is possible that Ogg1 inhibits the growth of 
cdc13-1 mutants by indirectly promoting Rap1 binding and thus inhibiting Mre11 
activity (Foster et al., 2006, Bonetti et al., 2009). Pol32 was discounted as a possible 
nuclease activity as it clearly has a strong protective role in cdc13-1 mutants (Figure 
11). However, given that Sgs1 has a strong protective role in cdc13-1 mutants (Figure 
8) but also functions in resection, Pol32 cannot be discounted as having a role as a 
nuclease activity at uncapped telomeres. 
3.4 Further Work 
3.4.1 Pif1, Exo1 and Rad24 
The primary question arising from this work is how Pif1, Exo1 and Rad24 interact with 
each other in the resection of uncapped telomeres. As Pif1 inhibits the growth of cdc13-
1 mutants in a different pathway to Exo1 and Rad24, it will be important to determine 
the contribution of Pif1 to checkpoint activation and ssDNA generation in cdc13-1 
mutants. As cdc13-1 exo1∆ pif1∆ mutants grow robustly at 36°C (Figure 6) while 
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cdc13-1 rad24∆ pif1∆ mutants show a clear growth defect (Figure 6) it will also be 
important to determine whether any ssDNA is generated at uncapped telomeres in 
cdc13-1 exo1∆ pif1∆ mutants and whether this is slightly increased in cdc13-1 rad24∆ 
pif1∆ mutants. Finally, to conclusively determine whether Exo1 and Rad24 function in 
the same or different pathways to resect uncapped telomeres, it will be important to 
directly compare ssDNA generated at uncapped telomeres in cdc13-1, cdc13-1 exo1∆, 
cdc13-1 rad24∆ and cdc13-1 exo1∆ rad24∆ mutants. 
Perhaps most importantly, it will be interesting to carry out screens similar to those 
described (Addinall et al., 2008, Downey et al., 2006) to identify genes that inhibit the 
growth of cdc13-1 exo1∆ and cdc13-1 rad24∆ mutants and cdc13-1 pif1∆ mutants. This 
should identify genes involved in the same pathways as PIF1 (those which inhibit the 
growth of cdc13-1 exo1∆ and cdc13-1 rad24∆ mutants) and EXO1 (those which inhibit 
the growth of cdc13-1 pif1∆ mutants) and, if so, it will be interesting to see whether any 
novel combinations of mutations permit the growth of cdc13-1 mutants at 36°C. 
3.4.2 Sgs1/Dna2 
Sgs1 and Dna2 both inhibit the growth of cdc13-1 pif1∆ mutants (Figures 8-9) 
suggesting they both contribute to the vitality of cdc13-1 mutants, and thus do not resect 
uncapped telomeres. However, recent work has shown that Sgs1 contributes to resection 
at uncapped telomeres in cdc13-1 mutants and inhibits the growth of cdc13-1 rad9∆ 
exo1∆ mutants. Thus it is possible both Dna2 and Sgs1 contribute to resection at 
uncapped telomeres and this should be tested. If both Dna2 and Sgs1 contribute to 
resection at uncapped telomeres, it will be important to understand why these two 
proteins contribute to the vitality of cdc13-1 mutants when the other proteins that 
contribute to well-defined resection activities at uncapped telomeres (Exo1 and Rad24) 
contribute to the lethality seen in cdc13-1 mutants. 
It is believed that uncapped telomeres are recognized and resected in a manner 
analogous to unrepaired DSBs, at which Sgs1 and Dna2 appear to cooperate and form a 
single functional unit involved in resection (Cejka et al., 2010, Niu et al., 2010). 
However, cdc13-1 pif1∆ sgs1∆ mutants grow much better than cdc13-1 pif1∆ dna2∆ 
mutants (Figures 8-9). This suggests that Dna2 has a much more important role than 
Sgs1 in promoting the vitality of cdc13-1 mutants and thus, in contrast to the situation at 
DSBs, Dna2 and Sgs1 have different roles at uncapped telomeres. It will be important to 
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assess the contribution of Sgs1 and Dna2 to resection and checkpoint activation in 
cdc13-1 mutants, as it may provide valuable insight as to how uncapped telomeres 
differ from DSBs and how the functions of Dna2 and Sgs1 are coordinated. 
3.4.3 Rad27 
The growth of cdc13-1 pif1∆ rad27∆ mutants at 32°C (Figure 12) is remarkable, given 
that CDC13+ pif1∆ rad27∆ mutants grow poorly above 30°C. However, there is clear 
variability in the growth of CDC13+ pif1∆ rad27∆ mutants (Figure 12). It will be 
important to generate consistently-growing rad27∆ mutants of all relevant genotypes to 
assess whether there is a growth defect in cdc13-1 pif1∆ rad27∆ mutants compared to 
CDC13+pif1∆ rad27∆ mutants. It will then be important to establish whether Rad27 
contributes to resection at uncapped telomeres and to formally demonstrate that Rad27 
functions in the same pathway as Pif1 or Exo1. However, this will be challenging as 
rad27∆ mutants are inviable at 36°C (the temperature usually used to induce telomere 
uncapping in culture experiments) and the rad27∆ mutation is lethal with many 
checkpoint proteins (such as Rad24) and nucleases (such as Exo1). 
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4 Pif1 is a component of the DDR at uncapped telomeres 
“Molecular Biology is, essentially, the practise of biochemistry without a license.” 
- Erwin Chargaff 
4.1 Introduction 
Of the multiple proteins that had been assessed for their potential as nuclease activities 
at uncapped telomeres (Pif1, Sgs1, Dna2, Ogg1, Pol32, Rad27, Figures 4-12) Pif1 was 
the most promising. Most strikingly, cdc13-1 pif1∆ exo1∆ and cdc13-1 pif1∆ rad24∆ 
mutants were both able to grow at 36°C (Figure 6) a temperature at which Cdc13-1 is 
believed to be completely active. As these strains were viable at 36°C, it suggested that 
the DDR and subsequent checkpoint activation following telomere uncapping was 
severely diminished or possibly eliminated.  
To date, only two mechanisms have been identified through which cells with uncapped 
telomeres can avoid checkpoint activation and metaphase arrest in response to telomere 
uncapping. First, elimination of essential components of the G2/M checkpoint (such as 
Rad9, Mec1 or Rad53) prevents checkpoint activation and metaphase arrest and permits 
cdc13-1 mutants continue to divide at 36°C, but causes a rapid loss in viability due to 
resection at uncapped telomeres (Jia et al., 2004, Zubko et al., 2004). Second, 
elimination of Exo1, which is critically important for the resection of uncapped 
telomeres, reduces resection at uncapped telomeres and leads to a diminished 
checkpoint response, allowing a fraction of cdc13-1 exo1∆ mutants at 36°C to escape 
arrest while undergoing only a very moderate loss of viability (Zubko et al., 2004). Pif1 
was unlikely to function simply as a component of the checkpoint because 1.) cdc13-1 
rad24∆ pif1∆ mutants can grow at 36°C but cdc13-1 rad24∆ mutants do not undergo 
checkpoint activation and rapidly lose viability at 36°C and 2.) cdc13-1 exo1∆ pif1∆ 
mutants can grow at 36°C but elimination of the checkpoint in cdc13-1 exo1∆ mutants 
(e.g. in cdc13-1 sml1∆ mec1∆ exo1∆ mutants) does not permit growth at 36°C (Jia et 
al., 2004, Zubko et al., 2004). Instead, Pif1 was likely to function as a DDR component, 
responsible for loss of viability in cdc13-1 rad24∆ mutants and residual checkpoint 
activation in cdc13-1 exo1∆ mutants. 
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This purpose of this work was to define the role of Pif1 in the response to telomere 
uncapping, to gain insight into the DDR and checkpoint activation both at uncapped 
telomeres and in response to other stimuli, focusing on the interaction between Pif1 and 
Exo1 as neither of which were essential components of the G2/M checkpoint response 
to telomere uncapping in cdc13-1 mutants. 
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Figure 13: Pif1 is responsible for the loss of viability and residual checkpoint 
activation seen in cdc13-1 rad24∆ mutants 
Exponentially-dividing cultures of the genotypes indicated were shifted from 23°C to 
36°C to induce telomere uncapping for 6 hours. Every hour, samples were taken to 
measure A. total cell number B. viable cell number and C. percentage of cells at 
metaphase. Error bars represent the standard error of the mean for 3 independent 
biological replicates, the strain numbers for 2 of which are listed in the key. 
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4.2 Results 
4.2.1 Pif1 is responsible for the loss of viability seen in cdc13-1 rad24∆ mutants 
cdc13-1 rad24∆ mutants do not undergo checkpoint activation at 36°C but cannot form 
colonies, while cdc13-1 rad24∆ pif1∆ mutants were able to form colonies at 36°C 
(Figure 6). This suggested that Pif1 was responsible for the loss of viability seen in 
cdc13-1 rad24∆ mutants and possibly contributed to loss of viability in cdc13-1 
mutants. To test this hypothesis exponentially dividing cdc13-1, cdc13-1 pif1∆, cdc13-1 
rad24∆ and cdc13-1 rad24∆ pif1∆ mutants were shifted from 23°C to 36°C to induce 
telomere uncapping and cell number and viability were followed over time. cdc13-1 
rad24∆ mutants continued to divide and increase in cell number following telomere 
uncapping (Figure 13A) but this corresponded to a marked loss in the number of viable 
cells (Figure 13B), as expected. In contrast, cdc13-1 rad24∆ pif1∆ mutants continued to 
increase in both cell number (Figure 13A) and viable cell number (Figure 13B) over 
time, following telomere uncapping. Both cdc13-1 and cdc13-1 pif1∆ mutants 
underwent a very limited increase in cell number following telomere uncapping (Figure 
13A) and after 6 hours at 36°C, cdc13-1 mutants had began to lose viability, but cdc13-
1 pif1∆ mutants had retained viability (Figure 13B). It was concluded that Pif1 is 
responsible for the loss of viability seen in cdc13-1 rad24∆ mutants with uncapped 
telomeres and Pif1 also contributes to loss of viability in cdc13-1 mutants at 36°C. 
Exo1 contributes to loss of viability in cdc13-1 mutants and also contributes to cell 
cycle arrest following telomere uncapping. It was hypothesized that Pif1 might behave 
in the same manner. To test this hypothesis, exponentially dividing cdc13-1 and cdc13-
1 pif1∆ mutants were shifted from 23°C to 36°C to induce telomere uncapping and the 
fraction of cells at metaphase was measured (Figure 13C). After 2 hours at 36°C, >80% 
of cdc13-1 mutants had accumulated at metaphase and this persisted up to 4 hours, after 
which the fraction of cells at metaphase began to decrease as the cells began to adapt to 
the checkpoint (Figure 13C). cdc13-1 pif1∆ mutants did not accumulate at metaphase 
until 3 hours after telomere uncapping and only >70% of cells accumulated at 
metaphase, where they remained up until 6 hours (Figure 13C). It was concluded that 
Pif1 contributes to cell cycle arrest of cdc13-1 mutants following telomere uncapping.  
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It has been consistently reported that cdc13-1 rad24∆ mutants display a slight 
metaphase accumulation following telomere uncapping (Jia et al., 2004, Zubko et al., 
2004). This could potentially represent a very low level of checkpoint activation, to 
which Pif1 could contribute in the same manner as it contributes to cell cycle arrest in 
cdc13-1 mutants. To test this hypothesis, exponentially dividing cdc13-1 rad24∆ and 
cdc13-1 rad24∆ pif1∆ mutants were shifted from 23°C to 36°C to induce telomere 
uncapping and the fraction of cells at metaphase was measured (Figure 13C). As 
expected, there was a slight accumulation at metaphase of cdc13-1 rad24∆ mutants 
following telomere uncapping – at 23°C, approximately 15% of cdc13-1 rad24∆ 
mutants were at metaphase, but after shift to 36°C there was an increase to 
approximately 30% of cdc13-1 rad24∆ mutants at metaphase (Figure 13C). Strikingly, 
cdc13-1 rad24∆ pif1∆ mutants showed no significant accumulation at metaphase 
following shift to 36°C. It was concluded that Pif1 was responsible for the slight 
metaphase accumulation seen in cdc13-1 rad24∆ mutants at 36°C and that this may 
constitute a very low level of Pif1-dependent checkpoint activation. 
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Figure 14: Pif1 and Exo1 coordinate checkpoint activation following telomere 
uncapping in cdc13-1 mutants 
A. Synchronous cultures were subjected to telomere uncapping according to the 
diagram shown. Exponentially-dividing bar1∆ cells were arrested at 23°C in G1 using 
α factor then released from arrest and shifted to 36°C to uncap telomeres. Cells that 
arrested due to telomere uncapping (cdc13-1) would accumulate at metaphase, while 
cells which did not arrest due to telomere uncapping or escaped arrest would 
accumulate at anaphase (cdc15-2).  
Synchronous cultures of the genotypes indicated were subjected to telomere uncapping 
as in A. and samples taken every hour for 6 hours to measure B. fraction of cells at 
metaphase C. fraction of cells at anaphase and D. Rad53 phosphorylation by Western 
Blot. 
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Figure 15: Pif1 and Exo1 do not coordinate checkpoint activation following DSB 
induction 
Synchronous cultures were performed as in Figure 14A but instead of shifting the 
cultures to 36°C to uncap telomeres, DSBs were induced by addition of bleomycin. 
Following bleomycin treatment in synchronous cultures of the genotypes indicated, 
samples were taken every hour for 6 hours to measure A. fraction of cells at metaphase 
B. fraction of cells at anaphase and C. Rad53 phosphorylation by Western Blot. 
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4.2.2 Pif1 and Exo1 are responsible for checkpoint activation specifically in 
response to telomere uncapping 
Pif1 appeared to contribute to checkpoint activation in cdc13-1 mutants (Figure 13C), 
Exo1 is also known to contribute to checkpoint activation in cdc13-1 mutants (Zubko et 
al., 2004) and cdc13-1 exo1∆ pif1∆ mutants were able to form colonies at 36°C (Figure 
6). It was hypothesized that Pif1 and Exo1 might function in parallel to initiate 
checkpoint activation following telomere uncapping. 
To investigate the roles of Pif1 and Exo1 in telomere uncapping, a synchronous culture 
system was used to enable the checkpoint response of a single population of cells to be 
measured (Figure 14A) (Lydall and Weinert, 1995). Briefly, cells containing the cdc13-
1 allele were arrested in G1 with α factor, then released from arrest and shifted to 36°C 
to induce telomere uncapping. All cells also carried the cdc15-2 allele, which at 36°C 
prevented exit from anaphase, ensuring that any cells escaping from cdc13-1-induced 
metaphase arrest would not be able to enter another cell cycle. 
cdc13-1 mutants accumulated at metaphase (Figure 14B) but not at anaphase (Figure 
14C). Unexpectedly, cdc13-1 pif1∆ mutants also accumulated at metaphase and did not 
pass through to anaphase (Figure 14B,C). cdc13-1 exo1∆ mutants accumulated 
transiently at metaphase, but a subpopulation of cells leaked through to anaphase , as 
previously described (Figure 14B,C) (Jia et al., 2004, Zubko et al., 2004). cdc13-1 
exo1∆ pif1∆ mutants showed a peak at metaphase at 2 hours (Figure 14B) but then 
essentially all accumulated at metaphase. It was concluded that when cells passed 
through a single cell cycle with uncapped telomeres, Pif1 was not necessary for full 
metaphase arrest of cdc13-1 mutants but Pif1 was responsible for the arrest of a 
subpopulation of cdc13-1 exo1∆ mutants following telomere uncapping. Furthermore, 
elimination of Pif1 and Exo1 eliminated metaphase arrest in response to telomere 
uncapping (Figure 14B,C). 
It was surprising that Pif1 did not appear to contribute to the arrest of cdc13-1 mutants 
subjected to telomere uncapping in a synchronous culture system (Figure 14B,C), as 
asynchronously dividing cdc13-1 pif1∆ mutants shifted to 36°C showed a defect in 
metaphase arrest (Figure 13C). The likely explanation for this difference is due to the 
experimental system – using a synchronous culture system, all cells must pass from G1 
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to metaphase with uncapped telomeres, while using an asynchronous culture system 
means that cells are distributed throughout the cell cycle and significant fraction will 
only pass from S phase or G2 to metaphase with uncapped telomeres. Thus, it was 
concluded that Pif1 is important for checkpoint activation following telomere uncapping 
(Figure 13C) but was not necessary for full metaphase arrest in cells that passed from 
G1 to metaphase with uncapped telomeres (Figure 14B,C). 
One of the most upstream events in checkpoint activation in response to telomere 
uncapping, is hyperphosphorylation and activation of Rad53, leading to 
phosphorylation of downstream effector kinases and ensuing cell cycle arrest (Morin et 
al., 2008, Sweeney et al., 2005). To investigate how Pif1 and Exo1 affected activation 
of Rad53 following telomere uncapping, synchronous cultures of cdc13-1 mutants were 
subjected to telomere uncapping and then Western Blots were performed to detect 
Rad53. Following telomere uncapping, there was a marked decrease in mobility of 
Rad53 in cdc13-1 mutants, indicating hyperphosphorylation and activation and this was 
not altered in cdc13-1 pif1∆ mutants (Figure 14D) corresponding to the full metaphase 
arrest seen in cdc13-1 and cdc13-1 pif1∆ mutants following telomere uncapping (Figure 
14B). cdc13-1 exo1∆ mutants showed a slight decrease in mobility of Rad53 
phosphorylation, but it was severely reduced compared to cdc13-1 mutants (Figure 
14D) corresponding to the reduced metaphase arrest seen in cdc13-1 exo1∆ mutants 
compared to cdc13-1 mutants (Figure 14B). In cdc13-1 exo1∆ pif1∆ mutants, no 
discernable increase in Rad53 mobility was seen. It was concluded that Pif1 was not 
necessary for Rad53 activation of cdc13-1 mutants but Pif1 was responsible for the 
residual Rad53 activation seen in cdc13-1 exo1∆ mutants following telomere uncapping 
(Figure 14D). 
DSBs and uncapped telomeres in cdc13-1 mutants undergo checkpoint activation in a 
similar manner, involving resection to generate ssDNA and subsequent Mec1-
dependent checkpoint activation (Lydall, 2009). To determine whether Pif1 and Exo1 
were affecting checkpoint activation specifically in response to uncapped telomeres or 
in a more generalized manner, the checkpoint response to DSBs was assessed in the 
same strains used in Figure 14B. Briefly, cultures were synchronized at 23°C using α 
factor, released from G1, treated with bleomycin to induce DSBs and then assessed for 
cell cycle arrest and Rad53 phosphorylation. cdc13-1, cdc13-1 pif1∆, cdc13-1 exo1∆ 
and cdc13-1 exo1∆ pif1∆ mutants all accumulated at metaphase with similar kinetics 
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(Figure 15A) before gradually leaking out to anaphase from 4 hours onwards (Figure 
15B) and all strains were able to fully phosphorylate Rad53 in response to bleomycin 
(Figure 15C). It was concluded that cdc13-1 exo1∆ and cdc13-1 exo1∆ pif1∆ mutants 
were specifically defective in metaphase arrest and Rad53 activation in response to 
telomere uncapping (Figure 14B-D) and this was not due to a general checkpoint defect. 
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Figure 16: Pif1 and Exo1 coordinate ssDNA generation following telomere 
uncapping 
Synchronous cultures of cdc13-1 mutants (Figure 14A) were shifted to 36°C to induce 
telomere uncapping and samples were taken every hour to measure ssDNA at the loci 
indicated in A. Percentage ssDNA is shown B. on the TG strand at the Y’600 locus C. 
on the TG at the Y’5,000 locus D. on the AC strand at the Y’600 locus E. at various 
loci, 4 hours after telomere uncapping.  
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Figure 17: Exo1 is more important than Pif1 for ssDNA generation at loci further 
from the chromosome end 
Synchronous cultures of cdc13-1 mutants (Figure 14A) were shifted to 36°C to induce 
telomere uncapping and samples were taken every hour to measure ssDNA at the loci 
indicated in A. Percentage ssDNA is shown B. on the TG strand in the X repeats C. on 
the TG strand at the YER188W locus D. on the TG strand at the YER186C locus E. on 
the TG strand at the PDA1 locus F. on the AC strand at the YER186C locus G. on the 
AC strand at the PDA1 locus. 
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Figure 18: Exo1 is more important than Pif1 for ssDNA generation in the TG 
repeats 
A. Synchronous cultures of cdc13-1 mutants (Figure 14A) were shifted to 36°C to 
induce telomere uncapping and samples were taken every hour to measure ssDNA in 
the TG repeats by in-gel assay, then performing a Southern Blot to probe for CDC15 as 
a loading control. B. Quantification of the data shown in A., normalized for load using 
the CDC15 signal. ssDNA is expressed in Ku Units (KUs). A KU is defined as the 
amount of ssDNA detectable in the TG repeats of an exponentially-dividing yku70∆ 
mutant at 23°C. 
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4.2.3 Pif1 and Exo1 are the determinants of ssDNA generation at uncapped 
telomeres in cdc13-1 mutants 
cdc13-1 exo1∆ pif1∆ mutants did not undergo cell cycle arrest or checkpoint activation, 
specifically in response to telomere uncapping. A possible explanation was that 
resection at uncapped telomeres (which is the stimulus for cell cycle arrest and 
checkpoint activation in response to telomere uncapping) had been eliminated.  
It was hypothesized that Pif1 and Exo1 both contributed to ssDNA generation at 
uncapped telomeres and elimination of both Pif1 and Exo1 prevented ssDNA generation 
at uncapped telomeres, thus preventing checkpoint activation. To test this hypothesis, 
synchronous cultures of cdc13-1 mutants were subjected to telomere uncapping (Figure 
14A) and then ssDNA at various loci were measured (Figure 16A) using Quantitative 
Amplification of Single-Stranded DNA (QAOS) (Booth et al., 2001, Zubko et al., 
2006). In Y’ elements (which are components of most telomeres in budding yeast) 
cdc13-1 mutants generated ssDNA at loci approximately 600bp (Y’600) and 5,000bp 
(Y’5,000) from the chromosome end and this was reduced in cdc13-1 pif1∆ and cdc13-
1 exo1∆ mutants (Figure 16B,C). Strikingly, in cdc13-1 exo1∆ pif1∆ mutants, no 
detectable ssDNA was measured in the Y’ sequences 600bp or 5,000bp from the 
chromosome end (Figure 16B,C). It was confirmed that ssDNA generation in cdc13-1, 
cdc13-1 pif1∆ and cdc13-1 exo1∆ mutants was specifically on the TG strand and not 
due to generalized unwinding of telomeric duplex DNA as no ssDNA could be detected 
on the AC strand in the Y’ elements (Figure 16D). In conclusion, Pif1 and Exo1 are 
both required for resection of uncapped telomeres and elimination of Pif1 and Exo1 
prevents ssDNA generation at uncapped telomeres, thus preventing checkpoint 
activation. 
Elimination of Pif1 or Exo1 reduced ssDNA generation in the Y’600 elements 
following telomere uncapping to a similar extent. However, elimination of Pif1 had 
very little effect on checkpoint activation and cell cycle arrest following telomere 
uncapping, while elimination of Exo1 conferred a severe defect in checkpoint activation 
and cell cycle arrest (Figure 14B). This constituted a paradox, as ssDNA is believed to 
be the stimulus for checkpoint activation following telomere uncapping. It was 
hypothesized that the extensiveness of ssDNA generation at uncapped telomeres, rather 
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than the quantity of ssDNA at the chromosome end, might be more important for 
determining checkpoint activation. To test this hypothesis, ssDNA was measured at 
various single-copy loci on Chromosome V (Figure 16A) 4 hours after telomere 
uncapping, which was the time point at which no further alterations in the fraction of 
cdc13-1 exo1∆ cells at metaphase were seen. Following telomere uncapping, cdc13-1 
mutants generated detectable ssDNA at all loci examined, <30kb from the chromosome 
end, with the level of ssDNA decreasing further from the chromosome end (Figure 
16E). In contrast, cdc13-1 pif1∆ mutants generated ssDNA <15kb from the 
chromosome end, while cdc13-1 exo1∆ mutants generated ssDNA <5kb from the 
chromosome end (i.e. only in the Y’ elements) and cdc13-1 exo1∆ pif1∆ mutants had no 
detectable ssDNA at any locus examined (Figure 16E). In conclusion, the more 
extensive ssDNA generated in cdc13-1 pif1∆ mutants compared to cdc13-1 exo1∆ 
mutants following telomere uncapping (Figure 16E) most likely accounts for the 
sustained checkpoint activation in cdc13-1 pif1∆ mutants compared to the attenuated 
checkpoint activation seen in cdc13-1 exo1∆ mutants (Figure 14D). Interestingly, just as 
cdc13-1 exo1∆ mutants generate ssDNA <5kb from the chromosome end, exo1∆ 
mutants with an irreparable DSB generate ssDNA <5kb away from the break on each 
side (Mimitou and Symington, 2008). 
There are 64 G2 telomeres in budding yeast, so 1.6% (1/64) ssDNA would be expected 
to correspond to one single-stranded locus per cell. Essentially full metaphase arrest is 
seen in cdc13-1 pif1∆ mutants (Figure 14D) and >1.6% ssDNA is generated >9 kb but 
<15 kb from the chromosome end in cdc13-1 pif1∆ mutants (Figure 16E). Assuming 
one single-stranded telomere per cell is sufficient to cause sustained metaphase arrest 
(in an analogous manner to how one DSB per cell can cause sustained metaphase 
arrest), this suggests that one telomere with 9-15 kb of ssDNA is sufficient to cause 
sustained metaphase arrest. Consistent with this, elimination of Exo1 and Sgs1 limits 
resection to approximately 1.5-3.0kb either side of an irreparable DSB (3.0-6.0kb of 
ssDNA in total) and causes a severe checkpoint defect (Gravel et al., 2008, Mimitou and 
Symington, 2008, Zhu et al., 2008).  
The conclusion that the extensiveness of ssDNA generated at uncapped telomeres 
explained the difference in metaphase arrest seen in cdc13-1 mutants was drawn from a 
single time point (Figure 16E). To test whether this result was robust, ssDNA at other 
loci was measured 0, 2, 4 and 6 hours after telomere uncapping. X repeats are telomeric 
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sequences present on all chromosomes in S. cerevisiae, either present behind the Y’ 
elements on Y’-containing telomeres, such as Chromosome V (and thus far from the 
chromosome end, Figure 17A) or present close to the chromosome end on telomeres 
that do not contain Y’ elements (X-only telomeres, Figure 17A). Following telomere 
uncapping, cdc13-1 mutants generated ssDNA in the X repeats, cdc13-1 pif1∆ mutants 
generated less ssDNA and no detectable ssDNA could be measured in cdc13-1 exo1∆ or 
cdc13-1 exo1∆ pif1∆ mutants (Figure 17B). At the YER188W and YER186C loci, which 
are 6,500bp and 14,500bp respectively from the end of Chromosome V, the same trend 
was present – cdc13-1 mutants generated ssDNA, while cdc13-1 pif1∆ mutants 
generated less ssDNA and no detectable ssDNA was measured in cdc13-1 exo1∆ or 
cdc13-1 exo1∆ pif1∆ mutants (Figure 17C,D). However, at the PDA1 locus, which is 
29,700bp from the end of Chromosome V, cdc13-1 mutants generated ssDNA but no 
detectable ssDNA was measured in cdc13-1 pif1∆, cdc13-1 exo1∆ or cdc13-1 exo1∆ 
pif1∆ mutants (Figure 17E). It was confirmed that ssDNA was generated specifically on 
the TG strand at the more internal loci, as no detectable ssDNA was measure on the AC 
strand at YER186C or PDA1 (Figure 17F,G). In conclusion, the result presented in 
Figure 17E is robust – cdc13-1 pif1∆ mutants generate more extensive ssDNA than 
cdc13-1 exo1∆ mutants and this ssDNA occurs specifically on the TG strand. 
Pif1 negatively regulates telomere length and pif1∆ mutants have long telomeres, <500 
bases longer than those seen in wild type cells (Schulz and Zakian, 1994). Thus it was 
necessary to consider the possibility that in cdc13-1 pif1∆ mutants the reduced ssDNA 
measured in comparison to cdc13-1 mutants was simply due to resection initiating 
further from the loci measured. To test this hypothesis, ssDNA measured in cdc13-1 
pif1∆ mutants was compared ssDNA measured further from the chromosome end in 
cdc13-1 PIF1+ mutants. At the Y’600 locus, approximately 600 bases from the 
chromosome end, the ssDNA generated in cdc13-1 pif1∆ mutants was a maximum of 
4% (Figure 16B), which was comparable to the maximum ssDNA generated in cdc13-1 
PIF1+ mutants at YER186C (Figure 17C), approximately 14,500 bases from the 
chromosome end (and thus approximately 14,000 bases away from the Y’600 locus). 
Additionally, cdc13-1 pif1∆ mutants generated much less ssDNA at YER188W than 
cdc13-1 PIF1+ mutants did at YER186C, despite the loci being approximately 6,000 
bases apart (Figure 17 C,D). It was concluded that reduction in ssDNA measured in 
cdc13-1 pif1∆ mutants in comparison to cdc13-1 PIF1+ mutants following telomere 
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uncapping corresponded to a defect in resection of many kilobases (approximately 
6,000 to 14,000) and could not simply be attributed to an increase in telomere length 
corresponding to a few hundred bases (<500) and thus that Pif1 actively played a role in 
the resection of uncapped telomeres in cdc13-1 mutants. 
No ssDNA could be detected in cdc13-1 exo1∆ pif1∆ mutants with uncapped telomeres 
and no checkpoint activation or cell cycle arrest could be seen (Figure16, Figure14). 
However, yku70∆ mutants at 23°C do not undergo checkpoint activation or cell cycle 
arrest, but have detectable ssDNA in the telomeric TG repeats, at the very end of the 
chromosome. It was hypothesized that the same might be true of cdc13-1 pif1∆ exo1∆ 
mutants. To test this hypothesis, synchronous cultures of cdc13-1 mutants were 
subjected to telomere uncapping (Figure 14A) and then ssDNA in the telomeric TG 
repeats was measured by in-gel assay. cdc13-1 mutants generated 4-5 times the level of 
ssDNA of a yku70∆ mutants in the TG repeats following telomere uncapping and this 
was slightly reduced in cdc13-1 pif1∆ mutants (Figure 18A,B). cdc13-1 exo1∆ mutants 
generated slightly less ssDNA than a yku70∆ mutant in the TG repeats following 
telomere uncapping (Figure 18A,B). In contrast, cdc13-1 exo1∆ pif1∆ mutants 
transiently generated a similar level of ssDNA to a yku70∆ mutant 2 hours after 
telomere uncapping, but by 4 hours no ssDNA was detectable (Figure 18B). In 
conclusion, cdc13-1 exo1∆ pif1∆ mutants do generate ssDNA following telomere 
uncapping, but it is transient and not sustained. 
Interestingly, cdc13-1 pif1∆ mutants generated only slightly less ssDNA than cdc13-1 
mutants in the TG repeats (Figure 18A,B) yet cdc13-1 pif1∆ mutants generated much 
less ssDNA in the Y’ elements than cdc13-1 mutants (Figure 16B). This was in contrast 
to cdc13-1 exo1∆ mutants which generated very little ssDNA in the telomeric TG 
repeats (Figure 18A,B), but similar levels of ssDNA in the Y’ elements to Pif1 (Figure 
16B). These data indicate that the importance of Pif1 in ssDNA generation peaks in the 
Y’ elements while the importance of Exo1 peaks in the TG repeats. These data therefore 
suggest that Exo1 recognizes a substrate at the very end of the chromosome in the TG 
repeats, while Pif1 recognizes a substrate away from the chromosome end, towards the 
Y’ elements.  
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Figure 19: Pif1 and Exo1 inhibit the growth of yku70∆ mutants through parallel 
pathways 
Saturated cultures of the indicated genotypes were serially diluted across agar plates and 
grown on YEPD plates at the temperatures indicated for 2 days.
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4.2.4 Pif1 inhibits the growth of yku70∆ mutants in a parallel pathway to Exo1 
Thus far in this study, uncapped telomeres caused by inactivation of cdc13-1 have been 
used as a paradigm for telomere uncapping. However, telomere capping and ensuing 
metaphase arrest can be stimulated by multiple means (Figure 2B-D). Perhaps the most 
significant of these is the thermosensitive telomere capping defect conferred by yku70∆ 
mutants. Like cdc13-1 mutants, when yku70∆ mutants are exposed to semi- and non-
permissive temperatures they accumulate ssDNA and undergo metaphase arrest 
(Maringele and Lydall, 2002). Unlike ssDNA generation at uncapped telomeres in 
cdc13-1 mutants, which depends upon two parallel pathways dependent upon Pif1 and 
Exo1 (Figures 16-18), ssDNA generation at uncapped telomeres in yku70∆ mutants has 
been reported to be entirely dependent upon Exo1 (Maringele and Lydall, 2002). 
However, Pif1 does inhibit the growth of yku70∆ mutants with uncapped telomeres 
(Vega et al., 2007). This suggested that Pif1 might generate ssDNA in the same 
pathway as Exo1 at uncapped telomeres in yku70∆ mutants. Growth of yku70∆ mutants 
at non-permissive temperatures is inhibited by accumulation of telomeric ssDNA, which 
stimulates cell cycle arrest and causes loss of viability (Maringele and Lydall, 2002). 
Thus, it was hypothesized that if Pif1 generated ssDNA in the same pathway as Exo1 at 
uncapped telomeres in yku70∆ mutants, it would also inhibit the growth of yku70∆ 
mutants at non-permissive temperatures in the same pathway as Exo1.  
To test this hypothesis, the effect of Pif1 on the growth of yku70∆ and yku70∆ exo1∆ 
mutants at non-permissive temperatures was examined. At 34°C-36°C, yku70∆ pif1∆ 
mutants grew noticeably better than yku70∆ mutants, confirming that Pif1 inhibited the 
growth of yku70∆ mutants, as previously described (Figure 19) (Vega et al., 2007, 
Smith et al., 2008). At 34°C-37°C, yku70∆ exo1∆ mutants grew noticeably better than 
yku70∆ mutants, confirming that Exo1 also inhibited the growth of yku70∆ mutants, as 
previously described (Figure 19) (Maringele and Lydall, 2002). However, at 37.5°C-
38°C, yku70∆ exo1∆ mutants grew noticeably worse than YKU70+ exo1∆ mutants, 
indicating that there was a residual defect caused by telomere uncapping (Figure 19). 
yku70∆ exo1∆ pif1∆ mutants grew poorly at 37.5°C-38°C but there was no noticeable 
growth defect compared to YKU70+ exo1∆ pif1∆ mutants, indicating that there was no 
residual defect caused by telomere uncapping (Figure 19). In conclusion, Pif1 inhibits 
the growth of yku70∆ mutants in a different pathway to Exo1, but does not inhibit the 
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growth of yku70∆ mutants as potently as Exo1. This suggests that Pif1 and Exo1 might 
function in parallel pathways to generate ssDNA at uncapped telomeres in yku70∆ 
mutants, just like in cdc13-1 mutants (Figures 16-18). 
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Figure 20: a model for the DDR at uncapped telomeres in cdc13-1 mutants 
Following telomere uncapping by inactivation of Cdc13, both 3’ and 5’ overhangs 
occur and are substrates for resection and generation of 3’ tracts of ssDNA by Exo1 and 
Pif1, respectively. Pif1 in combination with an unidentified ssDNA endonuclease 
(ExoY) generates ssDNA from 5’ overhangs 0-5kb from the chromosome end while 
Exo1 in combination with Sgs1 and the 9-1-1 complex generates ssDNA from 3’ 
overhangs 0-5kb from the chromosome end. This processing <5kb from the 
chromosome end causes weak checkpoint activation, sufficient to cause robust arrest in 
a subpopulation of cells. >5kb from the chromosome end 3’ ssDNA is extended by 
Exo1 to cause robust checkpoint activation in essentially all cells. In the absence of 
Rad9, a third nuclease activity (ExoX) also supported by Sgs1 and Rad24 is able to 
resect uncapped telomeres 5-30kb from the chromosome end generating high levels of 
extensive ssDNA. 
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4.3 Discussion 
Here it has been shown that Pif1 contributes to the DDR at uncapped telomeres, playing 
an important role in both resection (Figures 16-18) and checkpoint activation (Figure 
14). Furthermore, elimination of Pif1 and Exo1 eliminates resection at uncapped 
telomeres along with the ensuing cell cycle arrest and checkpoint activation (Figures 
14,16). This permits a model for checkpoint activation at uncapped telomeres to be 
proposed (Figure 20). 
Figure 20 shows that following telomere uncapping, both Pif1 and Exo1 independently 
resect uncapped telomeres within 5kb of the chromosome end, causing weak checkpoint 
activation sufficient to arrest a subpopulation of cells in metaphase (Figure 14). 
Following this weak, initial checkpoint activation, Exo1 then extensively processes both 
Pif1- and Exo1- generated substrates to up to 30KB from the chromosome end, causing 
stronger, more robust checkpoint activation (Figure 20). According to this model, 
cdc13-1 pif1∆ mutants still undergo full checkpoint activation (Figure 14), despite the 
reduction in resection (Figures 16-17) seen in these cells because extensive resection 
and robust checkpoint activation by Exo1 still occur. This model also indicates, as 
previously suggested (Zubko et al., 2004), that a fraction of cdc13-1 exo1∆ mutants are 
able to escape from arrest (Figure 14) because extensive resection and robust 
checkpoint activation by Exo1 does not occur, but less extensive and weak checkpoint 
activation by Pif1 does occur. Finally, no checkpoint activation is seen in cdc13-1 
exo1∆ pif1∆ mutants because resection is eliminated (Figure 14). Notably, this model 
indicates that Pif1 is required for ExoY activity, the previously-hypothetical nuclease 
activity proposed to function in parallel to Exo1 to generate ssDNA <5kb from the 
chromosome end (Zubko et al., 2004). Based on the data from earlier (Figure 6) as well 
as other published data (Ngo and Lydall, 2010, Zubko et al., 2004) the model assumes 
that Sgs1 and the 9-1-1 complex support resection by Exo1 in RAD9+ and rad9∆ cells, 
while the 9-1-1 complex and Sgs1 can carry out Exo1-independent resection with ExoX 
in rad9∆ cells. 
The model proposed in Figure 20 assumes that, like at DSBs, it is the extent of the 
ssDNA generated that determines checkpoint activation. However, it should be noted 
that the 0-5kb range in which Pif1 has been demonstrated to carry out Exo1-
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independent resection (Figure 16) is within the Y’ elements. Thus, it is possible that it is 
the location of the ssDNA that determines checkpoint activation, not the length of the 
ssDNA tract i.e. resection beyond the Y’ elements might cause checkpoint activation, 
regardless of the extent of the ssDNA tract, as previously proposed (Zubko et al., 2004). 
However, without testing this hypothesis in strains of yeast lacking Y’ elements, no 
clear conclusions can be drawn. 
cdc13-1 exo1∆ pif1∆ mutants can grow at 36°C and do not undergo checkpoint 
activation or generate detectable ssDNA at their telomeres. Other recent work 
demonstrates that cdc13-1 exo1∆ sgs1∆ mutants cannot grow at 36°C, do undergo 
checkpoint activation and generate detectable ssDNA <5kb from the chromosome end 
(in the Y’ elements) (Ngo and Lydall, 2010). However, cdc13-1 rad9∆ sgs1∆ exo1∆ 
mutants are able to grow at 36°C due to inactivation of the checkpoint despite still 
generating ssDNA <5kb from the chromosome end, which is presumably due to Pif1 
activity (Ngo and Lydall, 2010). One possible explanation for the ability of cdc13-1 
rad9∆ sgs1∆ exo1∆ mutants but not cdc13-1 sgs1∆ exo1∆ mutants to grow at 36°C is 
that the ssDNA generated <5kb from the chromosome end in cdc13-1 exo1∆ sgs1∆ 
mutants is sufficient to cause checkpoint activation but not to cause loss of viability. 
Thus, removal of Rad9 eliminates the checkpoint and as Sgs1 is responsible for the 
increased ssDNA generated in cdc13-1 rad9∆ mutants (i.e. Sgs1 is required for ExoX as 
proposed in Figure 20), no net increase in ssDNA is seen in cdc13-1 rad9∆ exo1∆ 
sgs1∆ mutants and so the checkpoint is eliminated without compromising viability.  
The above hypothesis suggests that the ssDNA generated by Pif1 can cause checkpoint 
activation but not loss of viability. However, cdc13-1 rad24∆ exo1∆ mutants, which do 
not activate the checkpoint and should only generate Pif1-dependent ssDNA, are unable 
to grow at 36°C. Furthermore, an Exo1-dependent increase in ssDNA generation is seen 
in cdc13-1 mec1∆ mutants compared to cdc13-1 mutants and Mec1 is required for 
checkpoint activation in cdc13-1 exo1∆ mutants, yet cdc13-1 mec1∆ exo1∆ mutants 
(which, again, do not activate the checkpoint and should only generate Pif1-dependent 
ssDNA) are unable to grow at 36°C. These two observations suggest that Pif1-
dependent ssDNA in cdc13-1 rad24∆ exo1∆ strains and cdc13-1 mec1∆ exo1∆ strains is 
sufficient to cause loss of viability. 
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An alternative explanation for the growth of cdc13-1 rad9∆ exo1∆ sgs1∆ mutants but 
not cdc13-1 RAD9+ exo1∆ sgs1∆ mutants at 36°C is that perhaps in cells lacking Rad9, 
Sgs1 generates ssDNA from substrates that are usually processed by Pif1. This would 
suggest that in the absence of certain checkpoint components, a re-wiring of ssDNA 
generation pathways occurs and thus cdc13-1 rad9∆ exo1∆ sgs1∆ mutants are viable at 
36°C because Pif1 has less of a role in ssDNA generation in cdc13-1 rad9∆ mutants 
than in cdc13-1 RAD9+ mutants or alternatively that Pif1 has to cooperate with Sgs1 for 
ssDNA generation in cdc13-1 rad9∆ mutants. It will be tremendously important to 
investigate the interplay between Pif1, Sgs1 and Rad9 in the resection of uncapped 
telomeres. 
Figure 20 proposes that Pif1 functions to generate ssDNA to be cleaved by an 
unidentified ssDNA endonuclease, analogously to its proposed roles in Okazaki 
fragment processing and disassembly of replication forks (Pike et al., 2009, Rossi et al., 
2008, Chang et al., 2009). According to this model, Pif1 acts upon 5’ (AC) ssDNA as 
Pif1 is a 5’-3’ helicase and would need to act upon exposed 5’ ssDNA in order to 
generate ssDNA in a telomere-to-centromere direction (Figure 16E) (Lahaye et al., 
1991). However, Pif1 is primarily thought of as a negative regulator of telomerase at 
telomeres and has been proposed to inhibit the growth of cdc13-1 mutants by removing 
telomerase from the telomere, thus promoting access of nucleases to the telomeric DNA 
(Zhou et al., 2000, Boule et al., 2005, Vega et al., 2007). Work presented here clearly 
shows that Pif1 has a very strong contribution to ssDNA generation in the Y’ elements 
(Figure 16) but only a slight contribution in the TG repeats (Figures 16,18). This is 
inconsistent with a model in which Pif1 removes telomerase from the telomere, as the 
effect would be expected to be greatest in the TG repeats, where telomere-bound 
telomerase should be present. Thus, any model of how Pif1 contributes to resection at 
uncapped telomeres must explain why Pif1 has such a strong effect in the Y’ regions, 
but a relatively subtle effect at the chromosome end. A model in which Pif1 supports 
nuclease activity at a substrate arising away from the very end of the chromosome and 
towards the Y’ elements (such as a stalled replication fork) explains this (Chang et al., 
2009). Additionally, the 5’ (AC) ssDNA that Pif1 is proposed to act upon at uncapped 
telomeres could, in principle occur on the leading strand of a stalled replication fork. 
Pif1 is not required for full cell cycle arrest if cells progress from G1 to metaphase with 
uncapped telomeres (Figure 14B-C). However, when asynchronously-dividing 
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populations of cdc13-1 mutants are subjected to telomere uncapping, Pif1 is required 
for rapid cell cycle arrest (Figure 13C). This suggests that while resection by Exo1 can 
effect full cell cycle arrest at metaphase when cells pass from G1 to metaphase with 
uncapped telomeres, if telomere uncapping occurs mid cell cycle (as would be the case 
for many cells in an asynchronously dividing population) then Pif1 is necessary to 
cooperate with Exo1 to cause full checkpoint activation and robust arrest. This may 
have important physiological consequences cells, as telomere dysfunction is unlikely to 
occur spontaneously at G1. Alternatively, it might suggest that the resection by Pif1 and 
Exo1 is cell cycle coordinated. This alternative is particularly interesting when 
considering that the slight reduction in TG repeat ssDNA caused by elimination of Pif1 
(Figure 18) correlates with the low level of ssDNA that has been reported to occur at 
uncapped telomeres in cdc13-1 mutants in the TG repeats during S phase 
(Vodenicharov and Wellinger, 2006). It is also interesting to consider that the large 
reduction in TG repeat ssDNA caused by elimination of Exo1 (Figure 18) correlates 
with the high level of ssDNA that has been reported to occur at uncapped telomeres in 
cdc13-1 mutants in the TG repeats during metaphase (Vodenicharov and Wellinger, 
2006). 
Interestingly, slight accumulation at metaphase is seen in cdc13-1 rad24∆ mutants and 
this Pif1-dependent (Figure 13C), suggesting a very low level of checkpoint activation. 
Thus, loading of the 9-1-1 complex is unlikely to be absolutely required for checkpoint 
activation but instead promotes checkpoint activation. This is highly analogous to the 
role proposed here (section 3.3) for Rad24 in promoting resection by loading the 9-1-1 
complex, but not being absolutely required for it (presumably because the nucleases 
have natural affinity for telomeric DNA). Thus, the 9-1-1 complex might promote 
nuclease activity at uncapped telomeres and promote checkpoint activation, but be non-
essential for either. It is interesting to speculate that limited resection by ExoX might be 
the stimulus for checkpoint activation and telomere homeostasis might rely on the 
ability of Rad9 to inhibit ExoX, limiting its function to checkpoint activation and 
preventing extensive resection.  
Finally, Pif1 inhibits the growth of yku70∆ mutants and is responsible for the residual 
growth defect in yku70∆ exo1∆ mutants (Figure 19). This demonstrates that Pif1 and 
Exo1 constitute parallel pathways that inhibit the growth of uncapped telomeres in 
cdc13-1 and yku70∆ mutants (Figure 4, Figure 19). Thus, the Pif1- and Exo1- 
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dependent nucleases are likely to be general feature of dysfunctional telomeres. 
Unfortunately, at the temperatures at which yku70∆ exo1∆ mutants show a growth 
defect (37.5°C-38.0°C) even YKU70+ mutants show a defect, and YKU70+ pif1∆ 
mutants grow poorly, so it will be difficult to assess the contribution of Pif1 to Exo1-
independent ssDNA generation in yku70∆ mutants. 
4.4 Further Work 
Pif1 and Exo1 resect uncapped telomeres in cdc13-1 mutants and cdc13-1 exo1∆ pif1∆ 
mutants do not generate any detectable ssDNA >600bp from the chromosome end (Y’ 
elements, Figure 16B) and generate only transient ssDNA at the very end of the 
chromosome (the TG repeats, Figure 18). Rad9 inhibits resection at uncapped telomeres 
and cdc13-1 rad9∆ mutants generate elevated levels of ssDNA compared to cdc13-1 
mutants, dependent upon Sgs1 and Rad24 (Lydall and Weinert, 1995, Ngo and Lydall, 
2010, Zubko et al., 2004). It will be interesting to know whether any detectable ssDNA 
can be seen in the Y’ elements of cdc13-1 rad9∆ exo1∆ pif1∆ mutants and if so, 
whether this ssDNA is dependent upon Rad24 or Sgs1, or both. Furthermore, cdc13-1 
rad9∆ sgs1∆ exo1∆ mutants are viable for several generations at 36°C despite residual 
ssDNA generation still occurring in the Y’ elements (Ngo and Lydall, 2010). This 
residual ssDNA is, presumably, dependent upon Pif1 and it will be important to 
formally show this. 
If the residual ssDNA generated in cdc13-1 rad9∆ exo1∆ sgs1∆ mutants is dependent 
upon Pif1, then it will suggest that Pif1-dependent ssDNA can prevent growth at 36°C 
by stimulating checkpoint activation but the loss of viability incurred by Pif1 activity is 
negligible for short term growth at 36°C. Alternatively, in cdc13-1 rad9∆ mutants, 
substrates usually processed by Pif1 might be processed by Sgs1 and thus there might 
be less Pif1-dependent ssDNA generated in cdc13-1 rad9∆ mutants than cdc13-1 
mutants. It will be important to see what the contribution of Pif1 to ssDNA generation 
in cdc13-1 rad9∆ mutants is. 
Pif1 appears to contribute to the very slight loss in viability in yku70∆ exo1∆ mutants at 
high temperatures (Figure 19). Thus, it will be important to investigate whether Pif1 
also functions in parallel to Exo1 in yku70∆ mutants to generate ssDNA. As essentially 
no ssDNA is generated in yku70∆ exo1∆ mutants, even >600bp from the chromosome 
ends, this could likely only be assessed by in-gel assay. Alternatively, it may be 
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possible to carry out the experiments at a higher temperature, with the caveat that pif1∆ 
mutants are very sick at this temperature (Figure 19). 
Finally, it will be important to investigate the role of Rad24 in checkpoint activation 
and ssDNA generation following telomere uncapping, especially as strong evidence has 
been presented here that some Rad24-independent Pif1-dependent checkpoint activation 
does occur in cdc13-1 mutants following telomere uncapping (Figure 13C). It also will 
be of particular interest to investigate how the roles of Rad24 and Exo1 overlap, as 
elimination of either permits the growth of cdc13-1 pif1∆ (Figure 6) or cdc13-1 rad9∆ 
sgs1∆ mutants (Greg Ngo, Personal Communication) at 36°C. 
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5 What is Pif1 doing at Uncapped telomeres? 
“There is no adequate defence, except stupidity, against the impact of a new 
idea.” 
- Percy Williams Bridgman 
5.1 Introduction 
The primary role of Pif1 in yeast is believed to be negative regulation of telomerase at 
DSBs and telomeres, which Pif1 is believed to effect by unwinding the telomerase RNA 
subunit (TLC1, in yeast) from the telomeric DNA (Boule et al., 2005, Makovets and 
Blackburn, 2009, Schulz and Zakian, 1994, Zhou et al., 2000). Data presented in 
Chapter 4 shows that Pif1 appears to control a nuclease activity, which functions at 
uncapped telomeres in parallel to Exo1 (Figures 16-18). It has been suggested that in the 
absence of Pif1, increased levels of telomerase at the telomeres can inhibit nuclease 
activities in cdc13-1 mutants (Vega et al., 2007). However, telomerase binds to the very 
ends of chromosomes, in the telomeric TG repeats, so this model is inconsistent with 
data presented in Section 4, showing that Pif1 has only a moderate effect in the TG 
repeats (Figure 18) and functions primarily away from the TG repeats, towards the Y’ 
elements (Figure 16). 
Data presented in Section 4 is consistent with other models for Pif1 function, suggesting 
that Pif1 is involved in unwinding G-quadruplex structures (Ribeyre et al., 2009) or in 
destabilizing stalled replication forks (Chang et al., 2009). Additionally, Pif1 is believed 
to play a role in generating long flaps during Okazaki fragment processing (Budd et al., 
2006) and has been shown to be capable in vitro of unwinding dsDNA to generate 
ssDNA to be cleaved by nucleases involved in Okazaki fragment processing (Pike et al., 
2009). Finally, Pif1 also has roles in mitochondrial DNA maintenance (Van Dyck et al., 
1992), which are unlikely to account for the role of Pif1 at uncapped telomeres in the 
nucleus. 
The purpose of this work was to gain insight into whether Pif1 function could be 
attributed to telomerase-dependent or telomerase-independent roles in the nucleus or 
mitochondria. 
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Figure 21: Nuclear, helicase activity of Pif1 inhibits the growth of cdc13-1 exo1∆ 
mutants 
Saturated cultures of the genotypes indicated, lacking either mitochondrial Pif1 (pif1-
m1) or nuclear Pif1 (pif1-m2), carrying a helicase-dead allele of Pif1 (pif1-hd) or 
deleted for Pif1 (pif1∆) were serially-diluted across YEPD plates and grown at the 
temperatures indicated for 3 days. 
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5.2 Results 
5.2.1 Nuclear, helicase activity of Pif1 inhibits the growth of cdc13-1 mutants 
Pif1 exists as nuclear and mitochondrial isoforms (Schulz and Zakian, 1994) and Pif1 is 
responsible for the residual resection that inhibits the growth of cdc13-1 exo1∆ mutants 
with uncapped telomeres (Figure 6, Figure 16). To test the hypothesis that the nuclear, 
but not mitochondrial form of Pif1 inhibits the growth of cdc13-1 exo1∆ mutants, point 
mutations were inserted into the genome of cdc13-1 exo1∆ mutants to eliminate either 
nuclear Pif1 (pif1-m2) or mitochondrial Pif1 (pif1-m1) (Schulz and Zakian, 1994). 
cdc13-1 exo1∆ pif1-m2 mutants and cdc13-1 exo1∆ pif1∆ mutants were able to grow at 
30°C and 36°C, while cdc13-1 exo1∆ and cdc13-1 pif1∆-m1 mutants were not (Figure 
21). It was noted that cdc13-1 exo1∆ pif1-m2 mutants grew slightly worse at 36°C than 
cdc13-1 exo1∆ pif1∆ mutants. However, this is consistent with other reports that pif1-
m2 mutants retain a very low level of nuclear Pif1 activity (Schulz and Zakian, 1994, 
Ribeyre et al., 2009). It was concluded that nuclear, not mitochondrial Pif1 activity 
inhibits the growth of cdc13-1 exo1∆ mutants. 
The ability of Pif1 to unwind telomerase RNA from telomeric DNA and to unwind G 
quadruplex structures in vitro is dependent upon its helicase activity (Boule et al., 2005, 
Ribeyre et al., 2009). Although S. cerevisiae Pif1 has no reported cellular functions 
independent of its helicase activity, H. sapiens Pif1 has been reported to possess strand 
annealing activity (George et al., 2009). Thus it was possible that Pif1 might have an 
unidentified, helicase-independent catalytic activity at uncapped telomeres that inhibits 
the growth of cdc13-1 exo1∆ mutants. To test the hypothesis that Pif1 inhibits the 
growth of cdc13-1 exo1∆ mutants independently of its helicase activity, a point 
mutation was introduced into the genome of cdc13-1 exo1∆ mutants to eliminate the 
helicase activity of Pif1 (pif1-hd), thus causing a catalytically dead Pif1 to be expressed 
(Ribeyre et al., 2009). At 30°C and 36°C, cdc13-1 exo1∆ mutants were unable to grow, 
while cdc13-1 exo1∆ pif1∆ and cdc13-1 exo1∆ pif1-hd mutants were able to grow 
(Figure 21). It was concluded that the helicase activity of Pif1, rather than some other 
unidentified catalytic activity, inhibits the growth of cdc13-1 exo1∆ mutants. 
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Figure 22: Pif1 inhibits the growth of cdc13-1 tlc1∆ mutants 
Saturated cultures of the genotypes indicated were serially diluted across YEPD plates 
and grown at the temperatures indicated for 4 days. All strains and controls were 
germinated simultaneously from the same diploid at 23°C for 3 days.
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Figure 23: Pif1 inhibits the growth of cdc13-1 est2∆ mutants 
Saturated cultures of the genotypes indicated were serially diluted across YEPD plates 
and grown at the temperatures indicated for 4 days. All strains and controls were 
germinated simultaneously from the same diploid at 23°C for 3 days. 
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5.2.2 Pif1 functions independently of telomerase at uncapped telomeres in cdc13-1 
mutants 
Pif1 has been suggested to contribute to nuclease activity at uncapped telomeres by 
removing telomerase from telomeres and facilitating access by nucleases (Vega et al., 
2007), but this model is inconsistent with data presented here showing that Pif1 
functions primarily away from the very ends of the telomeres (Figure 18). Thus, it was 
important to test whether the roles of Pif1 in the DDR at uncapped telomeres were 
dependent upon telomerase or not. 
Pif1 acts upon the TLC1 subunit of telomerase to remove telomerase from telomeric 
DNA (Boule et al., 2005). It was hypothesized that Pif1 might function independently 
of this activity at uncapped telomeres and thus would inhibit the growth of cdc13-1 and 
cdc13-1 exo1∆ mutants even in the absence of TLC1. To test this hypothesis, the effect 
of Pif1 on the growth of tlc1∆ cdc13-1 and tlc1∆ cdc13-1 exo1∆ mutants was examined. 
Cells lacking telomerase undergo a gradual decrease in proliferative capacity over time 
due to telomere shortening, so in order to examine the growth of cdc13-1 mutants 
lacking the TLC1 subunit of telomerase, tlc1∆/TLC1+ cdc13-1/CDC13+ exo1∆/EXO1+ 
pif1∆ /PIF1+ diploids were generated, sporulated and spores germinated to generate all 
experimental strains and controls simultaneously. At 25°C, tlc1∆ cdc13-1 mutants grew 
poorly, while tlc1∆ cdc13-1 pif1∆ mutants grew well (Figure 22). Similarly, at 26°C 
and 27°C, tlc1∆ cdc13-1 exo1∆ mutants grew poorly, while tlc1∆ cdc13-1 pif1∆ exo1∆ 
mutants grew well (Figure 22). It was concluded that Pif1 inhibits the growth of cdc13-
1 and cdc13-1 exo1∆ mutants independently of TLC1. 
It was noted that tlc1∆ cdc13-1 mutants showed a severe growth defect at 25°C while 
cdc13-1 mutants did not (Figure 22). Similarly, tlc1∆ cdc13-1 exo1∆ and tlc1∆ cdc13-1 
pif1∆ mutants showed a severe growth defect at 26°C, while cdc13-1 exo1∆ and cdc13-
1 pif1∆ mutants did not (Figure 22) and tlc1∆ cdc13-1 exo1∆ pif1∆ mutants were unable 
to grow at 36°C while cdc13-1 exo1∆ pif1∆ mutants were not (Figure 22). In 
conclusion, TLC1 plays a protective role in all cdc13-1 mutants and is required for the 
growth of cdc13-1 exo1∆ pif1∆ mutants at 36°C, suggesting that cdc13-1 exo1∆ pif1∆ 
mutants are unable to survive at 36°C without telomerase. 
Pif1 clearly inhibited the growth of cdc13-1 mutants independently of TLC1 (Figure 
22). However, it was conceivable that Pif1 also removed telomerase from telomeres by 
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a hereto-unprecedented TLC1-independent mechanism. To test this hypothesis, it was 
necessary to examine the effect of Pif1 in cdc13-1 mutants lacking Est2, the catalytic 
subunit of telomerase, which believed to be responsible for inhibiting nucleases at the 
telomeres of cdc13-1 pif1∆ mutants (Vega et al., 2007). Similarly to before, 
est2∆/EST2+ cdc13-1/CDC13+ exo1∆/EXO1+ pif1∆ /PIF1+ diploids were generated, 
sporulated and spores germinated to generate all experimental strains and controls 
simultaneously. At 25°C est2∆ cdc13-1 mutants grew poorly while est2∆ cdc13-1 pif1∆ 
mutants grew better (Figure 23). Similarly, at 26°C, est2∆ cdc13-1 exo1∆ mutants grew 
poorly but est2∆ cdc13-1 exo1∆ pif1∆ mutants grew better (Figure 23). It was 
concluded that Pif1 inhibits the growth of cdc13-1 and cdc13-1 exo1∆ mutants 
independently of Est2.  
It was also noted that the absence of Est2 (Figure 23) conferred a similar defect to the 
absence of TLC1 (Figure 22). At 25°C, est2∆ cdc13-1 mutants had a severe growth 
defect while cdc13-1 mutants did not (Figure 23). est2∆ cdc13-1 exo1∆ and est2∆ 
cdc13-1 pif1∆ mutants showed a severe growth defect at 26°C while cdc13-1 exo1∆ and 
cdc13-1 pif1∆ mutants did not (Figure 23) and est2∆ cdc13-1 exo1∆ pif1∆ mutants were 
unable to grow at 36°C while cdc13-1 exo1∆ pif1∆ mutants were (Figure 23). It was 
concluded that Est2, like TLC1, plays a protective role at uncapped telomeres in all 
cdc13-1 mutants. 
pif1∆ mutants have long telomeres and telomerase is required for this (Zhou et al., 
2000). Furthermore cdc13-1 exo1∆ pif1∆ mutants are able to grow at 36°C, while 
cdc13-1 exo1∆ pif1∆ mutants lacking telomerase (TLC1, Est2, Figures 22-23) are not. 
Thus, it is possible that the long telomeres play an important causal role in permitting 
the growth of cdc13-1 exo1∆ pif1∆ mutants at 36°C. Alternatively, it is possible that the 
long telomeres seen in pif1∆ mutants are consequential of an increased requirement for 
telomerase and this requirement is heightened in cdc13-1 exo1∆ pif1∆ mutants. 
However, without investigating the consequences of telomere uncapping in cdc13-1 
exo1∆ pif1∆ mutants with short telomeres and in telomerase-deficient cdc13-1 exo1∆ 
pif1∆ mutants with long telomeres, no definitive conclusion can be made. 
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Figure 24: Pif1 contributes to Rad53 activation following telomere uncapping in 
cdc13-1 mutants lacking telomerase 
Exponentially-dividing cultures of cdc13-1 and cdc13-1 tlc1∆ mutants (those indicated 
with an asterisk in Figure 22) were shifted to 36°C to induce telomere uncapping. 
Samples were taken for Western blots, which were performed to detect Rad53 and 
tubulin as a loading control. Upper and lower panels were run on separate gels but 
transferred and detected simultaneously. 
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Figure 25: Pif1 contributes to ssDNA generation in the TG repeats of cdc13-1 
mutants lacking telomerase 
A. Exponentially-dividing cultures of cdc13-1 and cdc13-1 tlc1∆ mutants (those 
indicated with an asterix in Figure 22) were shifted to 36°C to induce telomere 
uncapping. Samples were taken every two hours to measure ssDNA in the TG repeats 
by in-gel assay, then Southern Blots were performed to probe for CDC15 as a loading 
control. B. Quantification of the data shown in A., as in Figure 18B. Dashed line 
represents the level of ssDNA detected in an asynchronously dividing yku70∆ mutant at 
23°C.
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Figure 26: Pif1 inhibits ssDNA generation up to 14,500bp from the chromosome 
end in cdc13-1 mutants lacking telomerase 
Exponentially dividing cultures of cdc13-1 and cdc13-1 tlc1∆ mutants (those indicated 
with an asterisk in Figure 22) were shifted to 36°C to induce telomere uncapping. 
Samples were taken every two hours to measure ssDNA in the TG repeats by in-gel 
assay (Figure 25). Samples were then used to measure ssDNA by QAOS at selected loci 
shown in Figure 16A. 
ssDNA was measured at the Y’600 locus (approximately 600bp from the chromosome 
end) on the TG strand (A. and B.) or the AC strand (C. and D.) and at the YER186C 
locus (approximately 14,500bp from the chromosome end) on the TG strand (E. and F.) 
or the AC strand (G. and H.). In all cases, the horizontal dashed line represents ssDNA 
detected in an asynchronously-dividing yku70∆ mutant at the permissive temperature.
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Figure 27: cdc13-1 mutants lacking telomerase accumulate at metaphase at the 
permissive temperature 
Samples were taken from exponentially dividing cultures of cdc13-1 and cdc13-1 tlc1∆ 
mutants (those indicated with an asterisk in Figure 22) at 23°C, then fixed and scored 
for the percentage of cells at metaphase. 
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5.2.3 Pif1 is a component of the DDR at uncapped telomeres in cdc13-1 mutants 
lacking telomerase 
Pif1 inhibits the growth of cdc13-1 exo1∆ mutants and Pif1 promotes checkpoint 
activation in cdc13-1 exo1∆ mutants in synchronous cultures (Figure 14D). Pif1 also 
inhibits the growth of tlc1∆ cdc13-1 exo1∆ mutants (Figure 22) so it was hypothesized 
that Pif1 might also contribute to checkpoint activation in tlc1∆ cdc13-1 exo1∆ mutants 
in synchronous cultures. However, due to the difficulty in working with telomerase-
deficient strains and the requirement to generate all strains and controls simultaneously, 
it was not feasible to carry out such an experiment in a synchronous culture system. 
Instead, the contribution of Pif1 to checkpoint activation in tlc1∆ cdc13-1 exo1∆ 
mutants was determined in asynchronous cultures, using the strains indicated in Figure 
22, and the contribution to checkpoint activation in cdc13-1 exo1∆ strains was 
determined as a control. 
Asynchronously dividing cdc13-1 and tlc1∆ cdc13-1 mutants were shifted to 36°C to 
induce telomere uncapping and samples were taken at 0, 2 and 4 hours to assess Rad53 
phosphorylation. cdc13-1 exo1∆ mutants displayed a slight decrease in Rad53 mobility 
2 and 4 hours after telomere uncapping, while no discernable mobility shift could be 
seen in cdc13-1 exo1∆ pif1∆ mutants (Figure 24) consistent with previous results in 
synchronous cultures (Figure 14D). tlc1∆ cdc13-1 exo1∆ mutants also displayed a 
decrease in Rad53 mobility 2 and 4 hours after telomere uncapping and tlc1∆ cdc13-1 
exo1∆ pif1∆ mutants also displayed a decrease in Rad53 mobility, but to a lesser extent 
than tlc1∆ cdc13-1 exo1∆ mutants  (Figure 24). It was concluded that Pif1 contributes 
to checkpoint activation in tlc1∆ cdc13-1 exo1∆ mutants, but while cdc13-1 exo1∆ 
pif1∆ mutants displayed no detectable Rad53 activation, this was partially restored in 
tlc1∆ cdc13-1 exo1∆ pif1∆ mutants. Thus, telomerase was required to prevent 
checkpoint activation in cdc13-1 exo1∆ pif1∆ mutants, providing an explanation for the 
inability of tlc1∆ cdc13-1 exo1∆ pif1∆ mutants to grow at 36°C (Figure 22). 
Pif1 has an important role in cell cycle arrest in asynchronously dividing cdc13-1 
mutants (Figure 13). It was hypothesized that Pif1 might also contribute to checkpoint 
activation in asynchronously-dividing tlc1∆ cdc13-1 mutants. To test this hypothesis, 
the contribution of Pif1 to Rad53 activation in cdc13-1 and tlc1∆ cdc13-1 mutants was 
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assessed. cdc13-1 mutants showed a decrease in Rad53 mobility following telomere 
uncapping and this was diminished in cdc13-1 pif1∆ mutants (Figure 24). tlc1∆ cdc13-1 
pif1∆ mutants also showed a decrease in Rad53 mobility following telomere uncapping 
and this was also diminished in tlc1∆ cdc13-1 pif1∆ mutants (Figure 24). It was 
concluded that in asynchronous cultures, Pif1 contributes to checkpoint activation in 
cdc13-1 mutants, consistent with its contribution to cell cycle arrest in asynchronous 
cultures (Figure 13) and that Pif1 contributes to checkpoint activation even in cells 
lacking telomerase. 
As Pif1 contributes to checkpoint activation in cdc13-1 exo1∆ mutants lacking 
telomerase (Figure 25), it was hypothesized that it might also contribute to ssDNA 
generation in cdc13-1 mutants lacking telomerase, which is the stimulus for checkpoint 
activation (Figure 25). To test this hypothesis, asynchronous cultures of the cdc13-1 and 
tlc1∆ cdc13-1 mutants shown in Figure 22 were subjected to telomere uncapping and 
then ssDNA in the telomeric TG repeats was measured by in-gel assay (as in Figure 18). 
tlc1∆ cdc13-1 strains underwent an approximately 10 fold increase in ssDNA in the TG 
repeats compared to a yku70∆ mutant and this was severely diminished in a tlc1∆ 
cdc13-1 mutant both 2 and 4 hours after telomere uncapping (Figure 25A-B). tlc1∆ 
cdc13-1 exo1∆ mutants generated a similar level of ssDNA to a yku70∆ mutant 2 hours 
after telomere uncapping and this was not altered in a tlc1∆ cdc13-1 exo1∆ pif1∆ 
mutants (Figure 25A-B). However, 4 hours after telomere uncapping, tlc1∆ cdc13-1 
exo1∆ mutants displayed an approximately 5-fold more increase telomeric ssDNA than 
a yku70∆ mutant and this was reduced in a tlc1∆ cdc13-1 exo1∆ pif1∆ mutant (Figure 
25A-B). It was concluded that Pif1 contributes to ssDNA generation in the telomeric 
TG repeats even in cells lacking telomerase. 
Following telomere uncapping in asynchronous cultures, cdc13-1 pif1∆ mutants 
generated much less ssDNA than cdc13-1 mutants in the telomeric TG repeats 2 hours 
after telomere uncapping, but by 4 hours there was no distinguishable difference 
between cdc13-1 and cdc13-1 pif1∆ mutants (Figure 25). This was in contrast to in 
synchronous cultures where there was a consistent, but slight, reduction in ssDNA in 
the TG repeats of cdc13-1 pif1∆ mutants compared to cdc13-1 mutants 2 and 4 hours 
after telomere uncapping (Figure 18). To clarify the role of Pif1 in the resection of 
uncapped telomeres in asynchronous cultures of cdc13-1 and tlc1∆ cdc13-1 mutants, 
172 
QAOS was performed to measure ssDNA in the telomeric Y’600 and YER186C loci, 
approximately 600bp and 14,500bp from the chromosome end, respectively. 
Asynchronously grown cdc13-1 mutants generated large quantities of ssDNA at the 
Y’600 locus following telomere uncapping and this was markedly reduced in cdc13-1 
pif1∆ mutants (Figure 26A), as observed in synchronous cultures (Figure 16B). ssDNA 
generation was specific to the TG strand and none was detected on the AC strand 
(Figure 26C). At the YER186C locus, cdc13-1 mutants generated a slight increase in 
ssDNA 2 hours after telomere uncapping and a large increase 4 hours after telomere 
uncapping (Figure 26E) and this was slightly reduced in cdc13-1 pif1∆ mutants (Figure 
26E). This was different to synchronous cultures, where cdc13-1 mutants had generated 
a large increase in ssDNA by 2 hours, which increased slightly by 4 hours and was 
drastically reduced in cdc13-1 pif1∆ mutants (Figure 17D). ssDNA generation in 
asynchronously dividing cdc13-1 mutants at the YER186C locus was specific to the TG 
strand a none was detected on the AC strand (Figure 26G). It was concluded that in 
asynchronous cultures, just like in synchronous cultures, Pif1 was most important for 
ssDNA generation in the Y’ elements, but unlike synchronous cultures, Pif1 was 
relatively unimportant for ssDNA generation further from the chromosome end in 
asynchronous cultures. These differences in ssDNA generation following telomere 
uncapping between synchronous and asynchronous cultures of cdc13-1 pif1∆ and tlc1∆ 
cdc13-1 pif1∆ mutants made it difficult to use these strains to draw conclusions about 
the effect of Pif1 on resection of uncapped telomeres in telomerase-deficient cdc13-1 
mutants.  
It was hypothesized that ssDNA generation in Y’ elements and beyond at uncapped 
telomeres in cdc13-1 exo1∆ and cdc13-1 exo1∆ pif1∆ mutants might be more 
comparable between asynchronous and synchronous cultures than was seen for cdc13-1 
and cdc13-1 pif1∆ mutants (Figure 26). To test this hypothesis, ssDNA was measured 
following telomere uncapping in asynchronously-dividing cultures of cdc13-1 exo1∆ 
and cdc13-1 exo1∆ pif1∆ mutants (Figure 26). cdc13-1 exo1∆ mutants showed a very 
slight increase in ssDNA generation in the Y’ elements following telomere uncapping 
(Figure 26B) and no increase was seen in asynchronously grown cdc13-1 exo1∆ pif1∆ 
mutants, as observed in synchronous cultures (Figure 16B). ssDNA generation by 
cdc13-1 exo1∆ mutants  at the Y’600 locus was specific to the TG strand as no ssDNA 
accumulated on the AC strand (Figure 16D). Additionally, no ssDNA accumulated on 
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the AC or TG strands in cdc13-1 exo1∆ or cdc13-1 exo1∆ pif1∆ mutants, consistent 
with previous results that synchronous cultures of cdc13-1 exo1∆ and cdc13-1 exo1∆ 
pif1∆ mutants did not generate any ssDNA beyond the Y’ elements (Figure 16E). It was 
concluded that in asynchronous cultures, cdc13-1 exo1∆ mutants behave similarly to in 
synchronous cultures and that Exo1 is important for ssDNA in the Y’ elements and 
essential for ssDNA generation beyond the Y’ elements. 
Following telomere uncapping, cdc13-1 exo1∆ mutants generated comparable levels of 
ssDNA when grown synchronously or asynchronously, so were therefore used to 
examine the effect of Pif1 and telomerase (TLC1) on the resection of uncapped 
telomeres. At the Y’600 locus, tlc1∆ cdc13-1 exo1∆ and tlc1∆ cdc13-1 exo1∆ pif1∆ 
mutants generated elevated levels of ssDNA compared to cdc13-1 exo1∆ and cdc13-1 
exo1∆ pif1∆ mutants, respectively, and also in comparison to an asynchronously 
dividing yku70∆ mutant (Figure 26B). However, asynchronously dividing tlc1∆ cdc13-
1 exo1∆ pif1∆ mutants generated less ssDNA than a tlc1∆ cdc13-1 exo1∆ mutant 
(Figure 26B). At the YER186C locus, no ssDNA was detectable in tlc1∆ cdc13-1 exo1∆, 
tlc1∆ cdc13-1 exo1∆ pif1∆, cdc13-1 exo1∆ or cdc13-1 exo1∆ pif1∆ mutants (Figure 
26F). It was concluded that Pif1 contributes to ssDNA generation at uncapped telomeres 
even in cdc13-1 mutants lacking telomerase (TLC1) and that telomerase inhibits ssDNA 
generation independently of both Pif1 and Exo1 in the Y’ elements but not at internal 
loci (such as YER186C). 
It had been concluded that telomerase inhibits ssDNA generation in cdc13-1 mutants 
(Figure 26B). However, 4 hours after telomere uncapping, tlc1∆ cdc13-1 pif1∆ mutants 
generated less ssDNA than cdc13-1 pif1∆ mutants in both the Y’600 and YER186C loci 
(Figure 26A,E).  Furthermore, at YER186C, 4 hours after telomere uncapping, 
asynchronously grown tlc1∆ cdc13-1 pif1∆ mutants showed a huge decrease in ssDNA 
at YER186C compared to tlc1∆ cdc13-1 mutants, while cdc13-1 pif1∆ mutants showed 
only a very slight decrease in ssDNA compared to cdc13-1 mutants (Figure 26E). As 
slightly different amounts of ssDNA were generated following telomere uncapping in 
synchronous cultures and asynchronous cultures (Figure 16B, Figure 26A) and ssDNA 
generation at uncapped telomeres is a cell cycle regulated process, occurring primarily 
at metaphase (Vodenicharov and Wellinger, 2006), it was hypothesized that these 
differences in ssDNA generation might be due to altered cell cycle progression and 
altered kinetics of arrest following telomere uncapping in cdc13-1 mutants. 
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To test this hypothesis, exponentially dividing cultures of cdc13-1 and tlc1∆ cdc13-1 
mutants were fixed and the fraction of cells at metaphase was scored (Figure 27). In 
TLC1+ cdc13-1, TLC1+ cdc13-1 pif1∆, TLC1+ cdc13-1 exo1∆ and TLC1+ cdc13-1 
exo1∆ pif1∆ mutants approximately 15-20% of cells were at metaphase in 
asynchronously dividing cultures grown at 23°C (Figure 27). However, in tlc1∆ cdc13-
1, tlc1∆ cdc13-1 pif1∆ and tlc1∆ cdc13-1 exo1∆ mutants 30-40% of cells were at 
metaphase (Figure 27). Notably this was not the case for tlc1∆ cdc13-1 exo1∆ pif1∆ 
mutants of which only 20% were at metaphase (Figure 27). In conclusion elimination of 
telomerase (TLC1) causes accumulation of cdc13-1 mutants at metaphase, even at the 
permissive temperature, and this cell cycle defect is likely to account for the increased 
ssDNA generation in cdc13-1 pif1∆ mutants compared to tlc1∆ cdc13-1 pif1∆ mutants 
(Figure 26E). Interestingly, the this cycle defect was not seen in cdc13-1 exo1∆ pif1∆ 
mutants lacking telomerase, suggesting that elimination of Pif1 and Exo1 might 
synergistically suppress defects caused by lack of telomerase. 
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Figure 28: Pif1 inhibits entry into, and promotes exit from, senescence 
A. Multiple colonies from strains of the genotypes indicated from the passages 
indicated were inoculated into YEPD and grown up to give saturated cultures which 
were serially-diluted across YEPD plates and grown at 30°C for 2 days. B. 
Quantification of the growth shown in A., each curve is the mean of two independent 
tlc1∆ strains relative to the appropriate TLC1+ strain. 
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Figure 29: Schematic of yeast telomeres as detected by Southern Blot 
A. XhoI digestion of a telomere containing Y’ elements will yield a 5.5 or 6.5kb Y’ 
fragment and a terminal fragment of approximately 850bp Y’ sequence in addition to 
the telomeric repeats. Both fragments will be detected by a Y’ or TG probe. B. XhoI 
digestion of a telomere lacking Y’ elements will yield a single fragment, varying in size 
from telomere-to-telomere depending upon the length of the TG repeats and the 
distance of the terminal XhoI fragment from the TG repeats. This fragment should only 
be detectable by a TG probe. C. Type I survivors undergo massive amplification of the 
Y’ elements but maintain short only short terminal TG repeats, to the terminal 
fragments are homogenous. D. Type II survivors undergo a modest amplification of the 
Y’ elements but a massive amplification of the TG repeats, leading to long, 
heterogeneous terminal fragments.
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Figure 30: Pif1 facilitates the generation of Type I and Type II survivors 
Strains of the genotypes indicated from the passages indicated were grown to saturation 
and then telomere Southern Blots were performed to detect A. TG repeats then stripped 
and reprobed for B. Y’ elements. Blots were stripped and reprobed for CDC15 as a 
loading control.  
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5.2.4 Pif1 inhibits entry into, and promotes recovery from, senescence in cells 
lacking telomerase 
Elimination of Pif1 and Exo1 eliminates telomere dysfunction caused by inactivation of 
Cdc13-1 (Figure 16) and eliminates the accumulation at metaphase seen in telomerase-
deficient cdc13-1 mutants at the permissive temperature (Figure 27). Elimination of 
Exo1 also inhibits telomere-dysfunction driven senescence caused by telomerase-
deficiency (Maringele and Lydall, 2004a). Thus it was hypothesized that elimination of 
Pif1 might also inhibit senescence and that elimination of both Pif1 and Exo1 might 
show synergy in inhibiting senescence. 
Telomerase-deficient yeast cultures undergo a gradual loss in proliferative capacity due 
to telomere shortening (senescence), before adopting telomerase-independent 
mechanisms of telomere maintenance corresponding to a subsequent increase in 
proliferative capacity (recovery) (Lundblad and Blackburn, 1993, Teng and Zakian, 
1999). To test the hypothesis that elimination of Pif1 might inhibit senescence, like 
elimination of Exo1, and that elimination of both Pif1 and Exo1 might show synergy in 
inhibiting senescence, tlc1∆, tlc1∆ exo1∆, tlc1∆ pif1∆ and tlc1∆ exo1∆ pif1∆ mutants 
and corresponding TLC1+ controls were germinated simultaneously and passaged over 
time by restreaking on agar plates. At various passage numbers, strains were inoculated 
into liquid medium, grown to saturation and then spotted onto agar plates to assess 
growth (Figure 28A), which was then quantified for each tlc1∆ strain relative to the 
growth of the appropriate TLC1+ strain (Figure 28B). 
tlc1∆ mutants grew well at passage 1, decreased in growth from passages 2-4 
(senescence) and improved in growth from passages 5-8 (recovery), before growing 
well again from passage 9 onwards (Figure 28B). tlc1∆ exo1∆ mutants also grew well at 
passage 1, decreasing in growth from passages 2-5 and improved in growth from 
passages 6-8, before growing well from passage 9 onwards (Figure 28B). At passages 
3-4 tlc1∆ exo1∆ mutants grew slightly better than tlc1∆ mutants, corresponding to 
inhibited entry into senescence, as expected (Figure 28B) (Maringele and Lydall, 
2004a). Both tlc1∆ pif1∆ mutants and tlc1∆ exo1∆ pif1∆ mutants grew well at passage 
1, decreased in growth from passages 2-6 (senescence) and then slowly improved in 
growth from passages 6-15. Strikingly, tlc1∆ pif1∆ and tlc1∆ pif1∆ exo1∆ mutants 
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underwent a much more rapid and more protracted decline in growth (senescence) than 
tlc1∆ and tlc1∆ exo1∆ mutants, and by the end of the senescence period (passage 6, 
Figure 28A-B) had almost completely lost proliferative capacity compared to tlc1∆ and 
tlc1∆ exo1∆ mutants, which had retained significant proliferative capacity at the end of 
their senescence periods (passages 4-5 Figure 28A-B). Furthermore, although tlc1∆ 
pif1∆ and tlc1∆ pif1∆ exo1∆ mutants had improved in growth from passage 6 onwards, 
by passage 15 they still grew extremely poorly compared to tlc1∆ and tlc1∆ exo1∆ 
mutants, which grew well (Figure 28B). In conclusion, elimination of Pif1 does not 
inhibit entry into senescence, but enhances it. Instead, it appears that elimination of Pif1 
(in the presence or absence of Exo1) causes a very rapid senescence, resulting in a near-
total loss in proliferative capacity. Furthermore, following senescence, tlc1∆ mutants 
lacking Pif1 continue to grow poorly, suggesting that they might not recover from 
senescence. 
When yeast cultures recover from senescence, ‘survivors’ are generated, which usually 
utilize recombination-dependent mechanisms to maintain telomeres even in the absence 
of telomerase, but in rare cases can also utilize recombination-independent mechanisms 
(Maringele and Lydall, 2005). However, in all cases, recovery from senescence leads to 
clear alterations in telomere structure. Most budding yeast telomeres containing 
repetitive Y’ elements, with a terminal TG repeats (Figure 29A), while some telomeres 
contain no Y’ elements and terminate in only a TG repeats (Figure 29B). Two types of 
survivors are generated by recombination-dependent mechanisms, leading to two 
different types of alteration in telomere structure (Teng and Zakian, 1999, Lundblad and 
Blackburn, 1993). In Type I survivors, very short TG repeats are maintained but a 
massive amplification of Y’ elements is seen as Y’ elements spread to all telomeres and 
undergo amplification to produce many tandem copies at the end of each telomere 
(Figure 29C). In Type II survivors there is only a slight amplification of Y’ elements 
and dramatic amplification of the terminal TG repeats is believed to occur by rolling-
circle-like mechanisms of DNA replication, producing extremely long telomeres which 
have a great variance in length (Figure 29D).  
To test whether tlc1∆ pif1∆ and tlc1∆ pif1∆ exo1∆ mutants recovered from senescence 
and generated ‘survivors’, Southern blots were performed to examine telomere 
structure, by probing to detect telomeric TG repeats (Figure 30A) and Y’ sequences 
(Figure 30B). Deletion of Pif1 has been reported to lead to telomere lengthening, so as 
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expected, at passage 1 WT and exo1∆ mutants had shorter telomeres than pif1∆ and 
pif1∆ exo1∆ mutants (Compare terminal fragments in 1 and 3 to lanes 2 and 4, Figure 
30A-B) and no distinguishable differences in Y’ copy number could be seen (compare 
Y’ 6.5kb and Y’ 5.5kb bands in lanes 1-4, Figure 30A-B). At passage 1, tlc1∆, tlc1∆ 
pif1∆, tlc1∆ exo1∆ and tlc1∆ exo1∆ pif1∆ all had short telomeres but had undergone no 
alterations in Y’ copy number (lanes 5-12, Figure30A-B). By passage 15, pif1∆ and 
pif1∆ exo1∆ mutants had increased in telomere length, but WT, pif1∆, exo1∆ and pif1∆ 
exo1∆ mutants had not altered in telomere structure (lanes 13-16, Figure 30A-B). In 
contrast, tlc1∆ mutants had undergone amplification of both the Y’ elements and TG 
repeats to generate Type II survivors (lanes 17-18, Figure 30A-B), while tlc1∆ exo1∆ 
mutants had undergone amplification of the Y’ elements to generate Type I survivors 
(lanes 21-22, Figure 30A-B). In contrast, neither tlc1∆ pif1∆ nor tlc1∆ exo1∆ mutants 
had generated typical Type I or Type II survivors, but instead had undergone a slight 
reduction in Y’ elements and maintained short terminal fragments (lanes 19-20, 23-24, 
Figure 30A-B). However, tlc1∆ pif1∆ and tlc1∆ exo1∆ mutants did share one 
characteristic with Type I survivors – no telomeres lacking Y’ elements (i.e. individual 
bands 1.4kb<5.0kb bands) were visible, indicating that all telomeres had acquired a 
terminal Y’ element (Figure 30A). It was notable, though, that the terminal fragments of 
tlc1∆ pif1∆ and tlc1∆ pif1∆ exo1∆ mutants were even shorter than the terminal 
fragments of Type I survivors, which themselves possess very few TG repeats (Figure 
30A-B). In conclusion, although tlc1∆ pif1∆ and tlc1∆ pif1∆ exo1∆ mutants undergo 
only subtle alterations in telomere structure and clearly do not adopt typical Type I or 
Type II survivor structures and by passage 15 (Figure 28B), tlc1∆ pif1∆ and tlc1∆ 
exo1∆ mutants cannot be conclusively said to have recovered from senescence. Thus, 
Pif1 is required for full recovery from senescence. 
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Figure 31: Overview of the Pif1 Synthetic Genetic Array (SGA) 
A query mutant containing the pif1∆ mutation (marked with natR) was crossed to a 
deletion library of approximately 4,500 non-essential yeast genes (each deletion marked 
with kanR). Diploids were selected, sporulated and MATa haploids were selected for. 
MATa progeny carrying the library mutations were selected for (kanR selection) then 
MATa progeny carrying both the library mutation and pif1∆ were selected for (kanR-
natR selection) to obtain double mutants, where viable.
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kanR-natR:kanR 
ORF Gene Variance Lethality 
Confirmed 
Phenotype Function 
YOR297C TIM18 4/4 1 - Membrane Trafficking. 
YIL098C FMC1 4/4 1 Synthetic Lethal Mitochondria. 
YNL315C ATP11 4/4 1 Synthetic Lethal Mitochondria. 
YJR120W   4/4 1 Synthetic Lethal Respiration/Fermentation. 
YDR388W RVS167 4/4 0.5 - Cytoskeleton. 
YLR234W TOP3 4/4 0.5 - DNA Damage Response. 
YBR036C CSG2 4/4 0.5 - Endoplastmic Reticulum. 
YIR023W DAL81 4/4 0.5 - Nitrogen Utilization. 
YML006C GIS4 4/4 0.5 - RAS/cAMP 
YGL045W RIM8 4/4 0.5 - RIM101-Related. 
YOR275C RIM20 4/4 0.5 - RIM101-Related. 
YOL004W SIN3 4/4 0.5 
Low Germination 
Efficiency Chromatin Remodelling. 
YDL035C GPR1 3/4 1 - RAS/cAMP 
YNL021W HDA1 3/4 0.5 No Sporulation Chromatin Remodelling. 
YMR063W RIM9 3/4 0.5 - RIM101-Related. 
YNL294C RIM21 3/4 0.5 - RIM101-Related. 
YML034W SRC1 3/4 0.5 - Transcription. 
YNL253W TEX1 3/4 0.5 - Transcription. 
YBR200W BEM1 2/4 1 - Cell Polarity. 
YBR231C SWC5 2/4 1 - Chromatin Remodelling. 
YNL246W VPS75 2/4 1 - Chromatin Remodelling. 
YJR117W STE24 2/4 1 - Mating. 
YNL106C INP52 2/4 1 - Membrane Trafficking. 
YNL259C ATX1 2/4 1 - Mitochondria. 
YBL011W SCT1 2/4 1 - Respiration/Fermentation. 
YGL029W CGR1 2/4 1 Not Tested Ribosome. 
YNL302C RPS19B 2/4 1 - Ribosome. 
YDL074C BRE1 2/4 1 No sporulation Chromatin Remodelling. 
YML032C RAD52 2/4 0.5 - DNA Damage Response. 
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Table 4: Results of a SGA for genes that showed synthetic lethal or synthetic sick 
interactions with PIF1 
A PIF1 SGA was performed as in Figure 31. Genes were scored by comparing the 
growth of the double mutant MATa progeny (i.e. on the kanR-natR selection plate) to 
the growth of the single mutant MATa progeny (i.e. on the kanR selection plate). 
Lethality was scored as 0.5 for a growth defect of the double mutants compared to the 
single mutants (i.e. synthetic sickness) and 1.0 for a very strong growth defect of the 
double mutants compared to the single mutants (i.e. synthetic lethality). Variance was 
scored as the number of biological repeats in which the growth defect was seen. The 
genes listed had a growth defect of 0.5 or 1.0 in 2/4 or more biological repeats. 
Synthetic lethality was confirmed by tetrad dissection, where possible (Alain Nicolas, 
personal communication) and function was manually annotated using Saccharomyces 
Genome Database (Costanzo et al., 2009). 
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5.2.5 PIF1 displays essential, functional redundancy with few genes 
Pif1 contributes to resection of uncapped telomere in cdc13-1 mutants lacking 
telomerase (Figures 25-26) and also has important roles in telomere maintenance in 
cells lacking telomerase (Figure 30A-B). Together these data suggest that negative 
regulation of telomerase, the role most commonly ascribed to Pif1, may not be the main 
role of Pif1 within the cell. To attempt to identify potentially novel roles for Pif1, a 
Synthetic Genetic Array was performed to identify genes with which Pif1 shared an 
essential but redundant role (Tong and Boone, 2006). 
A ‘query’ mutant was constructed in which the pif1∆ mutation was marked with the 
NATMX resistance cassette (conferring resistance to the antibiotic ClonNAT), in which 
LYP1 was deleted (conferring recessive resistance to thialysine) and in which the CAN1 
gene was deleted (conferring recessive resistance to canavanine) and replaced with 
HIS3 driven by the MFA1 promoter, which is only expressed in MATa yeast. The 
‘query’ mutant was mated to a Deletion Mutant Array library of approximately 4,500 
strains in which non-essential genes had been deleted (library mutations) and replaced 
with the KANMX resistance cassette (conferring resistance to G418) (Figure 31). 
Diploids were selected by selecting for G418R and ClonNATR cells, and were then 
sporulated and allowed to germinate (Figure 31). Following germination of spores, 
haploids were selected for by growing cells on media containing canavanine (lethal to 
CAN1+ haploids or can1∆+/CAN1+ diploids) and thialysine (lethal to LYP1+ haploids or 
lyp1∆/LYP1+ diploids) and only MATa haploids were allowed to grow by excluding 
Histidine from the medium (as HIS3 would only be expressed in MATa yeast, Figure 
31). Finally, strains containing either the query mutation alone or the query mutation 
and pif1∆ were selected for by selecting for G418R cells and then strains containing 
both the query mutation and pif1∆ were selected for by selecting for G418R ClonNATR 
cells (Figure 31). 
In order to rule out artifacts caused by the SGA process, a control SGA should usually 
be carried out using a query mutant that has been deleted for a gene that should not 
affect growth (for example, an auxotrophy gene corresponding to a nutrient that the 
growth medium is fully-supplemented for) (Tong and Boone, 2006). This also allows 
for alleviating genetic interactions to be determined, where the final double mutant 
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grows better than the library mutant (Costanzo et al., 2010). However, for the purposes 
of this experiment only synthetic lethal interactions were of interest, so this SGA could 
be controlled simply by comparing the kanR-natR selection plates to the kanR selection 
plates (Figure 31). Growth on the kanR selection plates indicated that viable haploid 
strains containing the library mutation (xxx∆::KANMX) had been produced, while 
decreased growth on the kanR-natR plates indicated that cells containing both the 
library and query mutations were either inviable, indicating a synthetic lethality 
between the mutations, or that cells containing both mutations grew very poorly, 
indicating a synthetic sick relationship. 
For each library mutation, four biological replicates were performed and scored 
manually for whether there was no growth defect (0.0), a growth defect (0.5) or a severe 
growth defect (1.0) along with the frequency at which the defect occurred. A list of 29 
hits was compiled in which at least half of the biological replicates displayed some 
growth defect (Table 4). Of these 29 hits, 28 were manually checked by mating a pif1∆ 
mutant to the appropriate library strains and performing tetrad dissection to see whether 
double mutants were obtained (A. Nicolas, personal communication). Null mutations in 
only 3 of the 29 hits gave a confirmed synthetic lethal interaction with PIF1 – FMC1, 
ATP11 and YJR120W (Table 4). However, this constituted 75% of the genes that were 
identified as having a severe growth defect in 4/4 biological replicates (Table 4). Fmc1 
and Atp11 are both required for assembly of the F1 subunit of the F1-F0 mitochondrial 
ATPase, while the gene product of YJR120W is of unknown function but appears to be 
required for respiration (Ackerman and Tzagoloff, 1990, Dunn et al., 2006, Lefebvre-
Legendre et al., 2001). Thus, it was concluded that the only genes in this screen with 
which Pif1 has a synthetic lethal relationship are mitochondrial genes, which probably 
reflects the role of Pif1 in maintenance of mtDNA (Lahaye et al., 1991). As the role of 
Pif1 at uncapped telomeres has been shown to be due to the nuclear, not mitochondrial 
role of Pif1 (Figure 21) the study of FMC1, ATP11 and YJR120W was unlikely to be 
informative about the role of Pif1 at uncapped telomeres. 
However, in addition to the 3 synthetic lethal interactions that were verified, a further 3 
out of the 29 hits were verified to display some sort of genetic interaction that was not 
synthetic lethality. Interestingly, these 3 hits (SIN3, HDA1, BRE1) all have roles in 
chromatin remodeling (Sussel et al., 1995, Wu et al., 2001, Yamashita et al., 2004). 
sin3∆ pif1∆ mutants were viable, but had a reduced germination efficiency (Table 4). 
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hda1∆/HDA1+ pif1∆/PIF1+ and bre1∆/BRE1+ pif1∆/PIF1+ diploids did not sporulate, 
suggesting that diploids heterozygous for these mutations were unable to pass through 
meiosis. It is not realistic to draw generalized conclusions about the interplay between 
Pif1 and processes involving chromatin remodeling, given the ambiguity of these 
genetic interactions. Indeed, given that only 3 chromatin remodeling genes are hits, this 
suggests a very specific interaction between SIN3, HDA1 and BRE1. It is concluded that 
Pif1 might have roles that interact with specific components of the chromatin 
remodeling machinery, but further work is required to elucidate those roles. 
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Figure 32: Pif1 contributes to the vitality of cells following camptothecin 
treatment, independently of Ku and Exo1 
A. and B. strains of the genotypes indicated were serially-diluted across YEPD plates 
containing camptothecin at the concentrations indicated and grown at 30°C for 2 days. 
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5.2.6 Pif1 functions in different pathways to Exo1 and Yku70 to confer sensitivity to 
camptothecin 
Pif1 and Exo1 appear to constitute parallel pathways that inhibit the growth of cdc13-1 
mutants and elimination of both Pif1 and Exo1 eliminates the growth defect seen in 
cdc13-1 mutants (Figure 5). The DDR at uncapped telomeres is believed to be a 
consequence of the DDR inappropriately recognizing uncapped telomeres as DNA 
damage (Lydall, 2009). Thus, it was hypothesized that Pif1 and Exo1 might constitute 
parallel pathways in a DNA repair process that aberrantly recognizes uncapped 
telomeres. If this was the case, then treatment with a chemical agent that induces the 
type of damage that Pif1 and Exo1 are involved in responding to should inhibit the 
growth of cells lacking Pif1 or Exo1 (due to an impaired ability to repair the damage) 
and should cause a severe growth defect in cells lacking both Pif1 and Exo1 (due to a 
severely impaired ability to repair the damage). 
Uncapped telomeres are believed to trigger a DDR because they resemble DSBs, but 
exo1∆ mutants in themselves are not sensitive to DSB-inducing agents such as 
Bleomycin. However exo1∆ mutants are sensitive to camptothecin, which induces 
replication-associated DSBs (Morin et al., 2008). Thus it was hypothesized that, Pif1 
and Exo1 might function in parallel pathways involved in the repair of replication-
associated DSBs. To test this hypothesis, the effect of Pif1 and Exo1 on the growth 
camptothecin-treated cells was measured. exo1∆ mutants grew slightly worse than 
EXO1+ mutants when treated with 4µM camptothecin and exo1∆ mutants were almost 
completely inviable when treated with 20µM camptothecin, while EXO1+ mutants grew 
poorly (Figure 32A). Surprisingly, pif1∆ mutants showed almost no growth defect when 
treated with 20µM and grew better than EXO1+ mutants (Figure 32A). Additionally, 
exo1∆ pif1∆ mutants showed only a slight growth defect when treated with 20µM 
camptothecin and clearly grew better than exo1∆ mutants (Figure 32A). It was 
concluded that Pif1 and Exo1 do not constitute parallel pathways involved in the repair 
of replication associated DSBs. Instead Pif1 contributes to the lethality of replication-
associated DSBs while Exo1 promotes vitality in response to replication-associated 
DSBs. 
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The resistance of pif1∆ mutants to camptothecin treatment was surprising. It was 
hypothesized that Pif1 might be involved in the processing of structures arising from 
replication associated DSBs and that elimination of Pif1 might direct these DSBs 
towards a more efficient repair pathway. As elimination of Pif1 was able to increase the 
resistance of exo1∆ mutants to camptothecin, this pathway was unlikely to be HR 
(Figure 32A). Therefore, it was hypothesized that elimination of Pif1 might direct 
replication-associated DSBs towards NHEJ for more efficient repair. To test this 
hypothesis, the effect of Pif1 and Yku70 (required for NHEJ) on the growth of 
camptothecin-treated cells was measured. yku70∆ mutants grew worse than YKU70+ 
mutants when treated with 20µM camptothecin (Figure 32B). As before, pif1∆ mutants 
grew better than YKU70+ mutants treated with 20µM camptothecin (Figure 32B) but 
yku70∆ pif1∆ mutants still grew better than yku70∆ mutants when treated with 20µM 
camptothecin (Figure 32B). In conclusion, NHEJ contributes to the vitality of cells in 
response to replication-associated DSBs, and elimination of Pif1 does not reduce the 
lethality associated with replication-associated DSBs by directing them towards NHEJ. 
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Figure 33: Pif1, Sgs1 and Dna2 promote tolerance to G-quadruplex structures 
Saturated cultures of the genotypes indicated were serially diluted across agar plates and 
grown at 23°C for 3 days on YEPD or 4 days on Synthetic (SD) or TMPyP4-containing 
media. Strains grown on each medium were split into separate panels for presentation 
purposes but were grown on the same plate.
197 
 
5.2.7 The helicases Pif1, Sgs1 and Dna2 cooperate in unwinding G-quadruplex 
structures 
The Pif1 helicase has been shown in vitro to unwind dsDNA containing G-quadruplex 
structures and has been shown in vivo to be important for the genomic stability of G-
quadruplex containing sequences (Ribeyre et al., 2009). It was hypothesized that the 
role of Pif1 in ssDNA generation at uncapped telomeres might be due to Pif1 unwinding 
G-quadruplex structures to facilitate nuclease access. To test this hypothesis, the effect 
of Pif1 on the growth of cells treated with the G-quadruplex stabilizing ligand TMPyP4 
was assessed, in comparison to the helicases Sgs1 and Dna2, which also have roles 
following telomere uncapping and in the unwinding of G-quadruplex structures (Huber 
et al., 2002, Lopes et al., 2002). 
As expected, pif1∆ mutants treated with TMPyP4 grew worse than PIF1+ strains 
(Figure 33). However, sgs1∆ strains showed no growth defect compared to PIF1+strains 
(Figure 33). Surprisingly, pif1∆ sgs1∆ and pif1∆ dna2∆ mutants showed a severe 
growth defect in comparison to pif1∆ mutants when treated with TMPyP4 (Figure 33).  
It was concluded that Pif1 is important for the processing of G-quadruplex structures 
that arise following TMPyP4 treatment, while Dna2 and Sgs1 are important for 
processing G-quadruplex structures in pif1∆ mutants. This contrasts to the roles of these 
proteins in maintaining the stability of a G-quadruplex containing microsatellite, where 
Pif1, Sgs1 and Dna2 all contribute to maintenance of G-quadruplex containing 
sequences but Sgs1 and Dna2 have no role in pif1∆ mutants (Ribeyre et al., 2009). 
Furthermore, Pif1 inhibits the growth of cdc13-1 mutants and promotes growth on 
TMPyP4 (Figure 5), while Dna2 and Sgs1 promote the vitality of cdc13-1 pif1∆ 
mutants and promote growth on TMPyP4 (Figures 8-9). As there appears to be no 
correlation between the effect of these 3 helicases on the growth of cells following 
telomere uncapping and treatment with a G-quadruplex stabilizing drug, it suggests 
there is little correlation between these two biological processes and thus that Pif1 is 
unlikely to generate ssDNA at uncapped telomeres by unwinding G quadruplex 
structures. 
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Figure 34: A model for how Pif1, Exo1 and Rad27 might function at stalled 
replication forks following telomere uncapping 
If stalled replication forks occurred following telomere uncapping, Pif1 could recognize 
exposed 5’ ssDNA on the leading strand and generate ssDNA to be cleaved by an 
unidentified nuclease. Exo1 could, in principle, act upon either the native telomeric 
overhang or the lagging strand of a stalled replication fork. Rad27 appears to function in 
the same pathway as Exo1 (Figure 12) and the gap endonuclease activity reported for 
Rad27 could, in principle, liberate a lagging strand to be resected by Exo1.
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5.3 Discussion 
Pif1 contributes to ssDNA generation at uncapped telomeres, checkpoint activation and 
poor growth of cells with uncapped telomeres (Figure 5, Figures 16-18) even in cells 
lacking telomerase (Figures 22-26). Interestingly, elimination of Pif1 does not affect 
telomere length in cells lacking telomerase (Figure 30), which provides a clear 
demonstration that Pif1 has a direct effect on the resection of uncapped telomeres 
independent of any effects it might have on telomere length (Figure 25). Furthermore, it 
is the nuclear, helicase activity of Pif1 responsible for its effect at uncapped telomeres, 
which is the same previously proposed to be responsible for removing telomerase from 
the telomeres (Boule et al., 2005, Zhou et al., 2000). Finally, it has been shown that Pif1 
has crucial roles in senescence and recovery of telomerase-deficient cells. These data 
conclusively demonstrate that Pif1 does not inhibit the growth of cdc13-1 mutants by 
removing telomerase from the telomere facilitate access to telomeres by nucleases, and 
call into question the very notion that Pif1 removes telomerase from telomeres (Vega et 
al., 2007, Schulz and Zakian, 1994). 
Three supportive lines of evidence have been used to argue that Pif1 functions to 
remove telomerase from yeast telomeres; pif1∆ mutants have long telomeres (Schulz 
and Zakian, 1994); telomere lengthening in pif1∆ mutants does not occur in the absence 
of telomerase (Zhou et al., 2000); Pif1 can be biochemically demonstrated to remove 
telomerase from telomeric substrates in vitro (Boule et al., 2005). For each line of 
evidence, a severe caveat exists; null or hypomorphic mutations in many genes are now 
known to increase telomere length (Askree et al., 2004, Ungar et al., 2009, Gatbonton et 
al., 2006); almost no genes have been identified that increase telomere length in the 
absence of telomerase (Zhou et al., 2000, Maringele and Lydall, 2004); Pif1 has been 
shown in vitro to be capable of at least 4 distinct biochemical activities (Boule et al., 
2005, George et al., 2009, Pike et al., 2009, Ribeyre et al., 2009, Rossi et al., 2008). 
Biochemical evidence for Pif1 function becomes particularly questionable when 
considering that it has all been carried out with unphosphorylated forms of Pif1, yet 
Pif1 is subject to a basal phosphorylation and removing Pif1 phosphorylation sites can 
lead to a null mutant phenotype (Makovets and Blackburn, 2009).  
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The main, conclusive line of evidence that Pif1 negatively regulates telomerase has 
been that induction of a DSB in pif1∆ cells leads to a dramatic increase in the number of 
breaks healed by de novo telomere addition compared to Wild Type cells (Schulz and 
Zakian, 1994). However, elimination of the nucleases Rad27 or Mre1 or elimination of 
Sgs1 and Exo1 also increases the rate at which DSBs are healed by de novo telomere 
addition (Chen and Kolodner, 1999, Marrero and Symington, 2010). Finally, pif1∆ 
mutants have been shown to have a severe BIR defect at DSBs, suggesting that the 
increased rate of healing by de novo telomere addition could be an indirect consequence 
of an impaired ability of pif1∆ mutants to repair DSBs (Chung et al., 2010). Thus, as 
proposed here, Pif1 is likely to function at DSBs, telomeres and uncapped telomeres by 
unwinding DNA substrates to be processed by nucleases.  
The reported BIR defect caused by elimination of Pif1 provides a possible explanation 
for the behavior of tlc1∆ pif1∆ cells (Figures 28-30). BIR is required for the generation 
of Type I and Type II survivor structures and elimination of Pol32, which is essential 
for BIR, causes tlc1∆ mutants to senesce rapidly and prevents their recovery (Lydeard 
et al., 2007). The rapid senescence of tlc1∆ cells lacking Pif1, their protracted poor 
growth period after senescence and relatively unaltered telomere structure are consistent 
with being defective enough in BIR to cause rapid senescence and inhibit recovery, but 
proficient enough to undergo slight alterations in telomere structure and maintain 
viability.  
The search for synthetic lethal interactions between PIF1 and other genes yielded only 
mitochondrial genes involved in respiration, so was not informative as to the nuclear 
function of Pif1 (Table 4). Furthermore, attempts to correlate the sensitivity caused by 
elimination of the helicases Pif1, Sgs1 and Dna2 to G-quadruplex structures with their 
effect on the growth of cdc13-1 mutants with uncapped telomeres were unsuccessful, so 
it does not seem likely that Pif1 functions at uncapped telomeres to unwind G-
quadruplex structures (Figure 32). However, elimination of Pif1 did confer a strong 
resistance to camptothecin treatment, in exo1∆, yku70∆ and even EXO1+ PIF1+ mutants 
(Figure 32). This was surprising, as cells lacking Exo1 were highly sensitive to 
Camptothecin and it was expected that Pif1 might function, like Exo1 at DDRs other 
than the one at uncapped telomeres (Morin et al., 2008).  
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Camptothecin treatment leads to the formation replication-associated DSBs, causing 
replication fork collapse. One possible explanation for the resistance to Camptothecin 
conferred by the elimination of Pif1 is that Pif1 is involved in the destabilization of 
stalled replication forks. Such a function for Pif1 has previously been proposed and 
human Pif1 has been shown to be capable of unwinding DNA structures that resemble 
the leading strand of a stalled replication fork (George et al., 2009, Chang et al., 2009). 
Thus, it is hypothesized that at uncapped telomeres, replication fork stalling occurs and 
Pif1 generates ssDNA at the lagging strand of stalled replication forks to be cleaved by 
an unidentified ssDNA endocnuclease (Figure 34). This is consistent with work in 
human cells demonstrating that telomeres are sites of replication stress and other work 
showing that the CST complex in plants and mammals is recruited to sites of replication 
difficulty (Sfeir et al., 2009, Surovtseva et al., 2009, Miyake et al., 2009).  
If Pif1 acts upon the leading strand of stalled replication forks, it is possible that Exo1 
acts upon the lagging strand of stalled replication forks (Figure 34). Alternatively Exo1 
might act upon the region ahead of the chromosome, at the native telomeric overhang, 
as previously proposed. Interestingly, Rad27 appears to act in the same pathway as 
Exo1 in cdc13-1 mutants (Figure 12) and gap endonuclease activity of Rad27 would be 
capable of liberating the lagging strand of stalled replication fork for further processing 
by Exo1 (Figure 34). Such a model seems very possible, given that FEN1, the 
mammalian orthologue of Rad27, ensures telomere stability by facilitating replication 
fork restart (Saharia et al., 2010). 
Finally, it has been definitively shown that Pif1, like Exo1, directly contributes to the 
resection and degradation of uncapped telomeres in budding yeast. EXO1 also 
contributes to the premature mortality seen in third generation telomerase knock-out 
mice, which age prematurely due to short, dysfunctional telomeres and elimination of 
EXO1 extends their lifespan (Schaetzlein et al., 2007). The implication of this is that in 
mammalian cells, EXO1 acts upon dysfunctional telomeres to facilitate cellular ageing. 
If the DDRs in mammalian cells resemble those at uncapped telomeres in budding 
yeast, then mammalian PIF1 should also act upon dysfunctional telomeres to facilitate 
cellular ageing and elimination of murine PIF1 should also extend the lifespan of 
telomerase knock-out mice (Snow et al., 2007). However, Pif1 plays an important 
protective role at telomeres in senescing yeast cells and is important to prevent rapid 
senescence (Figure 28). Therefore, it is possible that elimination of murine PIF1 might 
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accelerate senescence in telomerase knock-out mice. Thus, understanding the roles of 
mammalian PIF1 and EXO1 at dysfunctional telomeres caused by telomerase-
deficiency will provide a valuable opportunity to understand whether the DDRs at 
uncapped telomeres in budding yeast (such as those in cdc13-1 and yku70∆ mutants) or 
at short telomeres in senescing cells (such as those in tlc1∆) mutants are a better model 
for the DDRs that occur during the mammalian ageing process. 
5.4 Further Work 
It will be important to elucidate a generalized role for Pif1 within cells, one that is 
independent of telomerase. First, it will be important to establish whether tlc1∆ pol32∆ 
pif1∆ mutants senesce more rapidly than tlc1∆ pol32∆ mutants and thus whether Pif1 
functions to inhibit senescence and promote recovery from senescence by promoting 
BIR or by some other mechanism (Figure 28) (Chung et al., 2010, Lydeard et al., 2007). 
If Pif1 does function in the same pathway as Pol32 during senescence, it will be 
important to understand the more general role of Pif1 in BIR, though this work has been 
reported to already be underway (Chung et al., 2010).  
It will also be interesting to know whether Pif1 fulfills the same role in resection of 
uncapped telomeres in cdc13-1 mutants as at DSBs. Phosphomimetic (pif1-s4d) and 
phosphodeficient (pif1-s4a) alleles of Pif1 have been described that affect the function 
of Pif1 at DSBs (assayed by rate of telomerase-mediated healing of DSBs) but not at 
telomeres (assayed by alterations in telomere length) and these will be useful tools to 
probe Pif1 function (Makovets and Blackburn, 2009). Furthermore, Pif1 is a 5’-3’ 
helicase. If Pif1 does directly participate in the resection of uncapped telomeres, then it 
must recognize 5’ (AC) ssDNA at uncapped telomeres, which might be expected to 
accumulate in cdc13-1 pif1∆ mutants following telomere uncapping. As the in-gel assay 
can detect short (<20bp) stretches of ssDNA, it will be interesting to see whether it can 
be used to detect 5’ (AC) ssDNA at uncapped telomeres. If 5’ ssDNA can be detected at 
uncapped telomeres, it will also be interesting to use an inducible DSB system to see 
whether Pif1 also processes 5’ ssDNA at DSBs. 
It has previously been proposed that Pif1 functions to destabilize stalled replication 
forks and human Pif1 has been shown to be capable of participating in reactions which 
would be equivalent to unwinding the leading strand of a stalled replication fork (Chang 
et al., 2009, George et al., 2009). Here, it has been shown that Pif1 is a major cause of 
204 
the toxicity associated with camptothecin treatment, which is suggestive of a role for 
Pif1 at stalled replication forks (Figure 32). Thus, it will be interesting to see if stalled 
replication forks accumulate at uncapped telomeres in cdc13-1 mutants and whether 
Pif1 affects their processing. If stalled replication forks do accumulate at uncapped 
telomeres, it will be interesting to take a biochemical approach with nucleases and 
helicases known to function at uncapped telomeres (Pif1, Sgs1 and Exo1, and possibly 
Rad27, Figure 34) and apply them to structures resembling stalled replication forks in 
vitro to investigate how they might function individually and how they might cooperate.  
Finally, Exo1 activity is restrained at both uncapped telomeres and stalled replication 
forks by the checkpoint kinase Rad53 (Jia et al., 2004, Segurado and Diffley, 2008). 
Correspondingly, cdc13-1 rad53∆ mutants generate elevated levels of Exo1-dependent 
ssDNA and rad53∆ mutants are hypersensitive to MMS in an Exo1-dependent manner. 
Interestingly, mec1∆ mutants are hypersensitive to MMS in an Exo1-independent 
manner, suggesting that Mec1 inhibits a separate activity to promote the stability of 
stalled replication forks and it would be interesting to see if this activity is Pif1 
(Segurado and Diffley, 2008). 
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6 Can cells live without telomere capping? 
“Because all of biology is connected, one can often make a breakthrough with 
an organism that exaggerates a particular phenomenon, and later explore the 
generality.” 
- Thomas R. Cech 
6.1 Introduction 
Elimination of Pif1 and Exo1 permitted cdc13-1 mutants to grow at 36°C, at which 
temperature cdc13-1 is believed to be completely inactive (Figure 5B) suggesting that 
Cdc13 might be dispensable for survival in these cells. Survival in the absence of Cdc13 
can be achieved through several mechanisms. First, attenuation of nuclease activities 
and checkpoint components at uncapped telomeres by elimination of Exo1 and Rad9 or 
Rad24 permits the generation of cells that are viable without Cdc13 at a rate of 
approximately 4-6x10-5 (Zubko and Lydall, 2006). More recently it has been shown that 
elimination of Exo1, Rad9 and Sgs1 permits the viability of essentially all cells lacking 
Cdc13 but elimination of Cdc13 confers a severe growth defect and ultimately leads to 
senescence (Ngo and Lydall, 2010). Second, the alterations in telomere structure seen in 
Type I and Type II post-senescence survivors are sufficient to maintain viability in the 
absence of Cdc13 at a rate of approximately 8.5x10-4-1.3x10-3 (Larrivee and Wellinger, 
2006). However, it should be noted that the generation of Type I and Type II post-
senescence survivors is itself a very rare event. Finally, the essential requirement for 
Cdc13 can be overcome by over-expression of the C terminus of Stn1 with concurrent 
over-expression of Ten1 to permit viability in the absence of Cdc13 in aproximately 
1.6x10-1 of cells (Petreaca et al., 2006). Interestingly, this last mechanism does not 
eliminate the requirement for Cdc13-dependent telomere capping, but uses selective 
overexpression to fulfill the usual function of Cdc13 (to tether Stn1 and Ten1 to the 
telomere) by alternate means and is reminiscent of earlier work showing that Cdc13 
function can by bypassed by fusing the DNA binding domain of Cdc13 to Stn1 
(Pennock et al., 2001). 
This work focused on determining whether cells lacking Pif1 and Exo1 eliminated the 
requirement for Cdc13. If so, it would be important to determine the alterations in 
telomere structure that occurred in the absence of Cdc13 along in addition to 
determining the mechanisms through which these cells maintained their telomeres. 
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Figure 35: cdc13-1 exo1∆ pif1∆ mutants have a detectable growth defect at 36°C 
Exponentially-dividing cultures of the genotypes indicated were grown at 23°C then 
shifted to 36°C for 6 hours. Every hour samples were taken to measure A. total cell 
number and B. viable cell number.
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Figure 36: cdc13-1 exo1∆ pif1∆ mutants have a growth defect above 36°C 
Saturated cultures of the genotypes indicated were serially-diluted across A. YEPD or 
B. YEPG plates and grown at the temperatures indicated for 3 days.
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6.2 Results 
6.2.1 Cells lacking Pif1 and Exo1 have a detectable growth defect following 
telomere uncapping 
cdc13-1 exo1∆ pif1∆ mutants were able to grow at 36°C (Figure 5) and did not 
accumulate telomeric ssDNA (Figure 16) or undergo metaphase arrest (Figure 14), 
suggesting the possibility that there was no growth defect or loss in viability caused by 
telomere uncapping in these strains. To test this hypothesis, asynchronously dividing 
cultures of cdc13-1 and CDC13+ mutants grown at 23°C were shifted to 36°C to induce 
telomere uncapping and cell number and viability were measured over time. As 
expected, CDC13+ mutants increased in both cell number (Figure 35A) and viable cell 
number (Figure 35B) over time. cdc13-1 mutants increased in both cell number (Figure 
35A) and viable cell number (Figure 35B) for the first two hours, but subsequently 
underwent no further increase in cell number (Figure 35A) and showed a decrease in 
viable cell number at 5 and 6 hours (Figure 35B) corresponding to a loss in viability 
caused by persistent telomere uncapping. In contrast, both CDC13+ exo1∆ pif1∆ and 
cdc13-1 exo1∆ pif1∆ mutants continued to increase in both cell number and viable cell 
number over time (Figure 35A-B). However, cdc13-1 exo1∆ pif1∆ mutants clearly 
showed a decrease in growth rate compared to CDC13+ exo1∆ pif1∆ mutants (Figure 
35A). It was concluded that there was a slight growth defect in cdc13-1 exo1∆ pif1∆ 
mutants following telomere uncapping. 
Although cdc13-1 exo1∆ pif1∆ mutants were able to grow at 36°C, it was possible that 
extremely low levels of Cdc13-1 activity persisted at this temperature and contributed to 
their growth (Figure 5). To test this hypothesis, the growth of cdc13-1 exo1∆ pif1∆ 
mutants was compared to that of CDC13+ exo1∆ pif1∆ mutants at temperatures of 36°C 
and higher. At 23°C and 30°C, there was no discernable difference in growth between 
cdc13-1 exo1∆ pif1∆ and CDC13+exo1∆ pif1∆ mutants (Figure 36A). However at 36°C 
cdc13-1 exo1∆ pif1∆ mutants grew slightly worse than CDC13+ exo1∆ pif1∆ mutants, 
while at 37°C-38°C cdc13-1 exo1∆ pif1∆ mutants clearly grew worse than CDC13+ 
exo1∆ pif1∆ mutants (Figure 36A). However, it should be noted that at 37°C CDC13+ 
exo1∆ pif1∆ mutants grew slightly worse than CDC13+ mutants (Figure 36A) and 
CDC13+ and CDC13+ exo1∆ pif1∆ mutants both grew worse at 38°C than at lower 
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temperatures. It was concluded that low levels of Cdc13-1 activity persisted at 36-38°C 
and contributed to the growth of cdc13-1 exo1∆ pif1∆ mutants (Figure 36A).  
Mitochondrial activity inhibits the growth of cdc13-1 mutants (Addinall et al., 2008) 
and at high temperatures cells lacking Pif1 gradually lose mitochondrial function (Van 
Dyck et al., 1992). Thus, it was hypothesized that mitochondrial defects in cdc13-1 
pif1∆ exo1∆ mutants might contribute to their growth at 36°C. To test this hypothesis, 
the growth of cdc13-1 pif1∆ exo1∆ mutants was compared to the growth of CDC13+ 
exo1∆ pif1∆ mutants at high temperatures on YEPG plates. On YEPG plates, the only 
carbon source provided is Glycerol, which is non-fermentable, so only cells with 
functional mitochondria will be able to grow and form colonies. It was expected that if 
mitochondrial dysfunction contributed to the growth of cdc13-1 exo1∆ pif1∆ mutants at 
36°C, then growing them under conditions where only cells with functional 
mitochondria could grow and form colonies (YEPG) should lead to a growth defect. 
Surprisingly, cdc13-1 exo1∆ pif1∆ mutants actually grew better than CDC13+ exo1∆ 
pif1∆ mutants at 36°C (Figure 36B). It was concluded that mitochondrial defects in 
cdc13-1 exo1∆ pif1∆ mutants did not contribute to their growth at 36°C. Instead, the 
improved growth of cdc13-1 exo1∆ pif1∆ mutants at 36°C suggested that inactivation of 
Cdc13-1 actually improved the retention of mitochondrial function in cdc13-1 exo1∆ 
pif1∆ mutants. 
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Figure 37: cdc13-1 exo1∆ pif1∆ mutants do not undergo alterations in telomere 
structure that could account for their ability to grow at 36°C 
Saturated cultures of the genotypes indicated were grown to stationary phase at 23°C 
then diluted 1:500 and grown to stationary phase once more at either 23°C or 36°C (as 
indicated). DNA prepared from stationary phase cultures was then used for Southern 
blots that were performed to detect A. TG repeats or B. Y’ elements, as in Figure 30.
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6.2.2 cdc13-1 mutants lacking Pif1 and Exo1 do not generate alterations in 
telomere structure that permit telomere maintenance following telomere 
uncapping 
The alterations in telomere structure seen in Type I and Type II post-senescent survivors 
facilitate telomere maintenance in the absence of Cdc13, albeit at a low rate (Larrivee 
and Wellinger, 2006). It was hypothesized that at 23°C, cdc13-1 exo1∆ pif1∆ mutants 
might also undergo alterations in telomere structure, efficiently permitted their survival 
at 36°C, following inactivation of Cdc13-1. To test this hypothesis, Southern Blots were 
performed to examine the telomeres of cdc13-1 exo1∆ pif1∆ mutants at 23°C and 36°C 
using probes to detect TG (Figure 37A) and Y’ (Figure 37B) sequences. 
The telomeres of CDC13+pif1∆ and CDC13+ exo1∆ pif1∆ mutants were longer and 
more varied in length than those of CDC13+ and CDC13+ exo1∆ mutants (Figure 37A-
B), as expected (Figure 30A-B) (Schulz and Zakian, 1994). Surprisingly, the telomeres 
of cdc13-1 pif1∆ and cdc13-1 exo1∆ pif1∆ mutants were even longer and more varied in 
length than CDC13+ pif1∆ and CDC13+ exo1∆ pif1∆ mutants (Figure 37-B). This was 
consistent with data showing that Cdc13-1 at 23°C is still slightly defective compared to 
Cdc13 (Addinall et al., 2008, Foster et al., 2006) and that Cdc13 negatively regulates 
telomere length (Chandra et al., 2001, Ungar et al., 2009). It was concluded that Cdc13 
plays an important role in negative regulation of telomere length in cells lacking Pif1 
and that Cdc13-1, even at 23°C, has a defect in telomere length regulation that becomes 
apparent in cells lacking Pif1. 
At 36°C, the telomeres of cdc13-1 exo1∆ pif1∆ mutants were longer than those of 
CDC13+ exo1∆ pif1∆ mutants but had undergone no other noticeable rearrangements in 
either the terminal fragments or Y’ elements (Figure 37A-B). However, the telomeres of 
cdc13-1 exo1∆ pif1∆ mutants grown at 36°C were identical to those of cdc13-1 exo1∆ 
pif1∆ mutants grown at 23°C (Figure 37A-B), indicating that no alterations in telomere 
structure occur when cdc13-1 exo1∆ pif1∆ mutants are grown for short periods of time 
with uncapped telomeres. Furthermore, the telomere structure of cdc13-1 exo1∆ pif1∆ 
mutants at 36°C was identical to that of cdc13-1 pif1∆ mutants at 23°C (Figure 37A-B). 
As cdc13-1 pif1∆ mutants are unable to grow at 36°C (Figure 5), this indicates that the 
telomere structure shared by cdc13-1 exo1∆ pif1∆ and cdc13-1 pif1∆ mutants cannot 
215 
account for the growth of cdc13-1 exo1∆ pif1∆ mutants at 36°C. It was concluded that 
cdc13-1 exo1∆ pif1∆ mutants do not undergo alterations in telomere structure that 
efficiently permit their survival at 36°C. 
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Figure 38: cdc13∆ exo1∆ pif1∆ mutants are viable 
cdc13∆/CDC13+ exo1∆/EXO1+ pif1∆/PIF1+ diploids were generated, sporulated and 
spores micromanipulated apart on a YEPD plate and allowed to form colonies at 23°C 
for 5 days. Tetrad dissection plate is shown on the left, a key showing (where possible) 
the inferred genotypes of the spore manipulated to each position is shown on the right. 
cdc13∆ exo1∆ pif1∆ mutants are circled.
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Diploid 
Spores 
Dissected 
PIF1+ 
EXO1+ 
CDC13+ 
colonies 
(expected) 
PIF1+ 
EXO1+ 
CDC13+ 
colonies 
(observed) 
pif1∆ 
exo1∆ 
CDC13+ 
colonies 
(observed) 
pif1∆ 
exo1∆ 
cdc13∆ 
colonies 
(observed) 
cdc13∆/ 
CDC13+ 
viability 
(%) 
DDY340 176 22 17 13 12 92 
DDY341 176 22 23 19 16 84 
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Table 5: cdc13∆ exo1∆ pif1∆ mutants have a high rate of viability 
176 spores each from two independently generated diploids were dissected as in Figure 
38. The genotypes of viable spores were determined by replica plating to selective 
media. Table shows the number of strains obtained for each relevant genotype to 
determine the viability of cdc13∆ exo1∆ pif1∆ mutants. 
220 
!"
#
$
%&%'
()
*(+
,
-
.(/
)
0)
$
&#
1
2
03
%#
"
(4
%53
&$
1
!
"
#
$
%&#
'
#
$
(
%
!
"
#
$
%&#
'
#
$
(
%
!
"#$
%
&'
(
)
$
%
&*
+
,
$
%&#
'
#
$
(
%
-./
$
%
&,
0
,
$
1
%
!
"#$
%
&'
(
)
$
%
&*
+
,
$
%&#
'
#
$
(
%
-./
$
%
&,
0
,
$
1
%
!
"#$
%
&'
(
)
$
%
&-./
$
%
&,
0
,
$
1
%
!
"#$
%
&'
(
)
$
%
&-./
$
%
&,
0
,
$
1
%
#
'
#
$
(
%&!
"
#
$
%
#
'
#
$
(
%&!
"
#
$
%
#
'
#
$
(
%&!
"
#
$
%&'
(
)
$
%
&!
"#$
%
#
'
#
$
(
%&!
"
#
$
%&'
(
)
$
%
&!
"#$
%
#
'
#
$
(
%&-./
$
%
#
'
#
$
(
%&-./
$
%
#
'
#
$
(
%&-./
$
%
&'
(
)
$
%
&!
"#$
%
#
'
#
$
(
%&-./
$
%
&'
(
)
$
%
&!
"#$
%
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
6
7
8
9
:
:
;
6
7
8
9
:
:
<
6
7
8
9
:
:
=
6
7
8
9
:
:
>
6
7
8
9
:
:
?
6
7
8
9
:
:
:
6
7
8
9
:
:
@
6
7
8
9
:
:
9
!
"
#
$
%&/
2
/
$
1
%
!
"
#
$
%&/
2
/
$
1
%
!
"#$
%
&'
(
)
$
%
&*
+
,
$
%&/
2
/
$
1
%
-./
$
%
&/
2
/
$
1
%
!
"#$
%
&'
(
)
$
%
&*
+
,
$
%&/
2
/
$
1
%
-./
$
%
&/
2
/
$
1
%
!
"#$
%
&'
(
)
$
%
&-./
$
%
&/
2
/
$
1
%
!
"#$
%
&'
(
)
$
%
&-./
$
%
&/
2
/
$
1
%
/
0,
/
0,
/
2
/
$
1
%
&!
"
#
$
%&'
(
)
$
%
&!
"#$
%
/
2
/
$
1
%
&!
"
#
$
%&'
(
)
$
%
&!
"#$
%
/
0,
/
0,
/
0,
/
0,
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
%
&)
*
+
,
(
-#
'
#
$
(
.
6
7
8
9
:
:
A
6
7
8
9
:
@
@
6
7
8
9
:
:
B
6
7
8
9
:
@
;
6
7
8
9
:
@
=
6
7
8
9
:
@
>
6
7
8
9
:
@
?
6
7
8
9
:
@
:
!
"
#
$
%&
'
(
)
*
(
221 
 
Figure 39: Telomerase is essential for the viability of cdc13∆ exo1∆ pif1∆ mutants 
Strains of the genotypes indicated were all germinated from the same diploid for 3 days 
at 30°C, then struck onto –URA for 3 days at 30°C to ensure retention of the plasmid. 
Saturated cultures were then grown in YEPD, serially diluted across agar plates and 
grown for 2 days on YEPD or –URA or 5 days on FOA media. Growth from the lowest-
dilution spot for each strain was struck onto YEPD, then single colonies replicated to 
selective media to determine the genotype of any FOA-resistant colonies.
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Figure 40: Ku is essential for the viability of cdc13∆ exo1∆ pif1∆ mutants 
Strains of the genotypes indicated were all germinated from the same diploid for 3 days 
at 30°C, then struck onto –URA for 3 days at 30°C to ensure retention of the plasmid. 
Saturated cultures were then grown in YEPD, serially diluted across agar plates and 
grown for 2 days on YEPD or –URA or 5 days on FOA media. Growth from the lowest-
dilution spot for each strain was struck onto YEPD, then single colonies replicated to 
selective media to determine the genotype of any FOA-resistant colonies. 
Note: yku70∆ exo1∆ pif1∆ mutants grew very poorly on –URA so had to be grown up 
on YEPD. 
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Figure 41: Rad52 is essential for the viability of cdc13∆ exo1∆ pif1∆ mutants 
Strains of the genotypes indicated were all germinated from the same diploid for 3 days 
at 30°C, then struck onto –URA for 3 days at 30°C to ensure retention of the plasmid. 
Saturated cultures were then grown in YEPD, serially diluted across agar plates and 
grown for 2 days on YEPD or –URA or 5 days on FOA media. Growth from the lowest-
dilution spot for each strain was struck onto YEPD, then single colonies replicated to 
selective media to determine the genotype of any FOA-resistant colonies.
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Figure 42: Pol32 is not required for the viability of cdc13∆ exo1∆ pif1∆ mutants 
Strains of the genotypes indicated were all germinated from the same diploid for 3 days 
at 30°C, then struck onto –URA for 3 days at 30°C to ensure retention of the plasmid. 
Saturated cultures were then grown in YEPD, serially diluted across agar plates and 
grown for 2 days on YEPD or –URA or 5 days on FOA media. Growth from the lowest-
dilution spot for each strain was struck onto YEPD, then single colonies replicated to 
selective media to determine the genotype of any FOA-resistant colonies.
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6.2.3 Cells lacking Pif1 and Exo1 do not require Cdc13 for survival, provided that 
telomerase, Ku and Rad52 are present 
cdc13-1 exo1∆ pif1∆ mutants were able to grow at 36°C, suggesting that exo1∆ pif1∆ 
mutants might not need Cdc13 for viability (Figure 5). However, at 37°C -38°C, 
inactivation of Cdc13-1 caused a noticeable growth defect (Figure 36), suggesting that 
cdc13∆ exo1∆ pif1∆ mutants might grow poorly or be inviable. To test this hypothesis, 
it was decided to investigate whether cdc13∆ exo1∆ pif1∆ mutants were viable. 
cdc13∆/CDC13+ exo1∆/EXO1+ pif1∆/PIF1+ diploids were generated, sporulated, 
tetrads dissected and then spores micromanipulated apart on agar plates to allow viable 
meiotic progeny to form colonies (Figure 38). Surprisingly, cdc13∆ exo1∆ pif1∆ 
mutants were viable (Spores 3c, 7a, 8a, 8b, 9b, 10b, Figure 38) but clearly grew poorly 
compared to CDC13+ exo1∆ pif1∆ mutants (spores 1d, 2c, 5a, 10a, Figure 38). Two 
independently-derived diploids were dissected, and the fraction of cdc13∆ exo1∆ pif1∆ 
mutants compared to CDC13+ exo1∆ pif1∆ mutants was determined (Table 5). These 
data indicated that the germination efficiency of cdc13∆ exo1∆ pif1∆ mutants was 88% 
±5.7%. It was concluded that essentially all exo1∆ pif1∆ mutants did not require Cdc13 
for viability, but elimination of Cdc13 conferred a severe growth defect. 
cdc13∆ exo1∆ pif1∆ mutants were viable (Figure 38), just like cdc13-1 exo1∆ pif1∆ 
mutants grown at 36°C (Figure 5). However, telomerase was essential for the growth of 
cdc13-1 exo1∆ pif1∆ mutants at 36°C (Figures 22-23). Thus it was hypothesized that 
telomerase might be required for the viability of cdc13∆ exo1∆ pif1∆ mutants. To test 
this hypothesis a cdc13∆/CDC13+ exo1∆/EXO1+ pif1∆/PIF1+ tlc1∆/TLC1+ diploid was 
generated containing a plasmid expressing URA3 and over-expressing CDC13 
(pURA3[CDC13]). Sporulation of the diploid and tetrad dissection was then used to 
yield CDC13+ and cdc13∆ strains containing pURA3[CDC13]. Strains were passaged 
on –URA media to ensure retention of pURA3[CDC13], then grown up in liquid culture 
and serially-diluted across YEPD, -URA and FOA plates. Expression of URA3 permits 
growth on media lacking uracil (-URA) but is toxic to cells grown on media containing 
FOA. Thus, on –URA only cells able to tolerate overexpression of CDC13 would be 
able to grow while on FOA only cells able to tolerate the loss of plasmid-borne CDC13 
would be able to grow. 
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CDC13+ TLC1+, CDC13+ TLC1+ exo1∆ pif1∆, CDC13+ tlc1∆ and CDC13+ tlc1∆ exo1∆ 
pif1∆ were all able to grow on YEPD, -URA and FOA plates, indicating that 
overexpression of CDC13 was not toxic and that the additional copy of CDC13 was not 
essential (Figure 39). As expected, cdc13∆ TLC1+ strains could grow on YEPD and –
URA, but not FOA, indicating that the additional copy of CDC13 was essential. In 
contrast, cdc13∆ TLC1+ exo1∆ pif1∆ mutants were able to grow on YEPD, –URA, and 
FOA indicating that the additional copy of CDC13 was not essential in this genetic 
background. However, cdc13∆ TLC1+ exo1∆ pif1∆ mutants grew much worse than 
CDC13+ TLC1+ exo1∆ pif1∆ mutants on FOA, indicating a growth defect in these 
strains, consistent with previous results (Figure 38). Both cdc13∆ tlc1∆ and cdc13∆ 
tlc1∆ exo1∆ pif1∆ mutants could grow on YEPD and –URA, but not on FOA, 
indicating that the additional copy of CDC13 was essential. 
cdc13∆ tlc1∆ exo1∆ pif1∆ mutants grew very poorly on both YEPD and –URA, while 
CDC13+ tlc1∆ exo1∆ pif1∆ mutants did not (Figure 39). This suggested that the cdc13∆ 
mutation conferred a growth defect in tlc1∆ exo1∆ pif1∆ mutants that over-expression 
of CDC13 could not compensate for. It also raised the possibility that tlc1∆ cdc13∆ 
exo1∆ pif1∆ mutants might be viable without the plasmid, but grow so poorly (due to 
the combined growth defects seen in tlc1∆ cdc13∆ exo1∆ pif1∆ mutants carrying 
pURA3[CDC13] and in cdc13∆ exo1∆ pif1∆ mutants) that they could not be detected. 
However, the growth of cdc13∆ tlc1∆ exo1∆ pif1∆ mutants on –URA plates was judged 
to not be sufficiently worse than that of cdc13∆ TLC1+exo1∆ pif1∆ to prevent the 
detection of cdc13∆ tlc1∆ exo1∆ pif1∆ mutants on FOA plates, if they were viable. 
Thus, it was concluded that telomerase is essential for the viability of cdc13∆ exo1∆ 
pif1∆ mutants. 
In addition to its role in inhibition of nuclease activities at telomeres, Cdc13 is essential 
to recruit telomerase to the telomere. This is highlighted by the cdc13-2 mutation, which 
ablates the telomerase recruitment function of Cdc13 and confers the same phenotype as 
tlc1∆, leading to telomere shortening and senescence (Nugent et al., 1996). Therefore it 
was surprising that telomerase was essential for the growth of cdc13-1 exo1∆ pif1∆ 
mutants at 36°C (Figure 22) and for the viability of cdc13∆ exo1∆ pif1∆ mutants 
(Figure 39), given that Cdc13 should be either inactive or absent, respectively, and thus 
it should not be possible to recruit telomerase to the telomeres. However, the 
requirement of telomerase for the viability of cdc13-1 exo1∆ pif1∆ mutants at 36°C and 
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for the viability of cdc13∆ exo1∆ pif1∆ mutants suggested that telomerase had an 
essential function at the telomeres of these mutants and was being recruited 
independently of Cdc13. The DDR protein Ku (Yku70-Yku80) binds to telomeres and 
DSBs, and aids in telomerase recruitment by interaction with the TLC1 subunit of 
telomerase (Peterson et al., 2001). Thus, it was hypothesized that Ku might recruit 
telomerase to the telomeres of cdc13∆ exo1∆ pif1∆ mutants and thus be essential. 
To test this hypothesis, strains containing mutations in all combinations of CDC13, 
YKU70, EXO1 and PIF1 and carrying a CDC13 overexpression plasmid 
(pURA3[CDC13]) were generated as above (Figure 39) then tested for growth on 
YEPD, -URA and FOA plates. CDC13+ YKU70+, CDC13+ YKU70+ exo1∆ pif1∆ and 
CDC13+ yku70∆ and CDC13+ yku70∆ exo1∆ pif1∆ mutants were all able to grow on 
YEPD and FOA plates, indicating that the additional copy of CDC13 was not essential 
(Figure 40). As expected, cdc13∆ YKU70+ strains could grow on YEPD and –URA, but 
not FOA, indicating that the additional copy of CDC13 was essential, while cdc13∆ 
YKU70+ exo1∆ pif1∆ mutants could grow on YEPD, -URA and FOA, indicating that 
the additional copy of CDC13 was not essential (Figure 40). Furthermore, cdc13∆ 
yku70∆ and cdc13∆ yku70∆ exo1∆ pif1∆ mutants were able to grow on YEPD and –
URA but not on FOA, indicating that pURA3[CDC13] was essential (Figure 40). It was 
noted that it was not possible to passage CDC13+ yku70∆ exo1∆ pif1∆ mutants on –
URA, indicating that overexpression of CDC13 in this background was highly toxic, 
resulting in poor-to-no growth on –URA plates (Figure 40). However, cdc13∆ yku70∆ 
exo1∆ pif1∆ mutants were able to grow on both YEPD and –URA so it was judged that 
this toxicity was not an issue in the cdc13∆ yku70∆ exo1∆ pif1∆ mutants and did not 
affect the conclusions of the assay. In conclusion, Ku (Yku70) is essential for the 
survival of cdc13∆ exo1∆ pif1∆ mutants, suggesting that Ku functions to recruit 
telomerase to the telomeres in cdc13∆ exo1∆ pif1∆ mutants. 
As Ku and telomerase were essential for the survival of cdc13∆ exo1∆ pif1∆ mutants, 
even in the absence of Cdc13, it suggested Cdc13-independent telomerase-dependent 
mechanisms of telomere maintenance were being utilized. HR also contributes to 
telomere maintenance, and HR-based mechanisms are solely responsible for telomere 
maintenance in Type I and Type II post-senescent survivors (Lundblad and Blackburn, 
1993, Teng and Zakian, 1999). It was hypothesized that Cdc13-independent telomerase-
dependent mechanisms might be sufficient for telomere maintenance even in the 
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absence of HR. To test this hypothesis, strains containing mutations in all combinations 
of CDC13, RAD52 (essential for HR), EXO1 and PIF1 and carrying a CDC13 
overexpression plasmid (pURA3[CDC13]) were generated as above (Figures 39-40) 
then tested for growth on YEPD, -URA and FOA plates. 
CDC13+ RAD52+, CDC13+ RAD52+ exo1∆ pif1∆, CDC13+ rad52∆ and CDC13+ 
rad52∆ exo1∆ pif1∆ mutants were all able to grow on YEPD, -URA and FOA, 
indicating that pURA3[CDC13] was not essential for the viability of these strains. As 
expected, cdc13∆ RAD52+ exo1∆ pif1∆ mutants were also able to grow on FOA, 
indicating that pURA3[CDC13] was not essential for viability of these strains. 
However, cdc13∆ rad52∆ exo1∆ pif1∆, cdc13∆ RAD52+ and cdc13∆ rad52∆ mutants 
were able to grow on YEPD and –URA, but not on FOA, indicating pURA3[CDC13] 
was essential for the viability of these strains. It was concluded that Rad52 is essential 
for the viability of cdc13∆ exo1∆ pif1∆ mutants and thus HR is likely to be required for 
telomere maintenance in cdc13∆ exo1∆ pif1∆ mutants.  
cdc13∆ exo1∆ pif1∆ mutants require telomerase for survival (and presumably telomere 
maintenance) but also show characteristics of telomerase-independent post-senescent 
survivors (the requirement for HR for viability). Thus, it was possible that cdc13∆ 
exo1∆ pif1∆ mutants might utilized both telomerase-dependent mechanisms of telomere 
maintenance and survivor-like mechanisms. To test this hypothesis, it was decided to 
test whether the Pol32 subunit of DNA Polymerase δ, required for BIR (a subcategory 
of HR) and for the generation of Type I and Type II survivors was required for the 
viability of cdc13∆ exo1∆ pif1∆ mutants (Lydeard et al., 2007). To do so, strains 
containing mutations in all combinations of CDC13, POL32, EXO1 and PIF1 and 
carrying a CDC13 overexpression plasmid (pURA3[CDC13]) were generated as above 
(Figures 39-41) then tested for growth on YEPD, -URA and FOA plates. 
CDC13+ POL32+, CDC13+ POL32+ exo1∆ pif1∆, CDC13+ pol32∆ and CDC13+ 
pol32∆ exo1∆ pif1∆ mutants were all able to grow on YEPD, -URA and FOA, 
indicating that pURA3[CDC13] was not essential for the viability of these strains. As 
expected, cdc13∆ POL32+ and cdc13∆ pol32∆ strains were able to grow on YEPD and 
–URA, but not on FOA, indicating that pURA3[CDC13] was essential for the viability 
of these strains. (Note: several colonies of cdc13∆ pol32∆ strain 6469 did grow on the 
FOA plate, but upon passage and genotyping they were determined to be contaminating 
232 
CDC13+ pol32∆ strains). Surprisingly, both cdc13∆ POL32+ exo1∆ pif1∆  and cdc13∆ 
pol32∆ exo1∆ pif1∆ mutants were also able to grow on FOA, indicating that 
pURA3[CDC13] was not essential for viability of these strains. It was noted that the 
growth on FOA of the cdc13∆ pol32∆ exo1∆ pif1∆ mutants was extremely poor, but 
this was also true of CDC13+ pol32∆ and CDC13+ pol32∆ exo1∆ pif1∆ strains, 
suggesting this was in large part due to FOA sensitivity of pol32∆ strains rather than an 
indication that cdc13∆ pol32∆ exo1∆ pif1∆ mutants were extremely sick without 
pURA3[CDC13]. It was concluded that Pol32 was not essential for the viability of 
cdc13∆ exo1∆ pif1∆ mutants and thus they presumably relied on mechanisms that were 
clearly distinct from those of Type I and Type II survivors. 
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Figure 43: cdc13∆ exo1∆ pif1∆ mutants do not senesce 
A. Multiple colonies from strains of the genotypes indicated at the passage indicated 
were inoculated into YEPD and grown to saturation, then serially-diluted across YEPD 
plates and allowed to grow at 30°C for 2 days. B. Quantification of the plates shown in 
A. with the growth given relative to the appropriate CDC13+ TLC1+ strain. 
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Figure 44: cdc13∆ exo1∆ pif1∆ mutants maintain their telomeres for up to 11 
passages 
Multiple colonies of strains of the genotypes indicated, at the passages indicated, were 
grown to saturation, then DNA was prepared and Southern Blots were performed to 
detect A. TG repeats and B. Y’ fragments as in Figure 30. 
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Figure 45: cdc13∆ exo1∆ pif1∆ mutants maintain their telomeres for up to 25 
passages 
Multiple colonies of strains of the genotypes indicated, at the passages indicated, were 
grown to saturation, then DNA was prepared and Southern Blots were performed to 
detect A. TG repeats and B. Y’ fragments as in Figure 30.
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6.2.4 cdc13∆ exo1∆ pif1∆ mutants do not senesce and maintain their telomeres 
over time 
Cells lacking Cdc13, Exo1 and Pif1 required telomerase and HR for viability and 
(presumably) for telomere maintenance (Figures 39-40). Though cdc13∆ exo1∆ pif1∆ 
mutants were clearly viable for long enough to form colonies (assuming ~106 cells/Wild 
Type colony, <20 generations) but were clearly very sick on the germination plate 
(Figure 38). Thus, it was possible that the cdc13∆ exo1∆ pif1∆ strains were entering 
into a rapid senescence and HR and Ku-mediated telomerase recruitment were sufficient 
only to allow the cell to divide enough to form colonies, not for sustained growth.  
To test this hypothesis, exo1∆ pif1∆ cdc13∆ mutants were germinated simultaneously 
(as in Figure 28 and Figure 38) and passaged over time, alongside exo1∆ pif1∆ tlc1∆ 
mutants and tlc1∆ mutants (Figure 43A). Growth of the strains at different passage 
number was then measured relative to the appropriate TLC1+ CDC13+ strain and 
quantified (Figure 43B). At early passage, cdc13∆ exo1∆ pif1∆ mutants displayed a 
slight growth defect (Figure 43A-B) consistent with the growth defect seen on the 
germination plates (Figure 38). However, by passage 5, cdc13∆ exo1∆ pif1∆ mutants 
had improved in growth and continued to grow well for all subsequent passages (Figure 
43B). This was in contrast to tlc1∆ mutants, which underwent a clear senescence period 
(passage 5, Figure 43A-B), followed by a dramatic recovery (passage 11, Figure 43A-
B). In contrast, tlc1∆ pif1∆ exo1∆ mutants underwent a rapid senescence (passage 5, 
Figure 43A-B) and slowly improved in growth afterwards but did not recover (passage 
11-14, Figure 43A-B), consistent with previous results (Figure 28). It was concluded 
that cdc13∆ exo1∆ pif1∆ mutants did not undergo typical patterns of senescence and 
recovery or follow the same rapid senescence and protracted period of poor growth as 
tlc1∆ exo1∆ pif1∆ mutants (Figure 43A-B). Thus it was unlikely that cdc13∆ exo1∆ 
pif1∆ mutants were entering into senescence on the germination plate (Figure 38). 
Type I and Type II survivors undergo alterations in telomere structure that can permit 
telomere maintenance in the absence of Cdc13 (Larrivee and Wellinger, 2006). 
Additionally, cells that bypass the need for telomere capping, either through attenuation 
of the DDR at uncapped telomeres (Zubko and Lydall, 2006) or by co-overexpression 
of Stn1 and Ten1 (Petreaca et al., 2006) frequently undergo rearrangements in telomere 
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structure. cdc13-1 exo1∆ pif1∆ mutants can grow for approximately 9 generations 
without undergoing alterations in telomere structure (a 1:500 dilution is approximately 
1:29, see Figure 37) and cdc13∆ exo1∆ pif1∆ mutants grow poorly after approximately 
<20 generations of growth (Figure 38) but subsequently grow well upon passage 
(Figure 43). Thus it was hypothesized that cdc13∆ exo1∆ pif1∆ mutants might maintain 
a relatively normal telomere structure at early passage (like cdc13-1 exo1∆ pif1∆ 
mutants) but undergo rearrangements in telomere structure that permitted them to 
improve in growth at later passage. 
To test this hypothesis, Southern Blots were performed to analyze telomere structure of 
cdc13∆ exo1∆ pif1∆ mutants at passages 1 and 11 compared to tlc1∆ and tlc1∆ exo1∆ 
pif1∆ mutants (Figures 44A-B). As expected, tlc1∆ and tlc1∆ exo1∆ pif1∆ mutants had 
short telomeres at passage 1 (lanes 3-4, 7-8 Figure 44A-B). Consistent with previous 
results (Figure 28), by passage 11 tlc1∆ mutants had generated survivors (Type I - lane 
15, Type II - lane 16, Figure 44A-B) while tlc1∆ exo1∆ pif1∆ mutants had undergone a 
reduction in Y’ elements, acquired terminal Y’ elements at all telomeres and maintained 
extremely short terminal fragments (lanes 19-20, Figure 44A-B). In contrast, cdc13∆ 
exo1∆ pif1∆ mutants had extremely long telomeres at passage 1, with great variance in 
length (lanes 9-12, Figure 44A-B) and by passage 11 their telomeres had increased in 
length and variance but had otherwise undergone no alterations in telomere structure 
(lanes 21-24, Figure 44A-B). It was concluded that cdc13∆ exo1∆ pif1∆ mutants did not 
undergo gross rearrangements in telomere structure that permitted them to improve their 
growth in the absence of Cdc13. 
Interestingly, the telomeres of cdc13∆ exo1∆ pif1∆ mutants most closely resembled 
those of cdc13-1 exo1∆ pif1∆ mutants (which were not passaged) grown at 23°C 
(compare lanes 2 and 14 to lanes 9-12 and 21-24, Figure 44A-B). Furthermore, the 
telomeres of exo1∆ pif1∆ mutants, like those of cdc13∆ exo1∆ pif1∆ mutants also 
increased in length and variance with passage (compare lanes 5-6 to lanes 17-18, Figure 
44A-B). It was possible that telomere lengthening in cdc13-1 exo1∆ pif1∆ mutants and 
cdc13∆ exo1∆ pif1∆ mutants was an acceleration of the telomere lengthening that 
occurred with passage in exo1∆ pif1∆ mutants with passage number. If this was the 
case, then cdc13∆ exo1∆ pif1∆ and exo1∆ pif1∆ mutants should continue to increase in 
length over time and exo1∆ pif1∆ mutants should ultimately become as long a cdc13-1 
exo1∆ pif1∆ mutants. To test this hypothesis, all strains (except Wild Type and cdc13-1 
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exo1∆ pif1∆ controls) were passaged a further 14 times, (up to passage 25, amounting to 
a total of 100 days growth at 23°C) and Southern Blots were performed to analyze 
telomere length (Figure 45A-B). 
By passage 25, cdc13∆ exo1∆ pif1∆ mutants had increased in telomere length (compare 
lanes 21-24, Figure 44A-B to lanes 21-24, Figure 45A-B). This was also true for exo1∆ 
pif1∆ mutants (compares lanes 17-18, Figure 44A-B to lanes 17-18, Figure 45A-B), 
which by passage 25 had longer telomeres than an unpassaged cdc13-1 exo1∆ pif1∆ 
mutant (compares lanes 17-18 to lane 14, Figure 45A-B). Indeed, by passage 25 the 
telomeres of pif1∆ exo1∆ mutants were almost identical to those of cdc13∆ exo1∆ pif1∆ 
mutants at passage 1 (compare lanes 17-18 to lanes 9-12, Figure 45A-B). Thus, it was 
concluded that the telomere lengthening in cdc13∆ exo1∆ pif1∆ mutants was not 
specifically caused by impaired (cdc13-1) or absent Cdc13 (cdc13∆), but was an 
acceleration of the telomere lengthening phenotype seen in exo1∆ pif1∆ mutants. As the 
pif1∆ mutation is responsible for the telomere lengthening seen in exo1∆ pif1∆ and 
cdc13-1 exo1∆ pif1∆ mutants (Figure 37A-B) this telomere lengthening is probably due 
to the absence of Pif1. 
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Figure 46: growth in the absence of Cdc13 does not cause accumulation of ssDNA 
A. Exponentially-dividing cultures of strains of the indicated genotypes were either 
grown at 23°C for a further 4 hours or split and half the culture grown at 23°C for a 
further 4 hours while the other half was grown at 36°C. Samples were taken and DNA 
was prepared by for in-gel assays which were performed as in Figure 18. Gel is split 
into panels for presentation purposes, but all samples were run on the same gel. B. 
Quantification of the data given in A, as in Figure 18. Horizontal dashed line represents 
one KU. 
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6.2.5 Long term survival in the absence of Cdc13 does not lead to the accumulation 
of telomeric ssDNA 
Over a single cell cycle, cdc13-1 exo1∆ pif1∆ mutants accumulated only transient 
ssDNA in the telomeric TG repeats following telomere uncapping (Figure 18A-B) and 
none in the Y’ elements (Figure 16B). However, when asynchronously dividing cdc13-
1 exo1∆ pif1∆ mutants were subjected to telomere uncapping, a slight accumulation of 
ssDNA in the TG repeats could be seen (Figure 25B) but none in the Y’ elements 
(Figure 26B) and telomerase appeared to inhibit ssDNA generation in TG repeats of 
cdc13-1 independently of both Pif1 and Exo1 (Figure 25A-B). This suggested the 
possibility that a third nuclease activity was functioning at a low level in the absence of 
Pif1 and Exo1, causing exo1∆ pif1∆ mutants to gradually accumulate ssDNA with 
continued cell division in the absence of Cdc13. 
It was assumed that if a residual nuclease activity functioned in the absence of Pif1 and 
Exo1, following telomere uncapping, that the low level of telomeric TG repeat ssDNA 
seen in cdc13-1 exo1∆ pif1∆ mutants would be increased in cdc13∆ exo1∆ pif1∆ 
mutants which had gone through many more cell cycles in the absence of Cdc13. To 
test this hypothesis, asynchronously dividing cultures of cdc13-1 mutants and cdc13-1 
exo1∆ pif1∆ mutants were shifted to 36°C for 4 hours to induce telomere uncapping and 
ssDNA in the telomeric TG repeats was measured by in-gel assay in comparison to an 
asynchronously dividing cdc13∆ exo1∆ pif1∆ mutant and an asynchronously-dividing 
yku70∆ control (Figure 46A-B). cdc13-1 mutants at 36°C for 4 hours (approximately 1 
generation with uncapped telomeres) generated an approximately 10-fold increase in 
ssDNA in the TG repeats over a yku70∆ mutant (Figure 46A-B) consistent with 
previous results (Figure 25A-B).  cdc13-1 exo1∆ pif1∆ mutants at 36°C for 4 hours 
(approximately 2 generations with uncapped telomeres) generated an approximately 2-
fold increase in ssDNA in the TG repeats (Figure 46A-B) consistent with previous 
results (Figure 25A-B). cdc13∆ exo1∆ pif1∆ mutants passaged once (approximately 50 
generations with uncapped telomeres, Figures 43-44) generated less ssDNA than a 
yku70∆ mutant. It was concluded that exo1∆ pif1∆ mutants grown continuously in the 
absence of Cdc13 (50 generations with uncapped telomeres) did not accumulate more 
ssDNA than a cdc13-1 exo1∆ pif1∆ mutant grown at 36°C (2 generations with 
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uncapped telomeres) and thus there were unlikely to be residual nuclease activities 
functioning at uncapped telomeres in exo1∆ pif1∆ mutants. 
246 
!
"
!
"
Telom
erase
#
$
$
#
$
$
#
$
$
Cdc13
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
%
"
!
"
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
%
"
!
"
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
%
"
#
$
$
#
$
$
#
$
$
N
egatively Regulated Telom
ere Extension
#
$
$
#
$
$
#
$
$
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
%
"
!
"
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
%
"
#
$
$
#
$
$
#
$
$
D
eregulated Telom
ere Extension
%
"
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
&
'
'
!
"
#
$
$
#
$
$
#
$
$
#
$
$
#
$
$
#
$
$
#
$
$
%
"
!
"
!"
Telom
ere shortening to critical length
M
ore Frequent
Telom
ere shortening to critical length
Less Frequent
D
eregulated Steady State Telom
ere
Regulated Steady State Telom
ere
Telom
erase Recruited
to Short Telom
ere
Frequent
Telom
erase Recruited
to Short Telom
ere
Infrequent
H
om
ogeneous (200-500bp)
H
eterogeneous (500-3000bp)
Ku
247 
 
Figure 47: A model for the regulation of telomerase at the telomeres of cdc13∆ 
exo1∆ pif1∆ mutants 
A. At wild type telomeres, telomerase is primarily recruited by Cdc13 but aided by Ku. 
Cdc13 also negatively regulates telomere length at each telomere extension event by 
negatively regulating telomerase, ensuring that telomeres will become critically short 
within a relatively small number of divisions and thus telomere length is tightly 
regulated. B. At the telomeres of cdc13∆ exo1∆ pif1∆ mutants, telomerase is recruited 
at a very low rate by Ku alone. However, as Cdc13 is not present, each telomere 
extension event by telomerase produces a very long telomere, which will take many cell 
divisions to become critically short. 
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6.3 Discussion 
Previous work showed that elimination of checkpoint genes and nuclease activities 
(Exo1, Rad9 and Rad24) at uncapped telomeres permitted the generation of cells that 
were viable without Cdc13 at a rate of approximately 4-6x10-5. Here, it is shown that 
elimination of Exo1 and Pif1 is sufficient to permit the viability of approximately 90% 
(9x10-1) of cells in the absence of Cdc13 (Figure 38, Table 5). Furthermore, cells 
lacking Pif1 and Exo1 do not undergo alterations in telomeres structure that could 
account for their growth in the absence of Cdc13 (Figure 37) and selective expression of 
telomere cap components was not required, confirming that cdc13∆ exo1∆ pif1∆ 
mutants are viable due to attenuation of the DDR at uncapped telomeres (Larrivee and 
Wellinger, 2006, Peterson et al., 2001).  
Recently, it has been shown that elimination of Rad9, Exo1 and Sgs1 permits the 
viability of approximately 70% of cells lacking Cdc13 (Ngo and Lydall, 2010). Like 
cdc13∆ exo1∆ pif1∆ mutants, cdc13∆ rad9∆ exo1∆ sgs1∆ mutants grow poorly at 
germination. However, unlike cdc13∆ exo1∆ pif1∆ mutants, cdc13∆ rad9∆ exo1∆ 
sgs1∆ mutants undergo senescence and recovery, with corresponding rearrangements in 
telomere structure (though not alterations typical of Type I and Type II survivors). 
Though elimination of Sgs1 and Exo1 almost completely eliminates resection at 
uncapped telomeres in cdc13-1 mutants, accumulation of ssDNA is still detectable in 
the Y’ elements (presumably due to Pif1 activity) (Ngo and Lydall, 2010). It is likely 
that resection in the Y’ elements by Pif1 causes cdc13∆ rad9∆ exo1∆ sgs1∆ mutants to 
senesce, perhaps with recovery corresponding to alterations in telomere structure that 
attenuate Pif1 activity.  
In contrast to cdc13∆ rad9∆ exo1∆ sgs1∆ mutants, cdc13∆ exo1∆ pif1∆ mutants do not 
senesce and instead show a growth defect upon germination, but improve in growth 
with passage number and grow robustly for >100 days, undergoing no alterations in 
telomere structure other than lengthening of their telomeres (Figures 43-45). 
Furthermore, the survival of these mutants is dependent upon Ku, telomerase and 
homologous recombination (Figures 39-41). These data lend themselves easily to a 
model of telomerase regulation at the telomeres of CDC13+ and cdc13∆ (exo1∆ pif1∆) 
cells (Figure 47A-B). 
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In CDC13+ cells, Cdc13 is essential to recruit telomerase to the telomeres and Ku aids 
in the recruitment of telomerase (Figure 47A). Cdc13 also negatively regulates 
extension by telomerase, preventing the addition of more than 200-500 bases to 
telomeres (Figure 47A). This leads to regular shortening of individual telomeres to 
critical length, followed by telomerase recruitment and re-extension of the telomere by 
telomerase, causing telomere length to be tightly regulated within the cell. 
In cdc13∆ cells, Ku alone recruits telomerase at a very low level (Figure 47B). This low 
level of telomerase recruitment means that cells will be defective at responding to short 
telomeres, possibly explaining the poor growth of cdc13∆ exo1∆ pif1∆ mutants on the 
tetrad dissection plate (Figure 38) and at early passage (Figure 43). As Cdc13 is not 
present to negatively regulate telomeres, each telomerase recruitment event will lead to 
deregulated extension of the telomere by telomerase, producing a telomere of up to 
several kilobases (Figure 47B). Consistent with this, the telomeres of cdc13∆ exo1∆ 
pif1∆ mutants strongly resemble those of cdc13-5 mutants, which have a defect in 
negative regulation of telomerase (Chandra et al., 2001). The very long telomeres 
created by each telomerase extension event will become critically short only after many 
cell divisions. This means that recruitment of telomerase to the telomeres will only be 
required very infrequently as telomeres lengthen overall and thus the defect in 
telomerase recruitment will not pose a significant barrier to population growth. This 
may explain the improvement in growth and corresponding lengthening of cdc13∆ 
exo1∆ pif1∆ mutants over time (Figures 43-45). Interestingly, as Rad52 is required for 
the viability of cdc13∆ exo1∆ pif1∆ mutants, it suggests that homologous recombination 
can be used to distribute telomeric repeats from longer telomeres to shorter telomeres to 
aid in telomere maintenance. 
Although it is appealing to consider a model in which Ku alone recruits telomerase to 
the telomeres of cdc13∆ exo1∆ pif1∆ mutants and thus is essential for survival, Ku 
might also be essential for the survival of cdc13∆ exo1∆ pif1∆ mutants to inhibit 
nuclease activity at telomeres, as reported in CDC13+ mutants (Maringele and Lydall, 
2002, Teo and Jackson, 2001). However, yku70∆ exo1∆ pif1∆ (Figure 19) mutants with 
uncapped telomeres do not appear to show a growth defect, suggesting that there is no 
Pif1- and Exo1-independent nuclease activity at uncapped telomeres lacking Ku,making 
it unlikely that the essential role of Ku in cdc13∆ exo1∆ pif1∆ mutants is to inhibit a 
nuclease activity. However, at DSBs, independently-functioning nuclease activities 
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dependent upon Sgs1 and Exo1 are inhibited by Ku (Mimitou and Symington, 2010). 
Furthermore, at least some situations exist in which Sgs1 functions independently of 
Exo1 to resect uncapped telomeres lacking Cdc13 (i.e. in cdc13-1 rad9∆ mutants) (Ngo 
and Lydall, 2010). Thus it is possible, though unlikely, that the essential role of Ku in 
cdc13∆ exo1∆ pif1∆ mutants is to inhibit Sgs1 or some other nuclease activity at the 
telomeres. 
One question remains about cdc13∆ exo1∆ pif1∆ mutants – why is telomerase so 
important? The above model (Figure 47) proposes that in cdc13∆ exo1∆ pif1∆ mutants, 
telomerase is necessary to counteract shortened telomeres. However telomere 
shortening alone should not trigger such a pronounced lethality as seen in cdc13∆ 
exo1∆ pif1∆ mutants (Figure 39). This is highlighted by cultures of yeast lacking 
telomerase, which are usually viable for several generations before the growth of the 
culture goes through a gradual decline in growth (senescence) due to telomere 
shortening (Lundblad and Blackburn, 1993, Teng and Zakian, 1999). Instead, it is likely 
that cdc13∆ exo1∆ pif1∆ mutants have such a pronounced requirement for telomerase 
because they lack Pif1. Consistent with this, the telomere lengthening over passage in 
cdc13∆ exo1∆ pif1∆ mutants resembles an exaggeration of the telomere lengthening 
over passage seen in CDC13+ pif1∆ and CDC13+ exo1∆ pif1∆ mutants (Figure 30, 
Figure 44). Indeed, telomerase-deficient cells lacking Pif1 undergo rapid senescence, 
suggestive of a severe defect in telomerase-independent telomere maintenance (Figure 
28). Furthermore, it has been hypothesized that increased utilization of telomerase at the 
telomeres of pif1∆ mutants is a consequence of a severe defect in telomere maintenance 
that requires telomerase to heal unresolvable DNA substrates (Chang et al., 2009). 
Thus, it will be important to determine which DNA substrates Pif1 processes at DNA 
ends. In addition, it will be interesting to try and identify other genes that inhibit the 
growth of cdc13-1 mutants in the same pathway as PIF1, but are less important for 
telomerase-independent telomere maintenance, to see if it is possible to eliminate the 
requirement for telomerase for survival in the absence of Cdc13.  
Finally, it is important to consider the implications that the viability of cdc13∆ exo1∆ 
pif1∆ mutants have for human cancers. cdc13∆ exo1∆ pif1∆ mutants utilize telomerase 
for survival, but the levels of telomerase at the telomeres must be incredibly low due to 
the absence of Cdc13 (Figure 47). Similarly, in human somatic cells, telomerase 
recruitment to telomeres must also be extraordinarily low (due to low total cellular 
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levels of telomerase) (Kim et al., 1994). cdc13∆ exo1∆ pif1∆ mutants are able to survive 
without overexpression of telomerase because attenuation of the DDR (elimination of 
Pif1 and Exo1) has facilitated loss of a key negative regulators of telomerase (Cdc13) 
thus permitting low levels of telomeric telomerase to maintain telomeres. Perhaps a 
similar situation exists in a subset of the approximately 15% of human cancers that 
maintain telomeres without up-regulation of telomerase components (Bryan et al., 1997) 
that has been thought to occur by ALT mechanisms (Cesare and Reddel, 2010). Thus it 
is possible that in human cancers, elimination of DDR components also permits the loss 
of negative regulators of telomerase and allows for telomerase-dependent telomere 
maintenance without up-regulation of telomerase. It will be interesting to see whether 
Pif1 and Exo1 are both components of the telomeric DDR in mammalian cells.  
6.4 Further Work 
Here it has been shown that elimination of Pif1 and Exo1 permits the viability of cells 
in the absence of Cdc13 and the viability of these cells depends upon telomerase, Ku 
and homologous recombination. Four main lines of enquiry stem from this work. 
First, a model has been proposed for how telomerase is recruited to telomeres in the 
absence of Cdc13 (Figure 47), however this remains to be formally proven. This could 
be performed genetically by mutagenesis of TLC1, the telomerase template RNA, in 
cdc13∆ pif1∆ exo1∆ mutants to introduce a restriction site and passaging cells to look 
for incorporation of the restriction site into the telomeres over time (Singer and 
Gottschling, 1994). Alternatively, ChIP could be performed to show that telomerase is 
still recruited to telomeres in cdc13∆ pif1∆ exo1∆ mutants.  
Second, cdc13∆ exo1∆ pif1∆ mutants are viable but grow poorly at early passage and it 
will be important to test why (Figures 38, 43). It is proposed (Figure 47) that the poor 
growth of cdc13∆ pif1∆ exo1∆ mutants at early passage (Figures 38, 43) is due to an 
impaired ability to deal with short telomeres. This could be tested by introducing an 
inducible short telomere cassette into cdc13∆ exo1∆ pif1∆ mutants to follow growth 
after the induction of a single short telomere (Bianchi et al., 2004). Alternatively, it is 
possible that low levels of Sgs1-dependent resection occur at early passage in cdc13∆ 
exo1∆ pif1∆ mutants (though unlikely, as very limited ssDNA occurs, Figure 46) and it 
would be useful to test this (Ngo and Lydall, 2010) Additionally, the checkpoint kinase 
Tel1 is required for responding to short telomeres while Mec1 is involved in the 
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response to DSBs and uncapped telomeres (Bianchi and Shore, 2008). Therefore, it 
would be interesting to know whether either Mec1 or Tel1 restrains the growth of 
cdc13∆ exo1∆ pif1∆ mutants at early passage to determine whether the telomeres of 
cdc13∆ exo1∆ pif1∆ mutants are recognized as DSBs or short telomeres. Furthermore, it 
would be interesting to see whether the elimination of Mec1 or Tel1 affects the long-
term viability of cdc13∆ exo1∆ pif1∆ mutants. 
Third, an important role of the telomere cap is believed to be to promote genome 
stability (Longhese, 2008). cdc13∆ exo1∆ pif1∆ mutants provide a valuable tool to 
study the role of Cdc13 in genome stability. In particular, it will be interesting to 
examine the number of gross chromosomal rearrangements and telomere-telomere 
fusion events in these cells, using established methods (Chen and Kolodner, 1999, 
Pobiega and Marcand, 2010). Additionally, though Cdc13 is also non-essential in rad9∆ 
exo1∆ sgs1∆ mutants, the rad9∆ mutation also eliminates the Mec1-dependent 
checkpoint (Ngo and Lydall, 2010). As cdc13∆ exo1∆ pif1∆ mutants do not require the 
elimination of any checkpoint components for viability, they provide a model system 
for studying the interplay between checkpoint components and telomere capping 
proteins in the maintenance of genome stability. 
Fourth and finally, orthologues of Cdc13-Stn1-Ten1 (the CST complex) have recently 
been discovered in mammalian and plant cells (Miyake et al., 2009, Surovtseva et al., 
2009). These orthologous complexes appear to have roles at sites of replicational 
difficulty, including telomeres. It may prove informative to study the roles of Pif1 and 
Exo1 orthologues following knock-down of the Cdc13 orthologue in the cells of higher 
organisms. 
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7 Conclusions 
“Nothing in biology makes sense except in the light of evolution” 
- Theodosius Dobzhansky 
7.1 The yeast CST complex has telomere-specific roles, but the mammalian CST 
complex does not 
Cdc13 is the founding member of the CST (Cdc13-Stn1-Ten1) complex in budding 
yeast (Gao et al., 2007). In S. cerevisiae inactivation of Cdc13 leads to the accumulation 
of ssDNA specifically at telomeres (Garvik et al., 1995). In mammalian, plant and 
human cells, knocking down the CST components also leads to increased telomeric 
ssDNA (Miyake et al., 2009, Surovtseva et al., 2009). However, in contrast to yeast 
CST (yCST), mammalian CST (mCST) binds to DNA in a sequence-independent 
manner and only partially localizes to telomeres, suggesting that CST functions in some 
aspect of DNA metabolism frequently required at telomeres but also utilized elsewhere 
(Miyake et al., 2009). Yet, a more generalized function for the yCST complex is at odds 
with its highly specific telomeric role in yeast. The best illustration of the specific 
telomeric role of the CST complex in budding yeast is the requirement for Cdc13 to 
recruit telomerase to telomeres (Nugent et al., 1996). Thus, any model for the conserved 
roles of the CST complex must account for a highly specialized telomeric role in yCST 
and a more generalized role in mCST. 
Cdc13 has been assumed to function as a telomere ‘capping’ protein, protecting the 
telomere from recognition as a DSB by the cell’s DNA damage response (Lydall, 2009). 
However, Pif1 and Exo1 function in parallel pathways to coordinate the DDR at 
uncapped telomeres, but not at DSBs, calling this into question (Figures 14-18) (Zhu et 
al., 2008). Indeed, following inactivation of Cdc13, the nuclease components Sgs1 and 
Exo1, which function in different pathways in DSBR seem to function in a single 
pathway at uncapped telomeres, while Pif1 functions in a parallel pathway (Figure 20) 
(Ngo and Lydall, 2010, Mimitou and Symington, 2008). Elimination of Pif1 and Exo1 
displays remarkable synergy in eliminating the DDR at uncapped telomeres (Figure 5). 
However, the finding that Pif1 and Exo1 have opposite effects following camptothecin 
treatment (one of the few forms of DNA damage that Exo1 alone is absolutely crucial 
for the response to) suggests that Pif1 and Exo1 have remarkably different responses in 
most DDRs (Figure 32) (Morin et al., 2008). In fact, there is not a single published 
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example of Pif1 and Exo1 functioning in the same process except, as described here, at 
uncapped telomeres. Even at uncapped telomeres Pif1 and Exo1 appear to recognize 
different substrates – Pif1 is more important for resection away from the end of the 
chromosome, while the importance of Exo1 in resection increases closer to the 
chromosome end (Figure 16, Figure 18). Thus, any model for yCST function must 
explain how the nuclease activities that resect uncapped telomeres have such different 
properties at other sites in the genome. 
To resolve these issues, it is proposed that yCST fulfills two roles – a telomere-
nonspecific role, analogous to that of mCST, in dealing with a specific kind of DNA 
substrate and a telomere-specific role, including ‘end protection’ and telomerase 
recruitment, perhaps analogous to that of POT1 in mammalian cells. mCST is predicted 
to be structurally similar to RPA (Gao et al., 2007) and telomeric repeat sequences 
(either at the telomeres or when placed elsewhere in the genome) are sites of 
replicational difficulty (Sfeir et al., 2009). Thus, the proposed model of mCST 
functioning in a specialized aspect of DNA replication is favored for the telomere-
nonspecific role of yCST (Miyake et al., 2009). The Pif1 helicase enhances the toxicity 
of replicative lesions caused by camptothecin (Figure 32) or hydroxyurea (Chang et al., 
2009), has roles in Okazaki fragment processing (Pike et al., 2009) and must recognize 
5’ ssDNA occurring at uncapped telomeres away from the chromosome end (Figure 16, 
Figure 18). Thus, a role for Pif1 in responding to some form of replicative lesion caused 
by inactivation of yCST is favorable. These observations lead to the proposition Pif1 
functions to initiate the DDR at replicative lesions that occur following inactivation of 
the telomere-nonspecific role of yCST, while Exo1 functions to initiate the DDR that 
occurs following inactivation of the telomere-specific role of yCST. 
7.2 In the light of evolution 
The S. cerevisiae genome is relatively free of simple repetitive sequences and in general 
possesses less non-coding DNA than higher organisms (Lander et al., 2001, Cherry et 
al., 1997). Thus, it is possible that telomeric DNA in budding yeast could be the only 
site that poses a specific replicational difficulty of the sort that the mCST complex 
might be required to deal with. This would mean that in an ancestor of S. cerevisiae, an 
evolutionary ancestor of the current yCST or ‘pre-CST’ would naturally be deposited at 
telomeres due to its role in DNA replication. It is not unreasonable to assume that such a 
pre-CST might be co-opted to also fulfill telomere-specific roles, while in mammalian 
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cells multiple sites of replicational difficulty might have necessitated the telomere-
specific roles of yCST to be taken up by a separate protein, such as POT1 (Wu et al., 
2006). 
A caveat with such a model is that the budding yeast genome certainly does have at 
least one other site of repetitive sequence in the yeast genome – the ribosomal DNA 
(rDNA) (Cherry et al., 1997). Curiously, Rrm3, the budding yeast paralogue of Pif1, is 
required for proper replication fork progression through rDNA (Torres et al., 2004). 
Furthermore, Pif1 is important for the stability of G-rich repetitive sequences in 
budding yeast and although this has been attributed to the ability of Pif1 to unwind G 
quadruplexes in vitro it could be due to a more generalized role of Pif1 at sites of 
replicational difficulty (Ribeyre et al., 2009). Additionally, overexpression of Pif1 
renders cells hypersensitive to hydroxyurea and MMS, suggesting that it causes 
replication fork disassembly (Chang et al., 2009). Consistent with such a model, Pif1 
appears to generate ssDNA away from the end of the chromosome, perhaps recognizing 
and disassembling stalled replication forks (Figure 16, Figure 18). It will be important 
to investigate the role of mammalian Pif1 in response to dysfunction of the mCST 
orthologues.  
Here, the telomeric role of the yCST is assumed to be the same as the current working 
model for yCST in ‘end protection’ – to prevent recognition of the telomeric DNA as a 
DSB (de Lange, 2009, Lydall, 2009). The notion of Exo1 ‘chewing away at DNA ends’ 
is consistent with the increasing importance of Exo1 in resection of uncapped telomeres 
closer to the chromosome end (Figure 16, Figure 18). The lack of a requirement for 
MRX in this process is presumably that telomeres are unique, in that they already 
possess ssDNA that can be readily extended by a rampant nuclease activity (Foster et 
al., 2006). At uncapped telomeres in yku70∆ mutants, Exo1 is almost entirely 
responsible for resection, but Pif1 clearly plays a role in inhibiting the growth of 
yku70∆ mutants at higher temperatures. This raises the possibility that although the 
primary defect caused by inactivation of Ku at the telomeres is one of resection by 
Exo1, a replication defect might also occur (Figure 19) (Maringele and Lydall, 2002). It 
is tempting to consider that telomere ‘capping’ may be a universal phenomenon, 
consisting of a combination of the ‘end protection’ and ‘end replication’ problems. 
Indeed, the Ku complex functions as a ‘last resort’ at stalled replication forks in higher 
organisms (Adamo et al., 2010).  
256 
It is tempting to speculate on exactly which aspect of DNA replication telomeres are 
defective in (Sfeir et al., 2009) and thus what process mCST and Pif1 might be involved 
in. Given the unidirectionality of DNA replication at telomeres, the resolution of 
replisomes at telomeres must require some specialized mechanism compared to sites of 
bidirectional replication within the genome. Though telomeric repeats cause 
replicational difficulty when placed within the genome, it is noteworthy that telomeric 
repeat sequences are de facto regions of DNA sequence that lack origins of replication. 
If the converging replisomes were not sufficiently stable to synthesize across the entire 
sequence, such regions would also require unidirection replisome resolution, much like 
the terminal replisome. Perhaps the CST complex plays a role in the resolution of the 
terminal replisome and perhaps Pif1 is a helicase that has roles in replisome resolution. 
Intriguingly, the Pif1 paralogue Rrm3 has recently been show to have roles in replisome 
resolution (Fachinetti et al., 2010). 
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ABSTRACT
In Saccharomyces cerevisiae, Cdc13 binds telomeric DNA to recruit telomerase and to ‘‘cap’’ chromosome
ends. In temperature-sensitive cdc13-1 mutants telomeric DNA is degraded and cell-cycle progression is
inhibited. To identify novel proteins and pathways that cap telomeres, or that respond to uncapped
telomeres, we combined cdc13-1 with the yeast gene deletion collection and used high-throughput spot-test
assays to measure growth. We identified 369 gene deletions, in eight different phenotypic classes, that
reproducibly demonstrated subtle genetic interactions with the cdc13-1mutation. As expected, we identified
DNA damage checkpoint, nonsense-mediated decay and telomerase components in our screen. However, we
also identified genes affecting casein kinase II activity, cell polarity, mRNA degradation, mitochondrial
function, phosphate transport, iron transport, protein degradation, and other functions. We also identified
a number of genes of previously unknown function that we term RTC, for restriction of telomere capping, or
MTC, for maintenance of telomere capping. It seems likely that many of the newly identified pathways/
processes that affect growth of budding yeast cdc13-1 mutants will play evolutionarily conserved roles at
telomeres. The high-throughput spot-testing approach that we describe is generally applicable and could aid
in understanding other aspects of eukaryotic cell biology.
LINEAR chromosomes are a feature of all eukaryotes.The single-celled model eukaryote Saccharomyces
cerevisiae, for example, has 16 linear chromosomes with
ends that are, in principle, no different from double-
stranded breaks elsewhere in the genome. However,
whereas S. cerevisiae cells can tolerate 32 or more chro-
mosome ends throughout its cell cycle, a single double-
stranded DNA break (DSB) elsewhere in the genome
elicits a swift and precise response (Sandell and Zakian
1993). This response includes checkpoint activation,
which leads to cell-cycle arrest prior to repair of the
break. The difference between DSBs and chromsosome
ends, then, comes down to specific nucleoprotein com-
plexes that occupy the ends of chromosomes to form a
structure referred to as a telomere (Longhese 2008).
A further issue at the ends of chromosomes is the
inability of semi-conservative DNA replication toreach the
very ends of linear double-stranded DNA molecules—the
‘‘end replication problem’’ (Olovnikov 1973). Telomer-
ase (Greider and Blackburn 1985), a telomere-specific
reverse-transcriptase complex, solves this problem by
adding G-rich repeat sequences to the 39-end of chromo-
somes, using a bound RNA molecule as a template. As a
result, eukaryotic chromosomes have long stretches of
TG repeats at their ends. These sequences serve as a
binding platform for proteins involved in end pro-
tection and telomerase recruitment.
The length of telomere repeat sequences in growing
and dividing cells depends on a balance between short-
ening, due to the end replication problem, and length-
ening, due to the actions of telomerase. Should the
length of telomere repeat sequences fall below a critical
level, budding yeast and mammalian cells stop dividing
in a checkpoint-dependent process referred to as senes-
cence (Reaper et al. 2004). In rare instances, cells can
evade this fate by employing telomerase-independent,
recombination-based pathways for maintaining a func-
tional number of TG repeats at the ends of chromo-
somes. In cells that lack telomerase—as is the case for
the majority of human somatic cells—telomere length
reduces with each cellular division until senescence is
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induced at a critical length. This is considered to serve as
a mechanism for determining a finite cellular life span,
and thus the link between telomeres, cancer, and aging
has been of wide interest (Blasco 2007; Cheung and
Deng 2008). A fuller understanding of telomere ho-
meostasis is therefore an important goal, critical for
understanding cellular senescence and the mechanisms
by which the response to DNA damage is appropriately
regulated and/or limited in eukaryotic cells. S. cerevisiae
provides an excellent model in which to carry out such
studies.
In S. cerevisiae, Cdc13 is a single-stranded DNA
(ssDNA)-binding protein that binds to short ssDNA
overhangs at telomeres and plays at least two important
roles at telomeres: (1) recruitment of telomerase (Nugent
et al. 1996) and (2) telomere capping (Garvik et al. 1995).
The cdc13-1point mutation confers temperature sensitivity
such that Cdc13-1 is proficient in telomere capping at the
permissive temperature (23) but deficient at the non-
permissive temperature (.26). Thus, in cdc13-1 mutant
cells grown at $26, telomeres become ‘‘uncapped’’ and
recognized as sites of DNA damage, eliciting a checkpoint
response (Garvik et al. 1995). Once uncapped, the
telomeres are vulnerable to 59–39 exonuclease activity,
which can generate extensive regions of ssDNA, thus
amplifying the DNA damage signal.
Applying a temperature shift to S. cerevisiae cells
harboring the cdc13-1 mutation is a simple method by
which telomere capping can be compromised and the
response to DNA damage at chromosome ends can be
induced and studied. For this reason cdc13-1 has proven
to be an informative tool for identifying genes whose
products function at uncapped telomeres and in the
DNA damage response. For example, cdc13-1 was the
primary tool used to show that Mec1, Mec3, Rad53
(Mec2), Rad17, and Rad24 are involved in DNA damage
checkpoint control (Weinert et al. 1994). Similarly,
deletion of the EXO1 gene, which encodes a 59–39 exo-
nuclease, allows cdc13-1 mutant cells to grow and divide
at 27, thus efficiently suppressing the temperature-
sensitive telomere-capping defect (Maringele and
Lydall 2002; Zubko et al. 2004). This led to the dis-
covery that Exo1 resects the ends of unprotected telo-
meres in at least two different situations (cdc13-1 mutants
and yku70D cells), resulting in long stretches of ssDNA,
which, in turn, act as a potent DNA damage signal
(Maringele and Lydall 2002; Zubko et al. 2004).
Importantly, the role of EXO1 and checkpoint genes in
responding to uncapped telomeres appears to be con-
served in mammals because it has been shown that
deletion of exonuclease-1 or the CDK inhibitor p21
leads to an extension of life span in a mouse telomerase
knockout model (Choudhury et al. 2007; Schaetzlein
et al. 2007). Therefore the identification of new genetic
interactions similar to those between RAD9 or EXO1 and
cdc13-1 in yeast has the potential to identify novel
conserved molecular pathways involved in the response
to telomere uncapping, for example (Maringele and
Lydall 2002; Zubko et al. 2004).
Here we describe a genomewide screen for gene
deletion mutations that demonstrate synthetic genetic,
suppressor, or enhancer interactions with the cdc13-1
mutation. Previously, we described the identification
and characterization of a novel, evolutionarily conser-
ved, telomere regulator complex (Downey et al. 2006).
The results of the complete screen reveals that multiple
cellular processes influence telomere capping and/or
the response to telomere uncapping.
MATERIALS AND METHODS
Genomewide screens: During the progression of this study,
approaches to performing genomewide genetic screens evolved
considerably; for example, yeast growth tests progressed from
manual to robotic spotting and from scoring by eye to scoring
by photography and automated image analysis. The evolution
of the screening process is described in supplemental material
and supplemental Table S1.
Strains: Strains used in this study are described in supple-
mental Table S2.
Synthetic genetic array: The synthetic genetic array (SGA)
technique (Tong et al. 2001; Tong and Boone 2006) was used
to combine a genomewide collection of gene deletions with
the recessive cdc13-1 temperature-sensitive mutation, flanked
by the selectable LEU2 and URA3 markers (Tong et al. 2001;
Downey et al. 2006; Tong and Boone 2006). This technique
was first performed on a Virtek Versarray Robot (BioRad) in
768-spot format, using a 768- 3 1-mm pin tool and, subse-
quently, in 1536-spot format on a Biomatrix BM3-09 robot
(S&P Robotics, Toronto) using a 384- 3 1-mm pin tool
(supplemental Table S1).
Temperature oscillation: The UP–DOWN assay was per-
formed in a programmable Sanyo 153 incubator. Plates were
incubated at 20 for 5 hr followed by 36 for 5 hr, and this cycle
was repeated a total of three times. Incubation was then con-
tinued at 20 for the remainder of the experiment and plates
were photographed as described above.
Gene ontology analysis: Version 2.4.0 of GOStats (Falcon
and Gentleman 2007) was used with the cutoff set to P ¼
0.00001 (empirically determined as returning no overrepre-
sented terms from random lists of genes) and the test-type set
as conditional. Genes identified in this study were compared
to a list of 4292 screened genes, not including slow growers,
strains that consistently perform poorly in SGA analysis (Tong
et al. 2001), or genes encoding markers used in strain con-
struction (e.g., CAN1). Gene ontology (GO) term annotations
were current as of December 18, 2007.
Gene list analysis: For systematic analysis of ontology
annotations and convenient access to gene functional infor-
mation, OSPREY (Breitkreutz et al. 2003) was used to access
the Biogrid database (Stark et al. 2006; Breitkreutz et al.
2008).
Hierarchical clustering: Data from multiple high-through-
put studies were collated and converted to a simplified scoring
system as described in the supplemental Methods. These were
then analyzed alongside our own data by hierarchical cluster-
ing using Cluster 3.0 for Mac OS X (Michiel de Hoon, Seiya
Imoto, and Satoru Miyano, Human Genome Center, Univer-
sity of Tokyo). Genes were clustered by centroid linkage using
the ‘‘absolute correlation (uncentered)’’ similarity metric
(Eisen et al. 1998) based on properties defined in 10 cate-
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gories: suppressors, enhancers, UP–DOWN assay, telomere
length (Askree et al. 2004; Gatbonton et al. 2006; Shachar
et al. 2008), nonsense-mediated decay upregulation (He et al.
2003), regulation in response to MMS ( Jelinsky and Samson
1999), sensitivity to MMS (Chang et al. 2002), sensitivity to
UV (Birrell et al. 2001), sensitivity to ionizing radiation
(Bennett et al. 2001), and requirement for replication of
Brome mosaic virus (Kushner et al. 2003); see supplemental
Methods. Clustering was displayed using Treeview (Saldanha
2004).
RESULTS
A screen for gene deletions that suppress or enhance
cdc13-1 temperature sensitivity was undertaken using the
SGA technique (Tonget al. 2001; Tongand Boone 2006)
as described in materials and methods and supple-
mental Methods. High-throughput yeast spot tests
(materials and methods; supplemental Methods; Fig-
ure 1) were used to identify gene deletions, which
allowed growth of strains carrying the cdc13-1 mutation
at the otherwise nonpermissive temperature of 27. Five
of these (identified during initial screens 1 and 2; sup-
plemental Table S1) were described previously (Downey
et al. 2006). At the end of a comprehensive screening
process during which a minimum of 4 and a maximum of
15 biological replicates for each viable gene deletion had
been tested (supplemental Table S1), a high confidence
list of 238 gene deletion suppressors of cdc13-1 temper-
ature sensitivity was obtained (Table 1). Of these 238, 37
strains that grew at the higher nonpermissive tempera-
ture of 28 (screens 3 and 4, supplemental Table S1)
were classed as strong suppressors (Table 1). A number
of gene deletions that have previously been described as
cdc13-1 suppressors were identified in our screen (Table
2). These included deletions of RAD9, RAD17, RAD24,
EXO1, andCHK1 among the group of strong suppressors
(Table 1), consistent with previous studies (e.g., Maringele
and Lydall 2002; Zubko et al. 2004).
Our approach also allowed us to identify gene dele-
tions that were lethal or sick in combination with cdc13-1
because double mutants were either missing or poor
growers after SGA (materials and methods; supple-
mental Methods; supplemental Figure S2). Twenty
genes demonstrated synthetic lethal and 32 showed
synthetic-sick interactions with cdc13-1 at 20 (Table 3).
In the discussion, we speculate on the roles of these
cdc13-1 suppressor and enhancer genes in telomere
biology.
Conservation of suppression in an alternative
genetic background: It is possible that second-site mu-
tations in gene deletion strains were responsible for
suppression of the cdc13-1 temperature-sensitive phe-
notype. Therefore, to confirm that the relevant gene
deletions suppressed cdc13-1, 10 suppressor genes were
deleted by transformation in the different W303 cdc13-1
genetic background and tested for growth at 26, 26.5,
and/or 27. In all 10 cases, growth was observed at a
higher temperature than the control cdc13-1 strains
(Table 2). In addition, as a result of identification of
OCA1, OCA2, SIW14 (OCA3), OCA4, and OCA6 as sup-
pressors of cdc13-1, we also tested deletion of the OCA5
gene in the W303 genetic background and found it to
suppress (Table 2); OCA5 was dropped from the list of
suppressors in this study at the screen 5 stage (see
supplemental Methods). Since 10/10 gene deletions
that we identified through high-throughput screening
also suppress cdc13-1 in the W303 genetic background,
we conclude that the majority of the cdc13-1 suppressors
that we have identified are likely to be true suppressors.
The UP–DOWN screen: Given the large number of
cdc13-1 suppressors, we wanted to differentiate between
different types of cdc13-1 suppressors. Therefore, we
Figure 1.—High-throughput robotic yeast
growth assay in 384-spot format. A total of 384
yeast strains were spotted onto four solid agar
plates, each of which was incubated under differ-
ent conditions, indicated in the top left corner of
each panel (20, 27, 36, and the UP–DOWN as-
say). Circles are drawn around examples of UDS
(9, rad9D; 17, rad17D) and UDR (E, exo1D; S,
srn2D) strains, all four of which are also cdc13-1
suppressors.
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also screened for gene deletions that, when combined
with the cdc13-1 mutation, significantly enhanced or re-
duced cell viability in a temperature oscillation (or ‘‘UP–
DOWN’’) experiment (materials and methods). The
cdc13-1 mutation has a reversible temperature-sensitive
phenotype; that is, cells with the cdc13-1 mutation main-
tain high viability and efficiently form colonies when re-
turned to permissive temperature after short periods at
nonpermissive temperature. DNA damage checkpoint
pathways, which inhibit cell division in response to un-
capped telomeres in cdc13-1 mutants, are important for
maintaining cdc13-1 cell viability (Weinert et al. 1994;
Zubko et al. 2004). In addition, nucleases and nuclease
inhibitors, which affect single-stranded DNA produc-
TABLE 1
Genes whose deletion rescues temperature sensitivity of cdc13-1
Strong suppressors Suppressors
ORF Gene ORF Gene ORF Gene ORF Gene ORF Gene ORF Gene
YOL138C RTC1a YBR147W RTC2 YKL087C CYT2 YKL008C LAC1 YAL023C PMT2 YNL224C SQS1
YER177W BMH1 YHR087W RTC3 YGL078C DBP3 YJL134W LCB3 YPL144W POC4 YLR119W SRN2
[YFL023W BUD27] YNL254C RTC4 YFL001W DEG1 YNL323W LEM3 YIL160C POT1 YHR066W SSF1
YBR274W CHK1 YOR118W RTC5 YKR035W-A DID2 YLR451W LEU3 YBL068W PRS4 YBR283C SSH1
[YJR109C CPA2] YPL183W-A RTC6 YGR227W DIE2 YDL051W LHP1 [YDL006W PTC1] YLR150W STM1
YIL036W CST6 YDL119C YDL119C YKL213C DOA1 YJR070C LIA1 YDR496C PUF6 YDR320C SWA2
YPL194W DDC1 YGR201C YGR201C YDR206W EBS1 YNL307C MCK1 YPR191W QCR2 YNL081C SWS2
[YNL080C EOS1] YIL055C YIL055C YBL047C EDE1 YPL098C MGR2 YKR055W RHO4 YLR354C TAL1
YOR033C EXO1 YIL057C YIL057C YKL048C ELM1 YLR035C MLH2 YNL180C RHO5 YIL011W TIR3
YCR034W FEN1 YIL161W YIL161W YDR512C EMI1 YIL110W MNI1 YIL053W RHR2 YPR074C TKL1
YMR058W FET3 YLR404W YLR404W YMR015C ERG5 YPR045C MNI2 YLR453C RIF2 YER007C-A TMA20
[YLR192C HCR1] YIL079C AIR1 [YML008C ERG6] YIR002C MPH1 YIL066C RNR3 YJR014W TMA22
YOL095C HMI1 YER073W ALD5 YER145C FTR1 YKL062W MSN4 YDL082W RPL13A YGR260W TNA1
YMR080C NAM7 YPL061W ALD6 YPL262W FUM1 YPR134W MSS18 [YKL006W RPL14A] YNL070W TOM7
YHR077C NMD2 YGL148W ARO2 YBL016W FUS3 YBR057C MUM2 YBR084C-A RPL19A YNL121C TOM70
YOR209C NPT1 YDR101C ARX1 YIL097W FYV10 YHR004C NEM1 YPL079W RPL21B YIL138C TPM2
YPL052W OAZ1 [YMR116C ASC1] YOR183W FYV12 YLR363C NMD4 YFR031C-A RPL2A YPL030W TRM44
YDL232W OST4 YKL185W ASH1 YMR307W GAS1 YER002W NOP16 YLR406C RPL31B YLR425W TUS1
YOR368W RAD17 YBL089W AVT5 YJR040W GEF1 YNL183C NPR1 YOR234C RPL33B YER151C UBP3
YER173W RAD24 YIL124W AYR1 YGL020C GET1 YNL099C OCA1 YER056C-A RPL34A YFR010W UBP6
YDR217C RAD9 YKR099W BAS1 YHL031C GOS1 YNL056W OCA2 YDL191W RPL35A YMR067C UBX4
YLR039C RIC1 YPL115C BEM3 YOL059W GPD2 YCR095C OCA4 [YLR185W RPL37A] YBR273C UBX7
YCR028C-A RIM1 YDR099W BMH2 YDL035C GPR1 YDR067C OCA6 YDR500C RPL37B YDL190C UFD2
YNL069C RPL16B YIL159W BNR1 YML121W GTR1 YML060W OGG1 [YPR043W RPL43A] YNL229C URE2
YDR389W SAC7 YFL025C BST1 YGL084C GUP1 YGR202C PCT1 YBR031W RPL4A YKR042W UTH1
YDR143C SAN1 YAR014C BUD14 YGL237C HAP2 [YER178W PDA1] YLR448W RPL6B YDL077C VAM6
YER120W SCS2 [YGR262C BUD32b] YBL021C HAP3 YER153C PET122 YGL147C RPL9A YGL212W VAM7
[YOR035C SHE4] YIL034C CAP2 YOR358W HAP5 YOR017W PET127 YER139C RTR1 YIL135C VHS2
YDL033C SLM3 YGR174C CBP4 YCR065W HCM1 YLR191W PEX13 YLR180W SAM1 YIL017C VID28
YOR327C SNC2 YKL208W CBT1 YHL002W HSE1 YOL044W PEX15 YDR181C SAS4 YKR001C VPS1
YLR313C SPH1 YML036W CGI121c YGL253W HXK2 YAL055W PEX22 YKL051W SFK1 YPL120W VPS30
YLR372W SUR4 YIL035C CKA1 [YJR118C ILM1] YDR329C PEX3 YNL032W SIW14 YJL154C VPS35
YBR126C TPS1 YOR061W CKA2 YDR315C IPK1 YGR133W PEX4 YLR398C SKI2 YKR020W VPS51
YBR082C UBC4 YOR039W CKB2 YFR055W IRC7 YGR231C PHB2 YPR189W SKI3 YDR486C VPS60
YGR072W UPF3 YOL008W COQ10 YGL016W KAP122 YJL117W PHO86 YOR076C SKI7 YIL101C XBP1
YOR089C VPS21 YPL172C COX10 YHR158C KEL1 YCR037C PHO87 YGL213C SKI8 YIL023C YKE4
YAL002W VPS8 YLL009C COX17 YNL238W KEX2 YGL023C PIB2 YNL311C SKP2 YBR104W YMC2
YHR116W COX23 YJL094C KHA1 [YML061C PIF1b] YBL007C SLA1 YDR349C YPS7
[YMR256C COX7] YAR018C KIN3 YDR466W PKH3 YGR229C SMI1 [YLR262C YPT6]
YDL117W CYK3 YNL322C KRE1 YDL095W PMT1 YER161C SPT2 YML001W YPT7
YOR065W CYT1
Underlined genes lie adjacent to other genes whose deletion rescues cdc13-1. In such cases, an effect on transcription of the
neighboring gene cannot be discounted. Brackets indicate genes previously identified as synthetic with wild-type during SGA
(Tong et al. 2001).
a The RTC gene name is reserved for previously unnamed ORFs.
b Deletion of PIF1 and BUD32 rescues cdc13-1 (Downey et al. 2006) but these genes were not tested further in robotic assays due
to slow growth.
c Deletion of CGI121 rescues cdc13-1 (Downey et al. 2006) but this was not detected in robotic assays subsequent to initial scoring.
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tion at uncapped telomeres of cdc13-1 mutants, affect
the ability of cdc13-1 to grow for periods at nonpermis-
sive temperature.
In an UP–DOWN assay, cdc13-1 mutants are cycled
between permissive and nonpermissive conditions and
then allowed to form colonies at permissive temperature.
In an UP–DOWN assay, rad9D cdc13-1 strains do not form
colonies efficiently because they do not arrest cell division
in response to telomere uncapping and accumulate very
high levels of single-stranded DNA. Conversely, exo1D
cdc13-1 cells grow demonstrably faster than EXO1 RAD1
cdc13-1 strains in this assay (Zubko et al. 2004; Figure 1),
presumably because high levels of Exo1-dependent
ssDNA at telomeres of cdc13-1 cells inhibit cell division
for long periods even after cells are returned to permis-
sive temperature. Therefore, we hypothesized that an
UP–DOWN screen would allow us to identify genes that
interact with cdc13-1 in a RAD9-like or EXO1-like manner.
The UP–DOWN assay was performed on between 2 and
10 biological replicates of cdc13-1 SGA strains. Those
gene deletions that, in conjunction with cdc13-1, showed
consistently poor growth (Figure 1) were scored as UP–
DOWN sensitive (UDS) while those that grew consis-
tently better than cdc13-1 his3TKANMX controls (Figure
1) were scored as UP–DOWN resistant (UDR) (Table 4).
A total of 96 UDS and five UDR genes were identified.
Interestingly, both classes included both genes that sup-
press cdc13-1 when deleted and genes that do not. The
15 UDS genes that are cdc13-1 suppressors includedRAD9,
RAD17,RAD24, andCHK1, which have well-characterized
roles in coordinating the DNA damage response to
uncapped telomeres, indicating that other novel genes
with this ‘‘RAD9-like’’ phenotype are likely to be of in-
terest. The 81 UDS genes that are not cdc13-1 suppres-
sors included YKU70, YKU80, EST1, EST2, and EST3.
These, too, have well-defined roles in telomere biology,
indicating that this class is also likely to contain novel
genes of interest. Deletion of YKU70, YKU80, and others
in this category has previously been reported to be syn-
thetically sick with cdc13-1 (Polotnianka et al. 1998).
However, since we germinated spores at 20, rather than
the 23 or 25 that is more usually used to grow cdc mu-
tants, we probably masked theYKU70/80 cdc13-1 synthetic-
sick interactions previously reported. Presumably, other
synthetic-sick interactions were also missed. There was
only one gene (YME1) that reproducibly fell into both
categories. Three of the five UDR genes were also cdc13-1
suppressors and hence EXO1-like; however, the only
gene in this category that has previously been connected
to telomere biology is EXO1 itself.
Thus, through a systematic and iterative process, we
arrived at a reliable classification of genes as one or
more of the following: cdc13-1 suppressor, UDS, RAD9-
like, UDR, EXO1-like, cdc13-1 synthetic lethal, and cdc13-1
synthetic sick (Tables 1, 3, and 4; Figure 2).
Neighboring genes that interact with cdc13-1: In our
lists of cdc13-1 interactors, we identified a number of pairs
or sets of genes that are adjacent to each other in the
genome. For example,YIL034C (CAP2),YIL035C (CKA1),
and YIL036W (CST5) are all classed as cdc13-1 suppres-
sors (Table 1). A likely explanation for such a group is
that one gene has a true genetic interaction with cdc13-1
and disruption of the neighboring gene(s) affects the
expression of the gene of interest. Indeed, a previous
study (Alvaro et al.2007) has demonstrated that deletion
of either overlapping or adjacent open reading frames
can occasionally result in false positives in genomewide
screens such as these. An inference can be made as to
whether a gene is a true interactor or is having an effect
TABLE 2
Comparison of expected cdc13-1 suppressors with actual
results and testing of novel suppressors in an
alternative genetic background
Gene
deletion
Suppressor
of cdc13-1
in BY4741
(this work)
Suppressor
of cdc13-1
in W303
(this work)
Previously
documented
suppressor
of cdc13-1
rad9D 11 NA 1
chk1D 11 NA 1
ddc1D 11 NA 1
rad24D 11 NA 1
rad17D 11 NA 1
upf3D 11 NA 1
nmd2D 11 NA 1
nam7D 11 NA 1
exo1D 11 NA 1
bub2D  NA 1
mec3D a NA 1
bmh1D 1 NA 1 (Downey et al.
2006)
san1D 11 NA 1 (Downey et al.
2006)
pif1D 1b NA 1 (Downey et al.
2006)
cgi121D 1c NA 1 (Downey et al.
2006)
ebs1D 1 NA 1 (Downey et al.
2006)
scs2D 11 1 
poc4D 1 1 
snc2D 11 1 
pkh3D 1 1 
pda1D 1 1 
oca1D 1 1 
oca2D 1 1 
siw14D (oca3D) 1 1 
oca4D 1 1 
oca6D 1 1 
oca5D  1 
11, yes, a strong suppressor; 1, yes; , no.
a Deletion of MEC3 rescues cdc13-1 but was not tested in ro-
botic assays due to slow growth.
b Deletion of PIF1 rescues cdc13-1 (Downey et al. 2006) but
was not tested further in robotic assays due to slow growth.
c Deletion ofCGI121 rescues cdc13-1 (Downey et al.2006) but
was not detected in robotic assays subsequent to initial scoring.
A Screen for CDC13 Interactors 2255
on transcription of neighboring genes. In the case of
CKA1 (above), for example, the identification of two
other subunits of casein kinase, CKA2 and CKB2, as
suppressors (neither of which lie adjacent to other
suppressors in the yeast genome) supports classification
ofCKA1 as a suppressor. Also, genes with previously well-
characterized roles in telomere/checkpoint biology
such as CHK1 (adjacent to UBX7) may safely be assumed
to be classified correctly. However, in most cases, inferring
a role is potentially misleading. We have therefore
highlighted (by underlining or boldface text in Tables
1, 3, 4, and 5; Figure 3) genes that, within a particular
classification, lie near each other on the chromosome
and have omitted them from statistical analyses of GO.
Gene ontology analysis of interactors: To better
understand the types of processes that interact with
uncapped telomeres, the different classes of cdc13-1-
interacting genes were subjected to statistical analysis
using the GOstats Bioconductor package (Falcon and
Gentleman 2007). GOstats analysis (supplemental Table
S3) allowed us to identify GO terms that were over-
represented. Genes previously identified as having roles
in telomere maintenance (GO:0000723) are overrepre-
sented in the results from both the cdc13-1 suppressor
screen (23 genes annotated as GO:0000723) and the UP–
DOWN assay (18 more genes annotated as GO:0000723);
3 genes annotated as both ‘‘telomerase activity’’ (GO:
0003720) and ‘‘telomerase holoenzyme complex’’ (GO:
0005697): EST1, EST2, and EST3 (supplemental Table
S3). The list of strong suppressors (Table 1) is enriched
for genes involved in DNA damage checkpoint con-
trol—namely DDC1, RAD17, RAD24, and RAD9—and in
nonsense-mediated decay—namely NAM7, NMD2, and
UPF3. RAD9-like genes (see Table 4) included the same
four genes involved in DNA damage checkpoint control
(DDC1, RAD17, RAD24, and RAD9) together with the
‘‘cell-cycle checkpoint’’ (GO:0000075) annotatedELM1.
Finally, the UDS genes that do not suppress cdc13-1
temperature sensitivity when deleted had multiple over-
represented GO terms describing aspects of chromo-
some architecture (supplemental Table S3).
All of the processes highlighted by statistical analysis
of cdc13-1 interactors have well-characterized links to
telomere biology. This analysis clearly shows that our
screens were successful in identifying known CDC13
interactors and suggests therefore that genes identified
in this study that were not previously linked to telomeres
are likely to have telomere-related roles.
Systematic analysis of gene lists: One caveat with
statistical analysis of GO terms is that annotations may
be biased toward processes that have been extensively
studied. Also, we used a relatively high P-value cutoff
(materials andmethods) to mitigate the likelihood of
false positives. We therefore performed a different sys-
TABLE 3
Genes whose deletion exacerbates the growth defects of cdc13-1 cells
Synthetic lethal Synthetic sick
ORF Gene ORF Gene ORF Gene
YJL123C MTC1a YKL098W MTC2 YMR035W IMP2
YNL196C YNL196C YGL226W MTC3 YGR238C KEL2
YOR058C ASE1 YBR255W MTC4 YOL064C MET22
YGL029W CGR1 YDR128W MTC5 YKL167C MRP49
YBR036C CSG2 YHR151C MTC6 YOL041C NOP12
YHR059W FYV4 YDL218W YDL218W YML103C NUP188
YEL003W GIM4 YIL040W APQ12 YBR093C PHO5
YNL014W HEF3 YBR131W CCZ1 YIL153W RRD1
YOL108C INO4 YGR157W CHO2 YHR178W STB5
YNL106C INP52 YGL078C DBP3b YBR231C SWC5
YKL176C LST4 YCL016C DCC1 YNL081C SWS2b
YGR078C PAC10 YDL219W DTD1 YJL138C TIF2
YNL015W PBI2 YLR342W FKS1 YPR173C VPS4
YNL003C PET8 YDL222C FMP45 YPR024W YME1c
YBL027W RPL19B YHR108W GGA2 YGL255W ZRT1
YGR118W RPS23A YML121W GTR1b YOL012C HTZ1
YNL206C RTT10
YOR297C TIM18
YNL197C WHI3
YMR302C YME2
Underlined genes lie adjacent to other genes whose deletion has synthetic interactions with cdc13-1. In such
cases, an effect on transcription of the neighboring gene cannot be discounted.
a The MTC gene name is reserved for previously unnamed ORFs.
b Also a suppressor of cdc13-1 (see Table 1).
c Also classed as UDS.
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tematic analysis of cdc13-1 interactors, which this time
included all genes identified in our study (see above;
Tables 1, 3, and 4). We grouped genes with clearly related
functions together, irrespective of GO term frequency and
chromosomal position, using the functional descriptions
in BioGrid (Stark et al. 2006; Breitkreutz et al. 2008).
Suppressors of cdc13-1 temperature sensitivity (Table
1) included clusters of genes involved in bud-site selec-
tion; mitochondrial function (including multiple genes
for electron transport, mitochondrial genome integrity,
mitochondrial ribosomes, and mitochondrial integrity);
nonsense-mediated decay; chromatin architecture; phos-
phate transport; signal transduction; ribosome function;
protein degradation; mRNA degradation; vesicular
transport; response to DNA damage; iron ion transport;
the actin cytoskeleton, cell polarity and mRNA local-
ization; and HO function (Table 5). Also of note in this
category were five putative tyrosine phosphatases
of largely unknown function [OCA1, OCA2, SIW14
(OCA3), OCA4, and OCA6)], four killer-toxin-related
genes, two aldehyde dehydrogenase genes, three genes
from the CCAAT-binding complex, and three of four
subunits of casein kinase 2 (Table 5).
A similar analysis of UDS genes (Table 4) identified
groups of genes with roles in the telomerase holoen-
zyme: the spindle checkpoint; the mitotic exit network;
the DNA damage checkpoint; regulation of transcrip-
tion termination and transposition; ribosome function;
chromosome architecture (including multiple SAS com-
plex, COMPASS complex, and Paf1 complex genes); the
TABLE 4
Genes whose deletion imparts a phenotype in the cdc13-1 UP–DOWN assay
UD sensitive UD sensitive UD sensitive UD resistant
ORF Gene ORF Gene ORF Gene ORF Gene
YEL033W MTC7a YJR075W HOC1 YML032C RAD52 [YMR116C ASC1b]
[YNL171C YNL171C] YDR158W HOM2 YDR217C RAD9b YOR033C EXO1b
[YLR370C ARC18] YER052C HOM3 YHL027W RIM101 YKL029C MAE1
YLR242C ARV1 YJR139C HOM6 YOR275C RIM20 YCR009C RVS161
YJR053W BFA1 YJL092W HPR5 YPR018W RLF2 YLR119W SRN2b
YER016W BIM1 [YHR067W HTD2] YJL136C RPS21B
YLR015W BRE2 YIL154C IMP29 [YBL072C RPS8A]
[YGR188C BUB1] YDR123C INO2 YDR289C RTT103
YMR055C BUB2 YMR294W JNM1 YLL002W RTT109
[YOR026W BUB3] YOR123C LEO1 YFR040W SAP155
YMR038C CCS1 YPL055C LGE1 YMR127C SAS2
YLR418C CDC73 YAL024C LTE1 YDR181C SAS4b
YBR274W CHK1b YPR164W MMS1 YBR171W SEC66
YMR198W CIK1 YJL183W MNN11 YBL031W SHE1
YPR119W CLB2 YCL061C MRC1 [YOR035C SHE4b]
YCR086W CSM1 YPL184C MRN1 YER118C SHO1
YPR135W CTF4 [YKL009W MRT4] YKR101W SIR1
YKR024C DBP7 YBR057C MUM2b YPR189W SKI3b
YPL194W DDC1b YNL119W NCS2 YMR016C SOK2
YKL213C DOA1b YKL040C NFU1 YPR032W SRO7
[YDR440W DOT1] [YKR082W NUP133] YOR027W STI1
YKL204W EAP1 YKL120W OAC1 YMR039C SUB1
YBL047C EDE1b YCR077C PAT1 YAR003W SWD1
YOR144C ELG1 YGR193C PDX1 YBR175W SWD3
YKL048C ELM1b YDR276C PMP3 [YLR182W SWI6]
YMR202W ERG2 YPL179W PPQ1 YDR260C SWM1
YGL054C ERV14 YGR135W PRE9 YOL018C TLG2
YLR233C EST1 YMR201C RAD14 YKR042W UTH1b
YLR318W EST2 YOR368W RAD17b YOR089C VPS21b
YIL009C-A EST3 YER173W RAD24b YMR284W YKU70
YLL043W FPS1 YKL113C RAD27 YMR106C YKU80
YMR307W GAS1b YER162C RAD4 YPR024W YME1c
YDR108W GSG1
Underlined genes lie adjacent to other genes whose deletion imparts a phenotype in the UP–DOWN assay distinct from cdc13-1
alone. In such cases, an effect on transcription of the neighboring gene cannot be discounted. Brackets indicate genes previously
identified as synthetic with wild type during SGA (Tong et al. 2001).
a The MTC gene name is reserved for previously un-named ORFs.
b Also a suppressor of cdc13-1 and so ‘‘RAD9-like’’ (see Table 1).
c Also classed as synthetic sick.
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actin cytoskeleton, cell polarity and mRNA localization;
glycerol osmosensing; methionine and threonine syn-
thesis; and vesicular transport (Table 5).
Finally, analysis of genes whose deletion exacerbates
the cdc13-1phenotype (Table 3) provided multiple ‘‘hits’’
affecting ribosome function, mitochondrial integrity,
and histone H2AZ exchange (chromatin remodeling)
(Table 5).
Uncharacterized genes identified in the cdc13-1
screen: A number of genes identified as cdc13-1 inter-
actors in this study were of previously unknown func-
tion. Suppressor genes, when present, have a negative
effect on telomere capping in cdc13-1 mutant cells at the
nonpermissive temperature; therefore we have named
such genes RTC (restriction of telomere capping; Table
1). Genes of previously unknown function whose de-
letion exacerbates the cdc13-1 phenotype have been
named MTC (maintenance of telomere capping) since
their presence increases the fitness of cdc13-1 mutant
cells at permissive temperature or during the UP–
DOWN assay (Tables 3 and 4). We did not apply new
acronyms to otherwise uncharacterized cdc13-1 interac-
tors if (1) they lay next to other cdc13-1 interactors in
the genome (see above) or (2) they were classified as
dubious open reading frames in the Saccharomyces
Genome Database (2008) and were adjacent to other
genes that could reasonably account for their deletion
phenotype (see supplemental Table S4); however, this
could be updated in the future.
DISCUSSION
The objective of our study was to identify proteins and
pathways that cap telomeres or regulate the cellular
response to uncapped telomeres. We combined the S.
cerevisiae gene deletion collection with the well-defined,
temperature-sensitive, and reversible cdc13-1 mutation
using the SGA strain construction technique and we
Figure 2.—Summary of cdc13-1 interactors. Genes designated as cdc13-1 suppressors (purple shaded area), UDS (red), UDR
(orange), synthetic sick (green), and synthetic lethal with cdc13-1 (blue) were arranged using OSPREY. Genes belonging to more
than one category (including RAD9-like and EXO1-like genes) are indicated in the overlap regions of shaded areas. Individual
genes are represented as solid circles, color coded by OSPREY with each color representing a gene ontology term, up to a max-
imum of four. Relevant gene ontology terms are indicated in the color key.
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TABLE 5
Groups of functionally related genes among cdc13-1 interactors
Group Function of related genes Suppressors UP–DOWN Synthetic
1 DNA repair/DNA damage
checkpoint/telomeres
MLH2, MPH1, CHK1,
DDC1, EXO1, RAD17,
RAD24, RAD9, DOA1
CHK1,a DDC1,a RAD17,a RAD24,a
RAD9,a MRC1, RAD14, RAD4,
RAD27, RAD52, YKU70,
YKU80, ELG1, DOA1,a
HPR5, MMS1, IMP2
2 Protein degradation UBP3, UBP6, UBX4, UBX7,
UFD2, DOA1, UBC4, SAN1,
VID28, POC4
PRE9
3 Nonsense-mediated decay NMD4, NAM7, UPF3,
EBS1, NMD2
4 Chromatin architecture/
silencing/histone
modification
SCS2, SPT2, NPT1, SAS4,
RIF2
[SAS2, SAS4;a SAS complex],
[SWD1, SWD3, BRE2; COMPASS
complex], [CDC73, LEO1; Paf1
complex], DOT1, SIR1, RLF2,
LGE1
[SWC5, HTZ1;
SWR1 complex]
5 Vesicular transport PEX13, PEX15, PEX22, PEX3,
PEX4, VAM6, VAM7, YPT6,
YPT7, VPS1, VPS30, VPS35,
VPS51, VPS60, DID2, SRN2,
HSE1, PIB2, RIC1, VPS21,
VPS8, SWA2, SSH1, SNC2, GOS1
[MNN11, HOC1; golgi mannosyl
transferase complex], ERV14, SEC66,
TLG2, RUD3, GSG1, SRO7, SRN2a
CCZ1, PBI2,b
VPS4
6 Casein kinase 2 CKA1, CKA2, CKB2
7 Ribosome function RPL13A, RPL14A, RPL19A,
RPL21B, RPL2A, RPL31B,
RPL33B, RPL34A, RPL35A,
RPL37A, RPL37B, RPL43A,
RPL4A, RPL6B, RPL9A,
RPL16B, NOP16, ARX1, ASC1,
DBP3, HCR1, TMA20, TMA22
RPS21B, RPS8A, ASC1,a DBP7,
MRT4
RPL19B,b DBP3,a
RPS23A,b NOP12,
CGR1b
8 Mitochondrial electron
transport/genome/
ribosomes and integrity
MSS18, COX7, COX10, COX17,
COX23, CYT1, CYT2, QCR2,
CBP4, COQ10, PET122, PET127,
ILM1, PIF1, MGR2, HMI1,
RIM1, TOM7, TOM70, YMC2,
YDL119C, SWS2, [HAP2, HAP3,
HAP5; CCAAT-binding complex]
UTH1a SWS2,a MRP49,
TIM18,b YME1,
YME2b
9 Tyrosine phosphatase OCA1, OCA2, OCA4, OCA6, SIW14
10 Signal transduction BMH1, BMH2
11 Bud site selection BEM3, BUD14, BUD27
12 Actin cytoskeleton/
cell polarity/mRNA
localization
EDE1, RHO4, BNR1, SLA1 EDE1*, ARC18, RVS161
13 Ergosterol biosynthesis ERG5, ERG6 ERG2
14 Iron ion transport FTR1, FET3
15 Aldehyde dehydrogenases ALD5, ALD6
16 HO function ASH1, PUF6, SHE4 SHE4a
17 mRNA degradation SKI2, SKI3, SKI7, SKI8 SKI3a
18 Phosphate transport PHO86, PHO87
19 Killer toxin related FYV10, FYV12, KRE1 FYV4b
20 Protein O mannosylation PMT1, PMT2
21 Telomerase holoenzyme EST1, EST2, EST3
22 Spindle checkpoint BUB1, BUB3, BIM1
23 Mitotic exit network KEL1 BFA1, BUB2, LTE1, SWM1 KEL2
24 Transposition RTT103, RTT109 RTT106 b
25 Glycerol osmosensing SHO1, FPS1
26 Methionine/threonine
biosynthesis
HOM2, HOM3, HOM6
Genes in boldface lie adjacent to other cdc13-1 interactors of the same category (e.g., synthetic); strong suppressors are underlined.
A number for each group of genes is indicated on the left.
a Also a suppressor of cdc13-1.
b Deletion of gene is synthetically lethal with cdc13-1.
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developed and optimized high-throughput yeast growth
assays. Although others have looked systematically for
synthetic lethality with temperature-sensitive mutations
(e.g., Measday et al. 2005; Baetz et al. 2006), to the best
of our knowledge, a genomewide screen for gene
deletions that confer subtle suppressor/enhancer phe-
notypes on a temperature-sensitive mutation has not
previously been reported. Our approach therefore com-
plements other high-throughput genetic techniques
such as SGA (Tong et al. 2001; Roguev et al. 2007) and
synthetic dosage lethal analysis (Measday et al. 2005).
We screened for gene deletions that suppress the
lethality of cdc13-1 at the nonpermissive temperature
and genes that compromise or contribute to the ‘‘re-
versibility’’ of cdc13-1mutants. Combined with synthetic-
lethal and synthetic-sick data from the SGA procedure,
this resulted in five overlapping categories of CDC13
interactors: suppressors of cdc13-1, synthetic lethal with
cdc13-1, synthetic sick with cdc13-1, UDS, and UDR—the
latter two categories, respectively, having RAD9-like and
EXO1-like subclasses, giving eight classes in all. Many of
the genes identified as interacting with CDC13 fit into
pathways with previously recognized roles in telomere
biology (Table 5). However, a significant number of
genes identified in this study have previously uncharac-
terized relationships to telomere function. A more
detailed analysis of their roles is likely to provide novel
information about eukaryotic telomere biology; for exam-
ple, in the same way as Exo1, discovered to have telomere-
related function in yeast (Maringele and Lydall 2002),
plays a role in life-span determination of telomerase
knockout mice (Schaetzlein et al. 2007).
cdc13-1 suppressors: cdc13-1 suppressors encode pro-
teins that inhibit growth of cdc13-1 mutant cells at the
nonpermissive temperature. Previous work has shown
that suppression of the temperature sensitivity of cdc13-1
can occur through different pathways and to different
extents. For example, deletion of EXO1 (which encodes
a 59–39 exonuclease required for resection at telomere
ends in the event of telomere uncapping) suppresses
cdc13-1 temperature sensitivity through a different mech-
anism from suppression by deletion of RAD9, which is
required for signaling cell-cycle arrest. There is there-
fore no single, simple explanation for the actions of the
many novel gene deletions that we have identified as
suppressing cdc13-1 (Table 1).
Some of the biological functions common to genes
identified as cdc13-1 suppressors (Table 5) have well-
understood relationships with telomere function. DNA
damage checkpoint and related genes, for example, act
at telomeres to detect uncapping and transduce signals
to the DNA repair and cell-cycle machinery (group 1,
Table 5; supplemental Figure S3) (Lydall 2003;
Longhese 2008).
For other ‘‘clusters’’ of genes, there are plausible
hypotheses to explain how they might affect telomeres.
Genes involved in protein degradation (group 2, Table
5; supplemental Figure S3) could potentially affect the
levels of many telomere-associated proteins. An exam-
ple is SAN1, the product of which functions in ubiquitin-
dependent degradation of aberrant proteins in the cell
nucleus. San1 degrades the defective Cdc13-1 protein
and therefore deletion of SAN1 stabilizes Cdc13-1 levels
Figure 3.—Comparison of CDC13-interacting genes with
telomere length genes. A Venn diagram shows hits from
two separate genomewide screens for telomere length regu-
lating genes compared to a list of cdc13-1 interactors. Lists
of genes that make up the cross sections between studies
are displayed and indicated by letters. The numbers of genes
in each segment are indicated. Boldface text highlights genes
that have neighboring genes in the genome whose deletion
results in a similar phenotype. *cdc13-1 suppressor (strong
suppressors are underlined); **synthetic (sick or lethal) with
cdc13-1; genes in parentheses either were not tested in this
study due to slow growth or were identified previously as giv-
ing consistently poor performance in SGA studies.
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(Gardner et al. 2005). What little function Cdc13-1 has
at elevated temperature might therefore be increased in
the absence of SAN1. Deletion of nonsense-mediated
decay genes (group 3, Table 5; supplemental Figure S3)
alters the stoichiometry of telomere cap components
and in particular elevates transcript levels for the essen-
tial Cdc13-interacting Stn1 protein (Dahlseid et al. 2003;
Enomoto et al. 2004).
Genes that affect chromatin architecture, silencing,
and/or histone modification influence telomere bi-
ology, presumably by modifying the accessibility of
chromatin to telomere proteins, for example (Yu et al.
2007). Chromatin modifiers are represented both as
cdc13-1 suppressors and as UDS genes in this category
(group 4, Table 5) and at least one silencing gene
(SAS4) is RAD9-like in that it is both a suppressor and
UDS. Therefore, the relationship between chromatin
and the telomere cap is complex. Recent experiments
show how the histone H3K79 methyl transferase Dot1
(identifed as UDS in our study) is required for check-
point activation and inhibition of resection in cdc13-1
mutants (Lazzaro et al. 2008).
A large number of suppressor genes have vesicular
trafficking functions (group 5, Table 5). This is consis-
tent with the observation that many vesicular traffic
genes affect telomere length (Askree et al. 2004). At
least some of those were shown to act upon telomere
length in a YKU70-dependent manner (Rog et al. 2005);
however, it seems likely from our studies that others may
influence Cdc13 function. There are extensive inter-
actions, described in BioGrid, between vesicular traffic
genes and other types of cdc13-1 suppressors (supple-
mental Figure S3); hence mutations that alter vesicular
trafficking may affect telomeres through multiple dif-
ferent pathways. It is interesting to note that transport
of telomerase proteins and TLC1 RNA across the nu-
clear membrane is important for telomerase function
(Teixeira et al. 2002; Gallardo et al. 2008) and that
deletion of KAP122, required for import of TLC1 from
the cytoplasm to the nucleus (Gallardo et al. 2008), sup-
presses cdc13-1.
Phosphorylation by human casein kinase 2 (CK2) has
been shown to regulate binding of human Trf1 to telo-
meres (Kim et al. 2008). Human Trf1 negatively regu-
lates telomere length by inhibiting access of telomerase
to telomeres. Possible Trf1 functional homologs in S.
cerevisiae are Tbf1 and Rap1, both of which are essential
TTAGGG-binding proteins with roles in gene silencing
at telomeres (Fourel et al. 1999; Koering et al. 2000;
Bhattacharya and Warner 2008; Hogues et al. 2008).
It is possible therefore that yeast CK2 (group 6, Table 5;
supplemental Figure S3) acts directly upon either Tbf1
or Rap1. Alternatively, multiple interactions between
CK2 subunits and genes involved in modulating chro-
matin architecture are known, including multiple genes
identified in this study (supplemental Figure S4) and so
S. cerevisiae CK2 may exert an influence on telomere
function through a general effect on chromatin. A third
alternative route through which CK2 might influence
the cdc13-1 phenotype is its influence on checkpoint
control, which was reported previously (Toczyski et al.
1997). Further studies will be required to distinguish
among these possibilities.
A large group of ribosomal protein genes (group 7,
Table 5; supplemental Figure S3) and a smaller number
of other genes with ribosome-related function were iden-
tified as suppressors of cdc13-1. We have no clear ex-
planation for this; however, a clue may come from the
observation that chromosomal regions containing ribo-
somal protein genes and telomeres have similar mech-
anisms for regulating their chromatin architecture
(Bhattacharya and Warner 2008; Hogues et al.
2008). Remarkably, this group includes 16 large ribo-
somal protein subunit genes but only one component of
the small ribososmal subunit.
Numerous groups of genes identified in this study have
not previously been linked to telomere function. Genes
affecting mitochrondrial function (group 8, Table 5)
(particularly those involved in electron transport and
import into mitochondria), for example, are cdc13-1
suppressors when deleted. Interestingly, Nautiyal et al.
(2002) showed that many mitochondrial genes are
transcriptionally upregulated in telomerase-deficient
mutants and we have recently found similar results in
cdc13-1 mutants (A. Greenall and D. Lydall, per-
sonal communication). Furthermore, there appear to
be evolutionarily conserved interactions between mito-
chondria and telomeres (Passos et al. 2007). Therefore,
one possible explanation of why so many genes involved
in mitochondrial function suppress cdc13-1when deleted
is that loss of mitochondrial function, and the ability to
respire, suppresses the poor growth of cdc13-1 mutants.
Indeed, we find that many petite mutants suppress the
cdc13-1 defect (Table 1).
The suppression of cdc13-1 temperature sensitivity by
petite mutations as a whole is interesting and warrants
further investigation. We sought to test whether many
other gene deletions might be suppressing cdc13-1
indirectly by causing loss of mitochondrial function.
Mitochondrial function (respiration) is essential for
growth on glycerol; therefore we spotted single-gene
deletion strains [corresponding to all cdc13-1 suppres-
sors (Table 1)] using glycerol as the sole carbon source.
We found that only those previously described as
‘‘petite’’ were unable to grow on glycerol (data not
shown). We also found that suppression by petite mu-
tations is not due simply to slower growth because
growth on synthetic medium does not suppress cdc13-1
temperature sensitivity and there are multiple nonpetite
mutations that confer slow growth but fail to suppress
cdc13-1 temperature sensitivity (data not shown). We
conclude that the vast majority of cdc13-1 suppressors
that we have identified are not suppressing because they
disrupt mitochondrial function.
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Five genes (OCA1, OCA2, OCA4, OCA6, SIW14; group
9, Tables 2 and 5; supplemental Figure S3) containing
a highly conserved tyrosine phosphatase motif were
identified as suppressors of cdc13-1. Little is known
about their function except that OCA1 and SIW14 have
roles in checkpoint response to oxidative stress and
actin filament organization, respectively (Alic et al.
2001; Care et al. 2004). Suppression of cdc13-1 has been
confirmed in a separate genetic background (W303) for
OCA2, OCA4, OCA6, and SIW14. It was also found that
OCA5, which lacks the tyrosine phosphatase motif and
was not detected as a suppressor in this screen, does
suppress cdc13-1 temperature sensitivity in the W303
background (Table 2). It will be interesting to deter-
mine how the OCA gene family interacts with uncapped
telomeres, possibly by interacting with the checkpoint
kinase cascade or perhaps by affecting telomere capping.
The partially redundant BMH1 and BMH2 genes
(group 10, Table 5; supplemental Figure S3) encode
14-3-3 proteins, which bind phosphopeptides (van
Heusden and Steensma 2006). It has been shown that
Bmh1 and Bmh2 affect checkpoint signal transduction
(Lottersberger et al. 2003, 2006, 2007) and therefore,
like Rad9 and Rad24, their absence is expected to im-
prove the growth of cdc13-1mutants. Further experiments
will be necessary to explain the roles of other groups of
genes (groups 11–20, Table 5; supplemental Figure S3) in
exacerbating the cdc13-1 telomere-capping defect.
UP–DOWN sensitive genes: We classify UDS genes as
those that contribute to the viability of cdc13-1 mutant
cells during brief incubation periods at high tempera-
ture. Their deletion causes cdc13-1 cells to grow poorly in
the UP–DOWN assay. Deletion of RAD9 suppresses the
temperature sensitivity of cdc13-1, as well as rendering
cdc13-1 cells sensitive to temperature oscillation (Figure
1) and we predicted that other UDS genes that similarly
suppressed cdc13-1 would be identified in this screen
and classed as truly ‘‘RAD9-like.’’ Indeed, RAD9, CHK1,
DDC1,RAD17,RAD24, and other genes with DNA-repair-
related roles (DOA1) were identified. However, also
included were genes for cell polarity and cellular mor-
phogenesis (ELM1, SHE4), membrane traffic (EDE1,
VPS21), response to oxidative stress (UTH1), mRNA de-
gradation (SKI3), DNA replication in meiosis (MUM2),
chromatin architecture (SAS4), and cell-wall biogenesis
(GAS1). SHE4 in particular is interesting since its de-
letion causes strong suppression (Table 1) and a strong
UDS phenotype (Table 4 and data not shown). She4 is an
UNC domain protein that interacts with type I and type
V myosins and has roles in mating-type switching (by
helping to localize the mRNA for Ash1) and endocytosis.
Since other genes involved in both vesicular traffic and
Ash1 function have been identified in this study, it
remains to be determined through which of these
pathways SHE4 exerts an influence on telomere biology.
Rather less predictable was a large number of UDS
genes (81), which do not suppress cdc13-1 temperature
sensitivity when deleted (Table 4, Figure 2). Deletion of
some of these genes caused reduced growth during spot
tests (not detected in SGA analysis; supplemental Figure
S2), even at the permissive temperature of 20 (data not
shown). They were classed as UDS because growth was
still poor in the UP–DOWN assay relative to growth at
the permissive temperature. There is a subtle distinc-
tion, therefore, between this class of genes and those
that exhibit a synthetic sick interaction with cdc13-1 at
temperatures .23.
Only deletion of YME1 appeared to demonstrate both
UDS (in screens 3 and 4; supplemental Table S1) and
synthetic sick (in screen 7; supplemental Table S1)
interactions with cdc13-1; null mutations in this mito-
chondrial protease have previously been shown to be
pleiotropic, including exhibiting cold sensitivity on rich
glucose medium (Thorsness et al. 1993). Genes such
as this with apparently ‘‘variable’’ phenotypes were rare.
However, another example is ASC1. Deletion of ASC1
has previously resulted in synthetic interactions with
wild-type query strains in the SGA procedure (Tong
et al. 2001; see supplemental Methods); however, we
obtained viable progeny from SGA in 5 of 10 biological
replicates with this gene deletion. Four of five of these
demonstrated suppression of cdc13-1 and UDR so ASC1
is, tentatively, classified as a suppressor and UDR, that is,
EXO1-like.
EST1, EST2, and EST3 genes encoding telomerase
holoenzyme components fell into the UDS category
(group 21, Table 5; supplemental Figure S4). This is
almost certainly because telomerase, and its product
telomeric DNA, contribute to forming the telomere cap.
The absence of telomerase therefore sensitizes cdc13-1
mutants to high temperature. Conversely, deleting PIF1,
which encodes a helicase that removes telomerase, sup-
presses the temperature sensitivity of cdc13-1 mutants.
The UDS genes included genes for both subunits of
the Ku complex (YKU70 and YKU80), BRE2, and DOT1.
The latter encodes the H3K79 methylase and appears to
Figure 4.—Hierarchical clustering of cdc13-1 genetic interactions with data from multiple genomewide studies. cdc13-1 suppres-
sor and enhancer data are combined with data from genomewide studies of telomere length, nonsense-mediated decay (nmd
upregulated), the effect of MMS on gene transcriptions (regulated MMS), MMS sensitivity, UV sensitivity, ionizing radiation sen-
sitivity (IR sensitive), and Brome mosaic virus (BMV) replication. cdc13-1 synthetic sick and synthetic lethal interactions are
grouped under the heading ‘‘cdc13-1 enhancers,’’ separately from interactors identified in the UP–DOWN (UD) assay. Yellow
and blue shading on the heat map indicate positive and negative values, respectively (as defined in the supplemental Methods).
Four interesting clusters are highlighted with magnified heat maps. One of these clusters (center, right) contains the previously
uncharacterized MTC7 gene, identified in this study (see discussion).
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help recruit Rad9 to chromatin and, like Rad9, inhibits
resection at uncapped telomeres (Lazzaro et al. 2008).
Spindle checkpoint and mitotic exit genes (groups 22
and 23, Table 5; supplemental Figure S4) also helped
cdc13-1 cells to recover from shifts to high temperature,
presumably because, after a period of arrest prior to
entry into mitosis, the mitotic exit network is important
for efficient completion of the cell cycle.
The telomere-related roles of genes involved in trans-
position, glycerol osmosensing, or methionine and
threonine synthesis (groups 24–26, Table 5; supplemen-
tal Figure S4) remain unclear, although the former
group has been implicated in chromatin remodeling.
UP–DOWN-resistant genes: EXO1 encodes a nucle-
ase that contributes to the vulnerability of cdc13-1
mutant cells to brief incubation periods at high tem-
perature. A likely explanation for this is that deletion of
EXO1 results in less resection and thus less DNA damage
at the nonpermissive temperature, thus hastening the
cells’ recovery when returned to the permissive temper-
ature (Zubko et al. 2004). We have hypothesized that
other nucleases, such as a putative RAD24-dependent
nuclease ExoX, also regulate resection at uncapped
telomeres ( Jia et al. 2004; Zubko et al. 2004). Therefore,
we searched for other EXO1-like genes. Deletion of
EXO1 suppresses the temperature sensitivity of cdc13-1,
as well as rendering cdc13-1 cells less sensitive to tem-
perature oscillation (Figure 1). In fact, only two genes—
ASC1 and SRN2—fall into this category. ASC1 encodes a
core component of the 40S ribosomal subunit, which
acts as a guanine nucleotide dissociation inhibitor for
Gpa2 (Zeller et al. 2007), and its deletion results in
longer telomeres (Askree et al. 2004). Srn2 is a member
of the ESCRT-1 endosomal sorting complex (Kostelansky
et al. 2007), which targets proteins to endosomes in a
ubiquitin-dependent manner. The other two subunits of
this complex (Stp22 and Vps28) were in the group of slow-
growing deletion strains that were not tested in this study
but have been shown previously to have shorter telomeres,
whereas deletion of SRN2 is not reported to affect telomere
length (Askree et al. 2004; Gatbonton et al. 2006). Two
other genes were UDR without being cdc13-1 suppressors:
MAE1 and RVS161. RVS161 encodes an amphiphysin-like
raft protein, which acts (with Rvs167) to regulate polar-
ization of the actin cytoskeleton; thus its deletion has
pleiotropic effects, which include disruption of endocytosis
(Breton et al. 2001; Lombardi and Riezman 2001). MAE1
encodes a mitochondrial malic enzyme that catalyzes the
oxidative decarboxylation of malate to pyruvate (Boles
et al. 1998). None of theEXO1-like genes identified here are
likely candidates for ExoX. Therefore, ExoX does not exist,
was missing from our library, is encoded by an essential
gene, or its activity is encoded by multiple, redundant
genes.
Comparisons with telomere length screens: Two
previous genomewide studies of telomere biology have
measured the length of telomere repeat regions in gene
deletion strains (Askree et al. 2004; Gatbonton et al.
2006). Interestingly, there was less overlap than might have
been expected between the two studies in terms of the
specific genes identified; however, the processes that af-
fected telomere length in each study were similar
(Gatbonton et al. 2006). Comparison of our results
with these two previous studies reveals moderate overlap
(Figure 3) but, again, some similar cellular processes
were identified.
Thirteen genes were identified in all three studies and
this clearly represents an important set of telomere-
related genes. Seven of these were found to support
telomere capping in our study—EST1, EST2, and EST3
(encoding subunits of telomerase); YKU70 and YKU80
(encoding the Ku heterodimer); andCDC73 andDCC1—
and show reduced telomere length when deleted. Dele-
tion of ELG1 (UDS) results in longer telomeres. Deletion
of PIF1 (Downey et al. 2006), which encodes a helicase
that removes telomerase from telomeres, and of RIF2
(Wotton and Shore 1997), which inhibits telomerase
activity, results in long telomeres and suppression of
cdc13-1. Deletion of NAM7, UPF3, and NMD2, which
regulate nonsense-mediated RNA decay, affecting levels
of the Cdc13-interacting protein Stn1, results in strong
suppression of cdc13-1 and short telomeres. Clearly, the
implications of altered telomere length or genetic in-
teraction with cdc13-1 arising from a gene deletion study
are complex.
Many of the genes identified by Askree et al. (2004) or
Gatbonton et al. (2006), which were not identified by
our screens, are particularly poor growing strains or
those previously demonstrated as working poorly in the
SGA techniques (in parentheses in Figure 3; Tong et al.
2001). Conversely, there are 326 genes identified in our
study as interacting with cdc13-1, which do not signifi-
cantly alter telomere length. These include genes that
are known to affect the response to telomere uncapping
without affecting telomere length (e.g., the checkpoint
genes RAD9 and CHK1). However, it also seems likely
that cdc13-1 mutants are sensitive to deletion of some
genes where the resulting changes in telomere length
are too small to be detected using high-throughput
Southern blot analysis.
Comparisons with multiple high-throughput studies:
In addition to telomere length, multiple genomewide
studies have examined processes that are relevant to
telomere biology including, for example, UV irradiation
(Birrell et al. 2001), ionizing radiation (Bennett et al.
2001), alkylating agents ( Jelinsky and Samson 1999;
Chang et al. 2002), and nonsense-mediated decay (He
et al.2003). We combined these data sets, a study of genes
affecting replication of a positive-strand DNA virus
(Kushner et al. 2003), and the telomere length studies
(Askree et al. 2004; Gatbonton et al. 2006; Shachar
et al. 2008) with our own data to produce a hierarchical
clustering map (Figure 4). For two previously unchar-
acterized genes identified in this study, such clustering
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may provide clues to their putative function. For example,
MTC7 lies in a cluster of genes that, when deleted, confer
UP–DOWN sensitivity and short telomeres. This cluster
includes telomere maintenance, histone methylation, and
silencing genes (Figure 4), indicating that Mtc7 might
influence telomere biology through one of these pro-
cesses.RTC1 lies in a cluster of genes that, when deleted,
confer suppression of cdc13-1 temperature sensitivity
and short telomeres (Figure 4). This cluster includes
genes involved in nonsense-mediated decay and mem-
brane transport, indicating that Rtc1 might influence
telomere biology through one of these processes.
In conclusion, the budding yeast telomere cap and
the response to telomere uncapping induced in cdc13-1
mutants appear to be affected by numerous and diverse
cellular pathways and processes. Further analyses will be
necessary to understand how these pathways and pro-
cesses interact at yeast telomeres. It seems likely that a
significant fraction of the pathways and processes iden-
tified in yeast will play roles at human telomeres and
thereby affect cancer and/or aging.
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Previewssmall RNAs, such as piRNAs from
mammals and Drosophila, 22G-RNAs
from C. elegans, and primal RNAs from
fission yeast (Ghildiyal and Zamore,
2009). Dicer-independent small RNAs
have not been reported in plants,
although they are likely also present in
plants. All of the described small RNAs
are ultimately loaded onto an effector
protein for carrying out their regulatory
functions (Figure 1). Most of the small
RNAs reported to date appear to asso-
ciate with AGOs. It should be noted that
some AGO proteins have the ability to
bind longer RNAs, such as 30- to 40-nt
small RNAs in the fission yeast AGO1
complex (Halic and Moazed, 2010) and
the milRNA precursors in the QDE-2
complex (Lee et al., 2010), suggesting
that more complex functions of these
AGO proteins remain to be discovered.In addition, some small RNAs may asso-
ciate with other types of RNA-binding
proteins, which may confer different func-
tions (Zheng et al., 2008).
The work of Lee et al. in this issue of
Molecular Cell provides an excellent
example of how new small RNAs can be
discovered by examining AGO-interact-
ing small RNAs. Importantly, this study
revealed previously unsuspected diver-
sity and complexity in small RNA bio-
genesis in fungal systems. It begs the
question, how many more small RNA
biogenesis pathways are there?REFERENCES
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In this issue ofMolecular Cell, Faure et al. (2010) establish a critical role for the Mre11 complex in the recruit-
ment of telomerase to leading- but not lagging-strand telomeres of budding yeast.Chromosomes of most eukaryotic organ-
isms terminate in specialized nucleopro-
tein structures called telomeres, which
contain double-stranded DNA (dsDNA)
with 30 single-stranded DNA (ssDNA)
overhangs. Most chromosomal regions
can be replicated by replication forks
moving in either direction, but a telomere
can only be replicated by a fork moving
in a single direction, toward the chromo-
some end. The inherent directionality of
telomere replication means that there is
a clear distinction between those telo-
meric DNA strands that are replicated
by leading- or lagging-strand replication
machinery (Figure 1A). The G-rich 30
strands, are replicated by lagging-standmachinery, while the C-rich 50 strands
are replicated by leading-strand ma-
chinery. Lagging-strand replication leaves
30 ssDNA overhangs at the telomere, as
the replication machinery is unable to
replicate the region of the template strand
that is occupied by the RNA primer of
the terminal Okazaki fragment, and this
constitutes the well-recognized ‘‘end re-
plication problem.’’ Leading-strand poly-
merases are presumed to be able to
replicate to the end of the chromosome,
producing blunt ends. Thus, while lag-
ging-strand synthesis has the inherent
ability to produce telomeric DNA struc-
tureswith 30 overhangs, the leading strand
most likely requires further processing toconvert blunt ends into 30 overhang struc-
tures. In this issue, Faure et al. (2010)
provide important insights into the pro-
cessing of leading and lagging strands
after telomere replication.
Telomeric DNA in eukaryotes is bound
by a number of specialized telomere-
capping proteins and more general DNA
damage response (DDR) proteins, which
cooperate to maintain telomere function
(de Lange, 2009; Lydall, 2009). Faure
et al. (2010) asked whether specific
proteins bind to telomeres replicated by
the leading-strand machinery, the lag-
ging-strand machinery, or both. To do
this, the authors incorporated BrdU into
DNA during a single S phase and38, June 25, 2010 ª2010 Elsevier Inc. 777
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Figure 1. Telomere Replication
(A) Telomeres are nucleoprotein caps at the end of eukaryotic chromosomes. Replication of telomeric
DNA occurs from sub-telomeric origins. This dictates that the G strand is replicated by the lagging strand
machinery, resulting in a 30 ssDNA overhang, while the C strand is replicated by the leading strand
machinery, resulting in a blunt end.
(B) In budding yeast, telomeres are bound by the Ku complex (Yku70-Yku80) and the CST complex
(Cdc13-Stn1-Ten1), which cooperate to recruit telomerase to the telomere. The CST complex only binds
30 ssDNA overhangs, while the Ku complex can bind to both blunt-ended telomeres and those with a 30
ssDNA overhang. The work of Faure et al. (presented in this issue) and others in the field, supports amodel
where the MRX/MRN (Mre11-Rad50-Xrs2/Nbs1) complex converts blunt-ended products of leading
strand synthesis into 30 overhangs to which the CST complex can bind, in a process essential for telome-
rase recruitment.
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Previewsperformed ChIP after either an initial or a
successive round of DNA replication to
measure binding of specific proteins at
the leading- and lagging-strand telomeres.
Budding yeast telomeres are capped
in part by binding of the CST complex
(Cdc13-Stn1-Ten1) to telomeric 30 ssDNA
(Gao et al., 2007). Interestingly, Faure et al.
(2010) found that the CST complex and
telomerase bound both leading- and
lagging-strand telomeres. This suggested
that blunt ends generated by leading-
strand synthesis of telomeric DNA (Fig-
ure 1A) are modified to generate ssDNA,
the substrate for CST binding. Consistent
with this hypothesis, Faure et al. (2010)
showed that Mre11, a component of the
MRXcomplex (Mre11-Rad50-Xrs2/Nbs1),
bound only to the leading-strand telo-
meres and was critical for CST complex
and telomerase binding to leading-strand
telomeres (Figure 1B). Importantly, Mre11
was not required for binding of all proteins
to leading-strand telomeres because
the Ku complex (Yku70-Yku80), a DDR
component that binds nonspecifically to778 Molecular Cell 38, June 25, 2010 ª2010dsDNA ends, could bind telomeres in the
absence of Mre11.
One outstanding question arising from
the work of Faure et al. (2010) is how
MRX functions at leading-strand telo-
meres. MRX has multiple functions at
DNA ends; one is to recruit the checkpoint
kinaseTel1 (ATM) via theXrs2subunit, and
this aids in telomerase recruitment to telo-
meres; another MRX activity is to help
generate 30 ssDNA overhangs via the
endonuclease Sae2 (CtIP) (Mimitou and
Symington, 2009). Therefore at least two
plausible mechanisms could explain the
role of Mre11 at leading-strand telo-
meres—one activating the Tel1 check-
point kinase, the other regulating nuclease
activity. It will be interesting to see if Sae2
or Tel1 also preferentially binds leading-
strand telomeres.
Interestingly, it seems that blunt-ended
telomeres induced by making DNA
double-strand breaks (DSBs) near telo-
meric DNA in metaphase-arrested cells
areconverted to30 ssDNAoverhangsusing
similar mechanisms to the resection ofElsevier Inc.internal DSBs (Bonetti et al., 2009;Mimitou
and Symington, 2009). In both cases,
Mre11 cooperates with Sae2 to create an
initial overhang, which is then extended
by Sgs1/Dna2 in cooperation with Exo1.
It is therefore possible that during normal
telomere replication Mre11/Sae2-gener-
ated overhangs on the leading strand and
the overhangs on the lagging strand are
processed by nuclease activities depen-
dent upon Sgs1/Dna2 and Exo1 (Fig-
ure 1B). Alternatively, Mre11/Sae2, Sgs1,
andExo1might be confined to the leading-
strand telomere, with 30 ssDNA on the
lagging strand being generated entirely
by the removal of the RNA primer. The
latter hypothesis would likely require
a specific mechanism for exclusion of
nuclease activities from the lagging strand
and would be consistent with the role of
Cdc13 in inhibiting nuclease activities at
telomeres. Using the approaches devel-
oped by Faure et al. (2010) it should now
be possible to ask if Sae2, Sgs1, Exo1, or
Dna2 shows any preference for binding to
leading- or lagging-strand telomeres.
Intriguingly, in fission yeast it has re-
cently been demonstrated that leading-
strand replication of telomeres precedes
lagging-strand replication (Moser et al.,
2009), suggesting perhaps that earlier
replication of the leading strand provides
more time for postreplicative process-
ing of this strand. Furthermore, Mre11
is important for telomere function in
Drosophila, an organism that does not
use telomerase to maintain chromosome
ends (Ciapponi et al., 2004), and therefore
Mre11-dependent postreplicative pro-
cessing of leading strands might be
a fundamental property of replication to
the end of all linear DNA molecules in
eukaryotes. It is clear that leading- and
lagging-strand telomeres of mammalian
cells also behave differently. For example,
in one study of human cells, inactivation
of the telomere-binding protein TRF2
caused telomere-telomere fusions specif-
ically between leading-strand telomeres
(Bailey et al., 2001). In another study of
mouse cells, inactivation of TRF2 com-
bined with deletion of Mre11 biased
fusions to leading- rather than lagging-
strand telomeres (Deng et al., 2009).
Finally, very recent experiments have
shown that other telomere-binding pro-
teins inhibit nuclease activities at yeast
telomeres (Bonetti et al., 2010). Future
Molecular Cell
Previewsstudies should help clarify the important
roles of telomere-binding proteins, nucle-
ases, and other DDR proteins at leading-
and lagging-strand telomeres.
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In this issue ofMolecular Cell, Lim et al. (2010) show that SIRT1 deacetylates HIF-1a and regulates its ability to
respond to hypoxia, revealing yet another important function of SIRT1 and suggesting a connection between
HIF function in aging and sirtuin enzymes.Appropriately responding to changes in
oxygen availability is essential for life. At
the cellular level, this response is largely
mediated by the hypoxia-inducible factor,
HIF (Semenza, 2007). HIF acts as a tran-
scriptional regulator of genes involved
in survival during periods of low oxygen
(the hypoxic response) and is regulated
primarily via oxygen-dependent proteaso-
mal degradation. Degradation of the regu-
lated HIF subunits (HIF-1a and HIF-2a) is
mediated by the von Hippel-Lindau tumor
suppressor pVHL, a ubiquitin E3 ligase
(Figure 1). Mutations in pVHL stabilize HIF
and cause the genetic von Hippel-Lindau
disease, which is characterized by a high
frequency of renal carcinoma. HIF-1a and
HIF-2a are frequently overexpressed in
tumors and are a negative predictor for
survival. Recently, a role for HIF in the
biology of aging has been revealed in
a series of studies in the nematodeCaeno-
rhabditis elegans. Hypoxic growth or nor-
moxic overexpression of the nematode
HIF protein, HIF-1, dramatically increases
life span and delays disease progression
in transgenic models of Huntington’s andAlzheimer’s diseases (Mehta et al., 2009;
Zhang et al., 2009). Interestingly, loss of
HIF-1 can also increase life span in C. ele-
gans under some conditions (Chen et al.,
2009; Zhang et al., 2009), defining HIF-1
as a context-dependent modifier of
longevity (Kaeberlein and Kapahi, 2009).
Three reports have recently suggested
an important connection between HIF
and another aging-related family of
enzymes, the sirtuins. Sirtuins are NAD-
dependent protein deacetylases, named
for their founding member, the yeast
histone deacetylase Sir2 (Finkel et al.,
2009). Overexpression of sirtuins has
been shown to slow aging in yeast, nema-
todes, and flies, and the mammalian sir-
tuin, SIRT1, has been implicated in a
variety of age-related disease processes.
Dioum and colleagues (Dioum et al.,
2009) first uncovered the link between
HIF and sirtuins by showing that SIRT1
deacetylates and activates HIF-2a in
cultured cells subjected to hypoxia. In
a second study, Zhong et al. (2010) found
that another sirtuin, SIRT6, regulates HIF-
1a-responsive genes by deacetylatinghistones and impairing transcription at
HIF-1-responsive promoters.
In this issue, Lim et al. (2010) report that
SIRT1 also interacts with HIF-1a in
multiple cell lines and mouse tissues.
They show that SIRT1 deacetylates HIF-
1a at a conserved residue, Lys674, which
is acetylated by the PCAF acetyltransfer-
ase. Unlike the previously reported activa-
tion of HIF-2a by SIRT1 (Dioum et al.,
2009), the current study indicates that
deacetylation of HIF-1a by SIRT1 inhibits
HIF activity (Lim et al., 2010). The data of
Lim et al. (Lim et al., 2010) also confirmed
the prior interaction between SIRT1 and
HIF-2a and indicated that that HIF-1a
and HIF-2a may compete for SIRT1
binding. HIF-1a and HIF-2a activate
separate but overlapping gene subsets
and are differentially expressed in various
tissues and times after onset of hypoxia
(Wang et al., 2005), suggesting a complex
interplay between the two hypoxia-
responsive factors and SIRT1.
In addition to describing yet another
function forSIRT1, this studyalsoprovides
a potentially important new mechanism38, June 25, 2010 ª2010 Elsevier Inc. 779
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Pif1- and Exo1-dependent nucleases coordinate
checkpoint activation following telomere
uncapping
This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial No
Derivative Works 3.0 Unported License, which permits distribution and reproduction in any medium, provided the
original authorandsourceare credited.This licensedoesnotpermit commercial exploitationor thecreationofderivative
works without specific permission.
James M Dewar1 and David Lydall1,2,*
1Centre for Integrated Systems Biology of Ageing and Nutrition, Institute
for Ageing and Health, Newcastle upon Tyne, Tyne-and-Wear, UK and
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Essential telomere ‘capping’ proteins act as a safeguard
against ageing and cancer by inhibiting the DNA damage
response (DDR) and regulating telomerase recruitment,
thus distinguishing telomeres from double-strand breaks
(DSBs). Uncapped telomeres and unrepaired DSBs can
both stimulate a potent DDR, leading to cell cycle arrest
and cell death. Using the cdc13-1mutation to conditionally
‘uncap’ telomeres in budding yeast, we show that the
telomere capping protein Cdc13 protects telomeres from
the activity of the helicase Pif1 and the exonuclease Exo1.
Our data support a two-stage model for the DDR at
uncapped telomeres; Pif1 and Exo1 resect telomeric DNA
o5kb from the chromosome end, stimulating weak
checkpoint activation; resection is extended 45kb by
Exo1 and full checkpoint activation occurs. Cdc13 is also
crucial for telomerase recruitment. However, cells lacking
Cdc13, Pif1 and Exo1, do not senesce and maintain their
telomeres in a manner dependent upon telomerase, Ku
and homologous recombination. Thus, attenuation of the
DDR at uncapped telomeres can circumvent the need for
otherwise-essential telomere capping proteins.
The EMBO Journal (2010) 29, 4020–4034. doi:10.1038/
emboj.2010.267; Published online 2 November 2010
Subject Categories: genome stability & dynamics
Keywords: Cdc13; DNA damage response; Exo1; Pif1;
uncapped telomeres
Introduction
Telomeres consist of double-stranded DNA (dsDNA) and
single-stranded DNA (ssDNA), bound by dsDNA- and
ssDNA-binding proteins (Blackburn et al, 2006; Lydall,
2009). This nucleoprotein ‘cap’ has at least two functions:
to shield the telomeric DNA from stimulating the DNA
damage response (DDR) and to regulate elongation of
the telomere by telomerase. In human senescent cells,
dysfunctional telomeres induce a sustained DDR (d’Adda di
Fagagna et al, 2003). In both budding yeast and mice, nuclease
activities that attack dysfunctional telomeres contribute to
telomere-driven senescence (Maringele and Lydall, 2004;
Schaetzlein et al, 2007). Therefore, understanding the regula-
tion of nuclease activities at dysfunctional telomeres in yeast is
likely to be informative about similar processes occurring at
mammalian telomeres and the human ageing process.
dsDNA-binding proteins and accessory factors are required
at both human telomeres (TRF1, TRF2, TIN2, TPP1, RAP1)
and budding yeast telomeres (Rap1, Rif1, Rif2) to prevent
DDRs (Wotton and Shore, 1997; de Lange, 2005; Celli and
de Lange, 2005; Marcand et al, 2008; Bonetti et al, 2010;
Vodenicharov et al, 2010). In budding yeast, telomeric ssDNA
is bound by Cdc13 with accessory proteins Stn1 and Ten1,
whereas in human cells, it is bound by POT1 (de Lange, 2005;
Gao et al, 2007). Cdc13–Stn1–Ten1 forms an evolutionarily
conserved complex (the CST complex) that has telomeric
roles in most organisms studied so far (Miyake et al, 2009;
Surovtseva et al, 2009). POT1 binds telomeric ssDNA and is
connected to the dsDNA-binding proteins of the telomere cap
by TPP1 and TIN2 (de Lange, 2009). Inactivation of POT1 or
Cdc13 induces ‘telomere uncapping’ and has similar conse-
quences—initiation of a DDR and resection of the telomeric
DNA by nuclease activities (Garvik et al, 1995; Baumann and
Cech, 2001; Pitt and Cooper, 2010).
The response to telomere uncapping is readily studied in
budding yeast by inactivation of Cdc13 using the thermo-
sensitive allele cdc13-1 (Garvik et al, 1995). Following Cdc13
inactivation, a potent DDR is initiated; telomeric DNA is
resected by nucleases, which degrade the AC (50) strand to
generate extensive TG (30) ssDNA that stimulates activation
of the DNA damage checkpoint, in a manner analogous to
that at DNA double-strand breaks (DSBs) (Figure 1A) (Garvik
et al, 1995; Lydall and Weinert, 1995; Vodenicharov and
Wellinger, 2006). There is relatively little understanding of
the nuclease activities responsible for generating ssDNA at
uncapped telomeres (Zubko et al, 2004). In contrast, there
has been much recent progress identifying nuclease activities
that function at DSBs (Gravel et al, 2008; Mimitou and
Symington, 2008; Zhu et al, 2008).
Exo1 is the only nuclease known to generate ssDNA at
uncapped telomeres in budding yeast (Maringele and Lydall,
2002). Exo1 is a 50 to 30 dsDNA exonuclease involved in DSB
resection and in mismatch repair (Tsubouchi and Ogawa,
2000; Gravel et al, 2008; Mimitou and Symington, 2008;
Zhu et al, 2008). In the absence of Exo1, ssDNA is still
generated following Cdc13 inactivation, demonstrating that
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other nuclease activities must also function at uncapped
telomeres. The determinant(s) of this Exo1-independent
ssDNA generation have not so far been identified, but at
least two hypothetical nuclease activities have been proposed
(ExoX and ExoY) (Zubko et al, 2004).
We sought to identify additional nuclease activities func-
tioning at uncapped telomeres following inactivation of
Cdc13. Bioinformatic analysis of genetic interactions found
the helicase Pif1 to be a candidate for contributing to nucle-
ase activity. Consistent with this hypothesis, we found
that Pif1 and Exo1 are required for different nuclease acti-
vities that generate ssDNA and activate the DNA damage
checkpoint following Cdc13 inactivation. Furthermore, deletion
of both PIF1 and EXO1 permits yeast cells to tolerate complete
loss of the essential telomere capping protein Cdc13.
Results
PIF1 and EXO1 define parallel pathways that inhibit
growth of cdc13-1 mutants
To identify potential nuclease(s) active in cdc13-1 mutants, we
reasoned that genes responsible for such activities would
interact with similar genes to those that EXO1 interacts with.
We used the BioGRID database to create a ranked list of genes
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Figure 1 Pif1 and Exo1 inhibit growth of cdc13-1 mutants. (A) Inactivation of Cdc13 by use of the temperature-sensitive allele cdc13-1 leads to
telomere uncapping. Exo1 and additional nuclease(s) generate ssDNA at uncapped telomeres, which is the stimulus for Mec1-dependent
checkpoint activation and cell cycle arrest. (B) Ranked diagram of genes that share genetic interactions with EXO1 and are important in the
context of telomeres. (Thicker lines mean more shared genetic interactions). (C) Strains of the genotypes shown were serially diluted across
agar plates and grown at the temperatures indicated for 3 days. In this and other figures, strain numbers (DLYs) are shown adjacent.
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that had similar genetic interactions to EXO1 (Figure 1B) (Stark
et al, 2006). Of these, 9/19 affected cdc13-1 growth or telomere
length. Deletion of EXO1 suppresses cdc13-1 growth defects,
so we focussed on those genes that also suppressed cdc13-1
growth defects. By these criteria, two previously characterized
checkpoint genes (RAD9 and RAD24) and the helicase-encod-
ing PIF1 behaved similarly to EXO1 (Figure 1B). Rad9 and
Rad24 do indeed regulate nuclease activities at uncapped
telomeres and are required for checkpoint activation (Garvik
et al, 1995; Lydall and Weinert, 1995; Zubko et al, 2004).
Pif1 has been shown to inhibit growth of cdc13-1 mutants
(Downey et al, 2006), whereas overexpression of Pif1 has been
shown to enhance growth defects seen in cdc13-1 mutants, but
the contribution of Pif1 to the nuclease activity and check-
point activation in cdc13-1 mutants had not been assessed
(Vega et al, 2007; Chang et al, 2009).
Pif1 is a helicase with both mitochondrial and nuclear
functions (Van Dyck et al, 1992; Schulz and Zakian, 1994). In
the nucleus, Pif1 has been implicated in negative regulation
of telomerase, generation of long flaps during Okazaki frag-
ment processing, unwinding of G-quadruplexes and disas-
sembly of stalled replication forks (Zhou et al, 2000; Boule
et al, 2005; Budd et al, 2006; Chang et al, 2009; George et al,
2009; Makovets and Blackburn, 2009; Pike et al, 2009;
Ribeyre et al, 2009; Zhang and Durocher, 2010). To test the
hypothesis that Pif1 contributes to a nuclease activity at
uncapped telomeres in cdc13-1 mutants, we compared the
effects of Pif1 and Exo1 on cell growth after Cdc13-1 inactiva-
tion. At the permissive temperature (231C), Cdc13-1 is func-
tional and efficiently caps the telomeres, permitting growth of
cdc13-1 mutants. At the non-permissive temperature (361C),
Cdc13-1 is completely defective and cdc13-1 mutants are
unable to grow (Figure 1A and C). At semi-permissive
temperatures (25–291C), moderate Cdc13-1 inactivation oc-
curs and growth of cdc13-1 mutants is inhibited (Figure 1C).
As previously reported, cdc13-1 pif1D and cdc13-1 exo1D
mutants are able to grow at 271C, whereas cdc13-1 mutants
are not (Figure 1C) (Zubko et al, 2004; Downey et al, 2006).
These effects on growth are consistent with the hypothesis
that Pif1, like Exo1, contributes to nuclease activity at
uncapped telomeres.
Pif1 and Exo1 inhibit growth of cdc13-1 mutants, possibly
by contributing to nuclease activity at uncapped telomeres.
To test whether the two proteins worked in the same path-
way/complex or in different pathways, we examined the
effect Pif1 on growth of cdc13-1 exo1D mutants. cdc13-1
exo1D mutants were unable to grow at 301C, whereas
cdc13-1 exo1D pif1D mutants were able to grow at 30 and
361C (Figure 1C). Remarkably, at 361C, the growth of cdc13-1
exo1D pif1D mutants was barely distinguishable from that of
CDC13þ exo1D pif1D mutants (Supplementary Figure S1A).
We confirmed that this effect was due to the pif1D and exo1D
mutations and not due to second site suppressors arising in
our strains by crossing a cdc13-1 mutant able to grow at 361C,
with a cdc13-1 strain and confirming that all cdc13-1 exo1D
pif1D progeny could all grow at 361C (Supplementary Figure
S1B). We conclude that Pif1 and Exo1 inhibit growth of
cdc13-1 mutants through different pathways, and inacti-
vation of these pathways may eliminate the requirement for
telomere capping by Cdc13.
At DSBs, parallel nuclease activities dependent upon Exo1,
the helicase Sgs1 and nuclease Dna2 generate extensive
ssDNA (Gravel et al, 2008; Mimitou and Symington, 2008;
Zhu et al, 2008). We hypothesized that, as with Exo1,
elimination of Sgs1 or Dna2 in cells lacking Pif1 might
improve the growth of cdc13-1 mutants and perhaps even
permit growth at 361C. However, we found that cdc13-1 pif1D
dna2D mutants grew less well than cdc13-1 pif1D mutants
(Supplementary Figure S2A). We were unable to examine the
effect of dna2D on the growth of cdc13-1 PIF1þ mutants, as
DNA2 is an essential gene unless PIF1 is deleted (Budd et al,
2006). We also found that cdc13-1 pif1D sgs1D mutants grew
slightly less well than cdc13-1 pif1D mutants and that cdc13-1
sgs1D mutants grew slightly less well than cdc13-1 mutants
(Supplementary Figure S2B), consistent with other work
from our laboratory (Ngo and Lydall, 2010). We conclude
that Exo1 inhibits the growth of cdc13-1 mutants with un-
capped telomeres, whereas Sgs1 and Dna2 contribute to the
vitality of such cells. Therefore, we chose to focus on the
roles of Pif1 and Exo1 at uncapped telomeres.
Elimination of Pif1 and Exo1 permits telomere
maintenance following inactivation of Cdc13
Yeast cells can overcome the requirement for Cdc13 by
altering telomere structure, as observed in rare variants,
which can be selected for after inactivation of telomerase or
after attenuation of nuclease/checkpoint activities at un-
capped telomeres (Larrivee and Wellinger, 2006; Zubko and
Lydall, 2006). To test whether elimination of Pif1 and Exo1
caused alterations in telomere structure that could explain the
growth of cdc13-1 cells at 361C, we performed Southern blots
to examine telomere structure, probing for Y0 sequences
(Figure 2B), which are components of the majority of yeast
telomeres (Supplementary Figure S3A and B). The Y0 probe
contained G-rich sequences and weakly cross-hybridized to
telomeres that did not contain Y0 sequences, so we also
probed for TG repeat sequences to detect telomeres that
lacked Y0 elements (Supplementary Figure S4).
pif1D mutants have long telomeres (Schulz and Zakian,
1994) and consistent with this, CDC13þexo1D pif1D mutants
have longer telomeres than CDC13þEXO1þPIF1þ strains
(compare lanes 1–2, 3–4 and 7–8; Figure 2B). The telomeres
of cdc13-1 exo1D pif1D mutants grown at 361C were longer
than those of CDC13þexo1D pif1D mutants grown at 231C
(compare lanes 9–10 with lanes 7–8, Figure 2B) but indis-
tinguishable from those of cdc13-1 exo1D pif1D mutants
grown at 231C (compare lanes 9–10 with lanes 17–18,
Figure 2B). This demonstrates that no gross alterations in
telomere structure occur when cdc13-1 exo1D pif1D mutants
are grown at 361C. Furthermore, cdc13-1 exo1D pif1Dmutants
are able to grow at 361C, whereas cdc13-1 pif1D mutants are
not, but are indistinguishable in telomere structure (compare
lanes 13–14 with lanes 17–18, Figure 2B). We conclude that
alterations in telomere structure most likely do not account
for the growth of cdc13-1 exo1D pif1D mutants at 361C.
Pif1 exists as both nuclear and mitochondrial isoforms
(Schulz and Zakian, 1994). Therefore, we wanted to know
whether the nuclear or mitochondrial function of Pif1 inhibited
growth of cdc13-1 exo1D mutants at 361C. The pif1-m2 allele,
lacking nuclear Pif1, permitted growth of cdc13-1 exo1D
mutants at 361C, whereas the pif1-m1 allele, lacking mitochon-
drial Pif1, did not (Figure 2C). We note that the growth of
cdc13-1 exo1D pif1-m2 mutants at 361C is less than cdc13-1
exo1D pif1D mutants (Figure 2C). This is consistent with other
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reports that low levels of nuclear Pif1 activity persist in pif1-m2
mutants (Schulz and Zakian, 1994; Ribeyre et al, 2009). We
also confirmed that helicase activity of Pif1 inhibited growth of
cdc13-1 exo1D mutants because the pif1-hd allele, deficient
in helicase activity, also permitted growth at 361C (Figure 2C)
(Zhou et al, 2000; Ribeyre et al, 2009). We conclude that
nuclear, helicase-dependent activity of Pif1 inhibits growth of
telomere capping-defective cdc13-1 mutants.
Pif1- and Exo1-dependent nucleases initiate the DDR
following Cdc13 inactivation
Upon Cdc13 inactivation, nuclease activities generate ssDNA,
which stimulates checkpoint kinase cascades and induces
metaphase arrest (Figure 1A) (Garvik et al, 1995). To test the
role of Pif1 in cell cycle arrest, cdc13-1 mutants were syn-
chronized in G1 using a factor at 231C, then released to 361C
to assess metaphase arrest (Figure 3A). All strains also
harboured the cdc15-2 mutation so that any cells that over-
came cdc13-1-induced metaphase arrest would arrest in late
anaphase due to cdc15-2 and be unable to enter another cell
cycle (Figure 3A) (Lydall and Weinert, 1995; Zubko et al,
2004). As expected, cdc13-1 mutants accumulated at meta-
phase and did not pass through to anaphase (Figure 3B and C).
cdc13-1 exo1D mutants accumulated at metaphase with simi-
lar kinetics to cdc13-1 mutants but, as previously reported,
a subpopulation of cdc13-1 exo1D cells escaped metaphase
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arrest and accumulated in late anaphase due to the cdc15-2
mutation (Figure 3B and C) (Zubko et al, 2004). cdc13-1 pif1D
mutants behaved like cdc13-1 mutants and did not pass
through to anaphase (Figure 3B and C). Interestingly, cdc13-
1 exo1D pif1Dmutants did not accumulate in metaphase at all
and passed readily through to anaphase (Figure 3B and C).
Taken together, these results show that Pif1 has no effect on
metaphase arrest of cdc13-1 mutants at 361C when Exo1 is
present, but it is responsible for the arrest of a subpopulation
of cells when Exo1 is absent.
Following inactivation of Cdc13, Mec1-dependent check-
point activation occurs, leading to activation and hyperphos-
phorylaiton of the kinase Rad53 (Figure 1A) (Sweeney
et al, 2005; Morin et al, 2008). We used the synchronous
cultures to examine Rad53 phosphorylation by western blot
(Figure 3A). cdc13-1 and cdc13-1 pif1D mutants exhibited
strong Rad53 phosphorylation, indicated by a marked
upward mobility shift of Rad53 (upper panels, Figure 3D).
A reduction in Rad53 phosphorylation was seen in cdc13-1
exo1Dmutants, correlating with the recovery from metaphase
arrest displayed by cdc13-1 exo1Dmutants following telomere
uncapping (Figure 3C and D). Interestingly, no discernable
change in the mobility of Rad53 could be seen in cdc13-1
exo1D pif1D mutants, consistent with their complete
failure to arrest cell division at 361C (Figure 3C and D). We
conclude that in the absence of Pif1 and Exo1, the checkpoint
kinase Rad53 is not activated after telomere uncapping in
cdc13-1 mutants.
To see whether cdc13-1 exo1D pif1D strains were defective
in the DDR after other types of DNA damage as well as after
telomere uncapping, we treated cells with bleomycin to
induce DSBs. At both DSBs and uncapped telomeres,
ssDNA is an important stimulus for the Mec1-dependent
checkpoint. We treated the same set of strains examined in
Figure 3B–D, with bleomycin at 231C after release from G1
arrest. cdc13-1, cdc13-1 pif1D, cdc13-1 exo1D and cdc13-1
exo1D pif1D mutants all behaved similarly, phosphorylating
Rad53 and arresting at methaphase (Figure 3E;
Supplementary Figure S4). We conclude that a functional
DDR pathway operates in (cdc13-1) exo1D pif1D cells but that
these cells are specifically defective in responding to telomere
uncapping.
Telomeric ssDNA stimulates metaphase arrest following
telomere uncapping (Garvik et al, 1995). We used synchro-
nous cultures (Figure 3A) and quantitative amplification
of ssDNA (QAOS) to measure subtelomeric ssDNA in repeti-
tive Y0 elements (present on Chromosome V and most other
chromosome ends) following Cdc13 inactivation (Figure 4A)
(Booth et al, 2001). cdc13-1 mutants with uncapped telo-
meres generated ssDNA at both the Y0600 and Y05000 loci
(Figure 4B and C). cdc13-1 exo1D mutants generated
less ssDNA following telomere uncapping at the Y0 loci, as
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previously reported (Maringele and Lydall, 2002; Zubko et al,
2004). Interestingly, cdc13-1 pif1D mutants, like cdc13-1
exo1D mutants showed reduced ssDNA generation in the
Y0600 and Y05000 loci following telomere uncapping.
Furthermore, cdc13-1 exo1D pif1D mutants generated no
detectable ssDNA at Y0600 or Y05000 loci following telomere
uncapping (Figure 4B and C). We confirmed that ssDNA
generation occurred on the TG (30) strand due to degradation
of the AC (50) strand, as we were unable to detect ssDNA
on the AC strand (Figure 4D). We conclude that Pif1, like
Exo1, is important for ssDNA generation after telomere
uncapping in cdc13-1 mutants and appears to regulate a
nuclease activity, which functions in parallel to Exo1 at
chromosome ends.
To examine how Pif1 and Exo1 affect ssDNA accumulation
further from chromosome ends, we measured ssDNA at single-
copy loci on Chromosome V after Cdc13 inactivation. At 4 h,
cdc13-1 mutants generated ssDNA at all loci examined, with
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the amount of ssDNA decreasing at loci further from the
chromosome end, as previously reported (Zubko et al,
2004). cdc13-1 exo1D mutants generated less ssDNA in the Y0
repeats and no ssDNA in single-copy loci on Chromosome V,
also as previously reported (Figure 4E) (Zubko et al, 2004).
cdc13-1 pif1D mutants generated similar amounts of ssDNA to
cdc13-1 exo1D mutants in the Y0 repeats. However, at more
distal, single-copy loci, cdc13-1 pif1D mutants generated less
ssDNA than cdc13-1 mutants but more than exo1D cdc13-1
mutants. The higher levels of ssDNA generated further from
the chromosome end in cdc13-1 pif1D mutants, in comparison
with cdc13-1 exo1D mutants, most likely accounts for their
sustained metaphase arrest following telomere uncapping
(Figure 3B and C). Furthermore, the ssDNA generated by
cdc13-1 and cdc13-1 pif1D mutants o10 kb from the chromo-
some end is 41.6% (1/64) (Figure 4E). Assuming 1 single-
stranded telomere per cell is sufficient to stimulate arrest, this
suggests that ssDNA extending o10 kb on one of the 64 G2
telomeres in Saccharomyces cerevisiae is sufficient to stimulate
metaphase arrest (Figure 4E) (Sandell and Zakian, 1993; Vaze
et al, 2002; Zubko et al, 2004).
No checkpoint activation was detected in cdc13-1 exo1D
pif1D mutants following telomere uncapping, and no ssDNA
was detected in the Y0 elements (Figures 3D and 4B). However,
yku70D mutants at 231C have detectable ssDNA in the telo-
meric TG repeats but do not undergo checkpoint activation
(Gravel et al, 1998; Polotnianka et al, 1998; Maringele and
Lydall, 2002). Thus, we hypothesized that cdc13-1 exo1D
pif1D mutants might still generate detectable ssDNA in the
TG repeats. We used synchronous cultures (Figure 3A) and
measured ssDNA by in-gel assay to measure ssDNA in the TG
repeats in cdc13-1 mutants (Figure 4F and G). cdc13-1 mutants
generated large amounts of TG ssDNA at 2 and 4 h following
telomere uncapping (Figure 4F), corresponding to an approxi-
mately five-fold increase in signal compared with yku70D
mutants (Figure 4G). cdc13-1 exo1D pif1D mutants also gen-
erated detectable ssDNA 2 h following telomere uncapping,
but at a level approximately equal to that of a yku70D mutant
(Figure 4F and G). However, the ssDNA generated in cdc13-1
exo1D pif1D mutants was transient and was no longer detect-
able 4 h after telomere uncapping (Figure 4F and G).
Surprisingly, cdc13-1 pif1D mutants displayed only a modest
decrease in ssDNA generation in the TG repeats following
telomere uncapping, whereas cdc13-1 exo1D mutants gener-
ated very little ssDNA (Figure 4F and G). We conclude that
cdc13-1 exo1D pif1D mutants generate limited, transient
ssDNA that is insufficient to stimulate checkpoint activation
and that Exo1 is much more important than Pif1 for ssDNA
generation in the TG repeats following telomere uncapping.
Pif1 has important functions in cells lacking telomerase
It has been suggested that increased levels of telomerase at
the telomeres of cdc13-1 pif1D cells shields uncapped telo-
meres from nuclease activities (Vega et al, 2007). However,
this is somewhat inconsistent with our observation that Pif1
has relatively little effect on ssDNA generation in the telo-
meric TG repeats, where telomerase presumably binds
(Figure 4G). Therefore, we wanted to know whether the
ability of the pif1D mutation to improve the growth of
cdc13-1 mutants was dependent upon the telomerase tem-
plate component (TLC1) or catalytic subunit (Est2).
Interestingly, we found that cdc13-1 tlc1D pif1D and cdc13-1
tlc1D exo1D mutants grew better at 251C than cdc13-1 tlc1D
mutants (compare rows 7–8 and 11–12 with 3–4, Figure 5A;
Supplementary Figure S6). We also found that cdc13-1
est2D pif1D and cdc13-1 est2D exo1D mutants were able to
grow at 251C, whereas cdc13-1 est2D mutants were not
(Supplementary Figure S7). We conclude that Pif1 has a
telomerase (TLC1, Est2) independent effect at uncapped
telomeres. However, we note that est2D cdc13-1 and tlc1D
cdc13-1 mutants grow worse than cdc13-1 mutants, demon-
strating that telomerase contributes to telomere capping
following inactivation of Cdc13.
Pif1 is responsible for the residual checkpoint activation in
cdc13-1 exo1D mutants (Figure 3D) and inhibits growth of
cdc13-1 mutants lacking telomerase (Figure 5A). We hypothe-
sized that Pif1 would contribute to ssDNA generation at
uncapped telomeres and subsequent checkpoint activation,
even in cdc13-1 mutants lacking telomerase. To test this, we
measured Rad53 phosphorylation (Supplementary Figure
S8A) and telomeric TG repeat ssDNA (Supplementary
Figure S8B and C) in cdc13-1 and cdc13-1 tlc1D mutants,
before and after telomere uncapping. In cdc13-1 tlc1D exo1D
pif1D mutants, there was a decrease in Rad53 phosphoryla-
tion compared with cdc13-1 tlc1D exo1D mutants
(Supplementary Figure S8A). We also found that cdc13-1
tlc1D pif1D and cdc13-1 tlc1D exo1D pif1D mutants generated
less ssDNA than cdc13-1 tlc1D and cdc13-1 tlc1D exo1D
mutants, respectively, following telomere uncapping
(Supplementary Figure S8B and C). We conclude that Pif1
has a contribution to ssDNA generation and checkpoint
activation following telomere uncapping that is independent
of telomerase. However, we note that 40% of cdc13-1 tlc1D
cells were at metaphase at 231C compared with 30% of
cdc13-1 tlc1D pif1D cells (Supplementary Figure S8D). Thus,
we cannot exclude the possibility that reduced ssDNA gen-
eration in cdc13-1 tlc1D pif1D mutants is due to altered
kinetics of accumulation at metaphase.
Although Pif1 clearly demonstrates a telomerase-indepen-
dent effect in cdc13-1 mutants, we note that cdc13-1 tlc1D
exo1D mutants could grow at 271C, whereas cdc13-1 tlc1D
pif1D mutants could not (compare rows 11–12 with 7–8,
Figure 5A). In contrast, cdc13-1 TLC1þexo1D mutants and
cdc13-1 TLC1þpif1D mutants could both grow similarly at
271C (compare rows 9–10 with 5–6, Figure 5A). This shows
that Pif1 is less potent than Exo1 at inhibiting growth of
cdc13-1 tlc1D mutants than cdc13-1 TLC1þ mutants.
To help clarify the role of Pif1 in cdc13-1 tlc1D and cdc13-1
TLC1þ mutants, we examined the effect of Pif1 in CDC13þ
tlc1D mutants. Yeast strains that cannot recruit telomerase
(e.g. tlc1D) lose telomeric DNA with each cell division until
the cultures senesce and lose proliferative capacity, much like
mammalian fibroblasts. Senescent, telomerase-deficient
yeast cultures usually recover, using telomerase-independent,
recombination-dependent mechanisms of telomere mainte-
nance, leading to clear changes in telomere structure
(Lundblad and Blackburn, 1993; Teng and Zakian, 1999).
Therefore, we germinated spores containing combinations
of null mutations in telomerase (TLC1), PIF1 and EXO1,
and assessed growth at various passages (Figure 5B). As
expected, tlc1D mutants grew well at passage 1, poorly from
passages 2–5 (senescence) and grew well again from passage
7 (recovery) (Figure 5B). tlc1D exo1D mutants showed a
similar pattern of growth to tlc1D mutants but grew slightly
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better prior to senescence, as previously reported (passages 3
and 4, Figure 5B) (Maringele and Lydall, 2004). In contrast,
tlc1D pif1D and tlc1D pif1D exo1D strains showed a rapid
decline in growth from passages 2–6 (senescence) and
exhibited a protracted senescence period but slowly recovered
by passage 15 (Figure 5B). We conclude that Pif1 inhibits
entry into senescence and promotes recovery. Taken with the
data discussed earlier, Pif1 contributes to good growth of tlc1D
mutants from passage 2 onwards, yet inhibits growth of
cdc13-1 mutants (Figures 1C and 5A). In contrast, Exo1 has
only a small effect on the growth of tlc1D mutants, yet inhibits
growth of cdc13-1 mutants (Figures 1C and 5A). Thus, it is
likely that the relatively poor growth of cdc13-1 tlc1D
pif1D compared with cdc13-1 tlc1D exo1D mutants is due to
the poor growth of tlc1D pif1D mutants compared with tlc1D
exo1D mutants.
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Figure 5 Pif1 has telomerase-independent effects at telomeres. (A) A cdc13-1/CDC13þ tlc1D/TLC1þexo1D/EXO1þpif1D/PIF1þ diploid
(DLY1628 x DLY5324) was sporulated, dissected and germinated at 231C to generate strains of the indicated genotype at 231C. These were
taken from the germination plate, grown to saturation, then serially diluted across agar plates and grown at the temperatures indicated for 3
days. (B) Strains of the genotypes indicated were passaged repeatedly by restreaking at 301C for 3 days along with TLC1þ controls. At the
passages indicated, strains were assayed for growth, which was then quantified (Supplementary Figure S9). Growth at each passage is given as
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Pif1 and Exo1 resect uncapped telomeres
JM Dewar and D Lydall
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 23 | 2010 4027
After long cultivation (passage 15, 45 days growth) tlc1D
pif1D and tlc1D pif1D exo1D mutants could be distinguished
from those of tlc1D and tlc1D exo1D mutants by their poor
growth (Figure 5B). Telomerase-deficient survivors typically
show clear alterations in telomere structure—type I survivors
undergo dramatic amplification of Y0 elements and retain
short TG overhangs, whereas type II survivors show modest
amplification of Y0 elements but amplify their TG overhangs
(Teng and Zakian, 1999). Therefore, we examined the telo-
meres of tlc1D pif1D and tlc1D pif1D exo1D mutants. At
passage 1, before entry into senescence, tlc1D, tlc1D exo1D,
tlc1D pif1D and tlc1D pif1D exo1D mutants all had short
telomeres (compare lanes 1–4 with lanes 5–12, Figure 5C).
At passage 15, tlc1D mutants and tlc1D exo1D mutants had
amplified Y0 elements and terminal fragments to generate
type II (lanes 17–18, Figure 5D) or type I (lanes 21–22,
Figure 5D) survivors. In contrast, tlc1D pif1D and tlc1D
pif1D exo1D mutants at passage 15 had shorter telomeres
than at passage 1 and had undergone a reduction in Y0
elements, but did not appear to have generated type I or
type II survivor telomere structures (compare lanes 7–8 with
19–20 and lanes 11–12 with 23–24, Figure 5D). We noted that
tlc1D pif1D and tlc1D pif1D exo1D mutants resembled type I
survivors in that our TG probe did not detect any individual
telomeres further up the gel (marked with arrows, compare
lanes 7–8 with 19–20 and lanes 11–12 with 23–24,
Supplementary Figure S10), indicating that all telomeres in
these strains had acquired a terminal Y0 fragment. However,
the terminal fragments of tlc1D pif1D and tlc1D pif1D exo1D
were even shorter than those of type I survivors and they had
undergone a reduction, not an amplification in Y0 elements,
clearly distinguishing them from typical type I survivors
(compares lanes 19–20, 23–24 with lanes 21–22, Figure 5D).
We conclude that Pif1 is required for the generation of type I
and type II survivors and that in the absence of Pif1, cells
lacking telomerase can improve growth following senescence
without adopting typical type I or type II survivor structures.
Telomerase is crucial for survival in the absence
of Cdc13
Cdc13 has two crucial functions at telomeres—one, to shield
telomeres from nuclease activities and the second to recruit
telomerase to the telomere (Nugent et al, 1996). Although
elimination of Pif1 and Exo1 permits cdc13-1 mutants to grow
at 361C (presumably when cdc13-1 is completely inactivated),
this does not permit cdc13-1 tlc1D mutants to grow at 361C
(compare rows 13–14 with 15–16, Figure 5A), demonstrating
that telomerase has a function in cdc13-1 mutants at 361C.
Therefore, we hypothesized that at 361C, Cdc13-1 might
retain the ability to recruit telomerase, and Cdc13-dependent
telomerase activity might be essential for growth.
Alternatively, telomerase might be recruited to telomeres in
a Cdc13-independent manner.
To test whether Cdc13-1 retained the ability to recruit
telomerase in cdc13-1 exo1D pif1D cells at 361C, we decided
to delete CDC13. We generated diploid strains heterozygous
for pif1D, exo1D and cdc13D mutations. Diploids were sporu-
lated, tetrads dissected and vegetative cells containing com-
binations of the three deletion mutations were allowed to
form colonies. Figure 6A shows a representative image of one
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tetrad dissection plate. Importantly, we found that cdc13D
exo1D pif1D strains were viable and had a germination
efficiency of B90% compared with CDC13 exo1D pif1D
strains (Figure 6A; Supplementary Table SI). However, it
was clear that cdc13D exo1D pif1D mutants grew less well
than CDC13þexo1D pif1D mutants on the tetrad dissection
plates (Figure 6A). No viable colonies were formed from
cdc13D cells that were either PIF1þ or EXO1þ . We conclude
that neither Cdc13-dependent telomerase activity nor
Cdc13-dependent capping activities are required for growth
following elimination of Pif1 and Exo1.
The viability of cdc13D exo1D pif1D strains was surprising
in the light of the requirement for telomerase in cdc13-1
exo1D pif1D strains. We hypothesized that Cdc13-indepen-
dent telomerase activity was essential for the viability of
cdc13D exo1D pif1D strains. To test this, we generated diploid
strains heterozygous for pif1D, exo1D, cdc13D and tlc1D
mutations, containing a plasmid that carried a wild-type
copy of CDC13. Diploids were sporulated and tetrad dissec-
tion was performed to generate strains containing combina-
tions of the four deletion mutations, in addition to the wild-
type copy of CDC13. These strains were diluted across agar
plates either fully supplemented (YEPD), lacking uracil
(URA) or containing FOA (FOA). FOA is toxic to cells with
an active uracil biosynthetic pathway so only cells able to
survive in the absence of the URA3- and CDC13-containing
plasmid would be able to grow. As expected, cdc13D TLC1þ
and cdc13D tlc1D mutants were able to grow on YEPD and
–URA, but not on FOA medium, demonstrating that CDC13
was essential for survival of these cell types (Figure 6B).
cdc13D TLC1þexo1D pif1D strains were able to grow on
FOA, YEPD and –URA, demonstrating that CDC13 was not
essential in this background (Figure 6B). However, cdc13D
TLC1þexo1D pif1D cells grew much more poorly on FOA
than on –URA and YEPD consistent the poor growth of
cdc13D exo1D pif1D cells on the tetrad dissection plate(s)
(Figure 6A). Importantly, cdc13D tlc1D exo1D pif1D cells were
able to grow on YEPD and –URA but not on FOA, demon-
strating that they could not survive in the absence of
Cdc13. We conclude that telomerase is essential for the
survival of cdc13D exo1D pif1D mutants, suggesting that
Cdc13-independent recruitment of telomerase is essential
for their survival.
We used the same plasmid-based method to assess the
requirement for various proteins involved in telomere main-
tenance to the growth of cdc13D exo1D pif1D mutants. We
confirmed that TLC1 was required for the viability of cdc13D
pif1D exo1D as cdc13D pif1D exo1D tlc1D mutants could not
lose a plasmid carrying CDC13 (p[URA3]CDC13) (Figure 6C).
We also found that Yku70 (a component of the Ku complex,
which binds TLC1 to aid in recruitment of telomerase to the
telomere) and Rad52 (required for homologous recombina-
tion and the generation of type I and type II survivor telomere
structures) were required for the viability of cdc13D pif1D
exo1D mutants (Figure 6C). However, we found that Pol32
(subunit of Polymerase d, required for the generation of
type I and type II survivor telomere structures) was dispen-
sable for the viability of cdc13D pif1D exo1D mutants
(Figure 6C), although elimination of Pol32 did reduce the
frequency at which cdc13D pif1D exo1D mutants were able to
lose the pURA3[CDC13] (Supplementary Figure S12). We
conclude that cdc13D pif1D exo1D mutants are distinct
from type I and type II survivors, as they do not require
Pol32, and their telomeres are maintained through a combi-
nation of homologous recombination, Ku and telomerase
activity.
If cdc13D exo1D pif1D mutants are able to recruit telomer-
ase then they may not senesce or undergo the rearrangements
in telomere structure characteristic of telomerase-deficient
strains. To test this hypothesis, we compared the growth
and telomere structure of cdc13D exo1D pif1D strains with
tlc1D and tlc1D exo1D pif1D strains. As expected, telomerase-
deficient tlc1D mutants senesced and recovered (Figure 7A)
and by passage 11 they had generated type I (lane 15,
Figure 7B) and type II (lane 16, Figure 7B) survivors.
Interestingly, cdc13D exo1D pif1D strains showed a slight
growth defect at passage 1 (Figure 7A), consistent with the
small colonies formed by cdc13D exo1D pif1D mutants on the
tetrad dissection plate (Figure 6A) and the growth defect of
cdc13D TLC1þexo1D pif1D pURA3[CDC13] mutants grown
on FOA (Figure 6B). However, by passage 5 and in
all subsequent passages cdc13D exo1D pif1D mutants had
improved in growth (Figure 7A). The telomeres of cdc13D
exo1D pif1D mutants were long with more variation in length,
and by passage 11, the median telomere length and variance
in length increased (lanes 9–12, 21–24, Figure 7B). This is
consistent with previous work showing that hypomorphic
alleles of Cdc13 can cause increased telomere length and
variance in telomere length (Chandra et al, 2001). No clear
alterations in the telomere structure of cdc13D exo1D pif1D
mutants were observed, and at passage 1, their telomeres
most closely resembled those of cdc13-1 exo1D pif1D mutants
with capped telomeres, which notably do not senesce (com-
pare lanes 2, 14 with lanes 9–12, Figure 7B). The growth and
telomere structure of cdc13D exo1D pif1Dmutants was clearly
distinct from that of telomerase-deficient tlc1D exo1D pif1D
mutants, which rapidly senesced and slowly recovered
(Figure 7A), while maintaining a relatively normal telomere
structure (compare lanes 7–8 with lanes 19–20, Figure 7B).
We conclude that cdc13D exo1D pif1D mutants do not under-
go senescence and maintain their telomeres for at least 11
passages (44 days). This is consistent with our notion that
cdc13D exo1D pif1D mutants are able to maintain telomeres
in a telomerase-dependent manner, even in the absence
of Cdc13.
Finally, although we observed that cdc13-1 exo1D
pif1D mutants generated ssDNA only in the TG repeats,
transiently over the course of a single cell cycle, we wished
to know whether repeated cell division in the absence of
telomere capping would lead to accumulation of ssDNA. By
in-gel assay, we found that cdc13-1 exo1D pif1D mutants
grown at 361C for 4 h (B2 population doublings with un-
capped telomeres) and cdc13D exo1D pif1D mutants
from Passage 1 (B50 population doublings with uncapped
telomeres) generated comparable levels of ssDNA in the
TG repeats to a yku70D mutant (Figure 7C and D).
This was comparable to the transient level of ssDNA seen
in cdc13-1 exo1D pif1D mutants 2 h after telomere uncapping,
within a single cell cycle (Figure 4G). We conclude
that continued growth following telomere uncapping in
exo1D pif1D mutants does not lead to ssDNA accumulation.
This suggests that no residual nuclease activities continue
to resect uncapped telomeres in the absence of Pif1
and Exo1.
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Discussion
We have shown that Pif1 and Exo1 are responsible for
extensive ssDNA generation at uncapped telomeres in
cdc13-1 mutants and also that Pif1 has telomerase-indepen-
dent functions at telomeres. This leads us to propose a model
where Pif1 can initiate the DDR at uncapped telomeres by
controlling nuclease activity. Furthermore, and remarkably,
cells lacking Pif1 and Exo1 are viable and grow well in the
absence of the usually essential telomere capping protein
Cdc13.
In our model (Figure 8), Pif1 unwinds telomeric duplex
DNA, generating ssDNA that is cleaved by an unidentified
ssDNA endonuclease in a manner analogous to the function
of Pif1 in Okazaki fragment processing and at stalled replica-
tion forks (Budd et al, 2006; Chang et al, 2009; George et al,
2009; Pike et al, 2009). We propose that close to the chromo-
some end (o5 kb) both Pif1- and Exo1-dependent activities
generate ssDNA, causing weak initial checkpoint activation.
We propose that Exo1 subsequently generates ssDNA 45 kb
from the chromosome end, leading to stronger checkpoint
activation that is sufficient to arrest all cells with uncapped
telomeres. Our model is consistent with Pif1 being ExoY, a
hypothetical nuclease proposed to function in parallel to Exo1
at uncapped telomeres (Zubko et al, 2004). Pif1, like ExoY, is
more important for ssDNA generation at the end of the
chromosome than further away (Figure 4E).
In our model, Exo1 recognizes the junction between 30
(TG) ssDNA and duplex DNA, at native telomeric overhangs
as previously suggested (Maringele and Lydall, 2002) or at
stalled replication forks (Segurado and Diffley, 2008). We
propose that Pif1 binds and unwinds 50 (AC) overhangs
because Pif1 is a 50–30 helicase (Lahaye et al, 1991; Zhou
et al, 2000; Pike et al, 2009). If Pif1 does engage telomeric
dsDNA and convert it to ssDNA, 50 (AC) ssDNA presumably
exists (Supplementary Figure S15A). Interestingly, 50 telo-
meric ssDNA has been observed both in mammalian cells
and in Caenorhabditis elegans (Cimino-Reale et al, 2003;
Raices et al, 2008) and but not so far in S. cerevisiae.
However, 50 ssDNA overhangs could in principle occur at
stalled replication fork structures (Supplementary Figure
S15B) or Okazaki fragments.
DSBs that can be repaired by homologous recombination
and DSB-induced shortened telomeres are processed by
nucleases dependent upon Sgs1/Dna2, Exo1 and MRX/Sae2
(Gravel et al, 2008; Zhu et al, 2008; Mimitou and Symington,
2009). Other work recently published from our laboratory
demonstrates that Sgs1 also contributes to resection of
uncapped telomeres, but elimination of Sgs1 and Exo1 is
insufficient to prevent the resection of uncapped telomeres
in cdc13-1 mutants (Ngo and Lydall, 2010). The work pres-
ented here demonstrates that elimination of Pif1 and Exo1
prevents resection of uncapped telomeres in cdc13-1 mutants.
However, at DSBs that can be repaired by homologous
recombination or at DSB-induced shortened telomeres, Pif1
has little effect on resection (Zhu et al, 2008; Bonetti et al,
2009). Interestingly, Pif1 has been shown to have a critical
role repair of DSBs where break-induced replication (BIR)
is the main repair pathway (Chung et al, 2010). A major
challenge will be to determine which substrates are exposed
at DSBs, shortened telomeres and uncapped telomeres and
how nuclease activities are coordinated to process them.
Pif1 contributes to the vitality of cells lacking telomerase,
both before and after recovery from senescence (Figure 5B).
Interestingly, pif1D cells improve their growth following
senescence without adopting typical survivor-like telomeric
DNA structures (Figure 5C). Usually following senescence,
survivors are generated by homologous-recombination- and
BIR-dependent alterations in telomere structure (Teng and
Zakian, 1999; Lydeard et al, 2007). If BIR is eliminated, cells
lacking telomerase senesce and undergo a complete loss in
viability (Lydeard et al, 2007). The relatively unaltered
telomere structure and poor growth following senescence in
cells lacking Pif1 and telomerase is consistent with the
impaired BIR seen in cells lacking Pif1 (Chung et al, 2010).
Therefore, reduced BIR in pif1D cells may be sufficient to
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maintain comparatively normal telomere structure in telo-
merase-deficient cells but insufficient to permit the typical
amplification of Y0 elements or terminal TG repeats seen in
survivors. The absence of telomeric repeat amplification
could prevent these cells from achieving the high levels of
post-senescence growth seen in other telomerase-deficient
mutants.
We have demonstrated that attenuation of the DDR at
uncapped telomeres, by elimination of Pif1 and Exo1 permits
telomere maintenance in a Cdc13-indpendent but telomerase
and Ku-dependent manner. This is surprising because Cdc13
is considered crucial for efficient recruitment of telomerase
and thus to prevent senescence (Nugent et al, 1996). We
propose that in the absence of Cdc13, Yku80 binds TLC1, the
telomerase RNA, to help recruit telomerase to the telomere
(Peterson et al, 2001). The requirement for Rad52 for the
survival of cdc13D exo1D pif1D mutants is surprising. It will
be interesting to investigate whether telomeric repeats from
extremely long telomeres in cdc13D exo1D pif1D mutants
(Figure 7B) can be distributed to shorter telomeres by homo-
logous recombination, thus preventing short telomeres from
becoming critically short. Finally, it will also be paramount to
determine whether the requirement for telomerase in cdc13D
exo1D pif1D mutants is a consequence of the increased
utilization of telomerase that has been reported at the telo-
meres of cells lacking Pif1 (Boule et al, 2005).
We show that following inactivation of Cdc13 or telomer-
ase, telomeric DNA can be stabilized by elimination of Pif1,
eliminating resection of uncapped telomeres in cells lacking
Cdc13 or permitting telomere maintenance without the gen-
eration of typical type I or type II survivor structures in cells
lacking telomerase. As Pif1 and Exo1 are conserved from
yeast, to mice, to humans, Pif1 might also contribute to
the premature mortality caused by telomere dysfunction in
telomerase knockout mice (Lahaye et al, 1991; Huang and
Symington, 1993; Wei et al, 2003; Mateyak and Zakian, 2006;
Snow et al, 2007). pif1/ and exo1/ mice have previously
been examined (Wei et al, 2003; Snow et al, 2007), and
it might be interesting to combine these mutations in a
telomerase knockout background to investigate the conse-
quences of telomere dysfunction in pif1/ exo1/ mice, as
EXO1 contributes to the telomere dysfunction and premature
mortality seen in telomerase knockout mice (Schaetzlein
et al, 2007).
Materials and methods
Bioinformatics/analysis
A genetic interaction network was created in Cytoscape using
S. cerevisiae genetic interactions from BioGRID (v2.0.53) (Stark
et al, 2006; Cline et al, 2007). Genes that had genetic interactions
with EXO1 were identified (first neighbours of EXO1). A ranked list
of all known genes was created, according to how many of the first
neighbours of EXO1 they had a genetic interaction with. The top
10% of this ranked list were then shown. Nodes for each gene were
coloured according to whether the genes affected cdc13-1 growth
defects or telomere length (Askree et al, 2004; Zubko et al, 2004;
Downey et al, 2006; Gatbonton et al, 2006; Tsolou and Lydall, 2007;
Addinall et al, 2008; Ungar et al, 2009).
Yeast strains
All strains used in this study are RAD5þ and in the W303 genetic
background (Strain Table, Supplementary data). Standard genetic
procedures of transformation and tetrad analysis were used. New
gene deletions were constructed by transforming a diploid with
PCR-based deletion modules (Goldstein and McCusker, 1999). Point
mutations were generated integrated into the genome as described
(Schulz and Zakian, 1994; Ribeyre et al, 2009).
Yeast growth assays
Growth assays were performed as previously described (Zubko
et al, 2004). Pooled colonies were inoculated into 2 ml of YEPD and
grown to saturation at 231C. Five-fold serial dilutions were
replicated onto agar plates and grown at a range of temperatures.
Plates were photographed using an SPimager (S&P Robotics).
Levels were adjusted with Photoshop CS4.
Passage experiments and quantification of growth
To passage cultures, multiple individual colonies were pooled and
restruck. Where growth was quantified, unmodified images were
analysed with Colonyzer (Lawless et al, 2010) and the sum of the
trimmed greyscale pixel values for all pixels corresponding to spots
and colonies of each strain were used as a measure of growth.
Growth was then expressed relative to a TLC1þ or TLC1þ CDC13þ
strain included on the same plate.
Telomere length detection
Southern hybridization to examine telomere length and structure
was performed similarly to previously described (Maringele and
Lydall, 2004). Genomic DNA was extracted, digested with XhoI then
run overnight on a 1% agarose gel at 1 V/cm. Southern transfer and
detection was then performed using DIG-High Prime Labelling and
Detection Kit (Roche) as per the manufacturer’s instructions and
visualized on a FUJI LAS4000. Telomeric probes were synthesized
using PCR DIG Probe Synthesis Kit (Roche). TG probe wasB180 bp
of TG repeats, whereas Y0 probe was B820 bp of Y0 sequence, both
amplified from pDL987 (pHT128) (Tsubouchi and Ogawa, 2000)
using oligos m933 and m934 or m935 and m936, respectively.
CDC15 probe was synthesized using oligos m1045 and m1046 as
previously described (Foster et al, 2006).
Synchronous cultures, cell cycle scoring and QAOS
Experiments to measure cell cycle progression and ssDNA following
telomere uncapping were carried out in bar1D cdc15-2 cdc13-1 cells
and performed as described (Zubko et al, 2006). Where indicated,
cells were treated with Bleomycin at a final concentration of
50mg/ml (Morin et al, 2008).
Rad53 phosphorylation
Western blotting to detect Rad53 phosphorylation was performed
essentially as described (Morin et al, 2008). Antibodies against
Rad53 were from Dan Durocher, Toronto. Anti-tubulin antibodies
were from Keith Gull, Oxford. Multiple gels were run to process all
samples from a single experiment, but were transferred and
detected in parallel and imaged simultaneously.
In-gel assay
In-gel assays were performed essentially as previously described
(Zubko and Lydall, 2006) using a Cy5-labelled oligonucleotide
(m2188) detected on a GE Healthcare Typhoon Trio imager.
Following detection of ssDNA, the gel was subjected to Southern
transfer and hybridization to detect CDC15. To quantify ssDNA, the
fluorescent signal from the 0.7 to 12 kb range on the gel was
measured, relative to the intensity of an exponentially dividing
yku70D mutant on the same gel. All values were then normalized
relative to the CDC15 signal as determined by Southern blot.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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